DYSBIOSIS

1. Dysbiosis
2. Clinical applications of urinary organic acids. Part 2. Dysbiosis markers
3. Mechanisms of microbe–host interaction in Crohn’s disease: dysbiosis vs. pathobiont selection
4. Dysbiosis and the immune system
5. Administration of probiotic mixture DM# 1 ameliorated 5-fluorouracil–induced intestinal mucositis and dysbiosis in rats
6. Paneth cell defects in Crohn’s disease patients promote dysbiosis
7. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
8. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
9. Current understanding of dysbiosis in disease in human and animal models
10. Defining dysbiosis and its influence on host immunity and disease
11. Dysbiosis of the gut microbiota in disease
12. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
13. Antibiotics, pediatric dysbiosis, and disease
14. Proteobacteria: microbial signature of dysbiosis in gut microbiota
15. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
16. Mechanisms and consequences of intestinal dysbiosis
17. Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication
18. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
19. Dysbiosis in inflammatory bowel disease
20. Gut dysbiosis is linked to hypertension
21. Fungal microbiota dysbiosis in IBD
22. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology
23. Gut microbiota dysbiosis contributes to the development of hypertension
24. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
25. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease
26. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism
27. The causes of intestinal dysbiosis: a review
28. Microbial dysbiosis in colorectal cancer (CRC) patients
29. Microbiota dysbiosis controls the neuroinflammatory response after stroke
30. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of …
31. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis
32. Enteric dysbiosis associated with a mouse model of alcoholic liver disease
33. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
34. Fungal dysbiosis: immunity and interactions at mucosal barriers
35. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
36. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis
37. Dysbiosis and its discontents
38. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine
39. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
40. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis
41. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis
42. Intestinal dysbiosis associated with systemic lupus erythematosus
43. Microbial dysbiosis is associated with human breast cancer
44. Mechanisms of inflammation-driven bacterial dysbiosis in the gut
45. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction
46. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
47. Intestinal dysbiosis: a possible mechanism of alcohol‐induced endotoxemia and alcoholic steatohepatitis in rats
48. Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases
49. Gut microbiota dysbiosis in postweaning piglets: understanding the keys to health
50. Dysbiosis in inflammatory bowel disease: a role for bacteriophages?
51. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease
52. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation
53. PGRP-SC2 promotes gut immune homeostasis to limit commensal dysbiosis and extend lifespan
54. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis
55. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission
56. Polymicrobial synergy and dysbiosis in inflammatory disease
57. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity
58. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2
59. Dysbiosis signature of fecal microbiota in colorectal cancer patients
60. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers
61. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
62. Dysbiosis of gut microbiota with reduced trimethylamine‐N‐oxide level in patients with large‐artery atherosclerotic stroke or transient ischemic attack
63. Blooming’in the gut: how dysbiosis might contribute to pathogen evolution
64. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease
65. Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn’s disease
66. Extreme dysbiosis of the microbiome in critical illness
67. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances
68. Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome
69. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
70. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea
71. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease
72. Bile acids and dysbiosis in non-alcoholic fatty liver disease
73. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis
74. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review
75. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome
76. Gut dysbiosis and detection of “live gut bacteria” in blood of Japanese patients with type 2 diabetes
77. The global health impact of vaginal dysbiosis
78. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases
79. Intestinal dysbiosis and probiotic applications in autoimmune diseases
80. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s disease
81. Brief report: intestinal dysbiosis in ankylosing spondylitis
82. Cancer-promoting effects of microbial dysbiosis
83. Preventing age-related decline of gut compartmentalization limits microbiota dysbiosis and extends lifespan
84. Dysbiosis in intestinal inflammation: cause or consequence
85. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity
86. Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD–related systemic inflammation
87. Eubiosis and dysbiosis: the two sides of the microbiota
88. Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice
89. Faecalibacterium prausnitzii subspecies–level dysbiosis in the human gut microbiome underlying atopic dermatitis
90. Dog and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis networks
91. Intestinal dysbiosis in inflammatory bowel disease
92. Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated dysbiosis
93. Dysbiosis of fecal microbiota in Crohn’s disease patients as revealed by a custom phylogenetic microarray
94. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn’s disease
95. Therapeutic modulation of intestinal dysbiosis
96. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children
97. Gut dysbiosis impairs recovery after spinal cord injury
98. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study
99. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches
100. Urolithins, the rescue of “old” metabolites to understand a “new” concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health …
101. Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier
102. Gut microbiome dysbiosis and honeybee health
103. Diagnosis and interpretation of intestinal dysbiosis in dogs and cats
104. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
105. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response
106. Immunological consequences of intestinal fungal dysbiosis
107. Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity
108. Dysbiosis of Gut Microbiota (DOGMA)–a novel theory for the development of Polycystic Ovarian Syndrome
109. Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis
110. Functional characterization of inflammatory bowel disease–associated gut dysbiosis in gnotobiotic mice
111. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis
112. Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in Drosophila
113. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota
114. Chemotherapy‐driven dysbiosis in the intestinal microbiome
115. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
116. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease
117. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome
118. Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis
119. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice
120. Gut dysbiosis in patients with anorexia nervosa
121. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the …
122. Microbial dysbiosis: rethinking disease in marine ecosystems
123. A dysbiosis index to assess microbial changes in fecal samples of dogs with chronic inflammatory enteropathy
124. Bridging the gap between gut microbial dysbiosis and cardiovascular diseases
125. A role for bacterial urease in gut dysbiosis and Crohn’s disease
126. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice
127. Role of the microbiome, probiotics, and ‘dysbiosis therapy’in critical illness
128. Progression of Parkinson’s disease is associated with gut dysbiosis: two-year follow-up study
129. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
130. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis
131. 16S rRNA gene pyrosequencing reveals bacterial dysbiosis in the duodenum of dogs with idiopathic inflammatory bowel disease
132. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure
133. Smokers with active Crohn’s disease have a clinically relevant dysbiosis of the gastrointestinal microbiota
134. Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine
135. Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-γ-dependent elimination of Paneth cells
136. Diet‐related gut bacterial dysbiosis correlates with impaired development, increased mortality and Nosema disease in the honeybee (Apis mellifera)
137. Secondary bile acid‐induced dysbiosis promotes intestinal carcinogenesis
138. Dysbiosis is not an answer
139. Clinical consequences of diet-induced dysbiosis
140. The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?
141. Emerging insights on intestinal dysbiosis during bacterial infections
142. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults
143. Defective NOD 2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance
144. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis
145. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity
146. Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the DESIR study
147. Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients
148. Dysbiosis in gastrointestinal disorders
149. Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology
150. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s disease
151. Gut inflammation and dysbiosis in human motor neuron disease
152. Oxygen as a driver of gut dysbiosis
153. Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats
154. Gut dysbiosis in acute‐on‐chronic liver failure and its predictive value for mortality
155. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study
156. Relationship between vaginal microbial dysbiosis, inflammation, and pregnancy outcomes in cervical cerclage
157. Acute dextran sulfate sodium (DSS)‐induced colitis promotes gut microbial dysbiosis in mice
158. Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, and cognitive impairment
159. Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
160. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for …
161. Siblings of patients with Crohn’s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities
162. Signature of microbial dysbiosis in periodontitis
163. Microbial dysbiosis in pediatric patients with Crohn’s disease
164. Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma
165. A review on prebiotics and probiotics for the control of dysbiosis: present status and future perspectives
166. Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study
167. Microbial protection and virulence in periodontal tissue as a function of polymicrobial communities: symbiosis and dysbiosis
168. A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and gut-brain axis mechanism
169. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis
170. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients
171. Gut dysbiosis in animals due to environmental chemical exposures
172. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention
173. Gut microbiota dysbiosis as risk and premorbid factors of IBD and IBS along the childhood–adulthood transition
174. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome
175. Characterization of microbial dysbiosis and metabolomic changes in dogs with acute diarrhea
176. Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice
177. Essential oils in the treatment of intestinal dysbiosis: a preliminary in vitro study
178. The amphibian microbiome: natural range of variation, pathogenic dysbiosis, and role in conservation
179. Gut microbiota dysbiosis in obesity-linked metabolic diseases and prebiotic potential of polyphenol-rich extracts
180. Dysbiosis in chronic periodontitis: key microbial players and interactions with the human host
181. Dysbiosis in the inflamed intestine: chance favors the prepared microbe
182. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?
183. Dysbiosis and alterations in predicted functions of the subgingival microbiome in chronic periodontitis
184. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota
185. Consumption of two healthy dietary patterns restored microbiota dysbiosis in obese patients with metabolic dysfunction
186. Evidence of microbiota dysbiosis in chronic rhinosinusitis
187. Metabolic dysbiosis of the gut microbiota and its biomarkers.
188. Metagenomics reveals dysbiosis and a potentially pathogenic N. flavescens strain in duodenum of adult celiac patients
189. The Gordian Knot of dysbiosis, obesity and NAFLD
190. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome
191. Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas
192. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial
193. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson’s disease
194. The Circadian Clock Mutation Promotes Intestinal Dysbiosis
195. Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients
196. Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis
197. Dysbiosis—a consequence of Paneth cell dysfunction
198. Gut microbiota dysbiosis drives and implies novel therapeutic strategies for diabetes mellitus and related metabolic diseases
199. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis
200. Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia
201. Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders
202. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation
203. Gut mucosal barrier dysfunction, microbial dysbiosis, and their role in HIV-1 disease progression
204. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis
205. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review
206. Dysbiosis anticipating necrotizing enterocolitis in very premature infants
207. Dysbiosis of the microbiome in gastric carcinogenesis
208. Microbiota dysbiosis in select human cancers: evidence of association and causality
209. Prevalence of Clostridium perfringens, Clostridium perfringens enterotoxin and dysbiosis in fecal samples of dogs with diarrhea
210. Diet influence on the gut microbiota and dysbiosis related to nutritional disorders
211. Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis
212. Resolvin E1 reverses experimental periodontitis and dysbiosis
213. Honey bee gut dysbiosis: a novel context of disease ecology
214. Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences
215. Dietary heme induces gut dysbiosis, aggravates colitis, and potentiates the development of adenomas in mice
216. Increased expression of DUOX2 is an epithelial response to mucosal dysbiosis required for immune homeostasis in mouse intestine
217. Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium
218. Porphyromonas gingivalis virulence factors involved in subversion of leukocytes and microbial dysbiosis
219. Airway microbial dysbiosis in asthmatic patients: a target for prevention and treatment?
220. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
221. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism
222. Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis
223. Lactobacillus plantarum attenuates anxiety-related behavior and protects against stress-induced dysbiosis in adult zebrafish
224. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer
225. Apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of 5‐fluorouracil‐induced intestinal mucositis in mice
226. The role of oral pathobionts in dysbiosis during periodontitis development
227. Metabolome of human gut microbiome is predictive of host dysbiosis
228. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms
229. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy
230. Complement and dysbiosis in periodontal disease
231. Diet, microbiota, and dysbiosis: a ‘recipe’for colorectal cancer
232. Probiotic Bifidobacterium bifidum G9‐1 attenuates 5‐fluorouracil‐induced intestinal mucositis in mice via suppression of dysbiosis‐related secondary inflammatory …
233. Apple Polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats
234. Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status
235. Obesity in the United States–dysbiosis from exposure to low-dose antibiotics?
236. Antibiotic‐induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice
237. Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas
238. Clostridium butyricum Strains and Dysbiosis Linked to Necrotizing Enterocolitis in Preterm Neonates
239. Oral exposure of mice to carbendazim induces hepatic lipid metabolism disorder and gut microbiota dysbiosis
240. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects
241. Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma
242. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus
243. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis
244. Peripartum antibiotics promote gut dysbiosis, loss of immune tolerance, and inflammatory bowel disease in genetically prone offspring
245. Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice
246. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease
247. Vaginal biogenic amines: biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis?
248. Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects
249. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice
250. Therapeutic correction of bacterial dysbiosis discovered by molecular techniques
251. HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients
252. Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites
253. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis
254. Immune-microbiota interactions: dysbiosis as a global health issue
255. Gut dysbiosis and neurobehavioral alterations in rats exposed to silver nanoparticles
256. Food combination based on a pre‐hispanic Mexican diet decreases metabolic and cognitive abnormalities and gut microbiota dysbiosis caused by a sucrose …
257. … and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis
258. Dysbiosis signature of mycobiota in colon polyp and colorectal cancer
259. Dysbiosis of intestinal microbiota and decrease in paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats
260. Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine
261. Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases
262. Intestinal dysbiosis contributes to the delayed gastrointestinal transit in high-fat diet fed mice
263. Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood
264. PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis
265. Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis
266. Oral imazalil exposure induces gut microbiota dysbiosis and colonic inflammation in mice
267. Dysbiosis a risk factor for celiac disease
268. Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis
269. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis
270. Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice
271. Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes
272. Persistent microbial dysbiosis in preterm premature rupture of membranes from onset until delivery
273. Imazalil exposure induces gut microbiota dysbiosis and hepatic metabolism disorder in zebrafish
274. Dysbiosis of intestinal microbiota and decreased antimicrobial peptide level in paneth cells during hypertriglyceridemia-related acute necrotizing pancreatitis …
275. Intestinal dysbiosis and biotin deprivation induce alopecia through overgrowth of Lactobacillus murinus in mice
276. Dysbiosis as a prerequisite for IBD
277. Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle
278. Ursodeoxycholic acid and its taurine-or glycine-conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice
279. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures
280. Microbial dysbiosis in rabbit mucoid enteropathy.
281. Microbial dysbiosis in periodontitis
282. Barrier function and microbiotic dysbiosis in atopic dermatitis
283. Urinary and fecal metabonomics study of the protective effect of Chaihu-Shu-Gan-San on antibiotic-induced gut microbiota dysbiosis in rats
284. Gut microbiota dysbiosis drives the development of colorectal cancer
285. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells
286. The goblet cell-derived mediator RELM-β drives spontaneous colitis in Muc2-deficient mice by promoting commensal microbial dysbiosis
287. Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis
288. Enteric dysbiosis-linked gut barrier disruption triggers early renal injury induced by chronic high salt feeding in mice
289. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis
290. Dysbiosis may trigger autoimmune diseases via inappropriate post-translational modification of host proteins
291. Evidence that human skin microbiome dysbiosis promotes atopic dermatitis
292. Escherichia coli Dysbiosis Correlates With Gastrointestinal Dysfunction in Children With Cystic Fibrosis
293. Gut homeostasis, microbial dysbiosis, and opioids
294. … and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis
295. Prediction of functional profiles of gut microbiota from 16S rRNA metagenomic data provides a more robust evaluation of gut dysbiosis occurring in Japanese type 2 …
296. Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa
297. Dysbiosis and immune dysregulation in outer space
298. Defining functional signatures of dysbiosis in periodontitis progression
299. Dysbiosis in the intensive care unit: Microbiome science coming to the bedside
300. Neonatal androgen exposure causes persistent gut microbiota dysbiosis related to metabolic disease in adult female rats
301. Intestinal dysbiosis: an emerging cause of pregnancy complications?
302. Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia
303. Paneth cell defects induce microbiota dysbiosis in mice and promote visceral hypersensitivity
304. The enigmatic gut in cystic fibrosis: linking inflammation, dysbiosis, and the increased risk of malignancy
305. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
306. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases
307. Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases
308. TLR2 promoter hypermethylation creates innate immune dysbiosis
309. Oral antibiotic treatment induces skin microbiota dysbiosis and influences wound healing
310. Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis
311. What is living on your dog’s skin? Characterization of the canine cutaneous mycobiota and fungal dysbiosis in canine allergic dermatitis
312. Prebiotic milk oligosaccharides prevent development of obese phenotype, impairment of gut permeability, and microbial dysbiosis in high fat-fed mice
313. Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae
314. Gut dysbiosis and impairment of immune system homeostasis in perinatally-exposed mice to Bisphenol A precede obese phenotype development
315. Severe gut microbiota dysbiosis is associated with poor growth in patients with short bowel syndrome
316. Abrupt suspension of probiotics administration may increase host pathogen susceptibility by inducing gut dysbiosis
317. Dysbiosis across multiple body sites in critically ill adult surgical patients
318. Potassium is a key signal in host-microbiome dysbiosis in periodontitis
319. The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics
320. Western diet–induced dysbiosis in farnesoid X receptor knockout mice causes persistent hepatic inflammation after antibiotic treatment
321. Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes
322. Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs
323. From the cover: exposure to oral antibiotics induces gut microbiota dysbiosis associated with lipid metabolism dysfunction and low-grade inflammation in mice
324. Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free mice
325. Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis
326. Penile anaerobic dysbiosis as a risk factor for HIV infection
327. Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice
328. Dysbiosis of oral buccal mucosa microbiota in patients with oral lichen planus
329. Subgingival dysbiosis in smoker and non‑smoker patients with chronic periodontitis
330. Protein relative abundance patterns associated with sucrose-induced dysbiosis are conserved across taxonomically diverse oral microcosm biofilm models of …
331. Microbial fingerprinting detects intestinal microbiota dysbiosis in Zebrafish models with chemically-induced enterocolitis
332. Antibiotic growth promoter olaquindox increases pathogen susceptibility in fish by inducing gut microbiota dysbiosis
333. Mango supplementation modulates gut microbial dysbiosis and short-chain fatty acid production independent of body weight reduction in C57BL/6 mice fed a high-fat …
334. Aluminum and Glyphosate Can Synergisti-cally Induce Pineal Gland Pathology: Con-nection to Gut Dysbiosis and Neurological Disease
335. Nod2 Deficiency Leads to a Specific and Transmissible Mucosa-associated Microbial Dysbiosis Which Is Independent of the Mucosal Barrier Defect
336. Normoxic recovery mimicking treatment of sleep apnea does not reverse intermittent hypoxia-induced bacterial dysbiosis and low-grade endotoxemia in mice
337. Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis
338. Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis
339. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
340. Microbial dysbiosis in common variable immune deficiencies: evidence, causes, and consequences
341. Antibiotic-driven dysbiosis mediates intraluminal agglutination and alternative segregation of Enterococcus faecium from the intestinal epithelium
342. Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas
343. Gut dysbiosis and adaptive immune response in diet-induced obesity vs. systemic inflammation
344. Dysbiosis by neutralizing commensal mediated inhibition of pathobionts
345. Urinary microbiome of kidney transplant patients reveals dysbiosis with potential for antibiotic resistance
346. Complexities of gut microbiome dysbiosis in the context of HIV infection and antiretroviral therapy
347. Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity
348. Lactate-utilizing community is associated with gut microbiota dysbiosis in colicky infants
349. DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis
350. Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung’s disease
351. Host genetic susceptibility, dysbiosis and viral triggers in IBD
352. Dysbiosis in epizootic shell disease of the American lobster (Homarus americanus)
353. Salmonid alphavirus infection causes skin dysbiosis in Atlantic salmon (Salmo salar L.) post-smolts
354. Search for localized dysbiosis in Crohn’s disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA
355. Dysbiosis of the Fecal Microbiota in Cattle Infected with Mycobacterium avium subsp. paratuberculosis
356. Dietary gluten-induced gut dysbiosis is accompanied by selective upregulation of microRNAs with intestinal tight junction and bacteria-binding motifs in rhesus …
357. Acute necrotizing enterocolitis of preterm piglets is characterized by dysbiosis of ileal mucosa-associated bacteria
358. Part 2: treatments for chronic gastrointestinal disease and gut dysbiosis
359. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
360. Gut dysbiosis in cystic fibrosis
361. Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients
362. Gut immune dysfunction through impaired innate pattern recognition receptor expression and gut microbiota dysbiosis in chronic SIV infection
363. Dietary polysaccharides in the amelioration of gut microbiome dysbiosis and metabolic diseases
364. Loop ileostomy-mediated fecal stream diversion is associated with microbial dysbiosis
365. Detecting microbial dysbiosis associated with pediatric Crohn disease despite the high variability of the gut microbiota
366. Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease?
367. Intestinal dysbiosis: novel mechanisms by which gut microbes trigger and prevent disease
368. The distinct features of microbial ‘dysbiosis’ of Crohn’s disease do not occur to the same extent in their unaffected, genetically-linked kindred
369. Airway microbiota and the implications of dysbiosis in asthma
370. Targeting dysbiosis for the treatment of liver disease
371. High throughput sequencing analysis reveals amelioration of intestinal dysbiosis by squid ink polysaccharide
372. Koch’s postulates, microbial dysbiosis and inflammatory bowel disease
373. Dysbiosis of urinary microbiota is positively correlated with type 2 diabetes mellitus
374. Gut dysbiosis following C-section instigates higher colonisation of toxigenic Clostridium perfringens in infants
375. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis
376. Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents
377. Novel probiotics and prebiotics: how can they help in human gut microbiota dysbiosis
378. Docosahexaenoic acid, inflammation, and bacterial dysbiosis in relation to periodontal disease, inflammatory bowel disease, and the metabolic syndrome
379. The bacterial virulence factor CagA induces microbial dysbiosis that contributes to excessive epithelial cell proliferation in the Drosophila gut
380. Reduced Epithelial Na+/H+ Exchange Drives Gut Microbial Dysbiosis and Promotes Inflammatory Response in T Cell-Mediated Murine Colitis
381. Intestinal dysbiosis and innate immune responses in axial spondyloarthritis
382. Gut dysbiosis and neuroimmune responses to brain infection with Theiler’s murine encephalomyelitis virus
383. The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis
384. Perilla oil has similar protective effects of fish oil on high-fat diet-induced nonalcoholic fatty liver disease and gut dysbiosis
385. Interleukin-22 prevents microbial dysbiosis and promotes intestinal barrier regeneration following acute injury
386. A preliminary study of gut dysbiosis in children with food allergy
387. Influence of different probiotic lactic acid bacteria on microbiota and metabolism of rats with dysbiosis
388. Allergies and asthma: do atopic disorders result from inadequate immune homeostasis arising from infant gut dysbiosis?
389. Eggshell membrane powder ameliorates intestinal inflammation by facilitating the restitution of epithelial injury and alleviating microbial dysbiosis
390. Dysbiosis as a determinant factor of systemic and oral pathology: Importance of micorbiome
391. The human microbiota and chronic disease: Dysbiosis as a cause of human pathology
392. Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice
393. Doxycycline induces dysbiosis in female C57BL/6NCrl mice
394. … Sonn.) pulp phenolic extract provides protection against alcoholic liver injury in mice by alleviating intestinal microbiota dysbiosis, intestinal barrier dysfunction, and …
395. Sasa quelpaertensis leaf extract regulates microbial dysbiosis by modulating the composition and diversity of the microbiota in dextran sulfate sodium …
396. Extrahepatic diseases and NAFLD: the triangular relationship between NAFLD, type 2-diabetes and dysbiosis
397. Intestinal dysbiosis in systemic lupus erythematosus: cause or consequence?
398. Early-life antibiotic exposure causes intestinal dysbiosis and exacerbates skin and lung pathology in experimental systemic sclerosis
399. Blurred lines: dysbiosis and probiotics in the ICU
400. Is Helicobacter pylori associated functional dyspepsia correlated with dysbiosis?
401. Fecal microbial characterization of hospitalized patients with suspected infectious diarrhea shows significant dysbiosis
402. Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection
403. Dietary α‐mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice
404. Activation of kupffer cells is associated with a specific dysbiosis induced by fructose or high fat diet in mice
405. Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and …
406. Impaired selection of IgA and intestinal dysbiosis associated with PD-1-deficiency
407. Transglutaminases in dysbiosis as potential environmental drivers of autoimmunity
408. Dysbiosis of the urinary microbiota associated with urine levels of proinflammatory chemokine interleukin-8 in female type 2 diabetic patients
409. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling
410. Environmental and NSAID-enteropathy: dysbiosis as a common factor
411. Dysbiosis of the fecal microbiota in the TNBS-induced Crohn’s disease mouse model
412. SYN‐004 (ribaxamase), an oral beta‐lactamase, mitigates antibiotic‐mediated dysbiosis in a porcine gut microbiome model
413. High-fat diet–induced dysbiosis as a cause of neuroinflammation
414. Historical perspective: gut dysbiosis and hypertension
415. Dysbiosis: a review highlighting obesity and inflammatory bowel disease
416. The microbiota in gastrointestinal pathophysiology: implications for human health, prebiotics, probiotics, and dysbiosis
417. Diet promotes dysbiosis and colitis in susceptible hosts
418. Repeated Oral Exposure to N ε-Carboxymethyllysine, a Maillard Reaction Product, Alleviates Gut Microbiota Dysbiosis in Colitic Mice
419. Intestinal alkaline phosphatase deficiency leads to dysbiosis and bacterial translocation in the newborn intestine
420. Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility
421. Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice
422. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities
423. Antibiotics-induced gut microbiota dysbiosis promotes tumor initiation via affecting APC-Th1 development in mice
424. In silico modelling to differentiate the contribution of sugar frequency versus total amount in driving biofilm dysbiosis in dental caries
425. Symbiosis, dysbiosis, and rebiosis—The value of metaproteomics in human microbiome monitoring
426. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis
427. Gastroparesis and lipid metabolism-associated dysbiosis in Wistar-Kyoto rats
428. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?
429. Dietary Shifts May Trigger Dysbiosis and Mucous Stools in Giant Pandas (Ailuropoda melanoleuca)
430. A distinct bacterial dysbiosis associated skin inflammation in ovine footrot
431. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup?
432. Persistent diarrhea: a persistent infection with enteropathogens or a gut commensal dysbiosis?
433. Chronic rhinosinusitis: a microbiome in dysbiosis and the search for alternative treatment options
434. Effects of a treatment with Se‐rich rice flour high in resistant starch on enteric dysbiosis and chronic inflammation in diabetic ICR mice
435. Inflammatory colonic innate lymphoid cells are increased during untreated HIV-1 infection and associated with markers of gut dysbiosis and mucosal immune …
436. Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model
437. The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis
438. Intestinal microbial dysbiosis and colonic epithelial cell hyperproliferation by dietary α-mangostin is independent of mouse strain
439. An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota
440. Adherent-invasive Escherichia coli Exacerbates Antibiotic-associated Intestinal Dysbiosis and Neutrophil Extracellular Trap Activation
441. A low dose of an organophosphate insecticide causes dysbiosis and sex-dependent responses in the intestinal microbiota of the Japanese quail (Coturnix …
442. Gut microbiota dysbiosis and role of probiotics in infant colic
443. Association of vaginal dysbiosis and biofilm with contraceptive vaginal ring biomass in African women
444. AI-2 to the rescue against antibiotic-induced intestinal dysbiosis?
445. 6B. 07: Hypertensive patients exhibit gut microbial dysbiosis and an increase in TH17 cells
446. The role of lower airway dysbiosis in asthma: dysbiosis and asthma
447. Campylobacter jejuni Colonization Is Associated with a Dysbiosis in the Cecal Microbiota of Mice in the Absence of Prominent Inflammation
448. Fecal dysbiosis in miniature dachshunds with inflammatory colorectal polyps
449. TGF‐β1 improves mucosal IgA dysfunction and dysbiosis following intestinal ischaemia–reperfusion in mice
450. The relevance of intestinal dysbiosis in liver transplant candidates
451. Dysbiosis of gut microbiota induced the disorder of helper T cells in influenza virus-infected mice
452. Colonic Immune Suppression, Barrier Dysfunction, and Dysbiosis by Gastrointestinal Bacillus anthracis Infection
453. Gut microbial dysbiosis due to helicobacter drives an increase in marginal zone B cells in the absence of IL-10 signaling in macrophages
454. Relationship between enteric microecologic dysbiosis and bacterial translocation in acute necrotizing pancreatitis
455. Dysbiosis driven by inflammasome deficiency exacerbates hepatic steatosis and governs rate of NAFLD progression
456. Genetic deletion of the bacterial sensor NOD2 improves murine Crohn’s disease-like ileitis independent of functional dysbiosis
457. A DNA tool for early detection of vaginal dysbiosis in African women
458. Connecting female infertility to obesity, inflammation, and maternal gut dysbiosis
459. Dysbiosis and pouchitis
460. Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients
461. Intraluminal flagellin differentially contributes to gut dysbiosis and systemic inflammation following burn injury
462. Dysbiosis in ukrainian children with irritable bowel syndrome affected by natural radiation
463. Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection
464. Can vitamin K synthesis altered by dysbiosis of microbiota be blamed in the etiopathogenesis of venous thrombosis?
465. RNA interference directed against the transglutaminase gene triggers dysbiosis of gut microbiota in Drosophila
466. Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model
467. Microbial signatures of oral dysbiosis, periodontitis and edentulism revealed by gene meter methodology
468. Dysbiosis in Crohn’s disease-joint action of stochastic injuries and focal inflammation in the gut
469. Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine
470. Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot?
471. Defensins couple dysbiosis to primary immunodeficiency in Crohn’s disease
472. Antidiabetic drug treatment confounds gut dysbiosis associated with type 2 diabetes mellitus
473. Dysbiosis in the neonatal period: role of cesarean section
474. Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon
475. Microbiota and allergy: from dysbiosis to probiotics
476. Gut dysbiosis is a feature of MS and it is characterized by bacteria able to regulate lymphocyte differentiation in vitro
477. Infectious mastitis during lactation: a mammary dysbiosis model
478. Local appendiceal dysbiosis: the missing link between the appendix and ulcerative colitis?
479. Transcription profiling reveals potential mechanisms of dysbiosis in the oral microbiome of rhesus macaques with chronic untreated SIV infection
480. Inflammation, genetics, dysbiosis, and the environment: New paradigms for diagnosis in complex chronic gut syndromes
481. Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon?
482. The skin microbiome of caspase‐14‐deficient mice shows mild dysbiosis
483. Vaginal dysbiosis from an evolutionary perspective
484. A pea (Pisum sativum L.) seed albumin extract prevents colonic DSS induced dysbiosis in mice
485. Prevention of dysbiosis complications with autologous fecal microbiota transplantation (auto-FMT) in acute myeloid leukemia (AML) patients undergoing …
486. Dysbiosis in celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients?
487. Microbial dysbiosis in spouses of ulcerative colitis patients: Any clues to disease pathogenesis?
488. Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy
489. Correction: Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
490. Good bugs, bad bugs in the gut: the role of microbiota dysbiosis in chronic gastrointestinal consequences of infection
491. Transplantation of a bacterial consortium ameliorates trinitrobenzenesulfonic acid-induced colitis and intestinal dysbiosis in rats
492. Gastrointestinal dysbiosis
493. Leaky gut syndrome, dysbiosis, ama, free radicals, and natural antioxidants
494. Active and Secretory IgA-Coated bacterial fractions elucidate dysbiosis in clostridium difficile infection
495. Letter to the editor regarding the report of Duboc et al: connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease
496. A dietary-driven redox modulation of gut microbiome-host interactions: the rescue of epithelial barrier and mucus production during dysbiosis by dietary nitrate
497. Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease
498. Peripartum exposure to antibiotics promotes persistent gut dysbiosis, immune imbalance, and inflammatory bowel disease in genetically prone offspring
499. Malnutrition and gut flora dysbiosis: specific therapies for emerging comorbidities in heart failure
500. Fungal-type dysbiosis of the gut: the occurrence of fungal diseases and the response to challenge with yeasty and mould-containing foods
501. … and Inflammation Naturally. Part 6: Nutritional and Botanical Treatments Against” Silent Infections” and Gastrointestinal Dysbiosis, Commonly Overlooked Causes of …
502. Microbial dysbiosis in bronchiectasis
503. OS 05-10 THE MICROBIAL METABOLITE, BUTYRATE ATTENUATES ANGIOTENSIN II-INDUCED HYPERTENSION AND DYSBIOSIS.
504. SIV‐infection‐driven changes of pattern recognition receptor expression in mesenteric lymph nodes and gut microbiota dysbiosis
505. Influence of probiotic strain E. faecium L3 on myocardial tolerance to ischemia-reperfusion injury in the model of antibiotic-induced intestinal dysbiosis
506. Microbial dysbiosis and disease pathogenesis of endometriosis, could there be a link
507. Dysbiosis, spleen qi, phlegm, and complex difficulties
508. Active and secretory IgA-coated bacterial fractions elucidate dysbiosis in Clostridium difficile infection
509. Tissue damage induced midgut stem cell proliferation and microbial dysbiosis in Spodoptera litura
510. Can helminth infection reverse microbial dysbiosis?
511. Early-life Gut Dysbiosis: a driver of later-life fibrosis?
512. … S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune …
513. Human gut microbiota: dysbiosis and manipulation
514. Dysbiosis and inflammation in periodontitis: synergism and implications for treatment
515. The effect of polyvalent oral gel on biochemical parameters of dysbiosis and gum inflammation in the rats with prednizolone-induced periodontitis
516. The polymicrobial synergy and dysbiosis model of periodontal disease pathogenesis
517. Processed foods, dysbiosis, systemic inflammation, and poor health
518. Effect of Lactobacillus plantarum LS/07 on intestinal bacterial enzyme activities in the prevention of cancer, atherosclerosis and dysbiosis
519. Colonization of an acid resistant Kingella denitrificans in the stomach may contribute to gastric dysbiosis by Helicobacter pylori
520. Natural childbirth and breastfeeding as preventive measures of immune-microbiome dysbiosis and misregulated inflammation
521. Reply to: High-Fat Diet–Induced Dysbiosis as a Cause of Neuroinflammation
522. The role of intestinal dysbiosis in the pathogenesis of autism: Minireview
523. Dysbiosis and disease: many unknown ends, is it time to formulate guidelines for dysbiosis research?
524. Food allergy in infancy is associated with dysbiosis of the intestinal microbiota
525. … in ulcerative colitis and celiac disease: a metabolomics approach to identify candidate biomarkers of chronic intestinal inflammation associated with dysbiosis
526. In infants with necrotizing enterocolitis, gut dysbiosis precedes disease
527. A Comparison of Lactulose Breath Hydrogen Measurements with Gut Fermentation Profiles in Patients with Fungal‐type Dysbiosis
528. Relationship between gastrointestinal dysbiosis and Clostridium botulinum in dairy cows
529. Experimental vaginal dysbiosis on the model of white laboratory mice
530. … and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis
531. Dysbiosis of Gut Microbiota Contributes to Chronic Stress in Endometriosis Patients via Activating Inflammatory Pathway
532. Mn3+-saturated bovine lactoferrin as a new complex with potential prebiotic activities for dysbiosis treatment and prevention–On the synthesis, chemical …
533. Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
534. Intestinal dysbiosis in liver cirrhosis
535. The Cirrhosis Dysbiosis Ratio Provides Insight into Gut Microbiome Changes Across the Spectrum of Cirrhosis: A Prospective Study of 250 Patients: 132
536. Dysbiosis of the Intestinal Microbiota in IBS
537. Gut microbiome and its dysbiosis as an important factor influencing the human health condition
538. Cirrhosis and dysbiosis: new insights from next‐generation sequencing
539. An introduction to microbial dysbiosis
540. Cytokine response patterns to complex biofilms by mononuclear cells discriminate patient disease status and biofilm dysbiosis
541. Species characteristic and factors of persistence of gut bifidoflora during healthy state and dysbiosis
542. Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
543. Correction of vaginal dysbiosis in mice caused by a film-forming strain Staphylococcus aureus, using bacteriophages and probiotics
544. Urinary histidine excretion in patients with classical allergy (type A allergy), food intolerance (type B allergy), and fungal-type dysbiosis
545. ED 05-2 Interaction of gut dysbiosis and innate immune dysfunction in the development of metabolic syndrome
546. Intestinal dysbiosis: A possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats
547. Colon cancer is associated with microbial dysbiosis in humans and animals
548. DEVELOPMENT OF DYSBIOSIS IN PERIODONTAL TISSUES IN RATS AFTER SPLENECTOMY
549. The influence of intestinal dysbiosis on human’s health.
550. Bleaching as an obvious dysbiosis in corals
551. Microbial dysbiosis after lung transplantation
552. Early life dysbiosis increases asthma risk
553. Comparative studying of anaerobic bacteria located in woman’s reproductive ways in normal condition and dysbiosis
554. Investigation of dysbiosis developing during” dry” immersion and methods of correction
555. High-fat diet, dysbiosis, and gastrointestinal and colonic transit: is there a missing link?
556. Perinatal factors and type 1 diabetes-associated dysbiosis in Mexican infants
557. Aging-associated dysbiosis increases susceptibility to enteric viral infection in Drosophila
558. The pathogenetic aspects of vaginal dysbiosis and the current possibilities of its correction
559. NOD2 Genetic Variants Predispose One of Two Familial Adenomatous Polyposis Siblings to Pouchitis Through Microbiome Dysbiosis
560. Influence of biologically active substances from kombucha (Medusomyces gisevii) on rat gut microbiota with experimental antibiotic-associated dysbiosis
561. Dysbiosis in ulcerative colitis and celiac disease and its therapeutic correction by butyric acid plus inulin
562. Use of enterosorbent in the treatment of intestinal dysbiosis
563. Reproductive Health of women with early miscarriages in anamnesis associated with vaginal dysbiosis
564. Correction of Bifidobacterium spp. and Lactobacillus spp. populations in mice with experimental intestinal dysbiosis after therapy with enterosorbent-immobilized …
565. Rhein 8-O-β-D-glucopyranoside elicited the purgative action of daiokanzoto (da-huang-gan-cao-tang), despite dysbiosis by ampicillin
566. The gastroprotective action of the oral gel “Quertulin” on rats which received adrenalin at background dysbiosis
567. The gut microbiome dysbiosis and its potential role in psoriatic arthritis
568. The nutritional status and actual food of patients with metabolic syndrome and intestinal dysbiosis
569. Comparative characteristics of the composition of microbial associations of the gastrointestinal tract in humans in the norm and during dysbiosis
570. Gut microbiota dysbiosis precedes NEC
571. Changes in colon microbiocenosis composition and antioxidant properties of colonocytes under the condition of experimental dysbiosis and emoxipin prophylaxis
572. Long-term dysbiosis promotes insulin resistance during obesity despite rapid diet-induced changes in the gut microbiome of mice
573. Increased gut dysbiosis and leakiness in patients with pulmonary arterial hypertension
574. Gut dysbiosis induces lipopolysaccharide-mediated inflammation after cerebral ischemia in type 2 diabetic mice
575. Chronic kidney disease: pathophysiological role of dysbiosis of intestine and renoprotective effectiveness of interventions concerning its modulation
576. Pharmacokinetic study on ginsenoside Rg3 and ginsenoside Rh2 in gut microbiota dysbiosis rats
577. Intestinal microbiota dysbiosis associated with the development of colon cancer: progress and prospects
578. A175: dysbiosis of the enteric microbiota in pediatric spondyloarthritis
579. P06. 01 Women of dutch ethnic origin have lower prevalence of vaginal microbiome dysbiosis than women of other ethnic origin residing in amsterdam
580. Intestinal Dysbiosis During Neonatal Development Alters the Microbiota‐Gut‐Brain Axis in Adulthood
581. Enhanced Th17 responses with intestinal dysbiosis in human allergic, inflammatory, and autoimmune diseases
582. Intestinal vitamin D receptor protects mice from dysbiosis via modulating JAK/STAT pathway in tumorigenesis
583. Consequences of gut Dysbiosis on the human brain
584. CESAREAN-SECTION AND THE DYSBIOSIS OF NEONATAL GUT MICROBIOME: ILL-EFFECTS, SIDE-EFFECTS, OR JUST EFFECTS?
585. Association of Candida albicans fungi with some opportunistic microorganisms in intestinal dysbiosis in patients of different age groups
586. Paradigm of dysbiosis in the modern gastroenterology. The role of microbiota in the treatment and prevention of diseases in the xxi century
587. MicroRNAs: decoders of dysbiosis into metabolic diseases
588. Probiotic lactobacillus ameliorates heightened colonic inflammatory responses in infected stressor-exposed C57BL/6 mice and inhibits dysbiosis (MPF1P. 771)
589. Tissue hypoxia and intestinal dysbiosis in children with tuberculosis
590. Gut microbia dysbiosis in non-alcoholic fatty liver disease
591. Alteration of the liver in rats with experimental dysbiosis
592. … , SYNBIOTICS AND METABIOTICS FOR CORRECTION OF INTESTINAL MICROBIOCENOSIS IN ANIMALS WITH ANTIBIOTIC-ASSOCIATED DYSBIOSIS
593. OP0309 Intestinal sclerostin/serotonin axis is modulated by dysbiosis and regulates ilc3 expansion in as patients
594. Gluten, dysbiosis, and genetics in celiac disease: all are important
595. Establishment of mice model for dysbiosis of intestinal flora.
596. Intestinal dysbiosis and atherogenic dyslipidemia
597. High-fat diet and dysbiosis accelerate tumorigenesis in mice
598. Do Yeasts Play Any Part in “Candida”(Fungal‐type Dysbiosis)?: Discussion Paper
599. The persistence factors of the enterobacteria in the fecal flora in intestinal dysbiosis
600. Fungal‐type Dysbiosis of the Gut: The Occurrence of Fungal Diseases and the Response to Challenge with Yeasty and Mould‐containing Foods
601. Dysbiosis underlies CARD9 risk alleles in colitis
602. Urinary Histidine Excretion in Patients with Classical Allergy (Type A Allergy), Food Intolerance (Type B Allergy), and Fungal‐type Dysbiosis
603. Vaginal dysbiosis and pre-exposure prophylaxis efficacy
604. Oral microbial dysbiosis precedes development of pancreatic cancer
605. Homeostasis vs. Dysbiosis: Role of Commensal Escherichia coli in Disease
606. Age-related gut dysbiosis contributes to age-related colitis and colon cancer risk and appears B7-H1-dependent.(HUM8P. 352)
607. Antibiotics, intestinal dysbiosis and risk of celiac disease
608. Concept and Potential of Enteric Dialysis®-Treating the Cause of Dysbiosis and not the Symptoms in Chronic Kidney Diseases (CKD)
609. OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum …
610. Lung microbiome dysbiosis is a risk factor for pulmonary diffusion abnormalities in antiretroviral treated HIV-infection
611. Intestinal alkaline phosphatase deficiency leads to dysbiosis and bacterial translocation in the newborn intestine
612. Measures of local non-specific resistance during of colon dysbiosis
613. The epidemiological relationship of periodontitis, intestinal dysbiosis, atherogenic dyslipidemia and metabolic syndrome
614. Urinary Organic Acids Profiling for Assessment of Functional Nutrient Deficiencies, Gut Dysbiosis, and Toxicity
615. Gut Dysbiosis and Hypertension-new or resurrected
616. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in PD
617. Underlying dysbiosis may be the cause of some forms of IBS. Patients were free of symptoms after the administration of microbiota
618. Character of lipopolysaccharide-binding protein level changes in different pathological conditions and dysbiosis
619. The use of ozonated water and rectal insufflation in patients with intestinal dysbiosis
620. Investigating dysbiosis as a cause and predictor of intestinal pathology
621. 61: Probiotics alter the intestinal microbiome but do not prevent high fat diet dysbiosis in primates
622. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome
623. Dysbiosis associated with the acute respiratory distress syndrome: a prospective cohort study in adults
624. Correction of anaerobic vaginal dysbiosis in patients with cervical intraepithelial neoplasias
625. Microbial dysbiosis in bronchiectasis and cystic fibrosis
626. OC-051 siblings of Crohn’s disease patients exhibit a biologically relevant dysbiosis in the mucosal microbial community: a 16s Rrna Gene Pyrosequencing Study
627. Cranberry proanthocyanidins reverse microbial dysbiosis and inhibit bile acid metabolism in association with esophageal cancer prevention
628. Erratum to: Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis
629. Dysbiosis in the pathophysiology of coronary artery disease
630. Dysbiosis as a diagnostic
631. Correction: Brown, K., et al. Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease. Nutrients 2012, 4, 1095–1119
632. Datasets used to discover the microbial signatures of oral dysbiosis, periodontitis and edentulism in humans
633. Gut dysbiosis in ankylosing spondylitis
634. Mechanisms of Dysbiosis in the Inflamed Gut
635. Mango supplementation prevents gut microbial dysbiosis and modulates short chain fatty acid production independent of body weight reduction in C57BL/6 mice fed a …
636. Defining dysbiosis threatens Koch’s postulates and current dogma on the role of Paneth cells in Crohn’s disease
637. Parodont-protective action of oral gel” Arginine” applications in rats with intestinal dysbiosis which received a high-fat diet
638. PPIs shown to exacerbate NSAID injury in rats through dysbiosis
639. Gut microbiome is rescued by dietary nitrate during dysbiosis: The impact on epithelial fence function and inflammatory pathways during antibiotic therapy
640. Dysbiosis in fungal microbiota in IBD
641. The intestinal microbiota of irritable bowel syndrome patients is characterized by functional dysbiosis
642. Net Water Transport via Rat Colon Epithelium under the Experimental Dysbiosis
643. Correction: Intraluminal Flagellin Differentially Contributes to Gut Dysbiosis and Systemic Inflammation following Burn Injury
644. Characteristics of the intestinal dysbiosis and endotoxemia after hemicolectomy
645. Abstract# 1850 Early life stress predisposes to increased sensitivity to inflammatory stimuli through intestinal dysbiosis
646. Does probiotic and prebiotic treatement in ivf cycles of infertile women with intestinal dysbiosis, affect pregnancy rate?
647. New approaches to diagnosis intestinal dysbiosis of patients who have psoriatic disease
648. Prevention of colitis in rats receiving palm oil on the background of dysbiosis by using quertulin
649. Gut microbiota dysbiosis augments atherosclerosis in ldlr-/-mice
650. Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis
651. Effect of probiotic and autoprobiotic Enterococci on digestion in the gut at correction of experimental dysbiosis in rats
652. Dysbiosis and its consequences on oral cavity in children and adolescents
653. Intestinal Dysbiosis Increases the Incidence of Malignant Melanoma in Mice Model
654. Correlation between Dysbiosis of Intestinal Microbiota and Dysregulation of Brain-gut Axis in Irritable Bowel; Syndrome
655. Bacterial Dysbiosis Associates with Functional Intraepithelial Lymphocyte Changes in Inflammatory Bowel Disease and Spondyloarthritis
656. Microbiota dysbiosis induced by defect of paneth cells triggers visceral hypersensitivity in mice
657. DEVELOPMENT OF DYSBIOSIS AND INFLAMMATION IN RATS TREATED WITH ANTI-HELICOBACTER PYROLI THERAPY AND PREVENTION USING …
658. Role of local immunity factors in the development of vaginal dysbiosis in girls of prepubertal and pubertal age
659. Prevalence of Lactobacillus iners in the vaginal microbiota of women with moderate dysbiosis is associated with clinical symptoms of infectious inflammatory …
660. ACE2 activator, diminazene, rebalances gut microbial dysbiosis and attenuates pulmonary hypertension
661. A pilot study of TLR4 polymorphism in relation to intestinal dysbiosis and risk of necrotizing enterocolitis in preterm infants
662. Mucosal Inflammation, not Microbiome, Drives the Development Colorectal Cancer During Colitis-Associated Microbial Dysbiosis
663. Species characteristic and persistent factors of Candida genus fungi isolated from various biotopes during infectious-inflammation diseases and intestine dysbiosis
664. The gut-immune-brain interactome and microbial dysbiosis in psychiatric disorders
665. Prolonged Trigeminal Sensitization Induces Gut Dysbiosis: Implications for Migraine Pathology (S51. 006)
666. Skin Dysbiosis Goes “Off-Leish”
667. Left Ventricular Assist Devices and Heart Transplantation Reduces Gut Dysbiosis, Endotoxemia, Inflammation and Oxidative Stress in Advanced Heart Failure Patients
668. Predictive roles of gut dysbiosis on the severity of nonalcoholic fatty liver disease
669. Gut Dysbiosis is Associated to Diet Composition of Children with Type 1 Diabetes
670. Correction of vaginal dysbiosis with cavitated solution of chlorhexidine in the 1st trimester of pregnancy: effectiveness and safety
671. Abstract P134: Increased Gut Permeability and Dysbiosis in Patients With Pulmonary Arterial Hypertension
672. Temperature Gradient Gel Electrophoresis as a Valuable Accessory Tool for Assessment of Dysbiosis in Crohn’s Disease
673. NAFLD severity associated with gut dysbiosis
674. INTESTINAL DYSBIOSIS IN CHILDREN WITH FOOD ALLERGY: PATHOGENETIC ASPECTS AND MODERN CORRECTION METHODS
675. Prevalence of dysbiosis and microbiotic effect of the low FODMAP diet in coeliac disease patients with IBS-like symptoms
676. Pre‐hispanic Mexican diet reduced dysbiosis and inflammation mediated by LPS in diet induced obesity
677. The interplay between microbial dysbiosis and immune dysfunction with age
678. The screening diagnosis of intestinal dysbiosis
679. Correlation between aerobic and anaerobic microflora of the urogenital tract at dysbiosis in women of Dnipropetrovsk city
680. Blueberries and fruit polyphenols modulate the gut microbiome and may prevent age-related dysbiosis
681. The correction of dysbiosis of the female reproductive tract by using an estradiol-containing preparation
682. The gastrointestinal microbiome and diet-induced dysbiosis: influence on obesity and chronic disease risk
683. Intestinal Microbiota, Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: The Potential Role of Dysbiosis in the Hepatocarcinogenesis
684. Intestinal dysbiosis in obese and undernourished Mexican school‐age children
685. Gynostemma pentaphyllum saponins alter the gut microflora composition and convert dysbiosis to eubiosis state in xenograft nude mice.
686. PS 2-8: Bile Acids and Intestinal Dysbiosis in Alcoholic Hepatitis
687. Gastric Acid Production, Pancreatic Secretions and Blood Levels of Higher Alcohols in Patients with Fungal‐type Dysbiosis of the Gut
688. SP0178 Gut dysbiosis and other challenges precipitate arthritis
689. Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?
690. The role of Vibrio bacteria in disease and dysbiosis of the threatened caribbean elkhorn coral, Acropora palmata
691. Gut bacteria and Alzheimer’s disease: from dysbiosis to beta-amyloid plaques
692. Position Statements and Fungal-Type Dysbiosis
693. A96 SEPSIS: Is Dysbiosis A Mediator Of Sepsis? Studying A Nationally Representative Patient Sample
694. Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis
695. Gut dysbiosis contributes to autoimmune pathogenesis in lupus-prone mice
696. SY39-1 INCREASED INTESTINAL PERMEABILITY IS RELATED TO GUT BACTERIAL DYSBIOSIS AND BEHAVIORAL MARKERS OF ADDICTION SEVERITY IN …
697. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin induced gut dysbiosis modulates delayed type hypersensitivity reaction
698. O-014 Bacterial Sensor NOD2 Deletion causes Th2-inflammatory bowel disease improvement without inducing acute metatranscriptomic dysbiosis in mice
699. Pathogenetic correction of vaginal dysbiosis
700. Obesity and dysbiosis
701. Cytokine Pathways and the Role of Dysbiosis in Psoriasis, Psoriatic Arthritis, and Crohn Disease.
702. Disturbed intestinal microbiota (dysbiosis) and micro dynamics in patients treated for appendicitis and diverticulitis
703. Intestine dysbiosis and atopic dermatitis in young children
704. The role of biliary decompression and correction of dysbiosis in the treatment of obstructive jaundice
705. Lacking vitamin D receptor leads to intestinal dysbiosis
706. Insights into the pathogenesis of ulcerative colitis from 1 dysbiosis, colonic metaplasia, and genetic susceptibility 2
707. Dysbiosis, a new medical concept
708. Additional file 1: of Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
709. Impact” Lecithin-2″ for the degree of dysbiosis oral health of students with high caries intensity
710. Parasite-induced TH 1 cells and intestinal dysbiosis cooperate in IFN-γ-dependent elimination of Paneth cells
711. Dysbiosis, inflammation, and response to treatment
712. Clinical Study on Live Lactobacillus Preparation in the Treatment of Postpartum Vagina Microenviroment Dysbiosis
713. Intestinal dysbiosis
714. Attenuating Dysbiosis with Diet, Resistant Starch and Microbiota Transplant.
715. EFFECT OF POLYCOMPONENT PROBIOTICS ON THE COMPOSITION OF COLON MICROBIOCENOSIS DURING EXPERIMENTAL DYSBIOSIS
716. Commensal dysbiosis alters the tumor microenvironment in luminal breast cancer
717. Pharmacokinetics of ginsenoside Rb1 in lincomycin-induced gut microbiota dysbiosis rats
718. 16S rRNA gene pyrosequencing indicate that siblings of Crohn’s disease patients exhibit a biologically relevant dysbiosis in the mucosal microbiota communities
719. Effect of the extract of Daigo lactic acid bacteria fermentation on the composition of the microflora and intestinal motor function in experimental dysbiosis
720. Siblings of Crohn’s Disease Patients Exhibit a Pathologically Relevant Dysbiosis: Examination of Mucosal Microbiota Communities Using 16S rRNA Gene …
721. Herbal Components which Assist in Eradicating Dysbiosis
722. P-330 Crohn’s Disease Dysbiosis Is More Intense than that in Ulcerative Colitis and Marked by an Unclassified Bacteria Enrichment
723. LB-005 Post-infection Dysbiosis–A Potential Cause Of Irritable Bowel Syndrome?
724. Arsenic Dysbiosis to the Zebrafish Microbiome: An Ecological or Physiological Response?
725. The assessment of pouch dysbiosis and the role of therapeutics in the treatment of pouchitis
726. The Role of Gut Dysbiosis in Obstructive Sleep Apnea Induced Hypertension
727. Dysbiosis preventing property of rice bran extract from glutinous black rice and germinated brown rice
728. Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa
729. Caspase-8 and caspase-3 activity in lymphocyte lysate of patients with chronic obstructive pulmonary disease and intestinal dysbiosis
730. Does Dysbiosis Cause Multiple Sclerosis?
731. A13 ROLE OF DYSBIOSIS IN LUNG DISEASE: Lung Microbiome Dysbiosis Is A Risk Factor For Pulmonary Diffusion Abnormalities In Antiretroviral Treated Hiv …
732. Effect of Dysbiosis of Intestinal Microbiota in Inflammatory Bowel Disease
733. Not So Sweet: Artificial Sweeteners Contribute to Dysbiosis and Glucose Intolerance
734. Vaginal dysbiosis: The species composition of lactobacilli and the potentialities of non-drug correction
735. Abstract P162: Butyrate, a Microbial Metabolite, Attenuates Angiotensin II-induced Hypertension and Gut Dysbiosis
736. Case study: Dientamoeba infection and post-infectious dysbiosis
737. Diarrheal Dysbiosis and Treatment
738. Influence of Different Probiotic Lactic Acid Bacteria on Microbiota and Metabolism of Rats with Dysbiosis
739. Vaginal anaerobic dysbiosis during pregnancy: ways of treatment and the characteristics of the pregnancy course
740. O13. 4 Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier
741. Answer to Ling et al “Predictive roles of gut dysbiosis on the severity of NAFLD”
742. Antibiotic induced intestinal dysbiosis in infant mice impacts CD8+ T cell anti-viral immune function and control of infection (IRC8P. 494)
743. THE INFLUENCE OF GELS WITH NANOPARTICLES OF GOLD AND SILVER ON THE DEGREE OF DYSBIOSIS OF MUCOUS MEMBRANE OF CHEEK OF …
744. P779 CD patients in deep remission harbor a high dysbiosis index similar to active CD at diagnosis, yet both are higher in comparison to healthy controls
745. Cecal Microbiota Dysbiosis and Hepatic Transcriptomic Alterations in Western Diet‐Induced NASH in Juvenile Ossabaw Swine
746. P776 Dysbiosis in Nlrp6/Asc-deficient mice does not result from inflammasome deficiency
747. Altered Tissue Metabolites Correlate with Microbial Dysbiosis in Colorectal Adenomas
748. Faecal (meta) proteomics: a tool to investigate dysbiosis and inflammation in patients with cystic fibrosis
749. Likopid in complex treatment of oral dysbiosis
750. Gut microbiome dysbiosis in metabolic disorders: implications for probiotics as prospective investigational new drugs
751. Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs.[poster]
752. … BLOOD CIRCULATION FORMATION IN WOMEN WITH SPONTANEOUS AND RECURRENT MISCARRIAGES ASSOCIATED WITH VAGINA DYSBIOSIS
753. Pelvic radiotherapy induces dysbiosis of gut microbiota and enteric infection in mice
754. Inflammation Drives Dysbiosis and Bacterial Invasion in Murine Models of Ileal
755. Complex treatment of recurrent herpetic stomatitis with dysbiosis
756. Study on the regulation of Decoction of four Noble Drugs and the Nano-TCM in intestinal microbiology dysbiosis mice
757. Clinical factors associated with dysbiosis of gut microbiota affects the risk of retinopathy of prematurity
758. Salivary Microbiome shows Dysbiosis comparable to Stool Microbiome in Cirrhotic Patients with Hepatic Encephalopathy: 112
759. Diet and dysbiosis
760. The Role of Stomatopharynx Dysbiosis in Formation of Susceptibility to Frequent Respiratory Diseases in Early Age Children
761. PWE-061 Dysbiosis in Patients with Bile Acid Diarrhoea (BAD) Demonstrated Using 16S RNA Gene Sequencing
762. The Role of Probiotics in the Management of Intestinal Dysbiosis
763. Dysbiosis of oral cavity in breast cancer patients during adjuvant chemotherapy
764. Postpartum endometritis prevention in abdominal delivery planning in pregnant with severe anaerobic vaginal dysbiosis
765. DYSBIOSIS, INFLAMMATORY BOWEL DISEASE AND COLON CANCER: THERE IS A CORRELATION?
766. Obstructive Sleep Apnea Induced Hypertension Involves Gut Dysbiosis and Neuroinflammation
767. A Metagenomic Analysis of a Streptomycin-Driven Dysbiosis on the Microbiome of Larval Zebrafish
768. Abstract WP427: Examining the Role of Gut Dysbiosis in Cerebral Small Vessel Disease
769. 2262: The impact of alcohol dysbiosis on host defense against pneumonia
770. In the Surgery: Gut Permeability and Intestinal Dysbiosis
771. Intestinal Permeability and Dysbiosis are Linked to Hypertension
772. Long‐term Western Diet Feeding Causes Severe NASH and Cecal Dysbiosis in Juvenile Ossabaw Swine
773. The role of oral dysbiosis in the development of oral diseases
774. Abstract P052: Subgingival Dysbiosis Predicts Longitudinal Glucose Change
775. YOUNG AGE CHILDREN WITH INTESTINE DYSBIOSIS AS CARRIERS OF ENTEROAGGREGATIVE ESCHERICHIA COLI
776. Genetic dysbiosis: how host genetic variants may affect microbial biofilms
777. CAROTID INTIMA-MEDIA THICKNESS, ABDOMINAL AORTA, INTESTINAL DYSBIOSIS AND POLYMORPHISM OF ACE (I/D), AGTR1 (A1166C) GENES IN …
778. Gut dysbiosis affects early inflammatory brain response to Theiler’s murine encephalomyelitis virus infection
779. WS16. 7 A cross-sectional and longitudinal metaproteomics approach reveals intestinal dysbiosis, and the presence of markers of chronic inflammation and …
780. Colon cancer is associated with microbial dysbiosis in humans and animals
781. Tributyrin supplementation attenuates alcohol induced dysbiosis and liver injury
782. Correction of vaginal dysbiosis with the use of probiotics
783. Assessing microbial dysbiosis of electronic cigarettes and cigarette smokers using oral and lung microbiome
784. Complex treatment of vaginal dysbiosis in women with recurrent miscarriage in assisted reproductive treatment (ART)
785. OC-011 Demographic, clinical and genetic factors associated with dysbiosis in patients with active Crohn’s disease
786. Dysbiosis: A Generation On
787. Intestinal Microbiota of Childhood: Dysbiosis and Diseases
788. Clinical classification of dysbiosis in cases of noninfectious gastrointestinal disorders in calves.
789. Comments on “The severity of non-alcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota”
790. Gut microbiota dysbiosis in patients with Multiple Sclerosis
791. Determining gastrointestinal tract dysbiosis using machine learning techniques
792. Intestinal HIF‐1α Deletion Exacerbates Alcoholic Liver Disease Mediated by Intestinal Dysbiosis and Barrier Dysfunction
793. Correction of gastrointestinal microbiocenosis and nutritional status in patients with metabolic syndrome and intestinal dysbiosis of individually selected probiotics
794. … Factors of Systemic Inflammatory Response and Monospacing Homeostasis in Patients with Ischemic Heart Disease with Normaliens and Intestinal Dysbiosis
795. Therapies to modulate the gut microbiota from a dysbiosis to a homeostasis state
796. Authors’ reply: Dysbiosis and pouchitis (Br J Surg 2006; 93: 1325–1334)
797. The role of persisting opportunistic intestinal microflora in dysbiosis in the occurrence of hepatobiliary system diseases
798. THE IDENTIFICATION OF BACTERIA OF THE GENUS LACTOBACILL US DURING INTESTINAL DYSBIOSIS WITH THE RESIDENTS OF THE URBANIZED NORTH.
799. Optimization of dysbiosis prevention and correction in children with gastrointestinal disturbance
800. Age-related features of dysbiosis of large intestine
801. Ability of a propionate producing consortium to promote recovery from antibiotic-associated gut dysbiosis
802. Intestinal Dysbiosis And Associations With Mortality In Critically Ill Adults
803. CORRECTION OF MANIFESTATIONS OF INTESTINAL DYSBIOSIS IN PATIENTS WITH ATOPIC DERMATITIS IN FAMILY DOCTOR PRACTICE
804. Assessment of safety and effectiveness of dietary fermented milk product using in the presence of dysbiosis in people with overweight and obesity
805. RIBOMUNYL IN CORRECTION OF DYSBIOSIS OF MUCOUS TUNICS OF UPPER AIRWAYS AND GASTROINTESTINAL TRACT IN CHILDREN WITH RECURRENT …
806. Study on dysbiosis of intestinal membranous flora in scalded rats
807. Gut dysbiosis in mice genetically selected for low antibody production
808. Dysbiosis in inflammatory bowel disease promotes Clostridium difficile colonization
809. Strategy for diagnosis and correction of vaginal dysbiosis in terms of preparation of pregnant for planned cesarean section and prevention of postpartum endometritis.
810. THE ELIMINATION OF INTESTINAL DYSBIOSIS AND FORMATION OF THE IMMUNE SYSTEM BY BACTERIA SYMBIOTIC (Literature rewiew)
811. Altered mucus composition and bacterial dysbiosis promote development of colitis following chronic Notch inhibition
812. Dysbiosis or Adaptation: How Stable Is the Gut Microbiome?
813. Inflammatory Bowel Disease-associated Dysbiosis and Immune Gardening of the Intestinal Microbiome
814. Two-year follow-up study reveals that Gut dysbiosis predicts progression of Parkinson’s disease
815. Methods of correcting intestine dysbiosis and their influence on the dynamics of clinical manifestations of hepatic encephalopathy among patients with liver cirrhosis
816. Methods of correcting intestine dysbiosis and their influence on the dynamics of clinical manifestations of hepatic encephalopathy among patients with liver cirrhosis
817. P06. 04 Gardnerella vaginalis presence in vaginal dysbiosis: a secondary analysis
818. Characterization of Transferable Intestinal Dysbiosis in Murine Crohn’s Disease Like Ileitis
819. Use of Lactobacillus paracasei for promoting intestinal clearance of opportunistic pathogens after antibiotic dysbiosis
820. Intestinal dysbiosis associated with systemic lupus erythematosus
821. Intestinal Dysbiosis Associated with
822. Friendly SBOs: the ideal biological therapy for immunological unresponsiveness and stubborn fungal infections that underlie dysbiosis
823. IMMUNE REGULATORY PROPERTIES OF BIFIDOBACTERIA METABOLITES DURING EUBIOSIS AND DYSBIOSIS OF THE HUMAN COLON
824. The incidence of intestinal dysbiosis in children
825. The interconnection acid-base blood balance and dysbiosis in children with chronic constipation
826. Disturbance of liver functions and dysbiosis in patients with lipid distress syndrome and its treatment with lactulose preparation” Duphalac”(lactulose)
827. MICROBIAL DYSBIOSIS ASSOCIATED WITH IMPAIRED INTESTINAL NA+/H+ EXCHANGE ACCELERATES AND EXACERBATES COLITIS IN GNOTOBIOTIC …
828. Reply to “Antibiotics, intestinal dysbiosis and risk of celiac disease” by Hakim Rahmoune et al.[Digestive and Liver Disease]
829. AN IMMUNOLOGICAL EVALUATION AND STUDY OF DYSBIOSIS ASSOCIATED WITH THALASSEMIC PATIENTS IN BABYLON PROVINCE
830. The level of immunoglobulins in coprofiltrates and blood serum of children with pneumonia complicated by intestinal dysbiosis
831. A Bowel Flora Protocol for Dysbiosis Management
832. Exploring the differences in intestinal dysbiosis induced by CNS inflammatory demyelination and diabetes in non-obese diabetic mice
833. RAT INTESTINAL MICROFLORA IN APPLYING AUTOCLAVED CAROTENED YEAST IN EXPERIMENTAL DYSBIOSIS
834. Combined therapy of Helicobacter-associated intestinal dysbiosis
835. Vitamin A deficiency in mice results in a hypermetabolic state, dysbiosis and alterations in bacterial metabolism
836. Dysbiosis of the oral commensal microbiota drives inflammatory periodontal disease in the mouse model.
837. Mucosal microbiome dysbiosis in gastric carcinogenesis
838. A bowel flora protocol for dysbiosis management
839. INFLAMMATORY GUT ILCS ASSOCIATE WITH DYSBIOSIS DURING UNTREATED HIV-1 INFECTION
840. Dysbiosis and pouchitis (Br J Surg 2006; 93: 1325–1334)
841. DEFINING THE ROLE OF T CELL DEPENDENT SHAPING OF THE MICROBIOTA TO PREVENT DYSBIOSIS AND DISEASE
842. The interaction between intestinal commensal microbiota and host immune system in health and dysbiosis.
843. Intestinal microbial community dysbiosis associated with chronic colitis and gluten-sensitive enteropathy in rhesus macaques (Macaca mulatta)
844. TARGET ORGAN INJURY IN HYPERTENSION: INTESTINAL DYSBIOSIS AND LIPIDS PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION AND THEIR …
845. Anti–inflammatory effect of Sasa quelpaertensis leaf extract by regulating anti-oxidant enzymes and gut microbiota dysbiosis on dextran sulfate sodium–induced colitis …
846. A phylogeny-free microbiome dysbiosis detection pipeline for non-invasive disease diagnosis
847. Hippophae leaf extract (SBL-1) countered radiation induced dysbiosis in jejunum of total body {sup 60} Cobalt gamma-irradiated mice
848. Dysbiosis of the Faecal Microbiota in Patients with Crohn’s Disease and Their Unaffected Relatives (Gut 2011; 60: 631-637)
849. Gut Microbiotal Dysbiosis and Increased Risk for Complex Polygenic Diseases Emerge with Genomic Selection for Low Aerobic Exercise Capacity
850. Benefits of application of the probiotic strain Lactobacillus plantarum LS/07 in the animal model of intestinal dysbiosis and colorectal carcinoma.
851. Non-alcoholic Fatty Liver Disease Progression: All Depends on the Inflammasome Deficiency Driven Dysbiosis
852. Effect of probiotic bacteria on intestinal digestion in correction of experimental dysbiosis in rats
853. The dysbiosis of the bacterial population of the digestive system (intestinal microbiota) in patients with metabolic syndrome improves after two models of healthy diets …
854. … Host Interactions: Prebiotic milk oligosaccharides prevent development of obese phenotype, impairment of gut permeability, and microbial dysbiosis in high fat …
855. Managing vaginal dysbiosis-a pharmacist’s guide
856. Hippophae leaf extract (SBL-1) countered radiation induced dysbiosis in jejunum of total body 60Cobalt gamma – irradiated mice
857. Dysbiosis and Host Health: Uncovering the Connection between the Microbiota and Disease
858. P-135 YI IL-22 Promotes Helicobacter Hepaticus-Induced H2AX Phosphorylation and Dysbiosis in the Large Bowel
859. Dysbiosis in inflammatory bowel disease
860. The Role of Intestinal Dysbiosis in the Pathogenesis of Autism: Minireview Review
861. PD12-03 NORMAL PERINEAL MICROBIOME IN PREPUBERTAL FEMALES WITH DYSBIOSIS IF RECURRENT URINARY TRACT INFECTIONS
862. Active prevention of postpartum endometritis in pregnant women with anaerobic dysbiosis and planned cesarian section
863. Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic
864. CONTENTS OF CYCLIC NUCLEOTIDS IN PREGNANT WITH PREECLAMPSIA AND STRESS DYSBIOSIS
865. Dysbiosis Of The Lung Bacterial Community In Stable COPD Subjects
866. 64 Dysbiosis and gut barrier dysfunction in antiphospholipid syndrome as revealed by iga-seq profiling
867. Dysbiosis of palatine tonsil microbiota associated with altered immune responses in rheumatoid arthritis
868. INTESTINAL DYSBIOSIS AND ITS’IMPORTANCE IN THE DAILY PRACTICE OF AN ALLERGOLOGIST-IMMUNOLOGIST
869. Allergens, dysbiosis and immune dysregulation: Case studies on inflammatory bowel disease
870. IS-profiling as a screening tool for intestinal dysbiosis in adenoma development
871. Relationship between intestinal dysbiosis and iodine insufficiency in children with endemic goiter
872. CLINICAL TRIAL ON EUBIOFLOR AND MYCOX EFFECTIVENESS IN THE TREATMENT OF DYSBIOSIS
873. POTASSIUM AND MAGNESIUM DEFICIENCY AS A CONSEQUENCE OF DIARRHEA AND INTESTINAL DYSBIOSIS: MECHANISMS OF DEVELOPMENT AND …
874. Intestinal Dysbiosis and Depletion of
875. SY19-2 GUT BACTERIAL DYSBIOSIS IS RELATED TO THE SEVERITY OF ALCOHOL-DEPENDENCE
876. Chronic morphine in the context of HIV infection, induce gut microbiome dysbiosis and lead to persistent GALT inflammation.(MUC4P. 843)
877. W1336 Dysbiosis in Diarrhoea-Predominant IBS: Significant Increase in Mucosa-Associated Bacteroides
878. The treatment of urogenital mixed infections caused of mycoplasma and ureaplasma against dysbiosis.
879. Gut microbial dysbiosis due to Helicobacter drives marginal zone B cell development in the absence of IL-10 signaling in macrophages (LYM7P. 623)
880. Protective effects of Δ9-Tetrahydrocannabinol (THC) results from alteration in lung dysbiosis mediated by SEB-induced acute lung injury
881. Giardia duodenalis induces dysbiosis of human intestinal microbiota
882. P-189 YI Components of Enteric Dysbiosis Are Present at the Onset of Immune-mediated, Spontaneous Colitis
883. Studies on Dysbiosis of Gut Microbiota in Drosophila
884. Intestinal dysbiosis in children with chronic pneumonia
885. Corrigendum: Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis
886. Glycolysis and pentose-phosphate pathway ratio in staphylococcus from the female genitalia in norm and dysbiosis
887. Diagnosis and correction of dysbiosis in patients with postcholecystectomy syndrome
888. Fecal microflora and dysbiosis in the horse: possible contribution to metabolic related conditions, inflammation and leaky gut syndrome.
889. EFFICIENCY OF LOCAL CORRECTION OF VAGINAL DYSBIOSIS IN WOMEN WITH CONCURRENT INFLAMMATORY AND HYPERPLASTIC DISEASES OF THE …
890. … TWO MICROORGANISMS LACTOBACILLUS RHAMNOSUS AND LACTOBACILLUS REUTERI WITH ESTRIOL IN THE TREATMENT OF VAGINAL DYSBIOSIS
891. Prevention of intestinal dysbiosis in patients after anti-Helicobacter therapy
892. 344: SYNBIOTICS THERAPY IMPROVES GUT DYSBIOSIS IN SEVERE SEPSIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL.
893. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis
894. A NEW APPROACH TO TREATMENT LIVER CIRRHOSIS IN CONNECTION WITH INTESTINAL DYSBIOSIS
895. From symbiosis to dysbiosis
896. A13 ROLE OF DYSBIOSIS IN LUNG DISEASE: Lung Cancer And Lung Microbiome
897. The development of the upper respiratory microbiome on infancy and the dysbiosis related with wheezing syndrome and health on children from the rural tropics of …
898. A13 ROLE OF DYSBIOSIS IN LUNG DISEASE: Early-Life Nasopharyngeal Colonization With Lactobacillus Reduces Risk Of Childhood Wheezing Illnesses Following …
899. Age-related features of colonic dysbiosis in Lamblia infestation
900. INCREASED INTESTINAL PERMEABILITY IS RELATED TO GUT BACTERIAL DYSBIOSIS AND BEHAVIORAL MARKERS OF ADDICTION SEVERITY IN ALCOHOL …
901. Investigation of Dysbiosis and Bile Salt Composition Associated withC. difficileInfection: Presidential Poster: 1310
902. A13 ROLE OF DYSBIOSIS IN LUNG DISEASE: Cigarette Smoke Dysregulates Gut Microbiome In Multiple Strains Of Mice Correlating With Inflammation In The Lung
903. Dysbiosis in Epizootic Shell Disease of the American Lobster (Homarus americanus)
904. Gut dysbiosis in mania: A viable therapeutic target?
905. A13 ROLE OF DYSBIOSIS IN LUNG DISEASE: Disruption Of Lung Microbiota Precedes Peak Lung Injury In A Mouse Model Of Acute Respiratory Distress Syndrome
906. Microflora of the upper respiratory tract of normal young children and in respiratory tract diseases. Normal microflora and dysbiosis at different levels of the upper …
907. Development of sustainable strategies to mitigate the use of antibiotics and maintain gut homeostasis in intestinal dysbiosis
908. Persistent microbial dysbiosis in preterm premature rupture of membranes
909. Retraction: Human gut microbiota: dysbiosis and manipulation
910. Comparison of dysbiosis in Gut Microbiota of Dyslipidemic Patients and Rat, and the Impact of Anti-lipidemic Drugs
911. Loss of the protective arm of renin-angiotensin-system results in hematopoietic stem/progenitor cell defects, gut dysbiosis and retinopathy in diabetes
912. The Role of Dysfunctional Na+/H+ Exchange in the Development of Dysbiosis and Subsequent Colitis
913. Vaginal dysbiosis in women undergoing in vitro fertilisation
914. Rethinking the Biology of IL-33 Outside of Disease: Distinct Functions in Eosinophil Development and Microbiome Dysbiosis
915. Data Management tools For Metagenomic Datasets, A Case Study: Characterization and Dysbiosis of Gut Microbiota In Apcmin/+ Mice With and Without Colon …
916. Retraction: Human gut microbiota: dysbiosis and manipulation
917. Vaginal dysbiosis and cervical pathology
918. Intestinal dysbiosis enhances gut microflora‐induced neutrophil extracellular traps (LB517)
919. S-11: Inflammasomes in health, dysbiosis, and disease
920. EP1219: MELATONIN IMPROVES GUT DYSBIOSIS IN HIGH FAT-HIGH FRUCTOSE DIET MODEL OF NAFLD AND/OR PHOTOPERIOD INDUCED …
921. O-026 Intestinal Epithelium Specific TLR4 Over-Expression Causes Transmissible Colitis via Microbial Dysbiosis
922. Dysbiosis of gut microbiota drives cancer development
923. In the article entitled,“Western DieteInduced Dysbiosis in Farsenoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment” …
924. Parkinson’s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation
925. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery
926. Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
927. Interleukin‐17/interleukin‐17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high‐fat diet‐induced …
928. Accumulation of different shapes of microplastics initiates intestinal injury and gut microbiota dysbiosis in the gut of zebrafish
929. Defining dysbiosis for a cluster of chronic diseases
930. Mucosal microbiome dysbiosis in gastric carcinogenesis
931. Polystyrene microplastics induce microbiota dysbiosis and inflammation in the gut of adult zebrafish
932. Human defensin-5 blocks ethanol and colitis-induced dysbiosis, tight junction disruption and inflammation in mouse intestine
933. Polystyrene microplastics induce gut microbiota dysbiosis and hepatic lipid metabolism disorder in mice
934. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients
935. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet
936. Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors
937. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis
938. Dysbiosis of Gram‑negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic …
939. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease
940. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis
941. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer
942. Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
943. Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus
944. Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting
945. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery
946. Homeostasis and dysbiosis of the gut microbiome in health and disease
947. Resilience of the oral microbiota in health: mechanisms that prevent dysbiosis
948. Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction
949. Microplastics and the gut microbiome: how chronically exposed species may suffer from gut dysbiosis
950. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases
951. Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
952. Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications
953. Obesity-linked gut microbiome dysbiosis associated with derangements in gut permeability and intestinal cellular homeostasis independent of diet
954. Analysis of gut microbiota in rheumatoid arthritis patients: disease-related dysbiosis and modifications induced by etanercept
955. The caries microbiome: implications for reversing dysbiosis
956. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis
957. A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?
958. Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor–positive breast cancer
959. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection
960. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
961. Stroke dysbiosis index (SDI) in gut microbiome are associated with brain injury and prognosis of stroke
962. Dysbiosis-associated change in host metabolism generates lactate to support Salmonella growth
963. Infectious threats, the intestinal barrier, and its trojan horse: dysbiosis
964. The gut microbiota and dysbiosis in autism spectrum disorders
965. Microbiome and gut dysbiosis
966. Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease
967. Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis
968. Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis
969. Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy
970. Dysbiosis signatures of gut microbiota in coronary artery disease
971. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction
972. Association between impaired Vα7. 2+ CD161++ CD8+ (MAIT) and Vα7. 2+ CD161-CD8+ T-cell populations and gut dysbiosis in chronically HIV-and/or HCV …
973. Antibiotics in early life: dysbiosis and the damage done
974. Dysbiosis of gut microbiota in promoting the development of colorectal cancer
975. Obstructive sleep apnea and systemic hypertension: gut dysbiosis as the mediator?
976. The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis
977. Fungal dysbiosis in cirrhosis
978. Intestinal dysbiosis featuring abundance of Ruminococcus gnavus associates with allergic diseases in infants
979. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders
980. Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice
981. Analysis of the relationship between the degree of dysbiosis in gut microbiota and prognosis at different stages of primary hepatocellular carcinoma
982. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
983. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids
984. Dysbiosis of gut microbiota in a selected population of Parkinson’s patients
985. Gut microbial dysbiosis in Indian children with autism spectrum disorders
986. Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis
987. Mucosa-associated microbiota dysbiosis in colitis associated cancer
988. Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders
989. Anthocyanins protect the gastrointestinal tract from high fat diet-induced alterations in redox signaling, barrier integrity and dysbiosis
990. Gut microbiota dysbiosis in a cohort of patients with psoriasis
991. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study
992. Gut dysbiosis associated with hepatitis C virus infection
993. Oral bacteria and intestinal dysbiosis in colorectal cancer
994. Role of gut dysbiosis in liver diseases: what have we learned so far?
995. Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection
996. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis
997. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
998. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice
999. Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice
1000. Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging
1001. Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis
1002. Dysbiosis of the gut microbiome is associated with tumor biomarkers in lung cancer
1003. Grifola frondosa polysaccharides ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet fed rats
1004. Human virome and disease: high-throughput sequencing for virus discovery, identification of phage-bacteria dysbiosis and development of therapeutic approaches …
1005. Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity
1006. Traumatic brain injury in mice induces acute bacterial dysbiosis within the fecal microbiome
1007. Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption
1008. Dysbiosis: from fiction to function
1009. Fecal microbiota transplantation for dysbiosis—predictable risks
1010. High-fat diet induces dysbiosis of gastric microbiota prior to gut microbiota in association with metabolic disorders in mice
1011. Dysbiosis in the gut bacterial microbiome of patients with uveitis, an inflammatory disease of the eye
1012. Chronic exposure to low concentrations of lead induces metabolic disorder and dysbiosis of the gut microbiota in mice
1013. Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea
1014. Response to fungal dysbiosis by gut-resident CX3CR1+ mononuclear phagocytes aggravates allergic airway disease
1015. Gut microbiota dysbiosis and increased plasma LPS and TMAO levels in patients with preeclampsia
1016. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study
1017. Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis
1018. Dysbiosis and metabolic endotoxemia induced by high-fat diet
1019. Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice
1020. Gut microbiota dysbiosis in human obesity: impact of bariatric surgery
1021. Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice
1022. Fecal short‐chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy
1023. Rice bran phenolic extract protects against alcoholic liver injury in mice by alleviating intestinal microbiota dysbiosis, barrier dysfunction, and liver inflammation …
1024. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer
1025. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM
1026. Dysbiosis of gut microbiota by chronic coexposure to titanium dioxide nanoparticles and bisphenol A: Implications for host health in zebrafish
1027. Meta-analysis of alcohol induced gut dysbiosis and the resulting behavioral impact
1028. Commensals suppress intestinal epithelial cell retinoic acid synthesis to regulate interleukin-22 activity and prevent microbial dysbiosis
1029. Effects of HLA–B27 on gut microbiota in experimental spondyloarthritis implicate an ecological model of dysbiosis
1030. Dysbiosis of the gut microbiome in lung cancer
1031. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy
1032. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis
1033. Gut microbiota in children with cystic fibrosis: a taxonomic and functional dysbiosis
1034. Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice
1035. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy
1036. Antimicrobial emulsifier–glycerol monolaurate induces metabolic syndrome, gut microbiota dysbiosis, and systemic low‐grade inflammation in low‐fat diet fed mice
1037. Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice
1038. The severity of human peri‐implantitis lesions correlates with the level of submucosal microbial dysbiosis
1039. Infant colic represents gut inflammation and dysbiosis
1040. Chlorpyrifos disturbs hepatic metabolism associated with oxidative stress and gut microbiota dysbiosis in adult zebrafish
1041. Reduction in hepatic secondary bile acids caused by short-term antibiotic-induced dysbiosis decreases mouse serum glucose and triglyceride levels
1042. Polysaccharide peptides from Ganoderma lucidum ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet-fed rats
1043. A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies
1044. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers
1045. Bacterial dysbiosis and translocation in psoriasis vulgaris
1046. Gut dysbiosis and muscle aging: searching for novel targets against sarcopenia
1047. Green tea extract prevents obesity in male mice by alleviating gut dysbiosis in association with improved intestinal barrier function that limits endotoxin translocation …
1048. A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis
1049. Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice
1050. Intestinal dysbiosis secondary to proton-pump inhibitor use
1051. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study
1052. Regulatory Effects of Stachyose on Colonic and Hepatic Inflammation, Gut Microbiota Dysbiosis, and Peripheral CD4+ T Cell Distribution Abnormality in High-Fat Diet …
1053. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
1054. Dysbiosis disrupts gut immune homeostasis and promotes gastric diseases
1055. Dietary cranberry suppressed colonic inflammation and alleviated gut microbiota dysbiosis in dextran sodium sulfate-treated mice
1056. Rebalancing the caries microbiome dysbiosis: targeted treatment and sugar alcohols
1057. Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease
1058. A correlation between intestinal microbiota dysbiosis and osteoarthritis
1059. Propionate-producing consortium restores antibiotic-induced dysbiosis in a dynamic in vitro model of the human intestinal microbial ecosystem
1060. High dietary salt–induced DC activation underlies microbial dysbiosis-associated hypertension
1061. Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety
1062. High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine
1063. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer
1064. Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases using oral …
1065. Defining dysbiosis in patients with urolithiasis
1066. Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics …
1067. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients
1068. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs
1069. Mediators between oral dysbiosis and cardiovascular diseases
1070. Gut microbiota in obstructive sleep apnea–hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities
1071. Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet–induced systemic inflammation, microglial activation, and reduced …
1072. Gut microbial dysbiosis is associated with allergen-specific IgE responses in young children with airway allergies
1073. A fucoidan from sea cucumber Pearsonothuria graeffei with well-repeated structure alleviates gut microbiota dysbiosis and metabolic syndromes in HFD-fed mice
1074. Salivary mycobiome dysbiosis and its potential impact on bacteriome shifts and host immunity in oral lichen planus
1075. Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis
1076. Activated ATF6 induces intestinal dysbiosis and innate immune response to promote colorectal tumorigenesis
1077. Gut microbiota dysbiosis in male patients with chronic traumatic complete spinal cord injury
1078. The Probiotic Lactobacillus fermentum Prevents Dysbiosis and Vascular Oxidative Stress in Rats with Hypertension Induced by Chronic Nitric Oxide Blockade
1079. Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis
1080. Horizontal and vertical transfer of oral microbial dysbiosis and periodontal disease
1081. Exercise prevents high fat diet-induced bone loss, marrow adiposity and dysbiosis in male mice
1082. Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis
1083. Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease
1084. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients
1085. Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction
1086. Protective properties of milk sphingomyelin against dysfunctional lipid metabolism, gut dysbiosis, and inflammation
1087. Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice
1088. Oral administration of compound probiotics ameliorates HFD-induced gut microbe dysbiosis and chronic metabolic inflammation via the G protein-coupled receptor 43 …
1089. Impact of gut dysbiosis on neurohormonal pathways in chronic kidney disease
1090. Microbiota dysbiosis is associated with HPV‑induced cervical carcinogenesis
1091. Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease
1092. Oral dysbiosis in pancreatic cancer and liver cirrhosis: A review of the literature
1093. Monascus yellow, red and orange pigments from red yeast rice ameliorate lipid metabolic disorders and gut microbiota dysbiosis in Wistar rats fed on a high-fat diet
1094. Dysbiosis of the fecal microbiota in feedlot cattle with hemorrhagic diarrhea
1095. Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis
1096. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a …
1097. SIRT3 deficiency promotes high‐fat diet‐induced nonalcoholic fatty liver disease in correlation with impaired intestinal permeability through gut microbial dysbiosis
1098. Enteric dysbiosis is associated with sepsis in patients
1099. Gut microbiota dysbiosis is associated with malnutrition and reduced plasma amino acid levels: lessons from genome-scale metabolic modeling
1100. Neonatal intestinal dysbiosis in necrotizing enterocolitis
1101. Longitudinal assessment of microbial dysbiosis, fecal unconjugated bile acid concentrations, and disease activity in dogs with steroid‐responsive chronic …
1102. Dysbiosis of skin microbiota in psoriatic patients: co-occurrence of fungal and bacterial communities
1103. High-fat diet consumption induces microbiota dysbiosis and intestinal inflammation in zebrafish
1104. Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: A multiomics approach
1105. Dysbiosis of the salivary microbiome is associated with non-smoking female lung cancer and correlated with immunocytochemistry markers
1106. Elevated temperature drives kelp microbiome dysbiosis, while elevated carbon dioxide induces water microbiome disruption
1107. … vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its …
1108. … cells and plasmacytoid dendritic cells within the tumor microenvironment in gastric cancer are correlated with gastric microbiota dysbiosis: a preliminary study
1109. Dysbiosis signatures of the microbial profile in tissue from bladder cancer
1110. Butyrate improves the metabolic disorder and gut microbiome dysbiosis in mice induced by a high-fat diet
1111. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death
1112. Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis
1113. Understanding the representative gut microbiota dysbiosis in metformin-treated type 2 diabetes patients using genome-scale metabolic modeling
1114. Chronic rhinosinusitis: potential role of microbial dysbiosis and recommendations for sampling sites
1115. Current understanding of the role of gut dysbiosis in type 1 diabetes
1116. Food Preservatives Induce Proteobacteria Dysbiosis in Human-Microbiota Associated Nod2-Deficient Mice
1117. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis
1118. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia
1119. Antibiotics as instigators of microbial dysbiosis: implications for asthma and allergy
1120. The valproic acid rat model of autism presents with gut bacterial dysbiosis similar to that in human autism
1121. Systemic Lupus Erythematosus and dysbiosis in the microbiome: cause or effect or both?
1122. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection
1123. Perfluorobutanesulfonate exposure causes durable and transgenerational dysbiosis of gut microbiota in marine medaka
1124. Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release
1125. Gut microbiota dysbiosis is associated with Henoch-Schönlein Purpura in children
1126. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics
1127. Structural and functional alterations in the microbial community and immunological consequences in a mouse model of antibiotic-induced dysbiosis
1128. Rutin and its combination with inulin attenuate gut dysbiosis, the inflammatory status and endoplasmic reticulum stress in Paneth cells of obese mice induced …
1129. Gut dysbiosis with bacilli dominance and accumulation of fermentation products precedes late-onset sepsis in preterm infants
1130. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease
1131. … of whole strawberry inhibited colonic inflammation in dextran-sulfate-sodium-treated mice via restoring immune homeostasis and alleviating gut microbiota dysbiosis
1132. Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function
1133. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and …
1134. In utero and lactational exposure to BDE-47 promotes obesity development in mouse offspring fed a high-fat diet: impaired lipid metabolism and intestinal dysbiosis
1135. Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia
1136. … of triphenyl phosphate exposure during fetal development on obesity and metabolic dysfunctions in adult mice: Impaired lipid metabolism and intestinal dysbiosis
1137. Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: a pilot study
1138. Exposure to the fungicide propamocarb causes gut microbiota dysbiosis and metabolic disorder in mice
1139. Adalimumab therapy improves intestinal dysbiosis in Crohn’s disease
1140. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study
1141. Dysbiosis of gut microbiota was closely associated with psoriasis
1142. Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional …
1143. Intestinal snakeskin limits microbial dysbiosis during aging and promotes longevity
1144. Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis
1145. Relationship between intestinal microbial dysbiosis and primary liver cancer
1146. Gut microbiota dysbiosis is associated with altered bile acid metabolism in infantile cholestasis
1147. Metagenomic and culturomic analysis of gut microbiota dysbiosis during Clostridium difficile infection
1148. Dietary supplementation with partially hydrolyzed guar gum helps improve constipation and gut dysbiosis symptoms and behavioral irritability in children with autism …
1149. Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease
1150. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease
1151. Salivary microbial dysbiosis is associated with systemic inflammatory markers and predicted oral metabolites in non-small cell lung cancer patients
1152. Gut microbiota dysbiosis increases the risk of visceral gout in goslings through translocation of gut-derived lipopolysaccharide
1153. Gut microbiota, dysbiosis and colon lavage
1154. Microbial dysbiosis and mortality during mechanical ventilation: a prospective observational study
1155. Relations between epidermal barrier dysregulation and Staphylococcus species–dominated microbiome dysbiosis in patients with atopic dermatitis
1156. Persistence of gut microbiota dysbiosis and chronic systemic inflammation after cerebral infarction in cynomolgus monkeys
1157. Gut–brain axis biochemical signalling from the gastrointestinal tract to the central nervous system: gut dysbiosis and altered brain function
1158. Ursolic acid improves intestinal damage and bacterial dysbiosis in liver fibrosis mice
1159. Dysbiosis and prematurity: is there a role for probiotics?
1160. In vivo microbiome and associated immune markers: New insights into the pathogenesis of vaginal dysbiosis
1161. Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice
1162. … mucosae and Bifidobacterium longum synergistically alleviate immobilization stress-induced anxiety/depression in mice by suppressing gut dysbiosis
1163. Dysbiosis of the buccal mucosa microbiome in primary Sjögren’s syndrome patients
1164. Gut microbiome‐induced shift of acetate to butyrate positively manages dysbiosis in high fat diet
1165. Infection-induced intestinal dysbiosis is mediated by macrophage activation and nitrate production
1166. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats
1167. Dysbiosis in functional bowel disorders
1168. Early origins of asthma. Role of microbial dysbiosis and metabolic dysfunction
1169. Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques
1170. Insights into a possible mechanism underlying the connection of carbendazim-induced lipid metabolism disorder and gut microbiota dysbiosis in mice
1171. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease
1172. A theoretical model of temperate phages as mediators of gut microbiome dysbiosis
1173. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
1174. Effects of cyanidin-3-O-glucoside on 3-chloro-1, 2-propanediol induced intestinal microbiota dysbiosis in rats
1175. Potential of omega-3 polyunsaturated fatty acids in managing chemotherapy-or radiotherapy-related intestinal microbial dysbiosis
1176. Melatonin treatment alleviates spinal cord injury-induced gut dysbiosis in mice
1177. Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy
1178. Single-cell glia and neuron gene expression in the central amygdala in opioid withdrawal suggests inflammation with correlated gut dysbiosis
1179. Markers of dysbiosis in patients with ulcerative colitis and Crohn’s disease
1180. Chronic alcohol exposure induced gut microbiota dysbiosis and its correlations with neuropsychic behaviors and brain BDNF/Gabra1 changes in mice
1181. Potato-resistant starch supplementation improves microbiota dysbiosis, inflammation, and gut–brain signaling in high fat-fed rats
1182. Inerolysin and vaginolysin, the cytolysins implicated in vaginal dysbiosis, differently impair molecular integrity of phospholipid membranes
1183. Functional dysbiosis within dental plaque microbiota in cleft lip and palate patients
1184. Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker
1185. Dysbiosis of gut microbiota by dietary exposure of three graphene-family materials in zebrafish (Danio rerio)
1186. Absorption of Codonopsis pilosula saponins by coexisting polysaccharides alleviates gut microbial dysbiosis with dextran sulfate sodium-induced colitis in …
1187. Microbial dysbiosis associated with impaired intestinal Na+/H+ exchange accelerates and exacerbates colitis in ex-germ free mice
1188. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis
1189. Short-term propamocarb exposure induces hepatic metabolism disorder associated with gut microbiota dysbiosis in adult male zebrafish
1190. Role of bile acids in dysbiosis and treatment of nonalcoholic fatty liver disease
1191. Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis
1192. Serotonin transporter deficiency is associated with dysbiosis and changes in metabolic function of the mouse intestinal microbiome
1193. Disease-specific enteric microbiome dysbiosis in inflammatory bowel disease
1194. Preventive effects and mechanisms of garlic on dyslipidemia and gut microbiome dysbiosis
1195. Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis
1196. Ovotransferrin ameliorates the dysbiosis of immunomodulatory function and intestinal microbiota induced by cyclophosphamide
1197. Administration of antibiotics can cause dysbiosis in fish gut
1198. Dysbiosis of inferior turbinate microbiota is associated with high total IgE levels in patients with allergic rhinitis
1199. PCBs–high-fat diet interactions as mediators of gut microbiota dysbiosis and abdominal fat accumulation in female mice
1200. Finger millet arabinoxylan protects mice from high-fat diet induced lipid derangements, inflammation, endotoxemia and gut bacterial dysbiosis
1201. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome
1202. Intervening Effects of Total Alkaloids of Corydalis saxicola Bunting on Rats With Antibiotic-Induced Gut Microbiota Dysbiosis Based on 16S rRNA Gene …
1203. Helicobacter pylori infection and gastric dysbiosis: can probiotics administration be useful to treat this condition?
1204. Dysbiosis in children born by caesarean section
1205. Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection
1206. Microbiota dysbiosis and its pathophysiological significance in bowel obstruction
1207. Attenuation of Microbiotal Dysbiosis and Hypertension in a CRISPR/Cas9 Gene Ablation Rat Model of GPER1
1208. Dysbiosis and early mortality in zebrafish larvae exposed to subclinical concentrations of streptomycin
1209. Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis
1210. Lactobacillus iners Is Associated with Vaginal Dysbiosis in Healthy Pregnant Women: A Preliminary Study
1211. N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis
1212. Fucosylated chondroitin sulfate from Isostichopus badionotus alleviates metabolic syndromes and gut microbiota dysbiosis induced by high-fat and high-fructose diet
1213. Dysbiosis-associated enteric glial cell immune-activation and redox imbalance modulate tight junction protein expression in gulf war illness pathology
1214. Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese …
1215. Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology
1216. Lung dysbiosis, inflammation, and injury in hematopoietic cell transplantation
1217. Chlorogenic acid relieves lead-induced cognitive impairments and hepato-renal damage via regulating the dysbiosis of the gut microbiota in mice
1218. Gut dysbiosis and paediatric Crohn’s disease
1219. … against colitis by attenuating Toll-like receptor 4-and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in …
1220. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change
1221. Hydrogen-rich saline regulates intestinal barrier dysfunction, dysbiosis, and bacterial translocation in a murine model of sepsis
1222. Taraxacum officinale extract ameliorates dextran sodium sulphate‐induced colitis by regulating fatty acid degradation and microbial dysbiosis
1223. Lack of short-chain fatty acids and overgrowth of opportunistic pathogens define dysbiosis of neuromyelitis optica spectrum disorders: a Chinese pilot study
1224. Chronic lead exposure induces histopathological damage, microbiota dysbiosis and immune disorder in the cecum of female Japanese quails (Coturnix japonica)
1225. Polymicrobial synergy and dysbiosis: An overview
1226. Dysbiosis of the Vaginal Microbiota and Higher Vaginal Kynurenine/Tryptophan Ratio Reveals an Association with Chlamydia trachomatis Genital Infections
1227. Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia
1228. Effect of the sulfation pattern of sea cucumber-derived fucoidan oligosaccharides on modulating metabolic syndromes and gut microbiota dysbiosis caused by HFD in …
1229. Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia
1230. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan–induced intestinal barrier dysfunction and gut microbial dysbiosis in mice
1231. Implicating dysbiosis of the gut fungal microbiome in uveitis, an inflammatory disease of the eye
1232. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH
1233. Chaihu-Shugan-San decoction modulates intestinal microbe dysbiosis and alleviates chronic metabolic inflammation in NAFLD rats via the NLRP3 …
1234. Zn (ii)-Curcumin supplementation alleviates gut dysbiosis and zinc dyshomeostasis during doxorubicin-induced cardiotoxicity in rats
1235. Toxoplasma gondii infection triggers chronic cachexia and sustained commensal dysbiosis in mice
1236. Dysbiosis associated with acute helminth infections in herbivorous youngstock–observations and implications
1237. Intervention for dysbiosis in children born by C-section
1238. The gut microbiota in collagenous colitis shares characteristics with inflammatory bowel disease-associated dysbiosis
1239. A high linoleic acid diet exacerbates metabolic responses and gut microbiota dysbiosis in obese rats with diabetes mellitus
1240. Dysbiosis of intestinal microbiota induced by dietary oxidized fish oil and recovery of diet-induced dysbiosis via taurine supplementation in rice field eel (Monopterus …
1241. Antibiotic-induced dysbiosis effects on the murine gastrointestinal tract and their systemic repercussions
1242. Gut dysbiosis is associated with the reduced exercise capacity of elderly patients with hypertension
1243. Intestinal microbiome analysis revealed dysbiosis in sickle cell disease
1244. Regulation of glucagon‐like peptide‐1 sensitivity by gut microbiota dysbiosis
1245. Microbiome, gut dysbiosis and inflammatory bowel disease: That moment when the function is more important than taxonomy
1246. Dysbiosis of gut microbiota is associated with serum lipid profiles in male patients with chronic traumatic cervical spinal cord injury
1247. The GC–MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology
1248. Helicobacter pylori infection aggravates dysbiosis of gut microbiome in children with gastritis
1249. Iron deficiency anemia-related gut microbiota dysbiosis in infants and young children: A pilot study
1250. Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis
1251. Detection of gut dysbiosis due to reduced Clostridium subcluster XIVa using the fecal or serum bile acid profile
1252. Pyroglutamyl leucine, a peptide in fermented foods, attenuates dysbiosis by increasing host antimicrobial peptide
1253. Lactobacillus rescues postnatal neurobehavioral and microglial dysfunction in a model of maternal microbiome dysbiosis
1254. Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism
1255. Urogenital schistosomiasis is associated with signatures of microbiome dysbiosis in Nigerian adolescents
1256. Protection from chemotherapy-and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement
1257. Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and …
1258. Remnant small bowel length in pediatric short bowel syndrome and the correlation with intestinal dysbiosis and linear growth
1259. Late‐Night Eating‐Induced Physiological Dysregulation and Circadian Misalignment Are Accompanied by Microbial Dysbiosis
1260. 1, 25 (OH) 2D3 deficiency-induced gut microbial dysbiosis degrades the colonic mucus barrier in Cyp27b1 knockout mouse model
1261. Enteric dysbiosis and fecal calprotectin expression in premature infants
1262. High-fat diet-mediated dysbiosis exacerbates NSAID-induced small intestinal damage through the induction of interleukin-17A
1263. Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: A systematic review
1264. Gastrointestinal motility, dysbiosis and opioid-induced tolerance: is there a link?
1265. Perilla oil supplementation improves hypertriglyceridemia and gut dysbiosis in diabetic KKAy mice
1266. Deletion of choline acetyltransferase in enteric neurons results in postnatal intestinal dysmotility and dysbiosis
1267. Intestinal microbial dysbiosis in Beagles naturally infected with canine parvovirus
1268. Antibiotic treatment triggers gut dysbiosis and modulates metabolism in a chicken model of gastro-intestinal infection
1269. Gastroduodenal “Dysbiosis”: a new clinical entity
1270. Interleukin-37 sensitize the elderly type 2 diabetic patients to insulin therapy through suppressing the gut microbiota dysbiosis
1271. Lactobacillus plantarum reverse diabetes-induced Fmo3 and ICAM expression in mice through enteric dysbiosis-related c-Jun NH2-terminal kinase …
1272. Respiratory dysbiosis in canine bacterial pneumonia: standard culture vs. microbiome sequencing
1273. Computational profiling of the gut–brain axis: microflora dysbiosis insights to neurological disorders
1274. Epithelial Hes1 maintains gut homeostasis by preventing microbial dysbiosis
1275. Manipulation of intestinal dysbiosis by a bacterial mixture ameliorates loperamide-induced constipation in rats
1276. Intestinal dysbiosis mediates experimental autoimmune pancreatitis via activation of plasmacytoid dendritic cells
1277. Crocin-I ameliorates the disruption of lipid metabolism and dysbiosis of the gut microbiota induced by chronic corticosterone in mice
1278. Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity
1279. Multi-compartment profiling of bacterial and host metabolites identifies intestinal dysbiosis and its functional consequences in the critically ill child
1280. Microbiome dysbiosis and alcoholic liver disease
1281. Tributyltin exposure induces gut microbiome dysbiosis with increased body weight gain and dyslipidemia in mice
1282. Supplementation of okra seed oil ameliorates ethanol-induced liver injury and modulates gut microbiota dysbiosis in mice
1283. Mulberry and dandelion water extracts prevent alcohol-induced steatosis with alleviating gut microbiome dysbiosis
1284. Galacto-oligosaccharides modulate gut microbiota dysbiosis and intestinal permeability in rats with alcohol withdrawal syndrome
1285. ω‐3 PUFAs Alleviate High‐Fat Diet–Induced Circadian Intestinal Microbes Dysbiosis
1286. Antibiotic-induced dysbiosis of gut microbiota impairs corneal nerve regeneration by affecting CCR2-negative macrophage distribution
1287. Astrovirus infections induce age-dependent dysbiosis in gut microbiomes of bats
1288. Loss of function dysbiosis associated with antibiotics and high fat, high sugar diet
1289. Gut microbiome meta-analysis reveals dysbiosis is independent of body mass index in predicting risk of obesity-associated CRC
1290. Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case–controlled study
1291. Dysbiosis in early sepsis can be modulated by a multispecies probiotic: a randomised controlled pilot trial
1292. Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of …
1293. Bacillus amyloliquefaciens Ameliorates Dextran Sulfate Sodium-Induced Colitis by Improving Gut Microbial Dysbiosis in Mice Model
1294. Pomegranate peel extract alters the microbiome in mice and dysbiosis caused by Citrobacter rodentium infection
1295. Oligosaccharides modulate rotavirus-associated dysbiosis and TLR gene expression in neonatal rats
1296. Bee pollen and propolis improve neuroinflammation and dysbiosis induced by propionic acid, a short chain fatty acid in a rodent model of autism
1297. Microbes and monoamines: potential neuropsychiatric consequences of dysbiosis
1298. Synthetic consortia of nanobody‐coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis‐associated diseases and …
1299. Gastrointestinal tract dysbiosis enhances distal tumor progression through suppression of leukocyte trafficking
1300. Gut microbiota dysbiosis in children with relapsing idiopathic nephrotic syndrome
1301. Diet‐Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in …
1302. Hepatic glycogen storage diseases are associated to microbial dysbiosis
1303. Depression promotes the onset of irritable bowel syndrome through unique dysbiosis in rats
1304. Demystifying dysbiosis: can the gut microbiome promote oral tolerance over IgE-mediated food allergy?
1305. Regulating gut flora dysbiosis in obese mice by electroacupuncture
1306. NLRP6 and dysbiosis: avoiding the luring attraction of over-simplification
1307. Influence of the lung microbiota dysbiosis in chronic obstructive pulmonary disease exacerbations: the controversial use of corticosteroid and antibiotic …
1308. Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin
1309. Malvidin 3‐Glucoside Modulated Gut Microbial Dysbiosis and Global Metabolome Disrupted in a Murine Colitis Model Induced by Dextran Sulfate Sodium
1310. Association of gut dysbiosis with intestinal metabolites in response to antibiotic treatment
1311. Intestinal microbiota dysbiosis in children with recurrent respiratory tract infections
1312. Gut dysbiosis with minimal enteritis induced by high temperature and humidity
1313. Upper respiratory dysbiosis with a facultative-dominated ecotype in advanced lung disease and dynamic change after lung transplant
1314. … metagenomes and metabolomes in healthy young males: inactivity and hypoxia generated negative physiological symptoms precede microbial dysbiosis
1315. Evidence of dysbiosis in the intestinal microbial ecosystem of children and adolescents with primary hyperlipidemia and the potential role of regular hazelnut intake
1316. Intestinal dysbiosis promotes epithelial-mesenchymal transition by activating tumor-associated macrophages in ovarian cancer
1317. Metabolomics as a clinical testing method for the diagnosis of vaginal dysbiosis
1318. Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration
1319. Probiotics and Clostridium difficile: a review of dysbiosis and the rehabilitation of gut microbiota
1320. … dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis
1321. Interactions between bitter taste, diet and dysbiosis: Consequences for appetite and obesity
1322. Fish oil, but not olive oil, ameliorates depressive-like behavior and gut microbiota dysbiosis in rats under chronic mild stress
1323. Dendrobium sonia polysaccharide regulates immunity and restores the dysbiosis of the gut microbiota of the cyclophosphamide-induced immunosuppressed mice
1324. Differences in epidemiological features between ulcerative colitis and Crohn’s disease: the early life-programmed versus late dysbiosis hypothesis
1325. GUT Microbiome-GUT dysbiosis-arterial hypertension: New horizons
1326. Antibiotic-induced dysbiosis predicts mortality in an animal model of Clostridium difficile infection
1327. … ginseng, shiitake mushroom and nattokinase potentiated insulin secretion and reduced insulin resistance with improving gut microbiome dysbiosis in insulin deficient …
1328. Dysbiosis in snoring children: an interlink to comorbidities?
1329. Immune tolerance attenuates gut dysbiosis, dysregulated uterine gene expression and high-fat diet potentiated preterm birth in mice
1330. Conjunctival dysbiosis in mucosa-associated lymphoid tissue lymphoma
1331. Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis
1332. 1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis
1333. STAT2 dependent Type I Interferon response promotes dysbiosis and luminal expansion of the enteric pathogen Salmonella Typhimurium
1334. Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency
1335. FAM96A protects mice from dextran sulfate sodium (DSS)-induced colitis by preventing microbial dysbiosis
1336. Profiling the airway in the macaque model of tuberculosis reveals variable microbial dysbiosis and alteration of community structure
1337. Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis
1338. Dysbiosis modulates ocular surface inflammatory response to liposaccharide
1339. Fungal dysbiosis predicts the diagnosis of pediatric Crohn’s disease
1340. Characterization of mucosal dysbiosis of early colonic neoplasia
1341. Altered immunity and microbial dysbiosis in aged individuals with long-term controlled HIV infection
1342. Dysregulation of intestinal microbiota elicited by food allergy induces IgA-mediated oral dysbiosis
1343. Microbial dysbiosis and microbiota–gut–retina axis: the lesson from brain neurodegenerative diseases to primary open-angle glaucoma pathogenesis of autoimmunity
1344. Molecular paths linking metabolic diseases, gut microbiota dysbiosis and enterobacteria infections
1345. Consumption of post-fermented Jing-Wei Fuzhuan brick tea alleviates liver dysfunction and intestinal microbiota dysbiosis in high fructose diet-fed mice
1346. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex …
1347. Dysbiosis-associated polyposis of the Colon—Cap polyposis
1348. Defining dysbiosis in disorders of movement and motivation
1349. Increased transferrin saturation is associated with subgingival microbiota dysbiosis and severe periodontitis in genetic haemochromatosis
1350. Heterogeneity of microbiota dysbiosis in chronic rhinosinusitis: potential clinical implications and microbial community mechanisms contributing to sinonasal …
1351. Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: A pilot study
1352. The correlation between intestinal dysbiosis and the development of ankylosing spondylitis
1353. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its …
1354. Idiopathic colitis in rhesus macaques is associated with dysbiosis, abundant enterochromaffin cells and altered T-cell cytokine expression
1355. Enteric infection coupled with chronic Notch pathway inhibition alters colonic mucus composition leading to dysbiosis, barrier disruption and colitis
1356. Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children
1357. Exposure of the host-associated microbiome to nutrient-rich conditions may lead to dysbiosis and disease development—an evolutionary perspective
1358. Intestinal epithelial cells respond to chronic inflammation and dysbiosis by synthesizing H2O2
1359. Alcohol consumption increases susceptibility to pneumococcal pneumonia in a humanized murine HIV model mediated by intestinal dysbiosis
1360. Gut dysbiosis in Spondyloarthritis: Cause or effect?
1361. Dysbiosis of the duodenal mucosal microbiota is associated with increased small intestinal permeability in chronic liver disease
1362. Aflatoxin exposure, child stunting, and dysbiosis in the intestinal microbiome among children in Guatemala
1363. Deficiency of Dietary Fiber in Slc5a8-Null Mice Promotes Bacterial Dysbiosis and Alters Colonic Epithelial Transcriptome towards Proinflammatory Milieu
1364. Integrated metabolomics and 16S rRNA sequencing to investigate the regulation of Chinese yam on antibiotic-induced intestinal dysbiosis in rats
1365. Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study
1366. Escherichia coli O101‑induced diarrhea develops gut microbial dysbiosis in rats
1367. Influence of monostrain and multistrain probiotics on immunity, intestinal ultrastructure and microbiota in experimental dysbiosis
1368. The role of chronic kidney disease-associated dysbiosis in cardiovascular disease
1369. Keeping it tight: The relationship between bacterial dysbiosis, septate junctions, and the intestinal barrier in Drosophila
1370. Clinical concentrations of peroxidases cause dysbiosis in in vitro oral biofilms
1371. The unfolding story of ATF6, microbial dysbiosis, and colorectal cancer
1372. Microbiota dysbiosis in fungal rhinosinusitis
1373. Neuron-specific regulation of superoxide dismutase amid pathogen-induced gut dysbiosis
1374. Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity
1375. Regulatory effect of Garidisan on dysbiosis of the gut microbiota in the mouse model of ulcerative colitis induced by dextran sulfate sodium
1376. Acute intraperitoneal lipopolysaccharide influences the immune system in the absence of gut dysbiosis
1377. … amino acids alleviated high fat diet-induced nonalcoholic hepatic steatosis by improving hepatic insulin signaling and normalizing gut microbiome dysbiosis …
1378. Fecal microbiota dysbiosis in macaques and humans within a shared environment
1379. Dysbiosis, probiotics, and prebiotics: in diseases and health
1380. The divergent restoration effects of Lactobacillus strains in antibiotic-induced dysbiosis
1381. Development and validation of GC–MS/MS method useful in diagnosing intestinal dysbiosis
1382. Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosis
1383. Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis
1384. Gut microbiota, dysbiosis and immune system; A brief review
1385. Gut microbiome: lactation, childbirth, lung dysbiosis, animal modeling, stem cell treatment, and CNS disorders
1386. Separating “good” from “bad” faecal dysbiosis–evidence from two cross-sectional studies
1387. Analysis of intestinal microbiome in multiple myeloma reveals progressive dysbiosis compared to MGUS and healthy individuals
1388. CRTAM protects against intestinal dysbiosis during pathogenic parasitic infection by enabling Th17 maturation
1389. … of Recurrent Clostridioides difficile (C. Difficile) infection (rCDI), Stably Restores the Gut Microbiota After Vancomycin (vanco)-Induced Dysbiosis in Adult Healthy …
1390. Defining dysbiosis in inflammatory bowel disease
1391. Dietary changes and gut dysbiosis in children with type 1 diabetes
1392. Influence of diet and dietary nanoparticles on gut dysbiosis
1393. Dysbiosis of gut microbiota contributes to the development of diabetes mellitus
1394. Military-related exposures, social determinants of health, and dysbiosis: The United States-Veteran Microbiome Project (US-VMP)
1395. Metabolic Modeling of Clostridium difficile Associated Dysbiosis of the Gut Microbiota
1396. Effect of mushroom (Schizophyllum spp.) derived β-glucan on low-fiber diet induced gut dysbiosis
1397. Oral microbial dysbiosis in patients with Kostmann syndrome
1398. A rat model of maternal polycystic ovary syndrome shows that exposure to androgens in utero results in dysbiosis of the intestinal microbiota and metabolic …
1399. Dysbiosis and variation in predicted functions of the granulation tissue microbiome in HPV positive and negative severe chronic periodontitis
1400. The microbiome of the footrot lesion in Merino sheep is characterized by a persistent bacterial dysbiosis
1401. Severe gut microbiota dysbiosis caused by malnourishment can be partly restored during 3 weeks of refeeding with fortified corn-soy-blend in a piglet model …
1402. Oral hydrolyzed type 2 collagen protects against the OA of obesity and mitigates obese gut microbiome dysbiosis
1403. The odyssee study: prevention of dysbiosis complications with autologous fecal microbiota transfer (FMT) in acute myeloid leukemia (AML) patients …
1404. Bronchoalveolar lavage fluid microbiota dysbiosis in infants with protracted bacterial bronchitis
1405. P852 A metabolomics approach to discover biomarkers of chronic intestinal inflammation associated with gut microbiota dysbiosis in ulcerative colitis and Celiac …
1406. Probiotic Bifidobacterium bifidum G9‐1 ameliorates phytohemagglutinin‐induced diarrhea caused by intestinal dysbiosis
1407. The dysbiosis and inter-kingdom synergy model in oropharyngeal candidiasis, a new perspective in pathogenesis
1408. Dysbiosis of oral microbiota in palmoplantar pustulosis patients
1409. Dysbiosis of the gut microbiota on the inflammatory background due to lack of suppressor of cytokine signalling-1 in mice
1410. Dental diseases and intestinal dysbiosis among children
1411. … report: Acute amebic colitis triggered by colonoscopy: Exacerbation of asymptomatic chronic infection with Entamoeba histolytica accompanied by dysbiosis
1412. Gut microbiota dysbiosis is not independently associated with neurocognitive impairment in people living with HIV
1413. Intestinal dysbiosis and hormonal neuroendocrine secretion in the fibromyalgic patient.
1414. Aerodigestive dysbiosis in children with chronic cough
1415. 48-OR: Gut dysbiosis promotes diabetic retinopathy (DR) through TLR-2 activation by peptidoglycan (PGN) in angiotensin converting enzyme 2 (ACE2) deficient type …
1416. Transcriptome landscape of a thermal-tolerant coral endosymbiont reveals molecular signatures of symbiosis and dysbiosis
1417. High-fat Diet Induced Dysbiosis & Amelioration by Astaxanthin
1418. Antimicrobials in constructed wetlands can cause in planta dysbiosis
1419. A novel animal model for regional microbial dysbiosis of the pioneer microbial community
1420. Interaction between gut microbiota dysbiosis and multiple sclerosis
1421. Identification, characterization, and formulation of a novel carbapenemase intended to prevent antibiotic-mediated gut dysbiosis
1422. Lack of small intestinal dysbiosis following long-term selective inhibition of cyclooxygenase-2 by rofecoxib in the rat
1423. Daisaikoto prevents post-dieting weight regain by reversing dysbiosis and reducing serum corticosterone in mice
1424. Gastrointestinal dysbiosis accompanied of Helicobacter pylori infection and its correction by probiotic
1425. Effects of indigenous Enterococci on the intestinal microbiota and the behavior of rats on correction of experimental dysbiosis
1426. Intestinal dysbiosis in RA development: difficulty of establishing causality. Response to:’Non-causal association of gut microbiome on the risk of rheumatoid …
1427. May dysbiosis caused by dietary chemicals such as sucralose and saccharin be more detrimental to the gut and health than antibiotics? How?
1428. Dysbiosis of oral microflora: a review
1429. Dysbiosis of the Oral Microbiome
1430. Fungal dysbiosis associated with colorectal cancer
1431. Rapid single-cell microbiological analysis: toward precision management of infections and dysbiosis
1432. Intestinal dysbiosis is a risk factor or a cause of miscarriage?
1433. Does dysbiosis in intestinal microbiome plays a role in children with relapsing idiopathic nephrotic syndrome?
1434. Amyotrophic lateral sclerosis (ALS) linked to intestinal microbiota dysbiosis & systemic microbial infection in human patients: a cross-sectional clinical study
1435. Enteric dysbiosis, gut barrier and liver disease
1436. Gut microbial dysbiosis in individuals with Sjögren’s disease
1437. Infection of the Biomphalaria glabrata vector snail by Schistosoma mansoni parasites drives snail microbiota dysbiosis
1438. Dysbiosis of the Biomphalaria glabrata vector snail microbiota following infection by Schistosoma parasites
1439. Gut Microbial Dysbiosis in Heart Failure―Is It a Future Therapeutic Target or Not?―
1440. To the question of vagina dysbiosis in girls with urinary tract infections
1441. Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome.
1442. Influence of oral fatty applications on biochemical indicators of inflammation and dysbiosis in the tissues of the rat mouth
1443. Allergy as a disease of dysbiosis: is it time to shift the treatment paradigm?
1444. B1 B cells link gut dysbiosis and insulin resistance
1445. Use of ozone in water, agriculture and zootechnics: Relationships between dysbiosis and mental disorders
1446. A method for comprehensive proteomic analysis of human faecal samples to investigate gut dysbiosis in patients with cystic fibrosis
1447. Intestinal dysbiosis, human health and functional nutrition
1448. Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus …
1449. Gut microbiome dysbiosis and increased intestinal permeability in Australian children with islet autoimmunity and type 1 diabetes
1450. Obesity causes pulmonary dysbiosis affecting innate immune response in murine asthma model
1451. Sanitization of early life and microbial dysbiosis
1452. Re: Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
1453. Too Fatty, Too Salty, Too Western: Does Diet-Induced Dysbiosis Create a Substrate for Sleep Apnea-Related Hypertension?
1454. Task force on design and analysis in oral health research: host-microbiome interactions in dysbiosis
1455. Characterization of the vaginal DNA virome in health and dysbiosis: an opening study in patients with non-female factor infertility
1456. The Physiological Response to Dysbiosis Impacting the Immune, Endocrine and Nervous Systems.
1457. Gut microbiota dysbiosis in cafeteria diet fed Sprague Dawley rats
1458. IgA-deficient humans exhibit gut microbiota dysbiosis despite production of compensatory IgM
1459. SAT-301 resistant starch ameliorates advanced glycation endproduct-induced gut dysbiosis and albuminuria in a mouse model of type 2 diabetes
1460. Risk for miscarriage and premature birth in women with HPV infection and recurrent vaginal dysbiosis
1461. Restoration of laboratory animal’s normal microflora with induced dysbiosis
1462. Systematic interrogation of the distinct metabolic potential in gut microbiomes of inflammatory bowel disease patients with dysbiosis
1463. Corrective effect of immunological drugs on oral microbiozinosis in patients with chronical apical periodontitis against the background of oral dysbiosis
1464. Dysbiosis of the microbiota in anorexia nervosa: pathophysiological implications
1465. Animal model of antibiotic induced gut microbiota dysbiosis
1466. PTU-043 Intestinal dysbiosis occurs in iron deficiency as well as active IBD
1467. Effect of antibiotic-induced microbiota dysbiosis on colonic mucosal barrier and immune response in juvenile mice
1468. 999: A distinct cervicovaginal microbiome dysbiosis precedes adverse reproductive outcomes in a primate model of PCOS
1469. Rapid Weight Gain and Feeding Practices in the First 6 Months of Life Are Associated with Dysbiosis of the Gut Microbiome in Toddlerhood (P21-032-19)
1470. Dietary fructose induced gut microbiota dysbiosis is an early event in the onset of metabolic phenotype
1471. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis
1472. IDDF2019-ABS-0339 High-fat diet-induced gut microbiota dysbiosis activate MCP-1/CCR2 pathway and promote intestinal carcinogenesis
1473. Colon dysbiosis and chronic kidney disease
1474. Research progress of gut microbiota dysbiosis after cholecystectomy
1475. Probiotics Ameliorate Gut‐Microbial Dysbiosis, Intestinal Permeability, Systemic Inflammation, and Skeletal Muscle Dysfunction in Cystathionine‐β‐synthase‐Deficient …
1476. Efficacy of Copper Metal on Probiotic Bacteria to Combat Dysbiosis
1477. Outpatient-to-inpatient transition causes marked dysbiosis in allogeneic hematopoietic cell transplantation recipients
1478. Microbiota of the gut: antibiotic-induced Dysbiosis and the adverse effects on human health
1479. The novel dimensions of cardio-metabolic health: Gut microbiota, dysbiosis and its fallouts
1480. Clinical investigation of gut microbiota dysbiosis in septic patients
1481. Severe Acne in Female Patients Treated with Isotretinoin is associated with Dysbiosis and its Consequences
1482. Gut microbiota: rational manipulation of gut bacterial Metalloenzymes provides insights into Dysbiosis and inflammation
1483. Obesity-induced gut microbiota dysbiosis can be ameliorated by fecal microbiota transplantation: a multiomics approach
1484. Microbial dysbiosis and its implications for disease in a genetically depauperate species
1485. Multiple Sampling and SAF-Fixative Triple-Faeces Testing for Dysbiosis and Pathogenic Infections of the Gastrointestinal Tract: Case Report.
1486. AB0147 Faecal microbiota study identifies dysbiosis in ankylosing spondylitis patients
1487. … Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis
1488. … Efficacy of Bifidobacterium animalis subsp. lactis (BB-12), B. infantis and Lactobacillus acidophilus (La-5) probiotics to prevent gut dysbiosis in preterm infants …
1489. Comparison of long-term effect of two dysbiosis models in Wistar rats
1490. Rofecoxib, in contrast to celecoxib, does not have direct antimicrobial effect and does not cause small intestinal dysbiosis in the rat
1491. Gut dysbiosis and recovery of function after spinal cord injury
1492. Intestinal HIF‐1α Deletion Exacerbates Alcoholic Liver Disease through Inducing Intestinal Dysbiosis and Barrier Dysfunction
1493. Development of Electronic-Nose technologies for early disease detection based on microbial dysbiosis
1494. Abstract TP117: Experimental Stroke Induces Chronic Gut Dysbiosis in Male C57BL/6J Mice
1495. Lung microbiome dysbiosis is associated with mortality in COPD
1496. Microbial Dysbiosis and Altered Gut Pathology in Monocrotaline-Induced Pulmonary Hypertension
1497. Gut Microbiota Dysbiosis and Their Impact on Biochemical and Inflammatory Profiles in Cafeteria Diet Fed Sprague Dawley Rats
1498. Omeprazole-induced dysbiosis impacts bile acid metabolism in mice and humans
1499. The relationship between Helicobacter pylori-related microbiota dysbiosis and gastrointestinal tract pathologies
1500. Early-life gut dysbiosis linked to mass mortality in ostriches
1501. Experience of treatment by yoghurt type probiotics in patients suffering from intestinal dysbiosis, which developed on background of polychemotherapy of …
1502. Gut Dysbiosis and Its Treatment in Patients with Functional Dyspepsia
1503. Chronic Psychological Stress Induces Gastritis in C57BL/6 Mice with Decreased Production of Hydrogen Sulphide (H 2S) and Microbial Dysbiosis
1504. Dysbiosis and resilience of gut microbiota in patients with ischemic stroke
1505. Intestinal dysbiosis in carbapenem-resistant Enterobacteriaceae carriers
1506. Gut microbiome meta-analysis reveals dysbiosis is independent of body mass index in predicting risk of obesity-associated CRC
1507. Berberine May Correct Corticosteroid Resistance Induced By Gut Microbiota Dysbiosis in Immune Thrombocytopenia
1508. Altered Non‐Coding RNA‐Histone Acetylation Regulatory Circuit Is Associated With Cognitive Impairment via Gut Dysbiosis in Aging Mice
1509. Dysbiosis personalizes fitness effect of antibiotic resistance in the mammalian gut
1510. Gut Microbiome Dysbiosis and Delirium in Mechanically Ventilated Adult Patients: A Prospective Cohort Study
1511. P861 Short-chain fatty acids as a marker of intestinal dysbiosis in patients with inflammatory bowel diseases
1512. … , Energy Balance, and Metabolism: High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw …
1513. Tc17 cells mediate gut GVHD via IL-22 and dysbiosis
1514. The importance of intestinal dysbiosis in mood disorders
1515. Dysbiosis of intestinal microbiota increases mortality to a respiratory viral infection through elevated production of IFNγ by innate lymphoid cells
1516. Gut dysbiosis and immunological profile in endometriosis
1517. Evaluation of the sensitivity of the intestinal microbiota to bacteriophage preparations in infants with dysbiosis
1518. Correction: fecal microbiota dysbiosis in macaques and humans within a shared environment
1519. Characterization of gut microbiota dysbiosis induced by weaning and diarrhea in Tibetan piglets
1520. Gut dysbiosis and its epigenomic impact on disease
1521. Microbiome, dysbiosis, and atopic dermatitis
1522. Captivity and exposure to the emerging fungal pathogen Batrachochytrium salamandrivorans are linked to perturbation and dysbiosis of the amphibian skin …
1523. … of aronia, red ginseng and shiitake mushroom potentiated insulin secretion and reduced insulin resistance with improving gut microbiome dysbiosis in insulin deficient …
1524. Correlation between dysbiosis of gut microbiota and human colorectal cancer
1525. Modulation of Neurodevelopmental Outcomes using Lactobacillus in a Model of Maternal Microbiome Dysbiosis
1526. Relationship between intestinal dysbiosis and intestinal failure associated liver disease in rat models with short bowel syndrome
1527. Gut Dysbiosis Impairs Serotonergic Gut-Brain Axis and Increases Blood Pressure
1528. Efficacy of Bifidobacterium animalis subsp. lactis (BB-12), B. infantis and Lactobacillus acidophilus (La-5) probiotics to prevent gut dysbiosis in preterm infants …
1529. … : Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis
1530. A Potential Role of Phospholipase 2 Group IIA (PLA2-IIA) in P. gingivalis-Induced Oral Dysbiosis
1531. 17 PERIPARTUM ANTIBIOTIC EXPOSURE INDUCES PERSISTENT GUT DYSBIOSIS, IMPAIRS THE DEVELOPMENT OF IMMUNE TOLERANCE, AND INCREASES …
1532. Compromised intestinal barrier underlies gut microbiota dysbiosis of intestinal diseases
1533. AB067. 209. Unravelling the dysbiosis concept in ulcerative colitis
1534. Dysbiosis before Fecal Microbiota Transplantation Is a Positive Predictor for a Favorable Outcome in Ulcerative Colitis Patients.
1535. Lower Airway Dysbiosis Leads to A Pro-Tumor Inflammatory State and Worsens Non-Small Cell Lung Cancer Prognosis in a Preclinical Model
1536. The virus integrations in gut microbes associated with dysbiosis of microbial community in tumorigenesis of colorectal carcinoma
1537. Microbial Manipulation of Dysbiosis: Prebiotics and Probiotics for the Treatment of Oral Diseases
1538. proton pump inhibition-microbial complications beyond dysbiosis
1539. AI-06 Lupus nephritis is linked to dysbiosis, increased gut leakiness and immunity to an intestinal commensal lachnospiracaea species
1540. Understanding gut function in poultry: the role of commensals, metabolites, inflammation and dysbiosis in intestinal immune function and dysfunction
1541. ESTABLISHING MOST IMPORTANT SYMPTOMS RELATED TO INTESTINAL DYSBIOSIS AND IMMUNODEFICIENCY SYNDROME
1542. Host transcriptomic signatures associated with dysbiosis in a preclinical model of lung cancer.
1543. Dysbiosis and Resulting Monocytosis and immunomodulation as Key Determinants to Nonalcoholic Fatty Liver Disease pathogenesis in Non-obese Non-DM2 …
1544. … ” FOR STATUS CORRECTION OF LARGE INTESTINE MICROBOICENOSIS AND ANTIOXIDANT PROPERTIES OF COLONOCYTES IN EXPERIMENTAL DYSBIOSIS
1545. Experimental treatment of dysbiosis in colitis with hepatitis
1546. Commensal dysbiosis modulates the tumor microenvironment in breast cancer and diminishes efficacy of PD-L1 inhibition
1547. New relation between dysbiosis of the vaginal and endometrial microbiota and RIF found
1548. Diet-Induced dysbiosis of the intestinal microbiota in broiler chickens
1549. Airway Microbial Dysbiosis Induced Neutrophilic Inflammation Leads to Bronchopulmonary Dysplasia-Like Phenotype in Mice
1550. High-Fat Diet-Induced Gut Dysbiosis Promotes Intestinal Adenoma-Adenocarcinoma Sequence Through Activation of MCP-1/CCR2 Axis
1551. Effect of intestinal fungal dysbiosis on corneal wound healing in mice
1552. Candida Parapsilosis Sensu Stricto Can Act as a Pathobiont in Conditions of Oral Dysbiosis
1553. Early-life gut microbiota dysbiosis in children with atopic dermatitis
1554. Gut Dysbiosis Leads to Increased Microglial Activation and Inflammatory Response Acutely after Traumatic Brain Injury in Rats
1555. Study of intestinal dysbiosis (“dysbacteriosis”): state of problem and new trends
1556. Plasticity of Vagal Afferent Neurons During Gut Microbial Dysbiosis and Inflammation
1557. THE SIGNATURE OF INTESTINAL DYSBIOSIS IN INFLAMMATORY RHEUMATIC DISEASES.
1558. IL-33 induced by dysbiosis in vaginal microbiota contributes to impaired antiviral immunity against herpes simples virus infection to vaginal mucosa
1559. Evaluation of Liquid Array Diagnostics for microbiota-based diagnosis of dysbiosis
1560. Glycomic Determinants of Gut Microbial Dysbiosis and Translocation During Suppressed HIV Infection
1561. Gut Dysbiosis in Dogs and Cats
1562. deficiency-induced gut microbial dysbiosis degrades the colonic mucus barrier in Cyp27b1 knockout mouse model
1563. Defining Microbial Signatures of Gut Dysbiosis in Models of Anxiety-related Disorders
1564. Dysbiosis of the Fecal Microbiota in Patients with Cholangiocarcinoma: A Pilot Study
1565. 774-P: Not Carbohydrate but Sucrose Intake Is Associated with Gut Dysbiosis in Japanese Patients with Type 2 Diabetes
1566. Commentary: Loss of Function Dysbiosis Associated with Antibiotics and High Fat, High Sugar Diet
1567. The attenuation of cytokine response might be correlated with gut dysbiosis in nontuberculous mycobacteria lung disease
1568. Lipocalin-2 Is Associated with Greater Intestinal Dysbiosis in a Mouse Model of Short Bowel Syndrome
1569. Intestinal Permeability and Microbial Dysbiosis in Acute Coronary Syndrome (MIACS study)
1570. 2581. An Invertebrate Model to Study Gut Microbiome Dysbiosis.
1571. Gut microbial dysbiosis in individuals with Sjögren’s disease
1572. Lower Airway Dysbiosis Is Necessary for Neutrophilic and Th17 Lower Airway Inflammation in a Pre-Clinical Model of Smoke Induced COPD
1573. Salivary mycobiome dysbiosis and its potential impact on bacteriome shifts and host immunity in oral lichen planus
1574. Index of conditionally-pathogenic microflora: forecasting the risk of dysbiosis development
1575. Dysbiosis of intestinal microbiota and application of probiotics and synbiotics
1576. Gut dysbiosis in ankylosing spondylitis is associated with increased fecal calprotectin
1577. Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
1578. The Impact of Uremia and Intestinal Dysbiosis on Hepatic Drug Metabolism in a Rat Model of Progressive Chronic Kidney Disease
1579. Lipopolisacharid disrupts the function of the liver in dysbiosis
1580. Sensing Fungal Dysbiosis by Gut-Resident CX3CR1+ Mononuclear Phagocytes Aggravates Allergic Airway Disease
1581. Oral Dysbiosis–Balancing Role of Oral Physicians.
1582. Prediction of the dysbiosis development risk by indicators of the condition-pathogenic microflora index
1583. A46 FECAL β-DEFENSIN LEVELS AS A RELIABLE BIOMARKER OF INTESTINAL DYSBIOSIS
1584. Rethinking microbial reconstruction for dysbiosis-related disease
1585. A285 MICROBIAL DYSBIOSIS ENHANCES PAIN PERCEPTION AND DRG NEURON EXCITABILITY
1586. Using oral and lung microbiome to assess microbial dysbiosis and inflammatory response to electronic cigarettes and to cigarettes
1587. Intestinal dysbiosis drives liver disease progression via NLRP3 in the Mdr2-/-model of primary sclerosing cholangitis
1588. Examining the Role of Gut Dysbiosis in Neuroinflammation and Hypertension in a Model of Obstructive Sleep Apnea
1589. PF760 DYSBIOSIS IN GUT MICROBIOTA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN BE DETERMINED BY THE COMBINATION …
1590. EXPERIMENTAL INTESTINAL DYSBIOSIS IN RATS INCREASES THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER AND INDUCES NEUROINFLAMMATION
1591. P267 Relationship between morphological alteration of paneth cells and dysbiosis in patients with inflammatory bowel disease
1592. Multi-compartment profiling of bacterial and host metabolites identifies intestinal dysbiosis and its functional consequences in the critically ill child
1593. Evaluation of large intestine dysbiosis in patients with combination of diabetes mellitus II type and chronic acalculous cholecistitis
1594. 747 Pilot Study of Gut Dysbiosis and Bile Acid Dysmetabolism in Active Ulcerative Colitis
1595. Cannabinoid receptor 1 blockade attenuates metabolic inflammation and gut microbial dysbiosis during high-fat diet-induced obesity.
1596. Bacterial dysbiosis in the mouse model of hemochromatosis: Increased risk of colitis and colitis-associated colon cancer
1597. Trust your gut–Understanding dysbiosis
1598. Understanding causality and treatment of bacterial dysbiosis in the human gut using systems biology approaches
1599. Role of Complement System in Dysbiosis and Periodontal Inflammation―An Overview.
1600. Dysbiosis and Probiotics in ICU
1601. Study of intestinal dysbiosis (“dysbacteriosis”): state of problem and new trends YS Tsimmerman
1602. Research Article Deficiency of Dietary Fiber in Slc5a8-Null Mice Promotes Bacterial Dysbiosis and Alters Colonic Epithelial Transcriptome towards …
1603. Abstract LB-062: Deficiency of dietary fiber in Slc5a8-null mice promotes bacterial dysbiosis and inflammatory milieu in colon
1604. Enteric Dysbiosis and Fecal Calprotectin Expression in Premature Infants
1605. Infection of theBiomphalaria glabrata vector snailbySchistosoma mansoniparasites drives snail microbiota dysbiosis
1606. Dysbiosis of gut microbiota in chronic stressed patients with endometriosis
1607. Microbiological characteristic of the experimental use of autobiotic on the model of antibiotic–induced dysbiosis in old rats
1608. The effect of amoxicillin-induced intestinal dysbiosis and cholera toxin on gut health and allergic sensitization to cow’s milk–a study in Brown Norway rats
1609. 513 A Survey of Bacterial Microbiome Dysbiosis in Burn ICU Patients
1610. CHANGES IN THE STRUCTURE OF THE DYSBIOSIS OF THE INTESTINE IN THE ADULT POPULATION FOR LONG-TERM OBSERVATION PERIOD
1611. Prebiotic and Probiotic Therapies for Gut Dysbiosis in Humans
1612. DOP088 Microbial dysbiosis increases experimental colitis by interfering with short-chain fatty acid-dependent mucosal Reg3B expression
1613. 3117 “A Gut Feeling”: Autonomic Instability and Dysbiosis in Connective Tissue Disease
1614. Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: A systematic review
1615. Examining the role of gut dysbiosis in cerebral small vessel disease
1616. Dysbiosis of Lower Respiratory Tract Microbiome Might Contribute to the Inflammation and Further Alter Its Function
1617. ROLE OF CART ON GUT MICROBIAL DYSBIOSIS, STUDYING THE GUT/BLOOD MICROBIOTA DURING THE FIRST TWO YEARS OF SUPPRESSIVE CART
1618. The Role of Gut Microbiota in Health and Disease: How Intestinal Dysbiosis Contributes to Pathogenesis in Undernutrition and How It Can Be Treated
1619. Biochemical indicators of inflammation and dysbiosis in the oral cavity of patients with mandibular fractures on the background of the hepato-biliary pathology
1620. Interplay between diet, gut microbiome and host responses during the development and management of dysbiosis
1621. L, Igor Y M. Microbiota of the gut: Antibiotic-Induced Dysbiosis and the Adverse Effects on Human Health. Sci J Gastroenterol & Hepatol. 1 (1): 2018
1622. 72: Dysbiosis of the cervicovaginal microbiome and decreased fertility occur in a nonhuman primate model of PCOS
1623. 2024-P: Protective Role of Lipocalin 2 in High-Fat Diet-Induced Gut Microbiota Dysbiosis
1624. Effect of direct vat set pickle on the restoration of antibiotic-induced intestinal dysbiosis in mice.
1625. Neonatal Oral Exposure to Environmental Chemicals Produces Persistent Dysbiosis Corresponding to Hepatic Epigenetic Reprogramming in Adult Mice
1626. Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
1627. Titanium particles/ions favour dysbiosis
1628. Food anaphylaxis induces oral dysbiosis and IL-33–mediated exacerbation in the intestine
1629. Gut microbiota dysbiosis by high fructose intake induces cardiometabolic syndrome
1630. Gut dysbiosis in the development of cerebral small vessel disease
1631. Modeling of viral-bacterial infections against antibiotic-induced intestinal dysbiosis
1632. Features of structural-morphological changes in cases of experimental intestinal antibiotic-induced dysbiosis
1633. Hypertension‐associated dysbiosis leads to elevated sympathetic drive and alterations in neurotransmitter signaling in the nucleus of the solitary tract in WKY
1634. Cutaneous and Gastrointestinal Dysbiosis in Immunodeficient Mice
1635. Development of intestinal dysbiosis and necrotizing enterocolitis in infants and the treatment of enterocolitis
1636. Intestinal dysbiosis in women in early pregnancy
1637. Metatranscriptomic Reveals Functional Abnormalities of Lower Airway Dysbiosis Signatures Identified in Humans
1638. Induction of Lower Airway Dysbiosis with Oral Commensals Leads to a Time-Dependent and Persistent Th17 Inflammatory Profile in the Lower Airways of Mice …
1639. The interest of inulin-type fructans in the modulation of dysbiosis and metabolic alterations: experimental approach and nutritional interventions in humans
1640. P871 Successful detection of dysbiosis and altered short-chain-fatty acids levels in in vitro colonic microbiota culture system using faecal samples of ulcerative colitis
1641. Abstract WP140: The Effect of Age-related Gut Dysbiosis on Microglial Function in Cerebral Amyloid Angiopathy
1642. Dysbiosis and depressive disorders. Survey review
1643. Necrotizing enterocolitis associated with dysbiosis of preterm gut microbiome: A review
1644. Targeting dysbiosis of diabetes and colorectal cancer: Gut a feeling, it plays a role
1645. Long-term iron deficiency and iron supplementation exacerbate acute DSS-induced colitis and are associated with significant dysbiosis
1646. P368 Low prevalence of vaginal dysbiosis in kenyan adolescent girls
1647. Dysbiosis Of The Gut Microbiome Associated With Parkinson’s Disease Pathophysiology
1648. Microbiological characteristic of the experimental use of autobiotic on the model of antibiotic induced dysbiosis in old rats
1649. Pomegranate Peel Extract Alters the Microbiome in Mice and Dysbiosis Caused by Citrobacter Rodentium Infection (P20-043-19)
1650. Correction of large intestine dysbiosis in patients with acute hepatitis B
1651. Would Helicobacter pylori eradication influence dysbiosis of gastrointestinal microbiota.
1652. Dietary sulfate-driven and gut dysbiosis-triggered breast cancer-related gene upregulation
1653. Dysbiosis reprograms the differentiation of thymus-derived regulatory T cells
1654. The relationship between Helicobacter pylori–related microbiota dysbiosis and gastrointestinal tract pathologies
1655. P860 Combination of prebiotic FOS and adalimumab for prevention of dysbiosis in active Crohn’s disease: A pilot study
1656. Dysbiosis of the digestive tract after antibiotics treatment
1657. MICROBIOLOGICAL ANALYSIS OF THE INTESTINAL MICROFLORA FOR DYSBIOSIS IN PATIENTS WITH CHRONIC HEPATITIS B
1658. The Gut Microbial Dysbiosis, its Fallouts and Redressal
1659. Maternal Exposure of Mice to Benzo [a] pyrene (BP) Leads to Potentiation of Neonatal Hyperoxic Lung Injury and Dysbiosis of Intestinal Microbiome: Potential Role of …
1660. Response to Treatment of Helicobacter pylori-associated Dyspepsia: Eradication of Helicobacter pylori or Correction of Gastric or Intestinal Dysbiosis?
1661. SP380 NORMAL WEIGHT OBESITY IS ASSOCIATED WITH GUT MICROBIOTA DYSBIOSIS AMONG PATIENTS ON HEMODIALYSIS
1662. 8.4 GUT DYSBIOSIS AND AUTOIMMUNE FEATURES IN SCHIZOPHRENIA FUEL BROKEN BARRIER HYPOTHESES
1663. P028 DYSBIOSIS DRIVEN LUMINAL MALMETABOLISM INCREASES THE RISK OF C. DIFFICLILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS
1664. NLRP6 inflammasome-mediated dysbiosis augments acetaminophen induced acute liver injury
1665. Western Diet-Induced Dysbiosis Is Associated with Intestinal Hyperplasia and Dysregulation of FXR-FGF19 Gene Expression in Juvenile Iberian Pigs (OR26 …
1666. P086 Eukaryotic microbial dysbiosis in treatment-naïve patients with newly diagnosed Crohn’s disease
1667. Effect of dysbiosis in Irritable Bowel Syndrome (IBS) via the modulation of the intestinal epithelial barrier: regulation of ROS production
1668. Exploratory Studies of Microbiome Dysbiosis and Plasticity in Mice and Humans
1669. A whiff of change for dysbiosis treatment
1670. Glyphosate Holds Potential to Induce Dysbiosis Associated Pathologies in Humans
1671. Dysbiosis in the Microbiome Associated with Inflammatory Bowel Disease and the Potential of Dietary Fibers
1672. Dysbiosis, gut, cognitive movement disorders and nonmotor skin diseases
1673. Pre-Transplant and Peri-d100 Gastrointestinal Dysbiosis Is Associated with the Subsequent Development of Chronic Graft-Versus-Host Disease
1674. IDDF2018-ABS-0203 Modulation of intestinal dysbiosis in patients with constipation-predominant irritable bowel syndrome using lactobacillus-containing cultured milk …
1675. Dysbiosis: A Potential Novel Strategy for Control of Subterranean Termites
1676. Food allergy is associated with altered epithelial gene expression driven by early life dysbiosis
1677. Candida albicans and staphylococcus aureus co-infection in mice after antibiotic-induced dysbiosis
1678. Gut microbial dysbiosis is associated with fatigue in Behçet’s Disease.
1679. Pre-Transplant and Peri-d100 Gastrointestinal Dysbiosis Is Associated with the Subsequent Development of Chronic Graft-Versus-Host Disease
1680. SP410 Microbiota dysbiosis contributes to liver injury in apolipoprotein knockout mice through the disruption of cholesterol homeostasis
1681. Gut dysbiosis in individuals with and without Sjögren’s disease
1682. Breaking the cycle of antimicrobial therapy in recurrent bacterial vaginosis. A multifactorial predisposition and risk vaginal dysbiosis case report
1683. 308-LB: A Short Period of Exposure to Air Pollution (PM2. 5) Is Sufficient to Induce Dysbiosis, Hyperphagia, and Fat Mass Gain
1684. Dysbiosis Promotes Gastric Diseases and Impede Therapies by Hijacking Gut Immune Homeostasis
1685. Diagnosis and treatment of dysbiosis in GI disease cases.
1686. Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
1687. Gut Dysbiosis and Enterotypes Distribution in Different Degrees of Patients with Obstructive Sleep Apnea-Hypopnea Syndrome
1688. Corrigendum to “Exercise prevents high fat diet-induced bone loss, marrow adiposity and dysbiosis in male mice”
1689. Abstract WP107: Estrogen Deficiency Induces Microbiota Dysbiosis Impacting Stroke Outcome in Female Rats
1690. The Pathobiology of Osteoarthritis in Obesity: The Role of Synovial Inflammation, Joint Insulin Resistance, and Dysbiosis of the Gut Microbiome
1691. Lung dysbiosis drives post hematopoietic cell transplantation inflammation
1692. Dysbiosis shapes vaccine responses
1693. Research Article Dysbiosis and Variation in Predicted Functions of the Granulation Tissue Microbiome in HPV Positive and Negative Severe Chronic …
1694. SuO031 DISRUPTION OF CELLULAR CHOLESTEROL HOMEOSTASIS INDUCED BY GUT MICROBIOTA DYSBIOSIS ACCELERATES INTERSTITIAL INJURY IN …
1695. Research progress of periodontitis and periodontal dysbiosis
1696. … Effect of Bifidobacterium Bifidum BGN4 Paraprobiotics on DSS-Induced Colitis Model in Mice: Impact on Intestinal Barrier Integrity, Inflammation and Gut Dysbiosis
1697. Gut Dysbiosis Increases Gut Barrier Damage during Anti-Leukemia Chemotherapy: Implications for Acute Graft-Versus-Host Disease
1698. Dysbiosis, small intestinal bacterial overgrowth and biofilms in autism and chronic illness
1699. IDDF2019-ABS-0159 Oligofructose ameliorates nonalcoholic fatty liver disease by regulating gut microbiota dysbiosis in mice
1700. Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel
1701. Dysbiosis-Associated Changes in Host Metabolism Produce Lactate to Support Enterobacterial Expansion During Inflammation
1702. Microbial Dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer
1703. DEVELOPMENT OF SUPPOSITORIES FOR THE CORRECTION OF VAGINAL DYSBIOSIS
1704. Signature Bacteria of Lower Airway Dysbiosis Activate TLR4 and Inflammasome Pathways in Airway Epithelial Cells
1705. Microbial Dysbiosis Associated with Impaired Intestinal Na+/H+ Exchange Accelerates and Exacerbates Colitis in Ex-Germ Free Mice
1706. Abstract# 3108 Combined exposure to air pollution and maternal stress induces sex-specific, autism-like social behavior deficits and gut dysbiosis in mice
1707. Peroxisome Proliferator Activated Receptor Activity and Microbial Dysbiosis: Convergence of Dual Mechanisms that Contribute to Obesity following Phthalate …
1708. Assessment of the cellular composition of the oral mucosa in young people, depending on the state of dysbiosis
1709. Nasal dysbiosis linked to GPA
1710. Dysbiosis in Children Born by C-section
1711. Gut dysbiosis with decreased Akkermansia muciniphila and differential expression of tumor‐associated genes contribute to a tumor‐preventive microenvironment in …
1712. Effects of Bacillus licheniformis BL63516 on the intestinal mucosal barrier function of mice with antibiotic-induced dysbiosis.
1713. … OF TERTIARY LYMPHOID TISSUES AND DECREASED LAMINA PROPRIA IGA+ B CELLS LEADING TO MICROBIOME DYSBIOSIS AND WORSE INFLAMMATION …
1714. Correction to: Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex …
1715. Activated Duodenal Eosinophilia Is Associated with Dysbiosis in Functional Dyspepsia Patients: 471
1716. Characterising dysbiosis in Alzheimer’s disease utilising the APP/PS1 mouse model
1717. Front Cover: ω‐3 PUFAs Alleviate High‐Fat Diet–Induced Circadian Intestinal Microbes Dysbiosis
1718. Early‐Life Sickness May Predispose Individuals to Behavioral Changes Following Gut Dysbiosis in Adulthood
1719. IDDF2019-ABS-0300 Dysbiosis of gut fungal microbiota in colorectal cancer: an assessment from faecal microbiome secretome
1720. Opioid Withdrawal Shifts Amygdalar Transcriptome and is Correlated with Gut Dysbiosis (P1. 1-031)
1721. Dysbiosis of the Oral Microbiome: Association with and Prevention of Human Diseases
1722. Colic linked to gut inflammation and dysbiosis
1723. … INFLAMMATORY CYTOKINES IN COPROFILTRATES OF THE PATIENTS WITH REACTIVE ARTHRITIS DEPENDING ON THE DEGREE OF INTESTINAL DYSBIOSIS
1724. Colic linked to gut inflammation and dysbiosis
1725. A distinct bacterial dysbiosis associated skin inflammation in ovine footrot.
1726. Microbial dysbiosis in very early onset inflammatory bowel disease patients with IL10RA deficiency: A cross-sectional study
1727. Development of an Antihypertensive Functional Food that Corrects Gut Dysbiosis
1728. Dysbiosis as influencing factor on persisting sinusitis
1729. Cognitive Movement Disorders, Gut Dysbiosis and Skin Diseases
1730. Microecological Koch’s postulates reveal that intestinal microbiota dysbiosis contributes to shrimp white feces syndrome
1731. Is Alzheimer’s disease a polymicrobial host microbiome dysbiosis?
1732. The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?
1733. Dysbiosis of the gut and lung microbiome has a role in asthma
1734. Meta‐analysis of gut dysbiosis in Parkinson’s disease
1735. A plant genetic network for preventing dysbiosis in the phyllosphere
1736. Gut microbiota and dysbiosis in Alzheimer’s disease: implications for pathogenesis and treatment
1737. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
1738. Gut-lung axis and dysbiosis in COVID-19
1739. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism
1740. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities–role of gut microbiota dysbiosis
1741. The nexus between periodontal inflammation and dysbiosis
1742. Problems with the concept of gut microbiota dysbiosis
1743. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation
1744. Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity
1745. Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production
1746. gutMDisorder: a comprehensive database for dysbiosis of the gut microbiota in disorders and interventions
1747. Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer’s disease
1748. Gallstone disease, obesity and the Firmicutes/Bacteroidetes ratio as a possible biomarker of gut dysbiosis
1749. Naringin attenuates high fat diet induced non-alcoholic fatty liver disease and gut bacterial dysbiosis in mice
1750. Gut dysbiosis is prevailing in Sjögren’s syndrome and is related to dry eye severity
1751. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson’s disease
1752. Exposure to microplastics impairs digestive performance, stimulates immune response and induces microbiota dysbiosis in the gut of juvenile guppy (Poecilia …
1753. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
1754. Modeling microbial abundances and dysbiosis with beta-binomial regression
1755. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation
1756. Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer’s disease mouse model
1757. Gut dysbiosis in Huntington’s disease: associations among gut microbiota, cognitive performance and clinical outcomes
1758. Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis
1759. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice
1760. Current perspectives on gut microbiome dysbiosis and depression
1761. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: Role of short‐chain fatty acids
1762. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
1763. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington’s disease
1764. Fatty acid diets: regulation of gut microbiota composition and obesity and its related metabolic dysbiosis
1765. Quercetin improves gut dysbiosis in antibiotic-treated mice
1766. Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats
1767. Lactobacilli‐containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs
1768. Oral dysbiosis and autoimmunity: from local periodontal responses to an imbalanced systemic immunity. A review
1769. Gut microbiota dysbiosis–immune hyperresponse–inflammation triad in coronavirus disease 2019 (COVID-19): Impact of pharmacological and nutraceutical …
1770. … enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by …
1771. Association of oral dysbiosis with oral cancer development
1772. Microbiome dysbiosis in lung cancer: from composition to therapy
1773. Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
1774. Impairment of spermatogenesis and sperm motility by the high-fat diet-induced dysbiosis of gut microbes
1775. The role of dietary fibre in modulating gut microbiota dysbiosis in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
1776. Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma
1777. The link between gut dysbiosis and neuroinflammation in Parkinson’s disease
1778. Gut microbiome dysbiosis and endotoxemia-Additional pathophysiological explanation for increased COVID-19 severity in obesity
1779. Gut microbial dysbiosis in the irritable bowel syndrome: a systematic review and meta-analysis of case-control studies
1780. Astragalin attenuates dextran sulfate sodium (DSS)-induced acute experimental colitis by alleviating gut microbiota dysbiosis and inhibiting NF-κB activation …
1781. Gut microbiota dysbiosis associated with altered production of short chain fatty acids in children with neurodevelopmental disorders
1782. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis
1783. Foodborne titanium dioxide nanoparticles induce stronger adverse effects in obese mice than non‐obese mice: gut microbiota dysbiosis, colonic inflammation, and …
1784. Hypertension is associated with intestinal microbiota dysbiosis and inflammation in a Brazilian population
1785. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases
1786. Warming drives ecological community changes linked to host-associated microbiome dysbiosis
1787. Amyloid–polyphenol hybrid nanofilaments mitigate colitis and regulate gut microbial dysbiosis
1788. Gut dysbiosis dysregulates central and systemic homeostasis via suboptimal mitochondrial function: assessment, treatment and classification implications
1789. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure
1790. Multi-modal single-cell analysis reveals brain immune landscape plasticity during aging and gut microbiota dysbiosis
1791. Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice
1792. The impact of lung microbiota dysbiosis on inflammation
1793. Gut dysbiosis contributes to the imbalance of Treg and Th17 cells in Graves’ disease patients by propionic acid
1794. Honeybee gut microbiota dysbiosis in pesticide/parasite co-exposures is mainly induced by Nosema ceranae
1795. Defining coral bleaching as a microbial dysbiosis within the coral holobiont
1796. Respiratory tract dysbiosis is associated with worse outcomes in mechanically ventilated patients
1797. The association between vaginal microbiota dysbiosis, bacterial vaginosis, and aerobic vaginitis, and adverse pregnancy outcomes of women living in sub …
1798. Gut microbiome dysbiosis alleviates the progression of osteoarthritis in mice
1799. Structural characteristics of a mannoglucan isolated from Chinese yam and its treatment effects against gut microbiota dysbiosis and DSS-induced colitis in mice
1800. … of a personalized medicine: a translational research on gene single nucleotide polymorphisms (SNPs) linked to chronic oral dysbiosis in 96 Caucasian patients
1801. Gut dysbiosis develops before metabolic disturbance and cognitive decline in high-fat diet–induced obese condition
1802. Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice
1803. Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22–dependent manner
1804. Characteristics and dysbiosis of the gut microbiome in renal transplant recipients
1805. Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis
1806. Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model
1807. Early-life gut dysbiosis linked to juvenile mortality in ostriches
1808. Long-term exposure of high concentration heavy metals induced toxicity, fatality, and gut microbial dysbiosis in common carp, Cyprinus carpio
1809. High‐fat diet‐induced dysbiosis mediates MCP‐1/CCR2 axis‐dependent M2 macrophage polarization and promotes intestinal adenoma‐adenocarcinoma sequence
1810. Vitamin D receptor protects against dysbiosis and tumorigenesis via the JAK/STAT pathway in intestine
1811. Probiotic strains and intervention total doses for modulating obesity-related microbiota dysbiosis: a systematic review and meta-analysis
1812. Probiotic supplementation during the perinatal and infant period: effects on gut dysbiosis and disease
1813. Sodium butyrate alleviates mouse colitis by regulating gut microbiota dysbiosis
1814. … cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis
1815. High-fat diet and antibiotics cooperatively impair mitochondrial bioenergetics to trigger dysbiosis that exacerbates pre-inflammatory bowel disease
1816. Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet
1817. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer
1818. … BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis
1819. Clostridium butyricum modulates the microbiome to protect intestinal barrier function in mice with antibiotic-induced dysbiosis
1820. Viral infection-induced gut dysbiosis, neuroinflammation, and α-synuclein aggregation: Updates and perspectives on COVID-19 and neurodegenerative disorders
1821. Sub-chronic carbendazim exposure induces hepatic glycolipid metabolism disorder accompanied by gut microbiota dysbiosis in adult zebrafish (Daino rerio)
1822. Gut microbiome reveals specific dysbiosis in primary osteoporosis
1823. Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner
1824. Hypoglycemic effect of ginsenoside Rg5 mediated partly by modulating gut microbiota dysbiosis in diabetic db/db mice
1825. Periodontal inflammation: Integrating genes and dysbiosis
1826. Gut microbiota dysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: a cross-sectional study in Taiwan
1827. Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer
1828. Dietary supplementation of black rice anthocyanin extract regulates cholesterol metabolism and improves gut microbiota dysbiosis in C57BL/6J mice fed a high‐fat …
1829. Overview on osteoporosis, periodontitis and oral dysbiosis: the emerging role of oral microbiota
1830. Bacillus subtilis HU58 and Bacillus coagulans SC208 Probiotics Reduced the Effects of Antibiotic-Induced Gut Microbiome Dysbiosis in an M-SHIME® Model
1831. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction
1832. Is gut microbiota dysbiosis a predictor of increased susceptibility to poor outcome of COVID-19 patients? An update
1833. Dysbiosis in the gut microbiota of soil fauna explains the toxicity of tire tread particles
1834. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route
1835. Dysregulation of synaptic pruning as a possible link between intestinal microbiota dysbiosis and neuropsychiatric disorders
1836. Gut dysbiosis and heart failure: navigating the universe within
1837. Vaginal dysbiosis associated-bacteria Megasphaera elsdenii and Prevotella timonensis induce immune activation via dendritic cells
1838. Bilberry anthocyanins ameliorate NAFLD by improving dyslipidemia and gut microbiome dysbiosis
1839. The gut microbiome in patients with chronic pancreatitis is characterized by significant dysbiosis and overgrowth by opportunistic pathogens
1840. Neonatal intestinal dysbiosis
1841. A core microbiota dominates a rich microbial diversity in the bovine udder and may indicate presence of dysbiosis
1842. Polysaccharide from flammuliana velutipes improves colitis via regulation of colonic microbial dysbiosis and inflammatory responses
1843. Intestinal dysbiosis and tryptophan metabolism in autoimmunity
1844. Titanium particles and ions favor dysbiosis in oral biofilms
1845. Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners
1846. Fungal gut microbiota dysbiosis and its role in colorectal, oral, and pancreatic carcinogenesis
1847. Liver cirrhosis and sarcopenia from the viewpoint of dysbiosis
1848. Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma
1849. Supplementation of inulin with various degree of polymerization ameliorates liver injury and gut microbiota dysbiosis in high fat-fed obese mice
1850. Dysbiosis of oral microbiota is associated with systemic lupus erythematosus
1851. Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modifications
1852. … structure of a Dendrobium officinale polysaccharide and its protective effect against dextran sulfate sodium-induced colitis via alleviating gut microbiota dysbiosis
1853. A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
1854. Gut microbiota dysbiosis-induced activation of the intrarenal renin–angiotensin system is involved in kidney injuries in rat diabetic nephropathy
1855. Traditional Chinese Medicine Formula Kang Shuai Lao Pian Improves Obesity, Gut Dysbiosis, and Fecal Metabolic Disorders in High-Fat Diet-Fed Mice
1856. Fungal dysbiosis and intestinal inflammation in children with beta-cell autoimmunity
1857. Probiotics dietary supplementation for modulating endocrine and fertility microbiota dysbiosis
1858. Starch-rich diet induced rumen acidosis and hindgut dysbiosis in dairy cows of different lactations
1859. Impact of Symbiosis Between Trichomonas vaginalis and Mycoplasma hominis on Vaginal Dysbiosis: A Mini Review
1860. Gut microbial dysbiosis in individuals with Sjögren’s syndrome
1861. Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms
1862. Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: a pilot study
1863. High-meat-protein high-fat diet induced dysbiosis of gut microbiota and tryptophan metabolism in wistar rats
1864. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity—a preliminary report
1865. Recent advancements in the development of modern probiotics for restoring human gut microbiome dysbiosis
1866. Intestinal dysbiosis and necrotizing enterocolitis: assessment for causality using Bradford Hill criteria
1867. Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
1868. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
1869. Candida Administration Worsens Cecal Ligation and Puncture-Induced Sepsis in Obese Mice Through Gut Dysbiosis Enhanced Systemic Inflammation …
1870. The dysbiosis of gut microbiota caused by low-dose cadmium aggravate the injury of mice liver through increasing intestinal permeability
1871. Porphyromonas gingivalis: Immune Subversion Activities and Role in Periodontal Dysbiosis
1872. Gut microbiota dysbiosis in functional dyspepsia
1873. Integrating the Ecosystem Services Framework to Define Dysbiosis of the Breastfed Infant Gut: The Role of B. infantis and Human Milk Oligosaccharides
1874. Probiotics protect against gut dysbiosis associated decline in learning and memory
1875. Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis
1876. Sarcodon aspratus polysaccharides ameliorated obesity-induced metabolic disorders and modulated gut microbiota dysbiosis in mice fed a high-fat diet
1877. Mucosal IgA Prevents Commensal Candida albicans Dysbiosis in the Oral Cavity
1878. Cognitive-behavioural correlates of dysbiosis: A review
1879. Gut microbiome dysbiosis and depression: A comprehensive review
1880. Odd-numbered agaro-oligosaccharides alleviate type 2 diabetes mellitus and related colonic microbiota dysbiosis in mice
1881. Paneth cell α-defensin misfolding correlates with dysbiosis and ileitis in Crohn’s disease model mice
1882. NLR and intestinal dysbiosis-associated inflammatory illness: drivers or dampers?
1883. Post-antibiotic gut dysbiosis-induced trabecular bone loss is dependent on lymphocytes
1884. Characterization of fungal and bacterial dysbiosis in young adult Chinese patients with Crohn’s disease
1885. Dysbiosis of gut microbiota is associated with gastric carcinogenesis in rats
1886. … -fermented red ginseng and its constituents ginsenoside Rd and protopanaxatriol alleviate anxiety/depression in mice by the amelioration of gut dysbiosis
1887. Repetitive, mild traumatic brain injury results in a progressive white matter pathology, cognitive deterioration, and a transient gut microbiota dysbiosis
1888. Intake of sucrose affects gut dysbiosis in patients with type 2 diabetes
1889. A polysaccharide from Fagopyrum esculentum Moench bee pollen alleviates microbiota dysbiosis to improve intestinal barrier function in antibiotic-treated mice
1890. Oxidation of fish oil exacerbates alcoholic liver disease by enhancing intestinal dysbiosis in mice
1891. Gastrointestinal disorders and metabolic syndrome: Dysbiosis as a key link and common bioactive dietary components useful for their treatment
1892. Wheat consumption aggravates colitis in mice via amylase trypsin inhibitor–mediated dysbiosis
1893. Characterization of the vaginal DNA virome in health and dysbiosis
1894. Intestinal dysbiosis in, and enteral bacterial therapies for, systemic autoimmune diseases
1895. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice
1896. Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice
1897. Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis
1898. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis
1899. Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding
1900. Human intervertebral discs harbour a unique microbiome and dysbiosis determines health and disease
1901. Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome
1902. Gut bacterial dysbiosis in children with intractable epilepsy
1903. Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (ALL) during chemotherapy
1904. The developing gut–lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model
1905. Different types of atrial fibrillation share patterns of gut microbiota dysbiosis
1906. Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson’s disease
1907. 12α-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats
1908. Consumption of a high energy density diet triggers microbiota dysbiosis, hepatic lipidosis, and microglia activation in the nucleus of the solitary tract in rats
1909. Minocycline and its impact on microbial dysbiosis in the skin and gastrointestinal tract of acne patients
1910. Integrated phosphoproteomic and metabolomic profiling reveals perturbed pathways in the hippocampus of gut microbiota dysbiosis mice
1911. Benzene exposure induces gut microbiota dysbiosis and metabolic disorder in mice
1912. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH
1913. Dysbiosis of saliva microbiome in patients with oral lichen planus
1914. Electroacupuncture relieves irritable bowel syndrome by regulating IL-18 and gut microbial dysbiosis in a trinitrobenzene sulfonic acid-induced post-inflammatory …
1915. Gut dysbiosis and serotonin: intestinal 5-HT as a ubiquitous membrane permeability regulator in host tissues, organs, and the brain
1916. Gut microbiota dysbiosis enhances migraine-like pain via TNFα upregulation
1917. Sodium butyrate ameliorates gut microbiota dysbiosis in lupus-like mice
1918. Dietary carbohydrate constituents related to gut dysbiosis and health
1919. Fucoidan isolated from Ascophyllum nodosum alleviates gut microbiota dysbiosis and colonic inflammation in antibiotic-treated mice
1920. Gut microbial dysbiosis and plasma metabolic profile in individuals with vitiligo
1921. Contribution of uremic dysbiosis to insulin resistance and sarcopenia
1922. Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson’s disease
1923. Inflammatory bowel diseases: host-microbial-environmental interactions in dysbiosis
1924. Cross-talk between diet-associated dysbiosis and hand osteoarthritis
1925. Fusobacterium nucleatum Causes Microbial Dysbiosis and Exacerbates Visceral Hypersensitivity in a Colonization-Independent Manner
1926. Apple polysaccharide protects ICR mice against colitis associated colorectal cancer through the regulation of microbial dysbiosis
1927. Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation
1928. Gut fungal dysbiosis and altered bacterial‐fungal interaction in patients with diarrhea‐predominant irritable bowel syndrome: An explorative study
1929. Gastrointestinal dysbiosis following diethylhexyl phthalate exposure in zebrafish (Danio rerio): Altered microbial diversity, functionality, and network connectivity
1930. Dysbiosis in Parkinson’s disease might be triggered by certain antibiotics
1931. Separating the empirical wheat from the pseudoscientific chaff: A critical review of the literature surrounding glyphosate, dysbiosis and wheat-sensitivity
1932. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age
1933. Gut microbiota dysbiosis might be responsible to different toxicity caused by Di-(2-ethylhexyl) phthalate exposure in murine rodents
1934. Intestinal dysbiosis and the developing lung: the role of toll-like receptor 4 in the gut-lung axis
1935. Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
1936. Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts
1937. Administration of Candida albicans to dextran sulfate solution treated mice causes intestinal dysbiosis, emergence and dissemination of intestinal Pseudomonas …
1938. The obesity-related gut bacterial and viral dysbiosis can impact the risk of colon cancer development
1939. Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism
1940. Meta-analysis of 16S rRNA microbial data identified distinctive and predictive microbiota dysbiosis in colorectal carcinoma adjacent tissue
1941. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: a cross sectional study
1942. Microbiome profiling reveals gut dysbiosis in the metabotropic glutamate receptor 5 knockout mouse model of schizophrenia
1943. Distinct types of gut microbiota dysbiosis in hospitalized gastroenterological patients are disease non-related and characterized with the predominance of …
1944. Inulin alleviates hypersaline-stress induced oxidative stress and dysbiosis of gut microbiota in Nile tilapia (Oreochromis niloticus)
1945. Gut Dysbiosis Thwarts the Efficacy of Vaccine Against Mycobacterium tuberculosis
1946. The emerging PFOS alternative OBS exposure induced gut microbiota dysbiosis and hepatic metabolism disorder in adult zebrafish
1947. The high-fat diet based on extra-virgin olive oil causes dysbiosis linked to colorectal cancer prevention
1948. … 4-phenyl-1, 2, 3, 6-tetrahydropyridine Induced Parkinson’s disease in mouse: potential association between neurotransmitter disturbance and gut microbiota dysbiosis
1949. The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer
1950. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice
1951. Adherent‐invasive Escherichia coli (AIEC): Cause or consequence of inflammation, dysbiosis, and rupture of cellular joints in patients with IBD?
1952. Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila
1953. Dysbiosis individualizes the fitness effect of antibiotic resistance in the mammalian gut
1954. The effects of low-nickel diet combined with oral administration of selected probiotics on patients with systemic nickel allergy syndrome (SNAS) and gut dysbiosis
1955. Is there a dysbiosis in individuals with a neurodevelopmental disorder compared to controls over the course of development? A systematic review
1956. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions
1957. Implications of gut microbiota dysbiosis and metabolic changes in prion disease
1958. Targeting gut microbiota dysbiosis: Potential intervention strategies for neurological disorders
1959. Effects of a high fat diet on gut microbiome dysbiosis in a mouse model of Gulf War Illness
1960. The emerging role of gut dysbiosis in cardio-metabolic risk factors for heart failure
1961. Sacha inchi oil alleviates gut microbiota dysbiosis and improves hepatic lipid dysmetabolism in high-fat diet-fed rats
1962. Chronic exposure to ambient particulate matter induces gut microbial dysbiosis in a rat COPD model
1963. Lead induces structural damage, microbiota dysbiosis and cell apoptosis in the intestine of juvenile bighead carp (Hypophthalmichthys nobilis)
1964. Dissimilarity of the gut–lung axis and dysbiosis of the lower airways in ventilated preterm infants
1965. Target dysbiosis of gut microbes as a future therapeutic manipulation in Alzheimer’s disease
1966. 16S metagenomics reveals dysbiosis of nasal core microbiota in children with chronic nasal inflammation: Role of adenoid hypertrophy and allergic rhinitis
1967. Niacin and butyrate: Nutraceuticals targeting dysbiosis and intestinal permeability in parkinson’s disease
1968. A gut feeling about stroke reveals gut-brain axis’ active role in homeostasis and dysbiosis
1969. Microscopic colitis is characterized by intestinal dysbiosis
1970. Antibiotic-induced dysbiosis of the rat oral and gut microbiota and resistance to Salmonella
1971. Malassezia species dysbiosis in natural and allergen-induced atopic dermatitis in dogs
1972. Genetic deletion of the angiotensin-(1–7) receptor mas leads to alterations in gut villi length modulating TLR4/PI3K/AKT and produces microbiome dysbiosis
1973. Muscadine grapes (Vitis rotundifolia) and dealcoholized muscadine wine alleviated symptoms of colitis and protected against dysbiosis in mice exposed to …
1974. Chemoprevention of colorectal cancer by anthocyanidins and mitigation of metabolic shifts induced by dysbiosis of the gut microbiome
1975. Extracellular biofilm matrix leads to microbial dysbiosis and reduces biofilm susceptibility to antimicrobials on titanium biomaterial: an in vitro and in situ study
1976. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
1977. Deleterious Effects of an Air Pollutant (NO2) on a Selection of Commensal Skin Bacterial Strains, Potential Contributor to Dysbiosis?
1978. Does intestinal dysbiosis contribute to an aberrant inflammatory response to severe acute respiratory syndrome coronavirus 2 in frail patients?
1979. Effect of sulfate group on sulfated polysaccharides-induced improvement of metabolic syndrome and gut microbiota dysbiosis in high fat diet-fed mice
1980. Dysbiosis of gut microbiota and short-chain fatty acids in encephalitis: a Chinese pilot study
1981. Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 alleviate Escherichia coli-induced depression and gut dysbiosis in mice
1982. Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters
1983. Antibiotic-induced dysbiosis of gut microbiota impairs corneal development in postnatal mice by affecting CCR2 negative macrophage distribution
1984. Gut microbiota dysbiosis associated with bile acid metabolism in neonatal cholestasis disease
1985. Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases
1986. Benzo [a] pyrene induces microbiome dysbiosis and inflammation in the intestinal tracts of western mosquitofish (Gambusia affinis) and zebrafish (Danio rerio)
1987. Serum LPS and CD163 biomarkers confirming the role of gut dysbiosis in overweight patients with NASH
1988. Gut dysbiosis contributes to high fructose–induced salt-sensitive hypertension in Sprague-Dawley rats
1989. Dysbiosis characteristics of gut microbiota in cerebral infarction patients
1990. Myoviridae phage PDX kills enteroaggregative Escherichia coli without human microbiome dysbiosis
1991. Lycium barbarum relieves gut microbiota dysbiosis and improves colonic barrier function in mice following antibiotic perturbation
1992. Dysbiosis of the gut microbiome: a concept analysis
1993. Analysis of flagellin-specific adaptive immunity reveals links to dysbiosis in patients with inflammatory bowel disease
1994. Hereditary hemochromatosis promotes colitis and colon cancer and causes bacterial dysbiosis in mice
1995. Distinct microbiota dysbiosis in patients with non-erosive reflux disease and esophageal adenocarcinoma
1996. Fermented feed supplement relieves caecal microbiota dysbiosis and kidney injury caused by high-protein diet in the development of gosling gout
1997. Advanced age impairs intestinal antimicrobial peptide response and worsens fecal microbiome dysbiosis following burn injury in mice
1998. Host dysbiosis negatively impacts IL-9-producing T-cell differentiation and antitumour immunity
1999. Gut dysbiosis and increased intestinal permeability drive microRNAs, NLRP-3 inflammasome and liver fibrosis in a nutritional model of non-alcoholic steatohepatitis in …
2000. Oral dysbiosis induced by Porphyromonas gingivalis is strain-dependent in mice
2001. Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation
2002. Helicobacter pylori antibiotic eradication coupled with a chemically defined diet in INS-GAS mice triggers dysbiosis and vitamin K deficiency resulting in gastric …
2003. Dietary emulsifier polysorbate‐80‐induced small‐intestinal vulnerability to indomethacin‐induced lesions via dysbiosis
2004. Vancomycin-induced gut dysbiosis during Pseudomonas aeruginosa pulmonary infection in a mice model
2005. The prophylactic effects of BIFICO on the antibiotic-induced gut dysbiosis and gut microbiota
2006. Disease, drugs and dysbiosis: understanding microbial signatures in metabolic disease and medical interventions
2007. Gut epithelial metabolism as a key driver of intestinal dysbiosis associated with noncommunicable diseases
2008. Melatonin attenuates microbiota dysbiosis of jejunum in short-term sleep deprived mice
2009. Association of colitis with gut-microbiota dysbiosis in clathrin adapter AP-1B knockout mice
2010. Intestinal flora dysbiosis aggravates cognitive dysfunction associated with neuroinflammation in heart failure
2011. Aggregatibacter, a low abundance pathobiont that influences biogeography, microbial dysbiosis, and host defense capabilities in periodontitis: the history of a bug …
2012. The role of gut dysbiosis in the bone–vascular axis in chronic kidney disease
2013. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model
2014. Characterization of conjunctival microbiome dysbiosis associated with allergic conjunctivitis
2015. Histamine H2-Receptor Antagonists Improve Non-Steroidal Anti-Inflammatory Drug-Induced Intestinal Dysbiosis
2016. Dysbiosis of fecal microbiota in allergic rhinitis patients
2017. Incidental prophylactic appendectomy is associated with a profound microbial dysbiosis in the long-term
2018. Resveratrol treatment improves the altered metabolism and related dysbiosis of gut programed by prenatal high-fat diet and postnatal high-fat diet exposure
2019. Blueberry malvidin-3-galactoside modulated gut microbial dysbiosis and microbial TCA cycle KEGG pathway disrupted in a liver cancer model induced by …
2020. Sensitivity to morphine reward associates with gut dysbiosis in rats with morphine-induced conditioned place preference
2021. Prebiotic inulin consumption reduces dioxin-like PCB 126-mediated hepatotoxicity and gut dysbiosis in hyperlipidemic Ldlr deficient mice
2022. Local necrotic cells trigger systemic immune activation via gut microbiome dysbiosis in Drosophila
2023. 5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
2024. Acetylcholinesterase inhibitor pyridostigmine bromide attenuates gut pathology and bacterial dysbiosis in a murine model of ulcerative colitis
2025. Effects of Maresin 1 (MaR1) on colonic inflammation and gut dysbiosis in diet-induced obese mice
2026. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives
2027. Intestinal dysbiosis in pediatric Crohn’s disease patients with IL10RA mutations
2028. Rebalancing glucolipid metabolism and gut microbiome dysbiosis by nitrate-dependent alleviation of high-fat diet-induced obesity
2029. Role of microbial dysbiosis in carcinogenesis & cancer therapies
2030. Bacteriomic Profiling of Branchial Lesions Induced by Neoparamoeba perurans Challenge Reveals Commensal Dysbiosis and an Association with Tenacibaculum dicentrarchi …
2031. Transient Expression of IL-17A in Foxp3 Fate-Tracked Cells in Porphyromonas gingivalis-Mediated Oral Dysbiosis
2032. … autophagy mediates sarcopenic obesity and its complications via AMPK and PGC1α signaling pathways: potential involvement of gut dysbiosis as a pathological link
2033. Dysbiosis in the dead: human postmortem microbiome beta-dispersion as an indicator of manner and cause of death
2034. Oligosaccharides from Gracilaria fisheri ameliorate gastrointestinal dysmotility and gut dysbiosis in colitis mice
2035. α-Defensins Promote Bacteroides Colonization on Mucosal Reservoir to Prevent Antibiotic-Induced Dysbiosis
2036. Microbial dysbiosis during simian immunodeficiency virus infection is partially reverted with combination anti-retroviral therapy
2037. Preventive antibiotic treatment of calves: emergence of dysbiosis causing propagation of obese state‐associated and mobile multidrug resistance‐carrying bacteria
2038. High‐salt diet‐induced gastritis in C57BL/6 mice is associated with microbial dysbiosis and alleviated by a buckwheat diet
2039. Dysbiosis in marine aquaculture revealed through microbiome analysis: reverse ecology for environmental sustainability
2040. Nitrate exposure induces intestinal microbiota dysbiosis and metabolism disorder in Bufo gargarizans tadpoles
2041. Gut DYSBIOSIS and altered barrier function precedes the appearance of metabolic syndrome in a rat model of nutrient-induced catch-up growth
2042. Intestinal dysbiosis and markers of systemic inflammation in viscerally and generally obese persons living with HIV
2043. Microbiome: insect herbivory drives plant phyllosphere dysbiosis
2044. Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in …
2045. Could lung bacterial dysbiosis predict ICU mortality in patients with extra-pulmonary sepsis? A proof-of-concept study
2046. Increased expression of colonic mucosal melatonin in patients with irritable bowel syndrome correlated with gut dysbiosis
2047. Gut dysbiosis in chagas disease. a possible link to the pathogenesis
2048. Gut microbial dysbiosis is associated with profibrotic factors in liver fibrosis mice
2049. Gut Mycobiome dysbiosis is linked to hypertriglyceridemia among home Dwelling elderly Danes
2050. Lipocalin 2 deficiency-induced gut microbiota dysbiosis evokes metabolic syndrome in aged mice
2051. Co-infection of Chicken Layers With Histomonas meleagridis and Avian Pathogenic Escherichia coli Is Associated With Dysbiosis, Cecal Colonization and …
2052. OP22 Crohn’s disease exclusion diet reduces bacterial dysbiosis towards healthy controls in paediatric Crohn’s disease
2053. Adipose tissue inflammation is directly linked to obesity-induced insulin resistance, while gut dysbiosis and mitochondrial dysfunction are not required
2054. Dietary riboflavin deficiency induces genomic instability of esophageal squamous cells that is associated with gut microbiota dysbiosis in rats
2055. Faecal microbial dysbiosis in children with Wiskott‐Aldrich syndrome
2056. Microbial dysbiosis in irritable bowel syndrome: A single‐center metagenomic study in Saudi Arabia
2057. Breath methane to hydrogen ratio as a surrogate marker of intestinal dysbiosis in head and neck cancer
2058. Feeding formula eliminates the necessity of bacterial dysbiosis and induces inflammation and injury in the paneth cell disruption murine NEC model in an osmolality …
2059. Bacteriophage deficiency characterizes respiratory virome dysbiosis in childhood asthma
2060. Acid hydrolyzed silk peptide consumption improves anti-diabetic symptoms by potentiating insulin secretion and preventing gut microbiome dysbiosis in non-obese …
2061. Contributors to dysbiosis in very-low-birth-weight infants
2062. Intestinal fungal dysbiosis in mice induced by fluoride
2063. Severe intestinal dysbiosis in rat models of short bowel syndrome with ileocecal resection
2064. CD8 T cells drive anorexia, dysbiosis, and blooms of a commensal with immunosuppressive potential after viral infection
2065. … peptide cecropin AD supplement alleviated soybean meal-induced intestinal inflammation, barrier damage, and microbial dysbiosis in juvenile turbot …
2066. Dysbiosis of gut microbiome affecting small intestine morphology and immune balance: a rhesus macaque model
2067. Salivary dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus
2068. Mammary dysbiosis and nipple blebs treated with intravenous daptomycin and dalbavancin
2069. Dysbiosis is not present in horses with fecal water syndrome when compared to controls in spring and autumn
2070. Development of an index score for intestinal inflammation-associated dysbiosis using real-world stool test results
2071. Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
2072. Opioid use potentiates the virulence of hospital-acquired infection, increases systemic bacterial dissemination and exacerbates gut dysbiosis in a murine model of …
2073. Preventive role of salsalate in diabetes is associated with reducing intestinal inflammation through improvement of gut dysbiosis in ZDF rats
2074. Dysbiosis in a canine model of human fistulizing Crohn’s disease
2075. Predictive metagenomic analysis reveals a role of cutaneous dysbiosis in the development of hidradenitis suppurativa
2076. Digestive gland microbiome of Pleurobema cordatum: mesocosms induce dysbiosis
2077. Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis
2078. Corrigendum: Candida Administration Worsens Cecal Ligation and Puncture-Induced Sepsis in Obese Mice Through Gut Dysbiosis Enhanced Systemic Inflammation …
2079. Antibiotic treatment does not ameliorate the metabolic changes in rats presenting dysbiosis after consuming a high fructose diet
2080. Ecological models of gastric microbiota dysbiosis: Helicobacter pylori and gastric carcinogenesis
2081. Mucosal dysbiosis in patients with gastrointestinal follicular lymphoma
2082. The development of intestinal dysbiosis in anemic preterm infants
2083. Dysbiosis signatures of fecal microbiota in South African infants with respiratory, gastrointestinal, and other diseases
2084. Respiratory dysbiosis and population-wide temporal dynamics in canine chronic bronchitis and non-inflammatory respiratory disease
2085. Absence of neurotensin attenuates intestinal dysbiosis and inflammation by maintaining Mmp7/α-defensin axis in diet-induced obese mice
2086. The events that may contribute to subgingival dysbiosis: a focus on the interplay between iron, sulfide and oxygen
2087. Amoxicillin‐induced gut dysbiosis influences estrous cycle in mice and cytokine expression in the ovary and the caecum
2088. Yogurt enriched to correct intestinal microflora in dysbiosis
2089. Gut dysbiosis-influence on amygdala-based functional activity in patients with end stage renal disease: a preliminary study
2090. Fungal dysbiosis correlates with the development of tumor-induced cachexia in mice
2091. The relationship between calcium oxalate lithiasis and chronic proinflammatory intestinal dysbiosis pattern: a prospective study
2092. Microbiological evidences for gastric cardiac microflora dysbiosis inducing the progression of inflammation
2093. Scutellarein aggravated carbon tetrachloride-induced chronic liver injury in gut microbiota-dysbiosis mice
2094. Bacterial dysbiosis incites Th17 cell revolt in irradiated gut
2095. Recent advances in cultivation-independent molecular-based techniques for the characterization of vaginal eubiosis and dysbiosis
2096. Dysbiosis in intestinal microbiome linked to fecal blood determined by direct hybridization
2097. Experimental stroke induces chronic gut dysbiosis and neuroinflammation in male mice
2098. Dysbiosis of the oral ecosystem in severe congenital neutropenia patients
2099. Leuconostoc pseudomesenteroides improves microbiota dysbiosis and liver metabolism imbalance and ameliorates the correlation between dihydroceramide and …
2100. Abnormal food timing promotes alcohol-associated dysbiosis and colon carcinogenesis pathways
2101. Isolation and identification of Klebsiella aerogenes from bee colonies in bee dysbiosis
2102. Effects of high-fat diet-induced gut microbiota dysbiosis: far beyond the gut
2103. … -macrophage colony-stimulating factor protects mice against hepatocellular carcinoma by ameliorating intestinal dysbiosis and attenuating inflammation
2104. Characterization of Oral bacteriome dysbiosis in type 2 diabetic patients
2105. Intestinal dysbiosis and probiotics in COVID-19
2106. Listeria monocytogenes induced dysbiosis in snails and rebiosis achieved by administration of the gut commensal Lactobacillus plantarum Sgs14 strain
2107. Fungal dysbiosis aggravates pouchitis in a rat model of ileal pouch anal anastomosis
2108. Efficacy and Gut Dysbiosis of Gentamicin-Intercalated Smectite as a New Therapeutic Agent against Helicobacter pylori in a Mouse Model
2109. In situ profiling of the three dominant phyla within the human gut using TaqMan PCR for pre-hospital diagnosis of gut dysbiosis
2110. Enteric dysbiosis in liver and kidney transplant recipients: a systematic review
2111. Probiotics-Containing Yogurt Ingestion and H. pylori Eradication Can Restore Fecal Faecalibacterium prausnitzii Dysbiosis in H. pylori-Infected Children
2112. The Cytokine System’s Status in Bacterial Dysbiosis and Bacterial Vaginosis
2113. Hyperoxia provokes gut dysbiosis in rats
2114. Porcine circovirus type 2 (PCV2) and Campylobacter infection induce diarrhea in piglets: Microbial dysbiosis and intestinal disorder
2115. Idiopathic chronic diarrhea associated with dysbiosis in a captive cynomolgus macaque (Macaca fascicularis)
2116. Is there a relationship between rosacea with gut dysbiosis?
2117. … of the use of dietary supplementation with probiotic Bacillus subtilis strain QST713 shows that it attenuates antimicrobial‐induced dysbiosis in weaned piglets
2118. Taxonomic dysbiosis of gut microbiota and serum biomarkers reflect severity of central nervous system injury
2119. The impact of childhood growth stunting and post-migration dysbiosis on the development of metabolic syndrome among indigenous immigrant Mexican women
2120. Environmental stimuli and gut inflammation via dysbiosis in mouse and man
2121. Dysbiosis in peripheral blood mononuclear cell virome associated with systemic lupus erythematosus
2122. Correction: Dietary riboflavin deficiency induces genomic instability of esophageal squamous cells that is associated with gut microbiota dysbiosis in rats
2123. non-nutritive sweeteners may have a bell-shaped dose response for dysbiosis-related adverse effects that contributed to discrepancies between prospective …
2124. Dysbiosis of the gut microbiota maybe exacerbate orf pathology by promoting inflammatory immune responses
2125. Vaccine therapy for dysbiosis-related diseases
2126. The combination of mare’s milk and grape polyphenol extract for treatment of dysbiosis induced by dextran sulfate sodium
2127. Shotgun metagenomic sequencing identifies dysbiosis in triplet sibling with gastrointestinal symptoms and ASD
2128. High altitude as a possible factor for dysbiosis of salivary microbiome in orthodontic patients
2129. Dysbiosis of the Skin Microbiome in Atopic Dermatitis
2130. The “culture” of pain control: A review of opioid-induced dysbiosis (OID) in antinociceptive tolerance
2131. A protocol for the multi-omic integration of cervical microbiota and urine metabolomics to understand human papillomavirus (HPV)-driven dysbiosis
2132. Adjunctive dental therapies in caries-active children: Shifting the cariogenic salivary microbiome from dysbiosis towards non-cariogenic health
2133. The stress hormones effect on the progression of vaginal bacterial dysbiosis
2134. Gut microbiome dysbiosis is associated with elevated toxic bile acids in Parkinson’s disease
2135. Bupi Hewei decoction ameliorates 5-fluorouracil-induced intestinal dysbiosis in rats through T helper 17/T regulatory cell signaling pathway.
2136. Gut microbial dysbiosis as a limiting factor in the management of primary and secondary sarcopenia: An Asian Indian perspective
2137. Sex-dependent effects on liver inflammation and gut microbial dysbiosis after continuous developmental exposure to trichloroethylene in autoimmune-prone …
2138. Gut Dysbiosis is related with activity and remission phases of ulcerative colitis and healthy condition
2139. Fermentation production of ganoderma lucidum by Bacillus subtilis ameliorated ceftriaxone-induced intestinal dysbiosis and improved intestinal mucosal …
2140. COVID-19 Pandemic and Dysbiosis: Can the Ivermectin Hysteria Lead to an Increase of Autoimmune Neuroinflammatory Diseases?
2141. Dysbiosis of Oral microbiota and its effect on epithelial-mesenchymal transition: a review
2142. Development of analytical tools and animal models for studies of small-intestine dysbiosis
2143. Dysbiosis of gut microbiota and human diseases
2144. A status of cellular immunity in bacterial dysbiosis and bacterial vaginosis
2145. Dysbiosis of gut microbiota with increased trimethylamine N-oxide level in patients with large artery atherosclerotic and cardioembolic strokes
2146. IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice
2147. … —A Perspective on “Adipose Tissue Inflammation Is Directly Linked to Obesity-Induced Insulin Resistance, while Gut Dysbiosis and Mitochondrial Dysfunction Are Not …
2148. Gut Microbiota Dysbiosis in High-Risk Individuals For Rheumatoid Arthritis Triggers Mucosal Immunity Perturbation and Promotes Arthritis in Mice
2149. Modified apple polysaccharide regulates microbial dysbiosis to suppress high-fat diet-induced obesity in C57BL/6J mice
2150. An analysis of gut dysbiosis in obesity, diabetes, and chronic gut conditions
2151. Effect of ayurveda gut therapy protocol in managing dysbiosis of children with autism: study protocol for a randomized controlled trial
2152. Microbiome characterization and reversal of dysbiosis in Parkinson’s disease by Fecal Microbiota Transplantation (1825)
2153. Age-Associated Tooth Loss and Oral Microbial Dysbiosis in a Mouse Genetic Model of Chronic Nicotine Exposure
2154. Influence of parasitosis on the immune system of the body and on intestinal dysbiosis
2155. Gut dysbiosis with a pathobiont shifts the intestinal microbiota profile and accelerates lupus nephritis
2156. Bacterial dysbiosis risk prediction according to vaginal normobiota indicator
2157. The role of probiotics and prebiotics in the proper functioning of gut microbiota and the treatment of diseases caused by gut microbiota dysbiosis
2158. Antibiotic-induced gut microbiota dysbiosis aggravates Mycoplasma pneumoniae infection
2159. Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia A
2160. Perinatal Administration of Chondroitin Sulfate Mitigates the Severity of Necrotizing Enterocolitis by Reducing Intestinal Dysbiosis
2161. Awareness and perspectives on paediatric dysbiosis among early-career clinicians at a tertiary care hospital in Delhi, India
2162. Gut microbiota dysbiosis and elevated lipopolysaccharide serum levels are associated with venous thromboembolism in pediatric patients
2163. Gut dysbiosis in severe acute malnutrition is not an immaturity: The irreversible quantitative-qualitative paradigm shift
2164. High dose saccharin supplementation does not induce gut microbiota dysbiosis or glucose intolerance in healthy humans and mice
2165. Reply to: Liu C, et al. Intestinal microbiota dysbiosis play a role in pathogenesis of patients with primary immune thrombocytopenia
2166. Pouchitis: Bile acid deficiency links inflammation to dysbiosis
2167. Acute Brain Dysfunction, Host Inflammation, and Gut Dysbiosis During Critical Illness: A Prospective Cohort Study in Mechanically Ventilated Adults
2168. Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update. Microorganisms 2021, 9, 53
2169. Functional and taxonomic dysbiosis of the gut, urine, and semen microbiome in male infertility
2170. Immune tolerance to colon cancer is mediated by colon dysbiosis: Human results and experimental In Vivo validation.
2171. The vaginal bacterial dysbiosis severity predicting model according to the normobiota index
2172. Neonatal dysbiosis has long‐lasting detrimental effects on the microbiota‐gut‐brain axis
2173. Treatment of COVID-19 patients suspected with gut microbiota dysbiosis with washed microbiota transplantation: study protocol for a randomized controlled trial
2174. Mycobiome Dysbiosis in Oral Lichen Planus
2175. P164 EPITHELIAL TLR4-INDUCED DYSBIOSIS INCREASES SUSCEPTIBILITY TO TUMORIGENESIS
2176. P030 Dynamics of intestinal inflammation and microbial dysbiosis in pregnant women with IBD and their infants
2177. Intestinal dysbiosis as a possible predictor of very early preterm labor in pregnant women with metabolic syndrome
2178. … : Impaired 25-hydroxylation of vitamin D in liver injury suppresses intestinal Paneth cell defensins, leading to gut dysbiosis and liver fibrogenesis
2179. Development of dysbiosis in the organism of rats receiving a high-fat diet
2180. Abstract TP108: dendritic cells mediate the detrimental effects of age-related gut dysbiosis after stroke
2181. … Titanium Dioxide Nanoparticles Induce Stronger Adverse Effects in Obese Mice than Non‐Obese Mice: Gut Microbiota Dysbiosis, Colonic Inflammation, and …
2182. Smoke-induced gut microbial dysbiosis promotes cancer progression by creating immunosuppressive tumor microenvironment
2183. Alleviation and recovery effects of Lactobacillus on the antibiotic-induced intestinal dysbiosis in early life stages of mice
2184. Changes in indices of chemical composition and mineralizing properties of oral fluid in children with intestinal dysbiosis
2185. Implications of Gut Microbiome Dysbiosis in Parkinson’s Disease: A Literature Review.(103)
2186. Gut microbiota dysbiosis and chronic kidney disease
2187. Longitudinal analyses reveal that aging-related alterations in the intestinal environment lead to gut dysbiosis with the potential to induce obesity
2188. Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis
2189. Deep skin dysbiosis in vitiligo patients: link with mitochondrial and immune changes
2190. Abstract A37: Restoration of oral microbiota dysbiosis in head and neck squamous cell carcinoma after surgery
2191. The role of the intestinal microflora dysbiosis in chronic kidney disease
2192. Dysbiosis of the intestinal microbiota and colorectal cancer
2193. Early-life microbial intervention reduces colitis risk promoted by antibiotic-induced gut dysbiosis
2194. Gut Microbiome Dysbiosis and Depression: a Comprehensive Review
2195. Peripheral inflammatory response in human tuberculosis treatment is predicted by a combination of pathogen sterilization and microbiome dysbiosis
2196. Effects of enteral administration of Bifidobacterium breve on dysbiosis infants and children: a review
2197. Gut dysbiosis induced by cardiac pressure overload promotes T cell activation and adverse cardiac remodeling through alterations in the aryl hydrocarbon receptor …
2198. Precision medicine and gut dysbiosis
2199. Comparative ionogram assessment before and after probiotic treatment for healthy dogs and dogs with apparent dysbiosis
2200. Noise exposure-induced intestinal flora dysbiosis disrupts homeostasis of oxi-inflamm-barrier in the gut–brain axis of APP/PS1 mice: implications for early onset …
2201. Urogenital dysbiosis: The importance of a complete immune/nutritional evaluation and the therapeutic intervention with probiotics, vitamins and minerals
2202. Exploring human gut microbiome variations across life: from eubiosis to dysbiosis in Western populations
2203. OP0016 GUT MICROBIOTA DYSBIOSIS IN THE HIGH-RISK INDIVIDUAL FOR RA TRIGGERS THE MUCOSAL IMMUNITY PERTURBATION AND …
2204. Pathological mechanisms in Crohn’s disease via dysbiosis triggered by Paneth cell α-defensin misfolding
2205. Ingestion of subtoxic doses of cadmium induces persistent dysbiosis and enhances susceptibility to DSS-induced colitis long after exposure
2206. Bone loss with aging is independent of age-related gut microbiome dysbiosis in mice
2207. Synergistic effects of an innovative combination therapy on treating Alzheimer’s disease involving modulation of gut dysbiosis: Nonhuman/Target identification and …
2208. Ethanolamine improves colonic barrier functions and inflammatory immunoreactions via shifting microbiome dysbiosis
2209. Rapid-Eye-Movement Sleep Behavior Disorder Exhibits Similar but Distinct Gut Dysbiosis Compared to Parkinson’s Disease
2210. Digital Technologies in Polymerase Chain Reaction for Analysis of Clindomycin-associated Dysbiosis
2211. Dietary Fibre, Gut Microbiota Dysbiosis and Type 2 Diabetes
2212. … and Their Interface with Host Physiology: Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a …
2213. 12762 Cutaneous and enteral dysbiosis: A rosacea pilot study from the Twins Day Festival
2214. Anti-TNF therapy reverses gut dysbiosis in AS
2215. The relationship between calcium oxalate lithiasis and chronic proinflammatory intestinal dysbiosis pattern: a prospective study
2216. Vaginal dysbiosis dominated by miscellaneous bacteria correlates with more severe clinical symptoms
2217. Changes in the Gut Metabolic Landscape Drive Inflammation-Associated Dysbiosis and Host Responses
2218. Of Mice and Microbiomes: Understanding the whole-organism impact of the microbiome and its role in dysbiosis and disease
2219. Microbiome evaluation revealed salivary dysbiosis in addicts of betel nut preparations
2220. Destabilization of The Bacterial Interactome Tracks Nutrient Restriction-Induced Dysbiosis in Insect Gut
2221. HIGH-FIBRE DIET REDUCES TRANSPLANT-ASSOCIATED DYSBIOSIS AND IMPROVES RENAL ALLOGRAFT SURVIVAL IN A MURINE MODEL OF KIDNEY …
2222. Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s
2223. Liver bacterial dysbiosis occurs in SIV-infected macaques and persists during antiretroviral therapy
2224. MP07-18 ACYLOXYACYL HYDROLASE REGULATES GUT DYSBIOSIS-MEDIATED PELVIC PAIN AND DEPRESSIVE-LIKE BEHAVIOR
2225. Sex-Based Differences in Obesity, Gut Dysbiosis and Intestinal Inflammation in High-Fat Diet Mice.
2226. Gulf War Illness and Gut Microbiome Dysbiosis: Treatment with Probiotics and Microbiota Transfer Therapy
2227. Dysbiosis Disconnect Between Research and Clinical Practice
2228. MATERIALS AND METHODS-FUNGAL DYSBIOSIS CORRELATES WITH THE DEVELOPMENT OF TUMOUR-INDUCED CACHEXIA IN MICE
2229. P073 Analysis of Dysbiosis in Crohn’s Disease by Next-Generation Sequencing: One Size Does Not Fit All
2230. Lower Airway Dysbiosis Induces a MyD88-Independent Th1 Inflammatory Response and Altered Th17 Inflammation
2231. Oral dysbiosis and autoimmunity: from local periodontal responses to an imbalanced systemic immunity. A review
2232. Fungal mycoflora dysbiosis in gastric cancer
2233. S3424 Exploring the Microbial Connection: Physicians, Dysbiosis, and Eosinophilic Esophagitis
2234. Gut Microbiota Dysbiosis Induces Breakdown of the Systemic Immune Firewall That Protects Against Bloodstream Infections
2235. Gut dysbiosis protects against liver injury in autophagy deficient mice by FXR-FGF15 feedback signaling
2236. Dysbiosis in the Gut Microbiota of Adolescents with Obesity
2237. Tracking Dysbiosis Where It Matters
2238. Risk stratification for intestinal dysbiosis in hospitalized adult patients according to the National Dysbiosis Survey (INDIS)
2239. NONSPECIFIC IMMUNITY IN BACTERIAL DYSBIOSIS AND BACTERIAL VAGINOSIS
2240. Infant gut fungal dysbiosis drives asthma onset and severity
2241. S3196 Dysbiosis in a Triplet With an Autism Spectrum Disorder: A Case Study
2242. The Vaginal Microbiota Impact of Antibiotic and Probiotic Compounds and Point-of-Care Testing for Vaginal Dysbiosis and Sexually Transmitted Infections
2243. Elevated Sputum Neutrophil Elastase Is Predictive of Microbiome Dysbiosis and Disease Severity in Bronchiectasis
2244. Correction of Dysbiosis in Diversion Proctitis: Possibilities of Intraluminal Sanitation and the Prevention of Complications after Reconstructive Surgery
2245. SAT0362 ASSOCIATION OF GUT DYSBIOSIS WITH STRUCTURAL DAMAGE AND ACTIVITY IN AXIAL SPONDYLOARTHRITIS PATIENTS. DATA FROM …
2246. You-Gui-Wan ameliorates house dust mite-induced allergic asthma via modulating amino acid metabolic disorder and gut dysbiosis
2247. Value of conditionally-pathogenic microflora index as predicting factor of bacterial dysbiosis’ development
2248. EVALUATION OF THE TREATMENT EFFECTIVENESS OF GINGIVITIS BY THE ORAL DYSBIOSIS INDEX IN PATIENTS WITH DIFFERENT REACTIONS OF …
2249. Model for predicting the vaginal dysbiosis’ severity according to the index of conditionally pathogenic microflora
2250. The impact of gut dysbiosis on Parkinson’s disease
2251. Modulation of Non-alcoholic Fatty Liver Disease and Dysbiosis of the Microbiome by a Periodontal Pathogen
2252. Therapeutic impact of Schizophyllum commune derived β-(1, 3/1, 6)-glucan on cutaneous wounds and metabolic dysbiosis
2253. … OF INTESTINAL DYSBIOSIS: THE NATURE OF CHANGES IN β-DEFENSINS IS DEPENDENT ON THE PROCESS UNDERLYING THE INDUCTION OF DYSBIOSIS
2254. Comparative effect of different pathogens on the condition of dysbiosis in rat kidneys
2255. Potential efficacy of gut microbiome dysbiosis on alleviation the progress of osteoarthritis in mice
2256. Effect of Porphyromonas gingivalis infection on gut dysbiosis and arthritis exacerbation in mouse model
2257. Influence of a high-fat diet on inflammation and dysbiotic processes in the gums and blood serum of rats with lincomycin dysbiosis
2258. Cholestyramine Administration Induces Gut Dysbiosis and Severe Liver Injury in ApoE-/-Mice
2259. Hematological Aspects on Dogs with Apparent Dysbiosis after Bacillus Subtilis, Bacillus Licheniformis and Pediococcus Acidilactici Probiotic Administration-Pilot …
2260. The stay of humoral immunity in bacterial dysbiosis and bacterial vaginosis
2261. Early-life microbial intervention reduces colitis risk promoted by antibiotic-induced gut dysbiosis
2262. Gut Microbiota Dysbiosis Contributes to the Development of the Constitutional Symptoms in Non-HIV Infected Patients with Mycobacterium Tuberculosis Infection
2263. Crohn’s Disease: Dysbiosis and IL-7
2264. Antibiotic-related Gut Dysbiosis Induces Lung Immunodepression and Worsens Lung Infection.
2265. Oral Dysbiosis and the Gut
2266. Gut microbiota dysbiosis and acute childhood diarrhea in Bangladesh
2267. Causal communication between gut microbiota dysbiosis and neuroinflammation in Alzheimer’s disease and therapeutic intervention by oligomannate: Microbiome in …
2268. Introduction of Probiotic Type of Yogurt for the Treatment of Dysbiosis of Patients with Lymphogranulomatosis Under Polychemotherapy by BEACOPP‑II Protocol.
2269. The Relationship Between Irritable Bowel Syndrome and Gastrointestinal Dysbiosis: A Systematic Integrative Review of Diagnostic and Treatment Approaches.
2270. Gut dysbiosis, probiotics and COVID-19
2271. Prevalence of signs and symptoms suggestive dysbiosis intestinal in an academic higher education institution/PREVALENCIA DE SINAIS E SINTOMAS SUGESTIVOS …
2272. Characterising Gut Dysbiosis in Rodent Models Relevant to Psychiatric and Neurodevelopmental Disorders
2273. Hypertension Is Associated With Intestinal Microbiota Dysbiosis and Inflammation in a Brazilian Population
2274. The role of sorbents and probiotics in prevention of structural and morphological disorders in the small intestine of animals developing in dysbiosis
2275. Sub‐diaphragmatic vagal nerve stimulation alleviates rodent hypertension associated with gut dysbiosis and reduced serotonergic vagal afferent signaling
2276. Azurocidin-1: a marker of COPD severity and microbial dysbiosis
2277. Dysbiosis of intestinal microbiota to predict in-hospital mortality in critically ill patients: results of a prospective observational cohort study
2278. Abstract A64: Commensal dysbiosis alters the tumor microenvironment in breast cancer and diminishes efficacy of PD-L1 blockade
2279. Side effects of tuberculosis chemotherapy: intestinal dysbiosis
2280. Dysbiosis and the Use of Pre‐, Pro‐and Synbiotics
2281. EVIDENCE OF A CLOSE RELATIONSHIP BETWEEN GUT MICROBIOTA DYSBIOSIS AND MULTIPLE SCLEROSIS
2282. Gut microbiota dysbiosis in diet-induced obesity. A focus on the influence of genetics, circadian rhythms and potential prebiotics
2283. AB1232 ORAL DYSBIOSIS REFLECTS THE IMMUNOLOGICAL ALTERATION OF RA REGARDING TO ACPA AND HLA DRB1* SE: NAGASAKI ISLAND STUDY
2284. Ileal bile acid transporter inhibitor improves hepatic steatosis by changing the gut microbiota dysbiosis in NAFLD model mice
2285. Dysbiosis and its modulation through the use of probiotics, prebiotics and other members of the bionics family. General concepts.
2286. Dynamics of Indicators of Psychoemotional Condition in Patients with Chronic Pancreatitis and Atherosclerosis on the Background of Intestinal Dysbiosis Correction
2287. Indole-3-carbinol prevents colitis and regulates microbial dysbiosis by induction of anti-microbial peptides and mucins in an IL-22 dependent manner
2288. Analysis of ileostomy stool samples reveals dysbiosis in patients with high-output intestinal fluid
2289. Dysregulated FXR-FGF19 signaling and choline metabolism is associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH
2290. Abstract IA20: Gut microbiota dysbiosis and dietary fermentable fibers in a pickle: A brew for liver cancer
2291. Transcriptomic Analysis of Lower Airway Dysbiosis
2292. Comparative ionogram assessment before and after probiotic treatment for healthy dogs and dogs with apparent dysbiosis
2293. TO ASSESS THE EFFECTIVENESS OF CORRECTION OF DYSBIOSIS OF THE ORAL MUCOSA IN PATIENTS WITH VIRAL GLOSSITIS
2294. The effect of diet induced gut dysbiosis on corneal wound healing
2295. Virus-mediated dysbiosis alters immune populations to promote type 1 diabetes onset
2296. EFFECTS OF HIGH URACIL DIET-INDUCED GUT DYSBIOSIS ON COURTSHIP BEHAVIOR IN DROSOPHILA
2297. Antibiotic-mediated gut dysbiosis alters innate-like T cell frequency and phenotype in tumor-bearing mice
2298. Dysbiosis in hypertension modulates kidney function through TLR4‐mediated gut barrier disruption
2299. Oral administration of engineered probiotic prevents gut dysbiosis in type 1 diabetes and alleviates diabetic retinopathy (DR)
2300. Dysbiosis-the disturbed intestinal microbiota (microflora) in patients with chronic kidney disease.
2301. EFFECT OF HORMONAL REGULATION ON VAGINAL COLONIZATION RESISTANCE IN BACTERIAL DYSBIOSIS
2302. High‐Fat Induces Cardiac Remodeling via Dysbiosis of the Gut Microbiome
2303. OP30 The interplay of microbiome dysbiosis and immune system deregulation in patients with Crohn’s disease
2304. Gene-environment interactions in non-visceral pain chronification: from Myo1a loss of function to environment-dependent gut microbiota dysbiosis
2305. Subclinical Infection and Disc Dysbiosis as a Cause of Degenerative Disc Disease and Low Back Pain
2306. Combined Dysbiosis in Upper and Lower Respiratory Tract Microbial Communities Is Associated with Inflammatory Host Responses and Worse Clinical Outcomes in …
2307. Quantitative Analysis of Relationship Between Gut Flora Dysbiosis and Severity of Liver Cirrhosis
2308. Sleep Dysfunction and Intestinal Dysbiosis
2309. Western Diet Increases the Severity of Giardia Infection in Association with Gut Microbiota Dysbiosis
2310. Characterizing Unmapped Reads To Decipher Microbiome Lead To Identification Of Possible Dysbiosis In Fatal Graft-Versus-Host Disease Of The Intestine
2311. The Role of Probiotics as Effective Therapies for Dysbiosis and GI Dysfunctions
2312. Gut dysbiosis: not only with checkpoint inhibitors!
2313. Recovery of Cenobiont Populations of Bifidobacterium spp. and Lactobacillus spp. After Treatment of Experimental Dysbiosis With Immobilized Probiotic Escherichia …
2314. Intestinal dysbiosis amplifies acetaminophen induced acute liver injury
2315. Intestinal dysbiosis predicts lower gastrointestinal tract acute graft-versus-host (aGVHD) disease development
2316. Aberrant TNF Signaling Links RIPK3-Dependent Cell Death and Loss of TLR5 with Intestinal Inflammation and Dysbiosis
2317. Abstract TP104: Post Stroke Depressive-Like Behaviors in Middle-Aged Female Rats is Associated With Gut Dysbiosis and Improved by Mir363-3p
2318. Study of Microbial Dysbiosis in Colorectal Cancer Using Co-Occurrence Networks and Regression Analysis
2319. Reduced responsiveness of bone marrow hematopoietic cells to sympathetic activation is protective against high fat diet‐induced obesity and gut dysbiosis
2320. Association between microbiota dysbiosis and endothelial dysfunction in Alzheimer’s disease: An in vivo cross‐sectional study: Inflammation: From basic science to …
2321. Role of invariant nature killer T cell in dysbiosis of gut microbiota among Mycobacterium tuberculosis infected patients
2322. 4.3 Dysbiosis and Depression
2323. Temporal Dysbiosis of Infant Nasal Microbiota Relative to Respiratory Syncytial Virus
2324. Acute Phase Inflammatory Proteins, Gut Microbiota Dysbiosis and Severity of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
2325. Gut Microbial Dysbiosis after Traumatic Brain Injury Induces Alterations in the Immune Response and Fear Memory
2326. Microbiota dysbiosis and functional outcome in acute ischemic stroke patients
2327. Sex Differences in Stroke Outcome Are Associated With Constitutive Gut Dysbiosis and Stroke-induced Gut Permeability
2328. Microbial Dysbiosis During Simian Immunodeficiency Virus infection is partially Reverted with combination Anti-retroviral therapy
2329. Development of an in vitro model of gut dysbiosis in weaning piglets. Application to the study of probiotics to fight against post-weaning diarrhea
2330. Tc17 cells cause gut graft-versus-host disease through induction of dysbiosis and depletion of CX3CR1hi phagocytes
2331. The effects of HSV-1 infection of the ENS on beta amyloid deposition during gut dysbiosis
2332. 1855-P: Early Life Dysbiosis in Offspring of Obese Mice Promotes Hepatic Macrophage Dysfunction
2333. 1867-P: White and Brown Rice Supplementation Changes High-Fat Diet–Induced Dysbiosis of Gut Microbiome and Improves Energy and Glucose Metabolism
2334. Plasma β-d-Glucan Levels Are Associated with Host Inflammation, Impaired Gut Barrier Function, Gut Bacterial Dysbiosis and Clinical Outcomes in Critical Illness
2335. Dietary riboflavin deficiency induces genomic instability of esophageal squamous cells that is associated with gut microbiota dysbiosis in rats [Erratum: Dec. 17, 2020 …
2336. Gut to Eye Axis: Probiotic Mitigates Dysbiosis and Improves Ocular Functions in Mice
2337. PD42-04 THE DYSBIOSIS OF MICROBIOTA AFFECTS BLADDER INFLAMMATION AND CARCINOGENESIS OF MUSCLE INVASIVE BLADDER CANCER
2338. The Role of Opioid-Induced Microbial Dysbiosis in Analgesic Tolerance
2339. Dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants–
2340. Non-nutritive sweeteners may have a bell-shaped dose response for dysbiosis-related adverse effects that contribute to discrepancies between prospective cohort …
2341. Hepatic steatosis in Crohn’s disease: associations with anti-TNFα treatment, dysbiosis, and FGF-19.
2342. Maturation of the Gut Microbiome and Its Dysbiosis in Infants with Atopic Dermatitis
2343. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role
2344. Gut–skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions
2345. Partners in leaky gut syndrome: intestinal dysbiosis and autoimmunity
2346. Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn
2347. The role of Enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases
2348. The oralome and its dysbiosis: New insights into oral microbiome-host interactions
2349. The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
2350. Gut microbial dysbiosis in the pathogenesis of gastrointestinal dysmotility and metabolic disorders
2351. Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis
2352. Lower airway dysbiosis affects lung cancer progression
2353. Structural and functional dysbiosis of fecal microbiota in Chinese patients with Alzheimer’s disease
2354. Dysbiosis of human gut microbiome in young-onset colorectal cancer
2355. Oral microbiome dysbiosis is associated with symptoms severity and local immune/inflammatory response in COVID-19 patients: a cross-sectional study
2356. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID
2357. Unhealthy lifestyle and gut dysbiosis: a better understanding of the effects of poor diet and nicotine on the intestinal microbiome
2358. Metabolic influences of gut microbiota dysbiosis on inflammatory bowel disease
2359. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis
2360. The role of gut dysbiosis in Parkinson’s disease: Mechanistic insights and therapeutic options
2361. Determining gut microbial dysbiosis: a review of applied indexes for assessment of intestinal microbiota imbalances
2362. Dysbiosis of gut microbiota and short‐chain fatty acids in acute ischemic stroke and the subsequent risk for poor functional outcomes
2363. Vaginal microbiome: normalcy vs dysbiosis
2364. Polystyrene microplastics induce microbial dysbiosis and dysfunction in surrounding seawater
2365. Microbiome diversity and dysbiosis in aquaculture
2366. Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: Recent updates
2367. Translational approaches with antioxidant phytochemicals against alcohol-mediated oxidative stress, gut dysbiosis, intestinal barrier dysfunction, and fatty liver …
2368. Dysbiosis and implication of the gut microbiota in diabetic retinopathy
2369. Gut microbiota dysbiosis in systemic lupus erythematosus: novel insights into mechanisms and promising therapeutic strategies
2370. Candida albicans promotes tooth decay by inducing oral microbial dysbiosis
2371. Aging, frailty, and the microbiome—how dysbiosis influences human aging and disease
2372. The link between obesity, microbiota dysbiosis, and neurodegenerative pathogenesis
2373. Nanoplastics induce more serious microbiota dysbiosis and inflammation in the gut of adult zebrafish than microplastics
2374. Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson’s disease
2375. The role of intestinal dysbiosis in Parkinson’s disease
2376. Antibiotic-induced gut microbiota dysbiosis damages the intestinal barrier, increasing food allergy in adult mice
2377. Gut microbiota dysbiosis induced by intracerebral hemorrhage aggravates neuroinflammation in mice
2378. Appropriate exercise level attenuates gut dysbiosis and valeric acid increase to improve neuroplasticity and cognitive function after surgery in mice
2379. Functional and taxonomic dysbiosis of the gut, urine, and semen microbiomes in male infertility
2380. Role of vaginal microbiota dysbiosis in gynecological diseases and the potential interventions
2381. Dysbiosis of the endometrial microbiota and its association with inflammatory cytokines in endometrial cancer
2382. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study
2383. Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis
2384. Sulfated polysaccharides from Undaria pinnatifida improved high fat diet-induced metabolic syndrome, gut microbiota dysbiosis and inflammation in BALB/c mice
2385. Dysbiosis and Alzheimer’s disease: a role for chronic stress?
2386. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation
2387. Fecal microbiota transplantation is a promising method to restore gut microbiota dysbiosis and relieve neurological deficits after traumatic brain injury
2388. Dysbiosis revisited: Understanding the role of the oral microbiome in the pathogenesis of gingivitis and periodontitis: A critical assessment
2389. The role of gut barrier dysfunction and microbiome dysbiosis in colorectal cancer development
2390. Deoxycholic acid-induced gut dysbiosis disrupts bile acid enterohepatic circulation and promotes intestinal inflammation
2391. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental …
2392. Xylan alleviates dietary fiber deprivation-induced dysbiosis by selectively promoting Bifidobacterium pseudocatenulatum in pigs
2393. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease
2394. Dysbiosis of oral microbiota during oral squamous cell carcinoma development
2395. Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases
2396. Dysbiosis of gut microbiota is associated with the progression of radiation-induced intestinal injury and is alleviated by oral compound probiotics in mouse …
2397. Oral microbial dysbiosis and its performance in predicting oral cancer
2398. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment
2399. High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease
2400. Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis
2401. Lactobacillus rhamnosus attenuates Thai chili extracts induced gut inflammation and dysbiosis despite capsaicin bactericidal effect against the probiotics, a …
2402. Tryptophan metabolism and bacterial commensals prevent fungal dysbiosis in Arabidopsis roots
2403. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes
2404. Neuropathy in COVID-19 associated with dysbiosis-related inflammation
2405. Interconnections between the oral and gut microbiomes: reversal of microbial dysbiosis and the balance between systemic health and disease
2406. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome
2407. The role of dysbiosis in critically ill patients with COVID-19 and acute respiratory distress syndrome
2408. Dysbiosis of the gut microbiome impairs mouse skeletal muscle adaptation to exercise
2409. Lactobacillus fermentum CECT5716 ameliorates high fat diet-induced obesity in mice through modulation of gut microbiota dysbiosis
2410. Gut dysbiosis as a driver in alcohol-induced liver injury
2411. Vaginal probiotics for reproductive health and related dysbiosis: systematic review and meta-analysis
2412. Dysbiosis of gut microbiota in patients with acute myocardial infarction
2413. Hidden role of gut microbiome dysbiosis in schizophrenia: Antipsychotics or psychobiotics as therapeutics?
2414. Relationship between sleep disorders and gut dysbiosis: what affects what?
2415. Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression
2416. SARS-CoV-2-induced gut microbiome dysbiosis: Implications for colorectal cancer
2417. Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients
2418. Perfluorooctanoic acid-induced liver injury is potentially associated with gut microbiota dysbiosis
2419. Sub-chronic exposure to antibiotics doxycycline, oxytetracycline or florfenicol impacts gut barrier and induces gut microbiota dysbiosis in adult zebrafish …
2420. Disruption of the endopeptidase ADAM10-Notch signaling axis leads to skin dysbiosis and innate lymphoid cell-mediated hair follicle destruction
2421. Gut dysbiosis during COVID-19 and potential effect of probiotics
2422. Gut Microbiota Dysbiosis Influences Metabolic Homeostasis in Spodoptera frugiperda
2423. Diarrhea predominant-irritable bowel syndrome (IBS-D): effects of different nutritional patterns on intestinal dysbiosis and symptoms
2424. FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice
2425. Links between gut dysbiosis and neurotransmitter disturbance in chronic restraint stress-induced depressive behaviours: the role of inflammation
2426. Dysbiosis of gut microbiota in patients with esophageal cancer
2427. Risk factors for gut dysbiosis in early life
2428. F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis
2429. Gut dysbiosis and IL-21 response in patients with severe COVID-19
2430. XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells
2431. Vaginal lactobacilli and vaginal dysbiosis-associated bacteria differently affect cervical epithelial and immune homeostasis and anti-viral defenses
2432. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation
2433. From Dysbiosis to Healthy Skin: Major Contributions of Cutibacterium acnes to Skin Homeostasis
2434. Oral dysbiosis and inflammation in Parkinson’s disease
2435. Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature
2436. Microbial dysbiosis reflects disease resistance in diverse coral species
2437. Gut dysbiosis and intestinal barrier dysfunction: potential explanation for early-onset colorectal cancer
2438. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients
2439. Duodenal dysbiosis and relation to the efficacy of proton pump inhibitors in functional dyspepsia
2440. Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis
2441. Fungal diseases: Oral dysbiosis in susceptible hosts
2442. Gut microbiota dysbiosis correlates with abnormal immune response in moderate COVID-19 patients with fever
2443. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
2444. Low levels of salivary lactoferrin may affect oral dysbiosis and contribute to Alzheimer’s disease: A hypothesis
2445. Gut dysbiosis and its associations with gut microbiota-derived metabolites in dogs with myxomatous mitral valve disease
2446. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers
2447. Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-art
2448. Is there a connection between gut microbiome dysbiosis occurring in COVID-19 patients and post-COVID-19 symptoms?
2449. Probiotic-fermented black tartary buckwheat alleviates hyperlipidemia and gut microbiota dysbiosis in rats fed with a high-fat diet
2450. Dysbiosis from a microbial and host perspective relative to oral health and disease
2451. Role of gut microbiota dysbiosis in breast cancer and novel approaches in prevention, diagnosis, and treatment
2452. Intestinal dysbiosis amplifies acetaminophen-induced acute liver injury
2453. Gut microbiota dysbiosis is a crucial player for the poor outcomes for COVID-19 in elderly, diabetic and hypertensive patients
2454. Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
2455. Atractylodin attenuates dextran sulfate sodium-induced colitis by alleviating gut microbiota dysbiosis and inhibiting inflammatory response through the MAPK …
2456. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice
2457. Metagenomic insights into the taxonomy, function, and dysbiosis of prokaryotic communities in octocorals
2458. Dextran sulfate sodium salt-induced colitis aggravates gut microbiota dysbiosis and liver injury in mice with non-alcoholic steatohepatitis
2459. Diazinon exposure produces histological damage, oxidative stress, immune disorders and gut microbiota dysbiosis in crucian carp (Carassius auratus gibelio)
2460. Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination
2461. Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology
2462. Comprehensive analysis of the lysine acetylome and succinylome in the hippocampus of gut microbiota-dysbiosis mice
2463. Environmental hexavalent chromium exposure induces gut microbial dysbiosis in chickens
2464. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus
2465. Tea polyphenols regulate gut microbiota dysbiosis induced by antibiotic in mice
2466. Inflammasome activation in ankylosing spondylitis is associated with gut dysbiosis
2467. Gut dysbiosis, bacterial colonization and translocation, and neonatal sepsis in very-low-birth-weight preterm infants
2468. Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma
2469. Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated Parkinson’s disease
2470. Chemotherapy-induced intestinal microbiota dysbiosis impairs mucosal homeostasis by modulating toll-like receptor signaling pathways
2471. … in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver …
2472. Gut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction
2473. Persistent diarrhea in patients with Crohn’s disease after mucosal healing is associated with lower diversity of the intestinal microbiome and increased dysbiosis
2474. A tryptophan-deficient diet induces gut microbiota dysbiosis and increases systemic inflammation in aged mice
2475. A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis
2476. n-6 High Fat Diet Induces Gut Microbiome Dysbiosis and Colonic Inflammation
2477. Long-term exposure to titanium dioxide nanoparticles promotes diet-induced obesity through exacerbating intestinal mucus layer damage and microbiota dysbiosis
2478. Ellagic acid prevents binge alcohol-induced leaky gut and liver injury through inhibiting gut dysbiosis and oxidative stress
2479. Decrease of α-defensin impairs intestinal metabolite homeostasis via dysbiosis in mouse chronic social defeat stress model
2480. Quercetin ameliorates gut microbiota dysbiosis that drives hypothalamic damage and hepatic lipogenesis in monosodium glutamate-induced abdominal …
2481. The microbiota–gut–brain axis and alzheimer disease. From dysbiosis to neurodegeneration: Focus on the central nervous system glial cells
2482. High sucrose diet-induced dysbiosis of gut microbiota promotes fatty liver and hyperlipidemia in rats
2483. Pregnancy exposure of titanium dioxide nanoparticles causes intestinal dysbiosis and neurobehavioral impairments that are not significant postnatally but …
2484. Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study
2485. Dysbiosis of gut microbiota is an independent risk factor of stroke-associated pneumonia: a Chinese pilot study
2486. Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales
2487. Parasite-derived excretory-secretory products alleviate gut microbiota dysbiosis and improve cognitive impairment induced by a high-fat diet
2488. Gut dysbiosis associated with the rats’ responses in methamphetamine‐induced conditioned place preference
2489. … of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: Involvement of alleviating intestinal microbiota dysbiosis
2490. … extract alleviated dextran sulfate sodium‐induced ulcerative colitis in C57BL/6 male mice by restoring bile acid metabolism disorder and gut microbiota dysbiosis
2491. Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease
2492. Metformin intervention ameliorates AS in ApoE-/- mice through restoring gut dysbiosis and anti-inflammation
2493. Ginsenoside Rk3 alleviates gut microbiota dysbiosis and colonic inflammation in antibiotic-treated mice
2494. Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria?
2495. APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
2496. A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine
2497. Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors
2498. Symbiosis and dysbiosis of the human mycobiome
2499. Sustained dysbiosis and decreased fecal short-chain fatty acids after traumatic brain injury and impact on neurologic outcome
2500. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline
2501. Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C
2502. Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly
2503. (−)-Epigallocatechin-3-gallate mitigates cyclophosphamide-induced intestinal injury by modulating the tight junctions, inflammation and dysbiosis in mice
2504. Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota
2505. Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis
2506. Salivary dysbiosis in Sjögren’s syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells
2507. Prebiotic impacts of soybean residue (okara) on eubiosis/dysbiosis condition of the gut and the possible effects on liver and kidney functions
2508. Sugar fructose triggers gut dysbiosis and metabolic inflammation with cardiac arrhythmogenesis
2509. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis
2510. Dysbiosis and Alzheimer’s disease: cause or treatment opportunity?
2511. Porphyromonas gingivalis-Induced Cognitive Impairment Is Associated With Gut Dysbiosis, Neuroinflammation, and Glymphatic Dysfunction
2512. Gut dysbiosis and abnormal bile acid metabolism in colitis-associated cancer
2513. … by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis
2514. Gut immunity and microbiota dysbiosis are associated with altered bile acid metabolism in LPS-challenged piglets
2515. Autonomic Nervous System Neuroanatomical Alterations Could Provoke and Maintain Gastrointestinal Dysbiosis in Autism Spectrum Disorder (ASD): A Novel …
2516. … Outperforms Enterococcus faecium dfa1 on Anti-Obesity in High Fat-Induced Obesity Mice Possibly through the Differences in Gut Dysbiosis Attenuation, despite the …
2517. Preventive and prebiotic effect of α-galacto-oligosaccharide against dextran sodium sulfate-induced colitis and gut microbiota dysbiosis in mice
2518. Gut microbiota dysbiosis in depressed women: The association of symptom severity and microbiota function
2519. Intensive, prolonged exercise seemingly causes gut dysbiosis in female endurance runners
2520. Cervicovaginal microbiota dysbiosis correlates with HPV persistent infection
2521. Deciphering gut microbiota dysbiosis and corresponding genetic and metabolic dysregulation in psoriasis patients using metagenomics sequencing
2522. Fecal fungal dysbiosis in chinese patients with Alzheimer’s disease
2523. Intestinal response characteristic and potential microbial dysbiosis in digestive tract of Bufo gargarizans after exposure to cadmium and lead, alone or combined
2524. Gut-lung dysbiosis accompanied by diabetes mellitus leads to pulmonary fibrotic change through the NF-κB signaling pathway
2525. Association between aging-dependent gut microbiome dysbiosis and dry eye severity in C57BL/6 male mouse model: a pilot study
2526. Dysbiosis-related advanced glycation endproducts and trimethylamine N-oxide in chronic kidney disease
2527. Analysis of matched skin and gut microbiome of patients with vitiligo reveals deep skin dysbiosis: link with mitochondrial and immune changes
2528. Depressive hypertension: a proposed human endotype of brain/gut microbiome dysbiosis
2529. Maternal emulsifier P80 intake induces gut dysbiosis in offspring and increases their susceptibility to colitis in adulthood
2530. Association of the microbiota dysbiosis in the hepatopancreas of farmed crayfish (Procambarus clarkii) with disease outbreaks
2531. Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis
2532. Developmental exposure to silver nanoparticles leads to long term gut dysbiosis and neurobehavioral alterations
2533. Gut microbiota functional dysbiosis relates to individual diet in subclinical carotid atherosclerosis
2534. Gut microbiota signature of pathogen-dependent dysbiosis in viral gastroenteritis
2535. Oral dysbiosis in severe forms of periodontitis is associated with gut dysbiosis and correlated with salivary inflammatory mediators: a preliminary study
2536. Insoluble dietary fiber derived from brown seaweed laminaria japonica ameliorate obesity-related features via modulating gut microbiota dysbiosis in high-fat diet–fed …
2537. The Influence of Microbiome Dysbiosis and Bacterial Biofilms on Epidermal Barrier Function in Atopic Dermatitis—An Update
2538. Detection of dysbiosis and increased intestinal permeability in brazilian patients with relapsing–remitting multiple sclerosis
2539. Tea polyphenols ameliorates memory decline in aging model rats by inhibiting brain TLR4/NF-κB inflammatory signaling pathway caused by intestinal flora dysbiosis
2540. Root exposure to apple replant disease soil triggers local defense response and rhizoplane microbiome dysbiosis
2541. Oral-gut-brain axis in experimental models of periodontitis: associating gut dysbiosis with neurodegenerative diseases
2542. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis
2543. Gut dysbiosis and western diet in the pathogenesis of essential arterial hypertension: a narrative review
2544. Dysbiosis of the gut microbiome is a risk factor for osteoarthritis in older female adults: a case control study
2545. Early-Life Microbial Restitution Reduces Colitis Risk Promoted by Antibiotic-Induced Gut Dysbiosis in Interleukin 10–/–Mice
2546. Gut and endometrial microbiome dysbiosis: a new emergent risk factor for endometrial cancer
2547. Gut microbiota dysbiosis accelerates prostate cancer progression through increased LPCAT1 expression and enhanced DNA repair pathways
2548. Fungal dysbiosis of the gut microbiota is associated with colorectal cancer in Chinese patients
2549. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients
2550. Antibiotic-induced dysbiosis of microbiota promotes chicken lipogenesis by altering metabolomics in the cecum
2551. Depletion of lipocalin 2 (LCN2) in mice leads to dysbiosis and persistent colonization with segmented filamentous bacteria
2552. Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis
2553. … casei strain T21 attenuates Clostridioides difficile infection in a murine model through reduction of inflammation and gut dysbiosis with decreased toxin …
2554. Anthropogenic interferences lead to gut microbiome dysbiosis in Asian elephants and may alter adaptation processes to surrounding environments
2555. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis
2556. Intestinal dysbiosis in inflammatory diseases
2557. Dysbiosis of the human oral microbiome during the menstrual cycle and vulnerability to the external exposures of smoking and dietary sugar
2558. Butyrate improves skin/lung fibrosis and intestinal dysbiosis in bleomycin-induced mouse models
2559. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
2560. IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice
2561. Structural characterization of peptides from huangjiu and their regulation of hepatic steatosis and gut microbiota dysbiosis in hyperlipidemia mice
2562. Synbiotics alleviate the gut indole load and dysbiosis in chronic kidney disease
2563. Dysbiosis of gut fungal microbiota in children with autism spectrum disorders
2564. Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis?
2565. Micro-and mycobiota dysbiosis in pancreatic ductal adenocarcinoma development
2566. Chronic cereulide exposure causes intestinal inflammation and gut microbiota dysbiosis in mice
2567. … pentosus GSSK2 and isomalto-oligosaccharides) supplementation modulates pathophysiology and gut dysbiosis in experimental metabolic syndrome
2568. The role of DNA damage response in dysbiosis-induced colorectal cancer
2569. Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early …
2570. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis
2571. Aging-Induced Dysbiosis of Gut Microbiota as a Risk Factor for Increased Listeria monocytogenes Infection
2572. Decabromodiphenyl ether induces male reproductive toxicity by activating mitochondrial apoptotic pathway through glycolipid metabolism dysbiosis
2573. Ileal bile acid transporter inhibitor improves hepatic steatosis by ameliorating gut microbiota dysbiosis in NAFLD model mice
2574. Virus infection is an instigator of intestinal dysbiosis leading to type 1 diabetes
2575. … asymptomatic gallstones is not associated with changes in intestinal microbiota composition and diversity but cholecystectomy with significant dysbiosis
2576. Could dysbiosis of inflammatory and anti-inflammatory gut bacteria have an implications in the development of type 2 diabetes? A pilot investigation
2577. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis
2578. Dysbiosis of gut microbiota promotes hepatocellular carcinoma progression by regulating the immune response
2579. The diarrhetic shellfish-poisoning toxin, okadaic acid, provokes gastropathy, dysbiosis and susceptibility to bacterial infection in a non-rodent bioassay …
2580. Mammary microbial dysbiosis leads to the zoonosis of bovine mastitis: a One-Health perspective
2581. Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma
2582. Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach
2583. The link between gut dysbiosis caused by a high-fat diet and hearing loss
2584. Neonatal exposure to BPA, BDE-99, and PCB produces persistent changes in hepatic transcriptome associated with gut dysbiosis in adult mouse livers
2585. The role of gut dysbiosis in acute-on-chronic liver failure
2586. Gut microbiota dysbiosis in human hypertension: a systematic review of observational studies
2587. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson’s disease progression
2588. Microbiota dysbiosis and functional outcome in acute ischemic stroke patients
2589. Repulsive guidance molecule b deficiency induces gut microbiota dysbiosis and increases the susceptibility to intestinal inflammation in mice
2590. Cigarette smoking exposure breaks the homeostasis of cholesterol and bile acid metabolism and induces gut microbiota dysbiosis in mice with different diets
2591. Fu instant tea ameliorates fatty liver by improving microbiota dysbiosis and elevating short-chain fatty acids in the intestine of mice fed a high-fat diet
2592. Dulaglutide alone and in combination with empagliflozin attenuate inflammatory pathways and microbiome dysbiosis in a non-diabetic mouse model of NASH
2593. Initial evidence of distinguishable bacterial and fungal dysbiosis in the skin of patients with atopic dermatitis or Netherton syndrome
2594. Dysbiosis exacerbates colitis by promoting ubiquitination and accumulation of the innate immune adaptor STING in myeloid cells
2595. Effects of microplastic fibers on Lates calcarifer juveniles: Accumulation, oxidative stress, intestine microbiome dysbiosis and histological damage
2596. The association between vaginal dysbiosis and reproductive outcomes in sub-fertile women undergoing IVF-treatment: a systematic PRISMA review and meta …
2597. Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats
2598. β-Defensin 2, an Antimicrobial Peptide, as a Novel Biomarker for Ulcerative Interstitial Cystitis; Can β-Defensin 2 Suspect the Dysbiosis of Urine Microbiota?
2599. … the protective effects of foxtail millet whole grain against dextran sulfate sodium-induced acute ulcerative colitis and gut microbiota dysbiosis in C57BL/6 mice
2600. Chestnut shell tannins: Effects on intestinal inflammation and dysbiosis in Zebrafish
2601. Effects of urolithins on obesity-associated gut dysbiosis in rats fed on a high-fat diet
2602. Influences of non-IgE-mediated cow’s milk protein allergy-associated gut microbial dysbiosis on regulatory T cell-mediated intestinal immune tolerance and …
2603. Mycobiota dysbiosis and gastric tumorigenesis
2604. Growth faltering regardless of chronic diarrhea is associated with mucosal immune dysfunction and microbial dysbiosis in the gut lumen
2605. Perilla seed oil alleviates gut dysbiosis, intestinal inflammation and metabolic disturbance in obese-insulin-resistant rats
2606. Interplay between skin microbiota dysbiosis and the host immune system in psoriasis: Potential pathogenesis
2607. Diet-induced dysbiosis of the maternal gut microbiome in early life programming of neurodevelopmental disorders
2608. Lactobacillus plantarum CCFM8610 alleviates irritable bowel syndrome and prevents gut microbiota dysbiosis: A randomized, double-blind, placebo …
2609. Gut microbial dysbiosis and changes in fecal metabolic phenotype in precancerous lesions of gastric cancer induced with N-methyl-N′-nitro-N …
2610. Streptozotocin-induced hyperglycemia alters the cecal metabolome and exacerbates antibiotic-induced dysbiosis
2611. Deep nasal sinus cavity microbiota dysbiosis in Parkinson’s disease
2612. Dysbiosis in pediatrics is associated with respiratory infections: is there a place for bacterial-derived products?
2613. Toll like receptors as sensors of the tumor microbial dysbiosis: implications in cancer progression
2614. Gut microbial dysbiosis associated with type 2 diabetes aggravates acute ischemic stroke
2615. Association of gut microbiome dysbiosis with neurodegeneration: can gut microbe-modifying diet prevent or alleviate the symptoms of neurodegenerative diseases?
2616. Dysbiosis of the shrimp (Penaeus monodon) gut microbiome with AHPND outbreaks revealed by 16S rRNA metagenomics analysis
2617. Dietary switch to Western diet induces hypothalamic adaptation associated with gut microbiota dysbiosis in rats
2618. Bacteroides vulgatus diminishes colonic microbiota dysbiosis ameliorating lumbar bone loss in ovariectomized mice
2619. IDDF2021-ABS-0164 Gut feelings in depression: microbiota dysbiosis in response to antidepressants
2620. Dysbiosis of fecal microbiota from complement 3 knockout mice with constipation phenotypes contributes to development of defecation delay
2621. Glucose but not fructose alters the intestinal paracellular permeability in association with gut inflammation and dysbiosis in mice
2622. Exogenous autoinducer-2 rescues intestinal dysbiosis and intestinal inflammation in a neonatal mouse necrotizing enterocolitis model
2623. Food processing, dysbiosis, gastrointestinal inflammatory diseases, and antiangiogenic functional foods or beverages
2624. Fecal fungi dysbiosis in nonalcoholic fatty liver disease
2625. Intestinal mucositis precedes dysbiosis in a mouse model for pelvic irradiation
2626. Dysbiosis in the human microbiome of Cholangiocarcinoma
2627. Paeonol alleviates dextran sodium sulfate induced colitis involving Candida albicans-associated dysbiosis
2628. Dysbiosis of the salivary microbiome is associated with hypertension and correlated with metabolic syndrome biomarkers
2629. Porphyran‐derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice
2630. Dysbiosis in food allergy and implications for microbial therapeutics
2631. Experimental Infection of the Biomphalaria glabrata Vector Snail by Schistosoma mansoni Parasites Drives Snail Microbiota Dysbiosis
2632. Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic‑associated fatty liver disease in mice
2633. Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between …
2634. Poria cocos could ameliorate cognitive dysfunction in APP/PS1 mice by restoring imbalance of Aβ production and clearance and gut microbiota dysbiosis
2635. The dysbiosis of ovine foot microbiome during the development and treatment of contagious ovine digital dermatitis
2636. Serum oxytocin level correlates with gut microbiome dysbiosis in children with autism spectrum disorder
2637. Danggui-Shaoyao-San improves gut microbia dysbiosis and hepatic lipid homeostasis in fructose-fed rats
2638. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review
2639. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream …
2640. Is gut dysbiosis an epicenter of Parkinson’s disease?
2641. Diurnal changes in the murine small intestine are disrupted by obesogenic Western diet feeding and microbial dysbiosis
2642. Studies of xenobiotic-induced gut microbiota dysbiosis: from correlation to mechanisms
2643. Dysbiosis in the development of Type I diabetes and associated complications: From mechanisms to targeted gut microbes manipulation therapies
2644. No hints at glyphosate-induced ruminal dysbiosis in cows
2645. Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma
2646. Association of intestinal microbial dysbiosis with chronic obstructive pulmonary disease
2647. Biomarkers of human gut microbiota diversity and dysbiosis
2648. Maternal sucralose exposure induces Paneth cell defects and exacerbates gut dysbiosis of progeny mice
2649. Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung
2650. Dysbiosis and intestinal barrier dysfunction in pediatric congenital heart disease is exacerbated following cardiopulmonary bypass
2651. Boric acid was orally toxic to different instars of Blattella germanica (L.)(Blattodea: Blattellidae) and caused dysbiosis of the, gut microbiota
2652. Intestinal dysbiosis in celiac disease: Decreased butyrate production may facilitate the onset of the disease
2653. Dysbiosis of intestinal microbiota in critically ill patients and risk of in-hospital mortality
2654. Gut mycobiota dysbiosis in pulmonary tuberculosis patients undergoing anti-tuberculosis treatment
2655. … of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis
2656. Dose-responses relationship in glucose lowering and gut dysbiosis to saskatoon berry powder supplementation in high fat-high sucrose diet-induced insulin resistant …
2657. The intestinal dysbiosis of mothers with gestational diabetes mellitus (GDM) and its impact on the gut microbiota of their newborns
2658. Dysbiosis, host metabolism, and non-communicable diseases: trialogue in the inborn errors of metabolism
2659. Dysbiosis of intestinal microbiota in early life aggravates high-fat diet induced dysmetabolism in adult mice
2660. Gut dysbiosis and mortality in hemodialysis patients
2661. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways
2662. Quercetin preserves Oral cavity health by mitigating inflammation and microbial Dysbiosis
2663. Dysbiosis in the Salivary Microbiome Associated with IgA Nephropathy—‍A‍ ‍Japanese Cohort Study
2664. Polyphenol enriched diet administration during pregnancy and lactation prevents dysbiosis in ulcerative colitis predisposed littermates
2665. Gut microbial dysbiosis and its association with esophageal cancer.
2666. Species-level gut microbiota analysis after antibiotic-induced dysbiosis in horses
2667. Inorganic nitrate: A potential prebiotic for oral microbiota dysbiosis associated with type 2 diabetes
2668. … effects of probiotics on cognitive and motor functions, anxiety level, visceral sensitivity, oxidative stress and microbiota in mice with antibiotic-induced dysbiosis
2669. Gut dysbiosis, insulin resistance and Alzheimer’s disease: review of a novel approach to neurodegeneration
2670. Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy
2671. Restraint stress in hypertensive rats activates the intestinal macrophages and reduces intestinal barrier accompanied by intestinal flora dysbiosis
2672. Perinatal high-salt diet induces gut microbiota dysbiosis, bile acid homeostasis disbalance, and NAFLD in weanling mice offspring
2673. Dysbiosis in metabolic genes of the gut microbiomes of patients with an ileo-anal pouch resembles that observed in crohn’s disease
2674. Impaired bile acid metabolism and gut dysbiosis in mice lacking lysosomal acid lipase
2675. Acesulfame potassium induces dysbiosis and intestinal injury with enhanced lymphocyte migration to intestinal mucosa
2676. Metagenomic analysis reveals the heterogeneity of conjunctival microbiota dysbiosis in dry eye disease
2677. Obesity-Induced Dysbiosis Exacerbates IFN-γ Production and Pulmonary Inflammation in the Mycobacterium tuberculosis Infection
2678. Intestinal SIRT1 deficiency-related intestinal inflammation and dysbiosis aggravate TNFα-mediated renal dysfunction in cirrhotic ascitic mice
2679. Dupilumab therapy improves stratum corneum hydration and skin dysbiosis in patients with atopic dermatitis
2680. Vitamin A deficiency exacerbates gut microbiota dysbiosis and cognitive deficits in amyloid precursor protein/presenilin 1 transgenic mice
2681. The Tick Microbiota Dysbiosis Promote Tick-Borne Pathogen Transstadial Transmission in a Babesia microti–Infected Mouse Model
2682. Tartrazine exposure results in histological damage, oxidative stress, immune disorders and gut microbiota dysbiosis in juvenile crucian carp (Carassius carassius)
2683. High-fat diet increases the severity of Giardia infection in association with low-grade inflammation and gut microbiota dysbiosis
2684. Intestinal dysbiosis in spondyloarthritis–chicken or egg?
2685. Glycyrrhizin Attenuates Salmonella Typhimurium-Induced Tissue Injury, Inflammatory Response, and Intestinal Dysbiosis in C57BL/6 Mice
2686. Microbiota dysbiosis in honeybee (Apis mellifera L.) larvae infected with brood diseases and foraging bees exposed to agrochemicals
2687. Different molecular weight black garlic melanoidins alleviate high fat diet induced circadian intestinal microbes dysbiosis
2688. Toll-like receptors, environmental caging, and lung dysbiosis
2689. Depression, deprivation, and dysbiosis: Polyiatrogenesis in multiple chronic illnesses
2690. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis
2691. Boeravinone B alleviates gut dysbiosis during myocardial infarction‐induced cardiotoxicity in rats
2692. Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers
2693. Development of the gut microbiota and dysbiosis in children
2694. Long-term exposure to phenanthrene at environmental-level induces intestinal dysbiosis and disrupted hepatic lipid metabolism in mice
2695. Analysis of oral microbial dysbiosis associated with early childhood caries
2696. Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: a review
2697. Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia
2698. Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosis
2699. Intestinal inflammation as a dysbiosis of energy procurement: new insights into an old topic
2700. Lower airway dysbiosis exacerbates lung cancer
2701. Dysbiosis of the saliva microbiome in patients with polycystic ovary syndrome
2702. Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women
2703. Alcohol‐associated intestinal dysbiosis alters mucosal‐associated invariant T‐cell phenotype and function
2704. Guadipyr, a new insecticide, induces microbiota dysbiosis and immune disorders in the midgut of silkworms (Bombyx mori)
2705. Sodium butyrate inhibits colitis-associated colorectal cancer through preventing the gut microbiota dysbiosis and reducing the expression of NLRP3 and IL-1β
2706. Dietary fibers extracted from Saccharina japonica can improve metabolic syndrome and ameliorate gut microbiota dysbiosis induced by high fat diet
2707. The gut reaction to couples’ relationship troubles: A route to gut dysbiosis through changes in depressive symptoms
2708. Intestinal dysbiosis correlates with sirolimus-induced metabolic disorders in mice
2709. The autistic-like behaviors development during weaning and sexual maturation in VPA-induced autistic-like rats is accompanied by gut microbiota dysbiosis
2710. Persistent purine metabolic abnormality induces the aggravation of visceral inflammation and intestinal microbiota dysbiosis in Magang goose
2711. … N-oxide remain elevated long term after left ventricular assist device and heart transplantation and are independent from measures of inflammation and gut dysbiosis
2712. Dysbiosis of fecal microbiota in cats with naturally occurring and experimentally induced Tritrichomonas foetus infection
2713. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis
2714. Linking the triad of telomere length, inflammation, and gut dysbiosis in the manifestation of depression
2715. Synbiotics supplements lower the risk of hand, foot, and mouth disease in children, potentially by providing resistance to gut microbiota dysbiosis
2716. Gut dysbiosis correction contributes to the hepatoprotective effects of Thymus quinquecostatus Celak extract against alcohol through the gut–liver axis
2717. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy—Is there a link?
2718. Propamocarb exposure has the potential to accelerate the formation of atherosclerosis in both WT and ApoE−/− mice accompanied by gut microbiota dysbiosis
2719. Dysbiosis triggers ACF development in genetically predisposed subjects
2720. Dysbiosis, gut-blood barrier rupture and autoimmune response in rheumatoid arthritis and schizophrenia
2721. Mussismilia braziliensis White Plague Disease Is Characterized by an Affected Coral Immune System and Dysbiosis
2722. … with Lactobacillus plantarum ameliorates compromise of growth performance by modulating short-chain fatty acids and intestinal dysbiosis in broilers under …
2723. Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans
2724. Gut microbiota dysbiosis in patients with preeclampsia: A systematic review
2725. Thermal stress interacts with surgeonfish feces to increase coral susceptibility to dysbiosis and reduce tissue regeneration
2726. Impaired salivary SIgA antibodies elicit oral dysbiosis and subsequent induction of alveolar bone loss
2727. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2−/− mouse model
2728. COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review
2729. Prolonged gut dysbiosis and fecal excretion of hepatitis a virus in patients infected with human immunodeficiency virus
2730. Chronic Opioid Administration is Associated with Prevotella-dominated Dysbiosis in SIVmac251 Infected, cART-treated Macaques
2731. A novel model for nephrotic syndrome reveals associated dysbiosis of the gut microbiome and extramedullary hematopoiesis
2732. A discussion of the gut microbiome’s development, determinants, and dysbiosis in cancers of the esophagus and stomach
2733. Profiling of gut microbial dysbiosis in adults with myeloid leukemia
2734. Effects of feeding a hypoallergenic diet with a nutraceutical on fecal dysbiosis index and clinical manifestations of canine atopic dermatitis
2735. Alcohol Use Is Associated With Intestinal Dysbiosis and Dysfunctional CD8+ T-Cell Phenotypes in Persons With Human Immunodeficiency Virus
2736. The influence of dysbiosis on kidney stones that risk up renal cell carcinoma (RCC)
2737. P16 I NK 4 a Deletion Ameliorates Damage of Intestinal Epithelial Barrier and Microbial Dysbiosis in a Stress-Induced Premature Senescence Model of Bmi-1 …
2738. Environmentally relevant concentrations of clozapine induced lipotoxicity and gut microbiota dysbiosis in Chinese rare minnow (Gobiocypris rarus)
2739. Dysbiosis in SARS-CoV-2–Infected Patients
2740. Neuro-immunity and gut dysbiosis drive Parkinson’s disease-induced pain
2741. Beneficial role of fruits, their juices, and freeze-dried powders on inflammatory bowel disease and related dysbiosis
2742. What makes a successful donor? Fecal transplant from anxious-like rats does not prevent spinal cord injury-induced dysbiosis
2743. Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa
2744. Neonatal hyperoxia induces gut dysbiosis and behavioral changes in adolescent mice
2745. Gut microbiota dysbiosis as a target for improved post-surgical outcomes and improved patient care: a review of current literature
2746. Eradication of chronic HCV infection: Improvement of dysbiosis only in patients without liver cirrhosis
2747. HIV infection as a risk factor for vaginal dysbiosis, bacterial vaginosis, and candidosis in pregnancy: A matched case‐control study
2748. Ovariectomy-induced dysbiosis may have a minor effect on bone in mice
2749. Alcohol use and abuse Conspires with HIV infection to aggravate intestinal dysbiosis and increase microbial translocation in people living with HIV: a review
2750. Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis
2751. Effect of You-Gui-Wan on House Dust Mite-Induced Mouse Allergic Asthma via Regulating Amino Acid Metabolic Disorder and Gut Dysbiosis
2752. Outbreak of acute larval cyathostominosis–A “perfect storm” of inflammation and dysbiosis
2753. Helminth-induced human gastrointestinal dysbiosis: a systematic review and meta-analysis reveals insights into altered taxon diversity and microbial gradient collapse
2754. Dysbiosis in the gut microbiome in streptozotocin-induced diabetes rats and follow-up during retinal changes
2755. Analysis of mouse faecal dysbiosis, during the development of cachexia, induced by transplantation with Lewis lung carcinoma cells
2756. Lacticaseibacillus rhamnosus TR08 alleviated intestinal injury and modulated microbiota dysbiosis in septic mice
2757. Long-term iron deficiency and dietary iron excess exacerbate acute dextran sodium sulphate-induced colitis and are associated with significant dysbiosis
2758. Dysbiosis and enhanced Beta-defensin production in hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia
2759. Gut dysbiosis and hypertension–is it cause or effect?
2760. SP-1, a serine protease from the gut microbiota, influences colitis and drives intestinal dysbiosis in mice
2761. Intestinal dysbiosis in young cystic fibrosis rabbits
2762. … granule prescription Mahuang decoction ameliorated chronic kidney disease which was associated with restoration of dysbiosis of intestinal microbiota in rats
2763. Reverse microbiomics: a new reverse dysbiosis analysis strategy and its usage in prediction of autoantigens and virulent factors in dysbiotic gut microbiomes …
2764. Dysbiosis of the intestinal microbiome as a component of pathophysiology in the inborn errors of metabolism
2765. Brief hydromorphone exposure during pregnancy sufficient to induce maternal and neonatal microbial dysbiosis
2766. Probiotic mixture reduces gut inflammation and microbial dysbiosis in children with atopic dermatitis
2767. Gut microbiota dysbiosis is associated with worse emotional states in HIV infection
2768. Intestinal dysbiosis and development of cardiometabolic disorders in childhood cancer survivors: a critical review
2769. Gut digestive function and microbiome after correction of experimental dysbiosis in rats by indigenous bifidobacteria
2770. Mitigation of obesity-related systemic low-grade inflammation and gut microbial dysbiosis in mice with nanosilver supplement
2771. Potato extract inhibits lipase activity and ameliorates gut microbiome dysbiosis and weight gain in mice fed a high-fat diet
2772. Study of miRNA interactome in active rheumatoid arthritis patients reveals key pathogenic roles of dysbiosis in the infection–immune network
2773. Association of Neonatal Jaundice with gut Dysbiosis characterized by decreased Bifidobacteriales
2774. Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
2775. Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting
2776. Lantibiotics produced by oral inhabitants as a trigger for dysbiosis of human intestinal microbiota
2777. Temporal dysbiosis of infant nasal microbiota relative to respiratory syncytial virus infection
2778. Gut microbiota dysbiosis associated with persistent fatigue in hematopoietic cell transplantation survivors
2779. Maternal gut dysbiosis alters offspring microbiota and social interactions
2780. Synbiotics containing nanoprebiotics: a novel therapeutic strategy to restore gut dysbiosis
2781. Atractylenolide I inhibits antibiotic-induced dysbiosis of the intestinal microbiome
2782. Exercise training reverses gut dysbiosis in patients with biopsy-proven nonalcoholic steatohepatitis: a proof of concept study
2783. New insights into pneumonia in patients on prolonged mechanical ventilation: need for a new paradigm addressing dysbiosis
2784. Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in mice
2785. Altered fecal microbiotas and organic acid concentrations indicate possible gut dysbiosis in university rugby players: an observational study
2786. … and safety of washed microbiota transplantation to treat patients with mild-to-severe COVID-19 and suspected of having gut microbiota dysbiosis: Study protocol for a …
2787. Association of Adherent-invasive Escherichia coli with severe Gut Mucosal dysbiosis in Hong Kong Chinese population with Crohn’s disease
2788. Coffee consumption modulates amoxicillin-induced dysbiosis in the murine gut microbiome
2789. The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model
2790. The prevalence of intestinal dysbiosis in patients referred for antireflux surgery
2791. Intestinal dysbiosis and autoimmune pancreatitis
2792. Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?
2793. Microbial dysbiosis together with nutrient imbalance cause the replant problem of upper six flue-cured tobacco in Central Henan
2794. Dysbiosis of oral microbiota associated with palmoplantar pustulosis
2795. Intestinal dysbiosis–a new treatment target in the prevention of colorectal cancer
2796. Nasopharyngeal Dysbiosis Precedes the Development of Lower Respiratory Tract Infections in Young Infants, a Longitudinal Infant Cohort Study
2797. Vaginal dysbiosis and partial bacterial vaginosis: the interpretation of the “Grey Zones” of clinical practice
2798. Upper‐airway dysbiosis related to frequent sweets consumption increases the risk of asthma in children with chronic rhinosinusitis
2799. Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias?
2800. A comparative pilot study of bacterial and fungal dysbiosis in neurodevelopmental disorders and gastrointestinal disorders: Commonalities, specificities and …
2801. Anti-allergic diarrhea effect of diosgenin occurs via improving gut dysbiosis in a murine model of food allergy
2802. … of green tea EGCG enhances healthspan and lifespan in mice by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis …
2803. Potential roles of the free salivary microbiome dysbiosis in periodontal diseases
2804. Gut modulation of dysbiosis induced by dextran sulfate sodium
2805. Epigenetics, 1-carbon metabolism, and homocysteine during dysbiosis
2806. Hematopoietic cell transplantation rescues inflammatory bowel disease and dysbiosis of gut microbiota in XIAP deficiency
2807. Antimicrobial Activity of a Vaginal Gel Formulation: Considerations Related to Vaginal Infection and Dysbiosis
2808. Regulation divergences of Lactobacillus fermentum PCC and Lactobacillus paracasei 431 on penicillin-induced upper respiratory tract microbial dysbiosis in BALB/c …
2809. Effect of the standard herbal preparation, STW5, treatment on dysbiosis induced by dextran sodium sulfate in experimental colitis
2810. Mucosal microbiome dysbiosis associated with duodenum bulb inflammation
2811. Markers of gastrointestinal permeability and dysbiosis in premenopausal women with PCOS: a case–control study
2812. Antimicrobial‐induced oral dysbiosis exacerbates naturally occurring alveolar bone loss
2813. Long‐lasting microbial dysbiosis and altered enteric neurotransmitters in adult rats following adolescent binge ethanol exposure
2814. Epigenetic regulation of gut microbial Dysbiosis
2815. Atopobiosis and dysbiosis in ocular diseases: Is fecal microbiota transplant and probiotics a promising solution?
2816. Goat and cow milk differ in altering microbiota composition and fermentation products in rats with gut dysbiosis induced by amoxicillin
2817. Gut Microbiota Dysbiosis Aggravates Mycoplasma gallisepticum Colonization in the Chicken Lung
2818. … delivery of chitosan derivative-based nanoparticles encapsulating quercetin to attenuate intestinal injury and regulate gut microbiota dysbiosis in mucositis treatment
2819. Interrelationship between the 5-lipoxygenase pathway and microbial dysbiosis in the progression of Alzheimer’s disease
2820. Decreased intestinal microbiome diversity in pediatric sepsis: a conceptual framework for intestinal dysbiosis to influence immunometabolic function
2821. Role of dietary micronutrients on gut microbial dysbiosis and modulation in inflammatory bowel disease
2822. Fungal dysbiosis and survival after allo-HCT
2823. Appetite suppression and interleukin 17 receptor signaling activation of colonic mycobiota dysbiosis induced by high temperature and high humidity …
2824. Intestinal Dysbiosis and Non-Alcoholic Fatty Liver
2825. In silico modeling of hyposalivation and biofilm dysbiosis in root caries
2826. risk of dietary hazardous substances and impact on human microbiota: possible role in several dysbiosis phenotypes
2827. Passive exposure to cannabidiol oil does not cause microbiome dysbiosis in larval zebrafish
2828. Glycation of gut proteins initiates microbial dysbiosis and can promote establishment of diabetes in experimental animals
2829. Dysbiosis of the duodenal microbiota as a diagnostic marker for pancreaticobiliary cancer
2830. Western lifestyle as a driver of dysbiosis in colorectal cancer
2831. Analysis of appendectomy samples identified dysbiosis in acute appendicitis
2832. A pilot study for metabolic profiling of obesity-associated microbial gut dysbiosis in male Wistar rats
2833. Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis
2834. Gut Dysbiosis–Induced Hypertension Is Ameliorated by Intermittent Fasting
2835. … the Human Microbiome: A Survey of Prescribing Clinicians’ Knowledge and Opinions Regarding the Link between Antibiotic-Induced Dysbiosis and Immune-Mediated …
2836. Dysbiosis in salivary bacterial diversity of postpartum females and its association with oral health problems and APOs
2837. Metagenomic analysis of RNA sequencing data reveals SARS-CoV-2-mediated progressive dysbiosis of upper respiratory tract microbiota
2838. The nursing home older adult gut microbiome composition shows time-dependent dysbiosis and is influenced by medication exposures, age, environment, and frailty
2839. … treatment protocol (Perrotta Protocol for Clinical Management of Intestinal Dysbiosis, PID) for the management and resolution of persistent or chronic dysbiosis
2840. High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis
2841. Changes in Gut Bacterial Translation Occur before Symptom Onset and Dysbiosis in Dextran Sodium Sulfate-Induced Murine Colitis
2842. Effects of dysbiosis and dietary manipulation on the digestive microbiota of a detritivorous arthropod
2843. Aicda deficiency exacerbates high-fat diet-induced hyperinsulinemia but not gut dysbiosis in mice
2844. … exposure during late gestation disrupts glycolipid metabolism and hepatic mitochondrial function tightly related to gut microbial dysbiosis in pregnant mice
2845. Efficacy of phototherapy with 308-nm excimer light for skin microbiome dysbiosis and skin barrier dysfunction in canine atopic dermatitis
2846. Chlorhexidine gluconate does not result in epidermal microbiota dysbiosis in healthy adults
2847. Bad “Good” Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same
2848. IDDF2021-ABS-0130 Dysbiosis of gut archaea in obesity recovered after bariatric surgery
2849. Effect of essential oils of Zingiber officinale, Cinnamomum verum, Trachyspermum ammi, Cuminum cyminum, and Carum carvi on Bacteria inducing clonal Dysbiosis …
2850. Looking into key bacterial proteins involved in gut dysbiosis
2851. Dysbiosis of gut microbiota in patients with post-stroke cognitive impairment
2852. Differential fecal microbiome dysbiosis after equivalent traumatic brain injury in aged versus young adult mice
2853. Influenza A virus infection in turkeys induces respiratory and enteric bacterial dysbiosis correlating with cytokine gene expression
2854. Predicting hyperoxia-induced lung injury from associated intestinal and lung dysbiosis in neonatal mice
2855. Dysbiosis and liver diseases
2856. Sodium dysbiosis and autism spectrum disorder
2857. Dysbiosis in aspirin‐exacerbated respiratory disease
2858. Dietary contamination with a neonicotinoid (Clothianidin) gradient triggers specific dysbiosis signatures of microbiota activity along the honeybee (Apis …
2859. Micro-and nanotechnological delivery platforms for treatment of dysbiosis-related inflammatory bowel disease
2860. Bacterial gut dysbiosis is associated with Crohn’s disease symptoms but not with elevated fecal calprotectin
2861. Association of microbial dysbiosis with gallbladder diseases identified by bile microbiome profiling
2862. RNA sequencing reveals changes in mouse retinal transcriptome caused by high-fat diet induced gut dysbiosis
2863. COVID-19 severity and complications associated with low diversity, dysbiosis and predictive metagenome features of the oropharyngeal microbiome.
2864. Gut Digestive Function and Microbiome after Correction of Experimental Dysbiosis in Rats by Indigenous Bifidobacteria. Microorganisms 2021; 9: 522
2865. Association of oral microbial community dysbiosis and dental disorders among pregnant woman attending Gatanga Health Center, Kigali, Rwanda
2866. Dysbiosis in the small intestine: towards an optimal therapy to normalize the gut microbiota
2867. Antibiotic-induced rat gut microbiota dysbiosis and salmonella resistance
2868. Co-treatment with cefotaxime and high-fructose diet inducing nonalcoholic fatty liver disease and gut microbial dysbiosis in mice
2869. … N-oxide Remain Elevated Long-Term After LVAD and Heart Transplantation and are Independent from Measures of Inflammation and Gut Dysbiosis.
2870. Early gut dysbiosis could be an indicator of unsuccessful diet control in gestational diabetes mellitus
2871. Persistent intestinal dysbiosis after SARS-CoV-2 infection in Brazilian patients
2872. Gut bacterial dysbiosis and its clinical implications
2873. Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis–No
2874. Effects of a perioperative antibiotic and veterinary probiotic on fecal dysbiosis index in dogs
2875. Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis–Yes
2876. Analysis of ileostomy stool samples reveals dysbiosis in patients with high-output stomas
2877. Impact of Subthalamic Deep Brain Stimulation on Hyposmia in Patients With Parkinson’s Disease Is Influenced by Constipation and Dysbiosis of Microbiota
2878. An Oxford nanopore-based characterisation of sputum microbiota dysbiosis in patients with tuberculosis: from baseline to 7 days after antibiotic treatment
2879. Glutamine deficiency links clindamycin-induced dysbiosis and intestinal barrier dysfunction in mice
2880. Zeolite‐containing mixture alleviates microbial dysbiosis in dextran sodium sulfate‐induced colitis in mice
2881. The link between obesity, microbiota dysbiosis, and neurodegenerative pathogenesis. Diseases. 2021; 9: 45
2882. Dysbiosis of the urinary bladder microbiome in cats with chronic kidney disease
2883. Individual diet relates to gut microbiota functional dysbiosis since subclinical stages of atherosclerosis
2884. Effects of gut microbiota remodeling on the dysbiosis induced by high fat diet in a mouse model of Gulf war illness
2885. Dysbiosis of intestinal microbiota in autism spectrum disorders: new horizons in search for pathogenetic approaches to therapy. Part 1. Features of intestinal …
2886. Therapeutic immunoglobulin A antibody for dysbiosis-related diseases
2887. Mycobiota dysbiosis: a new nexus in intestinal tumorigenesis
2888. Depression, Deprivation, and Dysbiosis: Polyiatrogenesis in Multiple Chronic Illnesses
2889. Human oral microbiome dysbiosis as a novel tool for detecting noninvasive biomarkers for colorectal cancer.
2890. Dysbiosis and liver diseases
2891. EEG Changes Related to Gut Dysbiosis in Diabetes
2892. IDDF2021-ABS-0054 Appendectomy increases the risk of colorectal cancer through causing gut microbiota dysbiosis in a large population-based study
2893. Dental biofilm microbiota dysbiosis is associated with the risk of aGVHD after allogeneic HSCT
2894. Dysbiosis of urine microbiota in obstructive urinary retention patients revealed by next-generation sequencing
2895. Immunological and genetic features of pathogenetic association between psoriasis and colonic dysbiosis
2896. Firmicutes Dysbiosis After Chlorhexidine Prophylaxis in Healthy Patients Submitted to Impacted Lower Third Molar Extraction
2897. A multidimensional Mendelian randomization study on the impact of gut dysbiosis on chronic diseases and human longevity
2898. Gut microbiome dysbiosis shapes disease course in the different stages of multiple sclerosis
2899. … of endoplasmic reticulum stress and activation of autophagy-protect intestinal and renal tissues from western diet-induced dysbiosis and abrogate inflammatory …
2900. EFFECTIVENESS OF GANODERMA LUCIDUM EXTRACT IN THE TREATMENT OF PATIENTS WITH DUEDENAL ULCER WITH INTESTINAL DYSBIOSIS
2901. Involvement of intestinal dysbiosis in the etiopathogenesis and treatment of autism spectrum disorder: a bibliographic review
2902. Comments on “Mammary microbial dysbiosis leads to the zoonosis of bovine mastitis: a One-Health perspective” by Maity and Ambatipudi
2903. Intestinal Dysbiosis Disguised as a Rectal Fistula Treated With Autologous Fecal Microbiota Transplantation
2904. Microbial community dysbiosis and functional gene content changes in apple flowers due to fire blight
2905. Dysbiosis, small intestinal bacterial overgrowth, and chronic diseases: a translational approach
2906. Gut microbiota dysbiosis in diabetes mellitus
2907. Oropharyngeal dysbiosis affects postoperative tissue reparative capacity in patients with congenital disorders of maxillofacial region
2908. POS0237 GUT DYSBIOSIS LINKED TO WORSE DISEASE STATUS IN AXIAL SPONDYLOARTHRITIS
2909. Impact of Helicobacter pylori-related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders
2910. Comments on “Mammary microbial dysbiosis leads to the zoonosis of bovine mastitis: a One-Health perspective” by Maity and Ambatipudi
2911. Dulaglutide alone and in combination with empagliflozin attenuate inflammatory pathways and microbiome dysbiosis in a non-diabetic mouse model of NASH …
2912. Development of a protocol with concentrated bacteria for fecal microbiota transplantation and impact on the equine fecal microbiota after antibiotic-induced dysbiosis
2913. Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis. Biomedicines 2021, 9, 728
2914. Association between Rosacea, Environmental Factors, and Facial Cutaneous Dysbiosis: A Pilot Study from the Largest National Festival of Twins
2915. DYSBIOSIS OR HOW IT CAN RUIN YOUR LIFE THROUGH THE NERVOUS SYSTEM
2916. Comments on “Mammary microbial dysbiosis leads to the zoonosis of bovine mastitis: a One-Health perspective” by Maity and Ambatipudi
2917. Monitoring of distribution of antibiotic-resistant strains of microorganisms in patients with dysbiosis of the urogenital tract
2918. Correction to: Bee pollen and propolis improve neuroinflammation and dysbiosis induced by propionic acid, a short chain fatty acid in a rodent model of autism
2919. Does Dysbiosis Increase the Risk of Developing Schizophrenia?-A Comprehensive Narrative Review
2920. Dysbiosis in microbiome leading to colitis-associated cancer: gut microbiome correlation with CAC
2921. … , BETA-DEFENSIN 2 (BD2), IS A NOVEL BIOMARKER ON ULCERATIVE INTERSTITIAL CYSTITIS; CAN BD2 SUSPECT THE DYSBIOSIS OF URINE MICROBIOTA?
2922. Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet
2923. Evaluation of endotoxemia, soluble CD14 and IL-1β in dogs with intestinal dysbiosis that were treated with probiotics: a prospective study
2924. Intestinal microbial dysbiosis induced tau accumulation establishes a gut‐brain correlation for pathology Alzheimer’s disease in Drosophila melanogaster
2925. COVID-19 and intestinal dysbiosis: the proposed mechanism of short-chain fatty acids for preventing cytokine storm and multi-organ failure
2926. Morphological characteristics of small intestine mucosa in dysbiosis and after its correction by probiotics and enterosorbents
2927. Uremia causes dysbiosis-mediated periodontal disease
2928. Digestive Dysbiosis in Systemic Scleroderma: A Review
2929. … Montorsi, and Andrea Salonia’s Letter to the Editor re: Scott D. Lundy, Naseer Sangwan, Neel V. Parekh, et al. Functional and Taxonomic Dysbiosis of the Gut, Urine …
2930. POS1429 ORAL DYSBIOSIS REFLECTS THE IMMUNOLOGICAL ALTERATION OF RA REGARDING TO HLA DRB1* SE, ACPA AND CIGARETTE SMOKING …
2931. Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson’s Disease
2932. Dysbiosis of the faecal and biliary microbiotas in biliary tract cancer
2933. The correlation between vaginal microecological dysbiosis-related diseases and preterm birth: A review
2934. Targeting gut dysbiosis as a means to enhance recovery from surgical brain injury
2935. Regulation of the intestinal dysbiosis of high–fat diet obese mice via gut microbia–TLR2/4 pathway by electroacupuncture
2936. No hints at glyphosate-induced ruminal dysbiosis in cows
2937. Bacterial dysbiosis predicts the diagnosis of Crohn’s disease in Saudi children
2938. Commentary: Lung cancer and dysbiosis: debugging the studies for the future
2939. Naturally Acquired Lactic Acid Bacteria from Fermented Cassava Improves Nutrient and Anti-dysbiosis Activity of Soy Tempeh
2940. Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis–Commentary
2941. Prophylactic Treatment of Undernourished Mice with Cotrimoxazole Induces a Different Profile of Dysbiosis with Functional Metabolic Alterations
2942. Gut dysbiosis and altered circulating microbial metabolites in patients with pulmonary arterial hypertension
2943. Reply to the letter by Ouyang et al. regarding our manuscript “Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who …
2944. Dysbiosis in pre-cancerous mucosa may drive immune dysfunction–a study of immune system: microbiota interaction in familial adenomatous polyposis
2945. Gut microbiota dysbiosis in Parkinson’s disease patients: Early feature and biomarker of disease progression?
2946. Comment on: “Long‑term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal …
2947. P009 Disease classifier and microbial dysbiosis index tools cross-predict various pathogenic conditions due to general microbial signal
2948. S159 The Role of Dysbiosis in Neurological Disorders
2949. Gut Microbial Dysbiosis is Correlated with Stroke Severity Markers in Aged Rats Following Stroke
2950. Bilateral Putaminal Haemorrhage and Blindness in Times of the Coronavirus Pandemic and Dysbiosis: Case Report and Literature Review.
2951. Dynamics of Respiratory Microbiome Profiles Contributes to Imbalance and Lung Dysbiosis in the Respiratory Tract
2952. IDDF2021-ABS-0211 Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in crohn’s disease
2953. Gut Microbial Dysbiosis and Enterococcus gallinarum in Common Variable Immunodeficiency with Immune Dysregulation
2954. … and FEB improved renal injury, including renal dysfunction and renal tubulointerstitial lesions; remodeled gut microbiota dysbiosis, including decreased Bacteroidales …
2955. Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis
2956. Vaginal Microbial Community Dysbiosis and Associated Outcomes among Women under Contraception at Musasa Health Center, Rwanda
2957. Yifei Sanjie Formula Treats Chronic Obstructive Pulmonary Disease by Regulating Lung Microbiota Dysbiosis
2958. Lactobacillus plantarum Outperforms Enterococcus faecium on Anti-obesity Possibly through the Differences in Gut Dysbiosis Attenuation, Despite the Similar Anti …
2959. Alterations in Co-abundant Bacteriome in Colorectal Cancer and Persistent Microbial Dysbiosis After Surgery
2960. Carbon Black Nanoparticles Exposure Induces Intestinal Flora Dysbiosis and Consequent Activation of Gut-Liver Axis Leading to Liver Lipid Accumulation in Zebrafish
2961. Antimicrobial Activity of a Vaginal Gel Formulation: Considerations Related to Vaginal Infection and Dysbiosis. Pathogens 2021, 10, 1576
2962. 104 Inflammation-Type Dysbiosis of the Oral Microbiome Associates With the Duration of Coronavirus Disease 2019 (COVID-19) and Long COVID Disease States
2963. … -resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Critically Ill Patients: Potential Inference with Respiratory Tract Microbiota Dysbiosis
2964. Interplay between systemic health features and gut dysbiosis in aging and clinical (wasting) conditions
2965. The Microbiota of a Mite Prey-predator System on Different Host Plants Are Characterized by Functional Redundancy and Dysbiosis
2966. Dysbiosis fuels ILC2 attack on hair follicles
2967. … susceptible to respiratory tract infection are characterised by reduced circulating memory T regulatory cells, upper airway microbial dysbiosis and dysregulation of …
2968. Oral dysbiosis exacerbates the virulence of Candida parapsilosis sensu stricto via up-regulation of the CPH2 biofilm master gene
2969. Microbiome dysbiosis regulates the level of energy production under anaerobic condition
2970. CANDIDA ALBICANS INTESTINAL DYSBIOSIS INCREASES LUNG RESIDENT ILC2 POPULATIONS AND ENHANCES THE SEVERITY OF HDM-INDUCED …
2971. Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress? Biomolecules 2021, 11, 678
2972. O03. 5 PID Treatment and Mycoplasma genitalium (MG): The Impact of Vaginal Dysbiosis
2973. Models of Dysbiosis to Investigate the Role of SOCS3 in Intestinal Inflammation
2974. Skin microbiome dysbiosis in leprosy cases
2975. Dynamic Dysbiosis of Maternal Gut Microbiome in Perinatal Anxiety
2976. Comparative Analysis of Phytobiotics Effectiveness for the Correction of Mucous Membranes Dysbiosis in Cattle
2977. Are Drugs that Cause Dysbiosis Longitudinally Associated with Cognitive Scores, Cognitive Impairment, & Dementia?
2978. DOES LOWER AIRWAY DYSBIOSIS HAVE UTILITY AS A BIOMARKER OF LUNG CANCER?
2979. Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress? Biomolecules 2021, 11, 678
2980. … acid improves the efficacy of a dietary intervention in counteracting Western-style diet-induced metabolic dysregulation and gut bacterial dysbiosis in mice
2981. Gut microbiome dysbiosis in anorexia nervosa
2982. DUODENAL DYSBIOSIS IS UNRELATED TO PROTON PUMP INHIBITOR EFFICACY IN FUNCTIONAL DYSPEPSIA PATIENTS
2983. P687 Development of a panel of microbial markers to distinguish transient from pathological dysbiosis
2984. Intestinal dysbiosis during pregnancy: the norm or pathology?
2985. Nutritional Effects on the Gut Microbiome & the Brain-Gut Axis: Unlocking the Therapeutic and Preventative Potential of Nutrition for Gut Dysbiosis Associated …
2986. P58. 01 Dysbiosis of Fecal Microbiome in Advanced Non-Small-Cell Lung Cancer
2987. Dysbiosis of intestinal microbiota in autism spectrum disorders: new horizons in search for pathogenetic approaches to therapy. Part 2. Gut–brain axis in …
2988. Processed Food And Food Additives In The Context Of Dysbiosis And Its Health Consequences
2989. Prevalence of Blastocystis and its Association with Intestinal Dysbiosis in Clinically Healthy and Metabolically Ill Subjects.
2990. Dysbiosis and obesity: implications of the gut microbiota
2991. Prevention of dysbiosis and antibiotic-associated diarrhea in children with acute respiratory infections after antibiotic therapy
2992. Using Genetic Algorithms to Model Microbiome Coevolutionary Dynamics and Dysbiosis Due to Environmental and Pharmaceutical Stressors
2993. Corrigendum: The Tick Microbiota Dysbiosis Promote Tick-Borne Pathogen Transstadial Transmission in a Babesia microti Infected Mouse Model
2994. Metagenomic Analysis of The Gut Microbiome of Term Infants In The United States Reveals Widespread Dysbiosis
2995. FP07. 01 Dysbiosis of Gut Microbiota Suppress the Brain Metastasis of Non-Small Cell Lung Cancer
2996. Fibrin (ogen) Promotes Immune Cell Infiltration, Dysbiosis and ROS Production in Experimental Colitis
2997. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease. Cells 2021, 10, 114
2998. Attention-Deficit/Hyperactivity Disorder (ADHD) symptom severity and gut microbiome dysbiosis: an aetiological perspective on an emerging relationship
2999. Infection and Diet-Induced Gut Dysbiosis: Impact on Sleep Quality in Danio rerio
3000. Cytokine profile in women with threatened miscarriage and intestinal dysbiosis
3001. Gut Microbiome Dysbiosis is Associated with Increased Mortality following Solid Organ Transplantation
3002. Disentangling dysbiosis in chronic kidney disease
3003. The Effect of Lower Airway Dysbiosis on PD-1 Therapy in Lung Cancer
3004. SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice. Cells 2021, 10, 2658
3005. In vitro and in vivo approaches to study oxidative stress, anemia and dysbiosis in Chronic Kidney Disease
3006. Dysbiosis-Related Medications and the Association With Cognitive Decline, Cognitive Impairment, and Dementia
3007. Gut dysbiosis thwarts the efficacy of vaccine against mycobacterium tuberculosis
3008. Investigating Microbiome-Targeted Treatments for Chronic Rhinosinusitis: A novel approach to combat dysbiosis in the nasal microbiome
3009. Host-genetics, dysbiosis, and clinical history explains fecal metabolic alterations in patients with Inflammatory Bowel Disease
3010. Alterations of Oropharyngeal Microbiome Reflected Disease Severity and Long-Term Dysbiosis in Patients With COVID-19
3011. Gut dysbiosis in Ocular Mucous Membrane Pemphigoid
3012. Іmmunological disorders and colonic dysbiosis in patients with biliary lesions in type 2 diabetes mellitus and obesity
3013. … INTO THE MECHANISMS UNDERLYING THE TRANSGENERATIONAL EFFECTS OF MATERNAL HIGH-FAT DIET-INDUCED DYSBIOSIS ON OFFSPRING BRAIN …
3014. Dynamic assessment of the impact of gut microbiota transfer in a mouse model of chronic intestinal dysbiosis
3015. High Myoglobin Diet Induced Colon Dysbiosis and Inflammation by Regulating Heme or Iron Metabolism
3016. Androgen-induced gut dysbiosis disrupts metabolism and endocrinal functions in PCOS
3017. Association of Neonatal Jaundice with Gut Dysbiosis Characterized by Decreased Bifidobacteriales. Metabolites 2021, 11, 887
3018. 713d Downregulation of Apolipoprotein H Induce Hepatocyte Steatosis to Promote Gut Microbiota Dysbiosis in Chronic Hepatitis B Infection
3019. Synbiotic (Lactobacillus Pentosus GSSK2 And Isomalto-Oligosaccharides) Supplementation Modulates Pathophysiology And Gut Dysbiosis In Experimental Metabolic …
3020. Enrichment of Gut Ecosystem by Daily Supplementation of Selective Probiotic Strains and Probiotic Complex in Dysbiosis Condition of Autism.
3021. THE ANTIDISBIOTIC EFFECT OF OIL CAKE FROM HIGH OLEIC SUNFLOWER SEEDS IN RATS WITH EXPERIMENTAL DYSBIOSIS.
3022. Circulating Metabolomics Suggest Neutropenic Fever As a Metabolic Derangement Related to Intestinal Tissue Damage and Gut Dysbiosis
3023. Therapeutic and preventive effect of feed additives on the state of periodonts of rats with experimental dysbiosis
3024. … OF FLOUR FROM PEA STRAW ON LIPID PEROXIDATION AND ANTIOXIDANT PROTECTION IN THE FOOD SYSTEM OF RATS WITH EXPERIMENTAL DYSBIOSIS.
3025. The Association of Renal Dysfunction with Gut Dysbiosis in Heart Failure, LVAD and Heart Transplant Patients-A Mediation Analysis
3026. Gastrointestinal dysbiosis caused by a lack of Paneth cells promotes diet-induced obesity and trafficking of inflammatory immune cells into adipose tissues.
3027. New insights into pneumonia in patients on prolonged mechanical ventilation: need for a new paradigm addressing dysbiosis
3028. Vitamin K2 as neuroprotective against gut dysbiosis association cognitive decline
3029. Dysbiosis of Gut Microbiota and Its Relationship with the Regulatory T Cells in Patients with Aplastic Anemia
3030. P63. 04 Dysbiosis of Sputum and Gut Microbiota Modulate Development and Distant Metastasis of Non-Small Cell Lung Carcinomas
3031. COVID-19 severity and complications associated with low diversity, dysbiosis and predictive metagenome features of the oropharyngeal microbiome.
3032. INTESTINAL DYSBIOSIS AS A FACTOR IN THE DEVELOPMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE
3033. Malnutrition is Associated with Gut Dysbiosis and Perioperative Infections in LVAD Patients
3034. Iron dynamics and microbiome dysbiosis during tobacco-associated lung adenocarcinoma development
3035. The Association of Sarcopenia with Gut Dysbiosis and Inflammation in Heart Failure, LVAD and Heart Transplant Patients
3036. Gut dysbiosis and gut‐derived inflammation contribute to endothelial dysfunction in Alzheimer’s disease: An in‐vivo cross‐sectional study
3037. Clostridium Difficile Pathogenicity Mechanism Associated with Dysbiosis Caused by the Use of Antibacterials
3038. Abstract MP57: Sex Differences in Stroke Outcome Are Associated With Constitutive Gut Dysbiosis and Stroke-Induced Gut Permeability
3039. Diet-induced gut dysbiosis alters corneal immune cell distribution and gene expression in response to wounding
3040. P–623 Comparative preliminary study of LPS, hs CRP and gut bacterial flora of women to support dysbiosis of gut microbiota (DOGMA) as cause of PCOS
3041. Mucosal-associated invariant T cells promote infiammation and intestinal dysbiosis leading to metabolic dysfunction during obesity
3042. Gut Dysbiosis and Barrier Disruption Are Associated with Diastolic Dysfunction in a Novel Mouse Model of Heart Failure with Preserved Ejection Fraction
3043. New insights into pneumonia in patients on prolonged mechanical ventilation: need for a new paradigm addressing dysbiosis
3044. Research progress of polymicrobial synergy and dysbiosis in periodontitis
3045. Association between Rosacea, Environmental Factors, and Facial Cutaneous Dysbiosis
3046. Aging-dependent gut microbiome dysbiosis is associated with dry eye severity in C57BL/6 male mouse model
3047. Persistent intestinal dysbiosis after SARS-CoV-2 infection in Brazilian patients (preprint)
3048. Pulmonary Microbial Dysbiosis Leads to Redox Imbalance Through the Nrf2 Pathway in Neonatal Murine Models
3049. Study of the gut metabolome in postoperative Hirschsprung’s disease patients hints at increased glycosaminoglycan breakdown and dysbiosis
3050. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes (preprint)
3051. Functional Immune Exhaustion Following Human Oral Commensal Exposure in the Murine Model of Lower Airway Dysbiosis
3052. Sex Differences in Gut Microbiome Dysbiosis between Individuals with or without Cardiovascular Disease
3053. Prophylactic Treatment of Undernourished Mice with Cotrimoxazole Induces a Different Profile of Dysbiosis with Functional Metabolic Alterations
3054. Neutrophil-Specific Defensin Receptors Prevent Skin Dysbiosis and Bacterial Infection
3055. Correlation between gut microbiota dysbiosis and the development of constipation in complement C3 knockout mice
3056. Assessment of murine gut dysbiosis with intraluminal fluorescence lifetime imaging
3057. Gut microbiota dysbiosis and altered bile acid catabolism lead to metabolic disorder in psoriasis mice
3058. Late Breaking Abstract-Dysbiosis in the lung microbiome of patients with HIV and pneumonia is associated with worse disease severity and mortality scores
3059. Dysbiosis in Anorexia Nervosa: restrictive diets’ impact and the role of gastrointestinal microbiota in improving patients’ care
3060. Development of antibiotic associated dysbiosis in children of early age with acute intestinal infections in Azerbaijan
3061. Peripartum Antibiotics Induce Dysbiosis and Predispose the Neonatal Gut Towards Inflammation
3062. THE EFFECTIVENESS OF THE USE OF SYNBIOTIC IN THE COMPLEX TREATMENT OF ORAL DYSBIOSIS
3063. Microbiome Dysbiosis in Obese Adolescents: A Potential Contributor to Inflammation
3064. … -The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of …
3065. A case of infantile botulism and CMV coinfection: Red flags of an insidious diagnosis and the role intestinal dysbiosis and hypogammaglobulinemia as risk factors
3066. Binge-on-Chronic Alcohol-Induced Gut Dysbiosis Results in Reduced Nitric Oxide Bioavailability and Endothelial Dysfunction
3067. A Shifted Composition and Dysbiosis of Urinary Microbiota in Rheumatoid Arthritis: A Case-Control Study
3068. Anaerobic dysbiosis of the cervical canal as a risk factor for premature rupture of membranes
3069. Microbial Dysbiosis and Lack of SCFAs Production on the Gut of Patients With Multiple Sclerosis in a Spanish Cohort
3070. Microbial Dysbiosis in Crohn’s Disease: Causes and Solutions
3071. RISK OF DIETARY HAZARDOUS SUBSTANCES AND IMPACT ON HUMAN MICROBIOTA: POSSIBLE ROLE IN SEVERAL DYSBIOSIS PHENOTYPES
3072. Impact of Psychotropics on the Gut Microbiota and Potential of Probiotics to Alleviate Related Dysbiosis
3073. Influence of Antibiotics in Intestinal Microbiota, and Association between Dysbiosis and Sepsis in Children Receiving Hematopoietic Stem Cell Transplants in Cali …
3074. Mucosal dysbiosis in patients with gastrointestinal follicular lymphoma
3075. Dysbiosis and relapse-related microbiome in inflammatory bowel disease
3076. Microbiota dysbiosis of adult zebrafish exposed to chlorinated persistent organic pollutants (C-POPs) mixture
3077. Antibiotic-associated dysbiosis affects intestinal inflammation via the gut microbiota
3078. DEVELOPMENT OF DOSAGE FORMS FOR TREATMENT OF INFLAMMATORY DISEASES OF PERIODONTAL TISSUES AND ORAL DYSBIOSIS
3079. Evaluation of the Effectiveness of Complex Orthopedic Treatment in patients with Oral Dysbiosis
3080. Improvement effect of buckwheat honey on alcohol induced liver injury and gut microbiota dysbiosis in mice
3081. Dysbiosis of Gut Microbiota and Activity of KYN Pathway as Potential Biomarkers in Patients With Major Depressive Disorder
3082. Role of intestinal dysbiosis on Complement C3 deficiency induced constipation in knockout mice
3083. Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways
3084. Dysbiosis of the gut is key for complex allergological problems
3085. Antagonistic activity of probiotic strain of Lactobacillus against opportunistic bacteria during dysbiosis of intestine
3086. Gut and neurodevelopment: The role of gut microbiota dysbiosis in attention-deficit hyperactivity disorder and autism spectrum disorder
3087. Rhamnogalacturonan-Ⅰ-Rich Polysaccharides from Molokhia Leaf Ameliorates Diet-Induced Obesity and Gut Dysbiosis
3088. Quantitative Characterization of Microbial Ecologies in Dysbiosis and Infection
3089. Association of Microbial Dysbiosis with Gallbladder Diseases Identified by Bile Microbiome Profiling
3090. Gut dysbiosis: does the gut microbiome affect the development of hepatic steatosis and how can this knowledge influence future treatment?
3091. Metabolomic analysis reveals unique biochemical signatures associated with microbial dysbiosis, inflammation and energy metabolism in breast tissues of obese and …
3092. A meta-analysis on the correlation between dysbiosis and mental health: the effects of probiotics/prebiotics/synbiotics on memory, with a specific focus on Alzheimer’s …
3093. Relationship Between Vitamin D Levels and Intestinal Dysbiosis in Children and Adolescents. A systematic review protocol
3094. … OF HYLAK FORTE ON THE RESTORATION OF THE COLON MUCOSA IN PATIENTS WITH TOXICOINFECTION AND CONCOMITANT INTESTINAL DYSBIOSIS
3095. Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis
3096. An alternative explanation for Alzheimer’s disease and Parkinson’s disease initiation from specific antibiotics, gut microbiota dysbiosis and neurotoxins
3097. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
3098. Mechanistic insights into the link between gut dysbiosis and major depression: An extensive review
3099. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia
3100. Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women
3101. Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation
3102. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
3103. Glucosylated nanoparticles for the oral delivery of antibiotics to the proximal small intestine protect mice from gut dysbiosis
3104. An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis
3105. The influence of gut dysbiosis in the pathogenesis and management of ischemic stroke
3106. Fucosylated Chondroitin Sulfate against Parkinson’s Disease through Inhibiting Inflammation Induced by Gut Dysbiosis
3107. Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts
3108. Periodontitis may induce gut microbiota dysbiosis via salivary microbiota
3109. Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis
3110. Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies
3111. Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets
3112. Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability
3113. Cancer induces a stress ileopathy depending on β-adrenergic receptors and promoting dysbiosis that contributes to carcinogenesis
3114. Implication of intestinal barrier dysfunction in gut dysbiosis and diseases
3115. Plant microbiota dysbiosis and the Anna Karenina Principle
3116. Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
3117. Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options
3118. Bacterial controlled mitigation of dysbiosis in a seaweed disease
3119. Glyphosate-induced gut microbiota dysbiosis facilitates male reproductive toxicity in rats
3120. Regulatory effects of marine polysaccharides on gut microbiota dysbiosis: A review
3121. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in …
3122. Diet preference of zebrafish (Danio rerio) for bio-based polylactic acid microplastics and induced intestinal damage and microbiota dysbiosis
3123. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19
3124. Psoriasis: Interplay between dysbiosis and host immune system
3125. The role of gut–liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC
3126. Gut dysbiosis and long COVID‐19: Feeling gutted
3127. … SAU-19 and SAU-20 isolated from Ageratina adenophora alleviates the intestinal structure and integrity damage associated with gut dysbiosis in mice fed …
3128. Polyphenols as modulators of pre‐established gut microbiota dysbiosis: State‐of‐the‐art
3129. Microbial dysbiosis in the gut drives systemic autoimmune diseases
3130. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications
3131. Gut dysbiosis and kidney diseases
3132. Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism
3133. Bacteriocin-producing probiotic lactic acid bacteria in controlling dysbiosis of the gut microbiota
3134. Gut microbiota dysbiosis induced by decreasing endogenous melatonin mediates the pathogenesis of Alzheimer’s disease and obesity
3135. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance
3136. Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies
3137. Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis
3138. Probiotics in periodontal and peri-implant health management: biofilm control, dysbiosis reversal, and host modulation
3139. Comparative chronic toxicities of PFOS and its novel alternatives on the immune system associated with intestinal microbiota dysbiosis in adult zebrafish
3140. Plasma microbiome in COVID-19 subjects: An indicator of gut barrier defects and dysbiosis
3141. Mechanisms leading to gut dysbiosis in COVID-19: Current evidence and uncertainties based on adverse outcome pathways
3142. Chronic exposure to polyvinyl chloride microplastics induces liver injury and gut microbiota dysbiosis based on the integration of liver transcriptome profiles and full …
3143. Gut dysbiosis induces the development of mastitis through a reduction in host anti-inflammatory enzyme activity by endotoxemia
3144. Microbiota dysbiosis in primary Sjögren’s syndrome and the ameliorative effect of hydroxychloroquine
3145. Gut microbiota and immunity relevance in eubiosis and dysbiosis
3146. Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation
3147. Dysbiosis of oral and gut microbiomes in SARS-CoV-2 infected patients in Bangladesh: elucidating the role of opportunistic gut microbes
3148. Food additives, a key environmental factor in the development of IBD through gut dysbiosis
3149. Aberrant hepatic lipid metabolism associated with gut microbiota dysbiosis triggers hepatotoxicity of novel PFOS alternatives in adult zebrafish
3150. Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies
3151. Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling
3152. Intestinal dysbiosis in patients with histamine intolerance
3153. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
3154. Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease
3155. Gut dysbiosis impairs hippocampal plasticity and behaviors by remodeling serum metabolome
3156. SMDI: an index for measuring subgingival microbial dysbiosis
3157. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
3158. Commensal cow Roseburia reduces gut-dysbiosis-induced mastitis through inhibiting bacterial translocation by producing butyrate in mice
3159. Stressful events induce long-term gut microbiota dysbiosis and associated post-traumatic stress symptoms in healthcare workers fighting against COVID-19
3160. Colonocyte-derived lactate promotes E. coli fitness in the context of inflammation-associated gut microbiota dysbiosis
3161. Link between gut microbiota dysbiosis and chronic kidney disease.
3162. Traumatic brain injury induces gastrointestinal dysfunction and dysbiosis of gut microbiota accompanied by alterations of bile acid profile
3163. Novel insights into non-alcoholic fatty liver disease and dementia: Insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
3164. Polystyrene nano/microplastics induce microbiota dysbiosis, oxidative damage, and innate immune disruption in zebrafish
3165. Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
3166. Lentinan improves intestinal inflammation and gut dysbiosis in antibiotics-induced mice
3167. Heat stress-induced mucosal barrier dysfunction is potentially associated with gut microbiota dysbiosis in pigs
3168. Detection of intestinal dysbiosis in post-COVID-19 patients one to eight months after acute disease resolution
3169. A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome
3170. Gut microbiota dysbiosis as one cause of osteoporosis by impairing intestinal barrier function
3171. Gut metabolites and breast cancer: the continuum of dysbiosis, breast cancer risk, and potential breast cancer therapy
3172. … (2-ethylhexyl) phthalate exacerbated the toxicity of polystyrene nanoplastics through histological damage and intestinal microbiota dysbiosis in freshwater Micropterus …
3173. Mechanistic insights into gut microbiome dysbiosis-mediated neuroimmune dysregulation and protein misfolding and clearance in the pathogenesis of …
3174. Enhanced bacteremia in dextran sulfate-induced colitis in splenectomy mice correlates with gut dysbiosis and LPS tolerance
3175. Fecal microbiota analysis in cats with intestinal dysbiosis of varying severity
3176. Smoking-induced microbial dysbiosis in health and disease
3177. Dysbiosis of skin microbiome and gut microbiome in melanoma progression
3178. Dysbiosis index to evaluate the fecal microbiota in healthy cats and cats with chronic enteropathies
3179. Gut dysbiosis and age-related neurological diseases in females
3180. Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development
3181. Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis
3182. Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin dysbiosis and bacterial infection
3183. New insights into the role of oral microbiota dysbiosis in the pathogenesis of inflammatory bowel disease
3184. Bacterial and fungal gut dysbiosis and Clostridium difficile in COVID-19: A review
3185. Homeostasis and Dysbiosis of the Intestinal Microbiota: Comparing Hallmarks of a Healthy State with Changes in Inflammatory Bowel Disease
3186. Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency
3187. Dual-hit model of Parkinson’s disease: impact of Dysbiosis on 6-Hydroxydopamine-insulted mice—neuroprotective and anti-inflammatory effects of butyrate
3188. Role of intestinal dysbiosis and nutrition in rheumatoid arthritis
3189. Effects of Bisphenol A on reproductive toxicity and gut microbiota dysbiosis in male rats
3190. Effects of antibiotics and metals on lung and intestinal microbiome dysbiosis after sub-chronic lower-level exposure of air pollution in ageing rats
3191. Antibiotic-induced gut dysbiosis leads to activation of microglia and impairment of cholinergic gamma oscillations in the hippocampus
3192. Gut microbiome health and dysbiosis: A clinical primer
3193. … worsens Klebsiella pneumoniae induced-sepsis in a mouse model with low dose dextran sulfate solution through gut dysbiosis and enhanced inflammation
3194. Association of increased serum lipopolysaccharide, but not microbial dysbiosis, with obesity‐related osteoarthritis
3195. Gut microbiota dysbiosis involves in host non-alcoholic fatty liver disease upon pyrethroid pesticide exposure
3196. Microplastics exposure causes oxidative stress and microbiota dysbiosis in planarian Dugesia japonica
3197. Sarcopenia is a cause and consequence of metabolic dysregulation in aging humans: effects of gut dysbiosis, glucose dysregulation, diet and lifestyle
3198. Aspergillus niger fermented Tartary buckwheat ameliorates obesity and gut microbiota dysbiosis through the NLRP3/Caspase-1 signaling pathway in high-fat …
3199. Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders
3200. Clustering analysis of the multi-microbial consortium by Lactobacillus species against vaginal dysbiosis among Ecuadorian women
3201. Selective IgA deficiency in spontaneously hypertensive rats with gut dysbiosis
3202. Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women
3203. Litchi-derived polyphenol alleviates liver steatosis and gut dysbiosis in patients with non-alcoholic fatty liver disease: a randomized double-blinded, placebo …
3204. Microbial dysbiosis and childhood asthma development: Integrated role of the airway and gut microbiome, environmental exposures, and host metabolic and …
3205. Innate immunity and microbial dysbiosis in hidradenitis suppurativa–vicious cycle of chronic inflammation
3206. Chromosomally normal miscarriage is associated with vaginal dysbiosis and local inflammation
3207. Interplay between dysbiosis of gut microbiome, lipid metabolism, and tumorigenesis: can gut dysbiosis stand as a prognostic marker in cancer?
3208. Heat stress in pigs and broilers: role of gut dysbiosis in the impairment of the gut-liver axis and restoration of these effects by probiotics, prebiotics and …
3209. Microbial profiles of peri‐implant mucositis and peri‐implantitis: Submucosal microbial dysbiosis correlates with disease severity
3210. Gut dysbiosis and immune system in atherosclerotic cardiovascular disease (ACVD)
3211. Polysaccharide from Scutellaria barbata D. Don attenuates inflammatory response and microbial dysbiosis in ulcerative colitis mice
3212. β-carotene improves fecal dysbiosis and intestinal dysfunctions in a mouse model of vitamin A deficiency
3213. Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity
3214. Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice
3215. Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents
3216. Gut dysbiosis and Clostridioides difficile infection in neonates and adults
3217. Oral and gut microbial dysbiosis and non-alcoholic fatty liver disease: the central role of Porphyromonas gingivalis
3218. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis
3219. α-Lactalbumin peptide Asp-Gln-Trp alleviates hepatic insulin resistance and modulates gut microbiota dysbiosis in high-fat diet-induced NAFLD mice
3220. Melatonin–Microbiome two-sided interaction in Dysbiosis-associated conditions
3221. Acute kidney injury and gut dysbiosis: A narrative review focus on pathophysiology and treatment
3222. Dietary regulations for microbiota dysbiosis among post-menopausal women with type 2 diabetes
3223. Gut microbiota modulation and prevention of dysbiosis as an alternative approach to antimicrobial resistance: a narrative review
3224. Induction of mastitis by cow-to-mouse fecal and milk microbiota transplantation causes microbiome dysbiosis and genomic functional perturbation in mice
3225. Emerging insights between gut microbiome dysbiosis and Parkinson’s disease: Pathogenic and clinical relevance
3226. Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome
3227. Abnormal blood bacteriome, gut dysbiosis, and progression to severe dengue disease
3228. Gut dysbiosis in nonalcoholic fatty liver disease: Pathogenesis, diagnosis, and therapeutic implications
3229. Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
3230. The oral-gut axis: salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease
3231. The role of gut dysbiosis in the pathophysiology of neuropsychiatric disorders
3232. Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders
3233. Insulin resistance per se drives early and reversible dysbiosis-mediated gut barrier impairment and bactericidal dysfunction
3234. Oral dysbiosis and its linkage with SARS-CoV-2 infection
3235. Dietary turmeric consumption alleviates ulcerative colitis via restoring tryptophan metabolism and alleviating gut microbiota dysbiosis in mice
3236. Current and future approaches for diagnosing small intestinal dysbiosis in patients with symptoms of functional dyspepsia
3237. Microbiota dysbiosis and gut barrier dysfunction associated with non-alcoholic fatty liver disease are modulated by a specific metabolic cofactors’ combination
3238. Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington’s disease mice
3239. Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway
3240. Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 …
3241. Zinc supplementation partially decreases the harmful effects of a cafeteria diet in rats but does not prevent intestinal dysbiosis
3242. Gut microbiota dysbiosis in acute ischemic stroke associated with 3-month unfavorable outcome
3243. Ten-week sucralose consumption induces gut dysbiosis and altered glucose and insulin levels in healthy young adults
3244. Periodontal and peri-implant microbiome dysbiosis is associated with alterations in the microbial community structure and local stability
3245. Microbiome dysbiosis and epigenetic modulations in lung cancer: from pathogenesis to therapy
3246. Host tp53 mutation induces gut dysbiosis eliciting inflammation through disturbed sialic acid metabolism
3247. Mycobiome dysbiosis in women with intrauterine adhesions
3248. Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis
3249. Proton pump inhibitor-induced gut dysbiosis increases mortality rates for patients with clostridioides difficile infection
3250. Intermittent hypoxia is involved in gut microbial dysbiosis in type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome
3251. Developmental arsenic exposure induces dysbiosis of gut microbiota and disruption of plasma metabolites in mice
3252. … of exchange protein directly activated by cAMP (EPAC)-1 in mice augments glucose intolerance, inflammation, and gut dysbiosis associated with Western diet
3253. Gut microbiome dysbiosis in alcoholism: consequences for health and recovery
3254. Gut dysbiosis and fecal calprotectin predict response to immune checkpoint inhibitors in patients with hepatocellular carcinoma
3255. Early-life antibiotic exposure increases the risk of childhood overweight and obesity in relation to dysbiosis of gut microbiota: a birth cohort study
3256. Inflammation in children with CKD linked to gut Dysbiosis and metabolite imbalance
3257. … fragilis supplementation deteriorated metabolic dysfunction, inflammation, and aorta atherosclerosis by inducing gut microbiota dysbiosis in animal model
3258. Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
3259. Polysaccharides from Callerya speciosa alleviate metabolic disorders and gut microbiota dysbiosis in diet-induced obese C57BL/6 mice
3260. Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury
3261. Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 …
3262. Heart failure severity closely correlates with intestinal dysbiosis and subsequent metabolomic alterations
3263. Fungal microbiota dysbiosis and ecological alterations in gastric cancer
3264. Viral dysbiosis in children with new-onset celiac disease
3265. Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.
3266. Human skin microbiota in health and disease: The cutaneous communities’ interplay in equilibrium and dysbiosis
3267. Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis
3268. High-fat diet enhances the liver metastasis potential of colorectal cancer through microbiota dysbiosis
3269. … consumption of green tea EGCG enhances murine health span by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis …
3270. Gut dysbiosis associated with antibiotics and disease severity and its relation to mortality in critically Ill patients
3271. Human genital tracts microbiota: dysbiosis crucial for infertility
3272. Human circulating bacteria and dysbiosis in non-infectious diseases
3273. Accumulation of polyethylene microplastics induces oxidative stress, microbiome dysbiosis and immunoregulation in crayfish
3274. Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice
3275. … of long non-coding RNAs, messenger RNAs, and MicroRNAs indicates the neurodevelopmental dysfunction in the Hippocampus of gut microbiota-dysbiosis …
3276. Periprosthetic joint infection and the trojan horse theory: examining the role of gut dysbiosis and epithelial integrity
3277. Cutaneous dysbiosis may amplify barrier dysfunction in patients with atopic dermatitis
3278. Gut microbiota dysbiosis associated with plasma levels of Interferon‐γ and viral load in patients with acute hepatitis E infection
3279. Opioid use, gut dysbiosis, inflammation, and the nervous system
3280. … extract of Polygonatum odoratum ameliorates colitis by improving intestinal short-chain fatty acids and gas production to regulate microbiota dysbiosis in mice
3281. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson’s patients
3282. The Antioxidant Activity of Thymus serpyllum Extract Protects against the Inflammatory State and Modulates Gut Dysbiosis in Diet-Induced Obesity in Mice
3283. Gut dysbiosis induced by antibiotics is improved by tangerine pith extract in mice
3284. Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis
3285. Gut dysbiosis in pancreatic diseases: a causative factor and a novel therapeutic target
3286. Vine Tea (Ampelopsis grossedentata) Extract Attenuates CCl4‐Induced Liver Injury by Restoring Gut Microbiota Dysbiosis in Mice
3287. Acute exposure to microplastics induces metabolic disturbances and gut dysbiosis in adult zebrafish (Danio rerio)
3288. Dysbiosis of gut microbiome is associated with rupture of cerebral aneurysms
3289. Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis
3290. The relationship of tumor microbiome and oral bacteria and intestinal dysbiosis in canine mammary tumor
3291. Respiratory dysbiosis in cats with spontaneous allergic asthma
3292. Pain and opioid-induced gut microbial dysbiosis
3293. … alleviates dietary soybean oil-induced intestinal physical barrier damage, oxidative stress, inflammatory response and microbial dysbiosis in Large yellow …
3294. Cultivable oral bacteriota dysbiosis in mechanically ventilated COVID-19 patients
3295. Microbiota dysbiosis in Parkinson disease—in search of a biomarker
3296. Gut microbiota and cardiovascular disease: Symbiosis versus dysbiosis
3297. Co‐occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn’s disease
3298. Zip8-mediated intestinal dysbiosis impairs pulmonary host defense against bacterial pneumonia
3299. Fluoride exposure cause colon microbiota dysbiosis by destroyed microenvironment and disturbed antimicrobial peptides expression in colon
3300. Dysbiosis of skin microbiota with increased fungal diversity is associated with severity of disease in atopic dermatitis
3301. The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis
3302. Dysbiosis in the gut microbiota in patients with inflammatory bowel disease during remission
3303. Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model
3304. The role of 4-phenylbutyric acid in gut microbial dysbiosis in a mouse model of simulated microgravity
3305. Gut-and oral-dysbiosis differentially impact spinal-and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset
3306. Understanding the pathways leading to gut dysbiosis and enteric environmental dysfunction in infants: the influence of maternal dysbiosis and other microbiota …
3307. Dental materials for oral microbiota dysbiosis: An update
3308. Age-related hearing loss: the link between inflammaging, immunosenescence, and gut dysbiosis
3309. Oral Supramolecular Adsorbent for Preventing Chemo‐Induced Gastrointestinal Mucositis and Microbial Dysbiosis and for Enhancing Chemoimmunotherapy
3310. Rhubarb enema increasing short-chain fatty acids that improves the intestinal barrier disruption in CKD may be related to the regulation of gut dysbiosis
3311. Loss-of-function SLC30A2 mutants are associated with gut dysbiosis and alterations in intestinal gene expression in preterm infants
3312. Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
3313. Dysbiosis and predicted function of dental and ruminal microbiome associated with bovine periodontitis
3314. Lifelong Exposure to a Low-Dose of the Glyphosate-Based Herbicide RoundUp® Causes Intestinal Damage, Gut Dysbiosis, and Behavioral Changes in Mice
3315. Oral dysbiosis and neurodegenerative diseases: correlations and potential causations
3316. Lactobacillus acidophilus Mitigates Osteoarthritis-Associated Pain, Cartilage Disintegration and Gut Microbiota Dysbiosis in an Experimental Murine OA …
3317. Fecal dysbiosis and immune dysfunction in Chinese elderly patients with schizophrenia: An observational study
3318. Sepsis-induced gut dysbiosis mediates the susceptibility to sepsis-associated encephalopathy in mice
3319. Orthopedic Surgery causes gut microbiome dysbiosis and intestinal barrier dysfunction in prodromal Alzheimer disease patients: a prospective observational …
3320. The impact of prebiotic fructooligosaccharides on gut dysbiosis and inflammation in obesity and diabetes related kidney disease
3321. Increased susceptibility to Aeromonas hydrophila infection in grass carp with antibiotic-induced intestinal dysbiosis
3322. Impact of gut dysbiosis on the risk of non-small-cell lung cancer
3323. Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells
3324. Dysbiosis of vaginal microbiota associated with persistent high-risk human papilloma virus infection
3325. Poria cocos water-soluble polysaccharide modulates anxiety-like behavior induced by sleep deprivation by regulating the gut dysbiosis, metabolic disorders and TNF …
3326. Murine response to the opportunistic bacterium Pseudomonas aeruginosa infection in gut dysbiosis caused by 5-fluorouracil chemotherapy-induced mucositis
3327. Dysbiosis of gut microbiota and intestinal barrier dysfunction in pigs with pulmonary inflammation induced by Mycoplasma hyorhinis infection
3328. Gut dysbiosis and multiple sclerosis
3329. Inulin mitigates high fructose-induced gut dysbiosis and metabolic dysfunction in mice
3330. Diet-induced gut dysbiosis and inflammation: key drivers of obesity driven NASH
3331. Gut dysbiosis is associated with the severity of cryptogenic stroke and enhanced systemic inflammatory response
3332. Aeromonas hydrophila Induces Skin Disturbance through Mucosal Microbiota Dysbiosis in Striped Catfish (Pangasianodon hypophthalmus)
3333. The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis
3334. Fish oil ameliorates neuropsychiatric behaviors and gut dysbiosis by elevating selected microbiota–derived metabolites and tissue tight junctions in rats under chronic …
3335. Polyvinyl chloride microplastics induced gut barrier dysfunction, microbiota dysbiosis and metabolism disorder in adult mice
3336. Intestinal microbiota dysbiosis in acute kidney injury: Novel insights into mechanisms and promising therapeutic strategies
3337. Smokeless tobacco consumption induces dysbiosis of oral mycobiome: a pilot study
3338. Gut dysbiosis is associated with acceleration of lupus nephritis
3339. Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease
3340. Escherichia/Shigella, SCFAs, and Metabolic Pathways—The Triad That Orchestrates Intestinal Dysbiosis in Patients with Decompensated Alcoholic …
3341. Microbial dysbiosis and epigenetics modulation in cancer development–A chemopreventive approach
3342. Dysbiosis and gastrointestinal surgery: current insights and future research
3343. Gastrointestinal autonomic neuropathy exacerbates gut microbiota dysbiosis in adult patients with type 2 diabetes mellitus
3344. High fat diet induced gut dysbiosis alters corneal epithelial injury response in mice
3345. Lactoferrin modulates gut microbiota and Toll-like receptors (TLRs) in mice with dysbiosis induced by antibiotics
3346. Effect of postbiotics derived from kefir lactic acid bacteria-mediated bioconversion of citrus pomace extract and whey on high-fat diet-induced obesity and gut dysbiosis
3347. Dysbiosis of skin mycobiome in atopic dermatitis
3348. How Gut Bacterial Dysbiosis Can Promote Candida albicans Overgrowth during Colonic Inflammation
3349. Supplementation of polyphenol-rich grapes attenuates colitis, colitis-associated colon cancer, and disease-associated dysbiosis in mice, but fails to mitigate colitis in …
3350. Probiotic supplementation demonstrates therapeutic potential in treating gut dysbiosis and improving neurocognitive function in age-related dementia
3351. Long-term exposure to microplastics induces intestinal function dysbiosis in rare minnow (Gobiocypris rarus)
3352. Cd exposure-triggered susceptibility to Bacillus thuringiensis in Lymantria dispar involves in gut microbiota dysbiosis and hemolymph metabolic disorder
3353. … SAFP from Sarcodon aspratus on Water Immersion and Restraint Stress-Induced Gastric Ulcer and Modulatory Effects on Gut Microbiota Dysbiosis
3354. Genital tract dysbiosis in infertile women with a history of repeated implantation failure and pilot study for reproductive outcomes following oral enteric coating …
3355. Sea minerals reduce dysbiosis, improve pasture productivity and plant morphometrics in pasture dieback affected soils
3356. Fecal microbiota transfer attenuates gut dysbiosis and functional deficits after traumatic brain injury
3357. Angong Niuhuang Pill ameliorates cerebral ischemia/reperfusion injury in mice partly by restoring gut microbiota dysbiosis
3358. Pesticides and their impairing effects on epithelial barrier integrity, dysbiosis, disruption of the AhR signaling pathway and development of immune-mediated …
3359. … casuarinin from Melastoma malabathricum against a mouse model of 5-fluorouracil–induced intestinal mucositis: Impact on inflammation and gut microbiota dysbiosis
3360. Gut dysbiosis and diabetic foot ulcer: role of probiotics
3361. Gut microbiota dysbiosis induced by a high-fat diet increases susceptibility to atrial fibrillation
3362. Hydrolyzed bound phenolics from rice bran alleviate hyperlipidemia and improve gut microbiota dysbiosis in high-fat-diet fed mice
3363. Dietary rhamnogalacturonan-Ⅰ rich extracts of molokhia ameliorate high fat diet-induced obesity and gut dysbiosis
3364. Vancomycin-induced gut microbiota dysbiosis aggravates allergic rhinitis in mice by altered short-chain fatty acids
3365. The impact of alcohol-induced dysbiosis on diseases and disorders of the central nervous system
3366. Canagliflozin prevents lipid accumulation, mitochondrial dysfunction, and gut microbiota dysbiosis in mice with diabetic cardiovascular disease
3367. Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice
3368. Dysbiosis of gut microbiota and metabolite phenylacetylglutamine in coronary artery disease patients with stent stenosis
3369. … -molecular-weight oyster peptides ameliorate cyclophosphamide-chemotherapy side-effects in Lewis lung cancer mice by mitigating gut microbiota dysbiosis …
3370. … from the chelation of Ganoderma lucidum polysaccharide and chromium (III) alleviates metabolic syndromes and intestinal microbiota dysbiosis induced by high-fat …
3371. Probiotic treatment vs empiric oral antibiotics for managing dysbiosis in short bowel syndrome: Impact on the mucosal and stool microbiota, short‐chain fatty acids …
3372. Differential modulations of lauric acid and its glycerides on high fat diet-induced metabolic disorders and gut microbiota dysbiosis
3373. The pass-on effect of tetracycline-induced honey bee (Apis mellifera) gut community dysbiosis
3374. Randomized Clinical Trial: Probiotics Alleviated Oral-Gut Microbiota Dysbiosis and Thyroid Hormone Withdrawal-Related Complications in Thyroid Cancer …
3375. Development and validation of a novel microbiome-based biomarker of post-antibiotic dysbiosis and subsequent restoration
3376. Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis
3377. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis
3378. Impact of IBD-associated dysbiosis on bacterial quorum sensing mediated by acyl-homoserine lactone in human gut microbiota
3379. Metabolic model of necrotizing enterocolitis in the premature newborn gut resulting from enteric dysbiosis
3380. Level of injury is an independent determining factor of gut dysbiosis in people with chronic spinal cord injury: A cross-sectional study
3381. Interleukin-6 absence triggers intestinal microbiota dysbiosis and mucosal immunity in mice
3382. Antibiotics Alter Pocillopora Coral-Symbiodiniaceae-Bacteria Interactions and Cause Microbial Dysbiosis During Heat Stress
3383. Gut mycobiota dysbiosis in drug-naive, first-episode schizophrenia
3384. Chronic intermittent hypoxia induces gut microbial dysbiosis and infers metabolic dysfunction in mice
3385. Febrile neutropenia duration is associated with the severity of gut microbiota dysbiosis in pediatric allogeneic hematopoietic stem cell transplantation …
3386. Chronic-antibiotics induced Gut microbiota dysbiosis rescues memory impairment and reduces β-amyloid aggregation in a preclinical Alzheimer’s disease model
3387. … enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis
3388. Endometrial dysbiosis is related to inflammatory factors in women with repeated implantation failure: a pilot study
3389. Vitamin B complex and experimental autoimmune Encephalomyelitis–Attenuation of the clinical signs and gut microbiota dysbiosis
3390. Faecal microbiota transplantation alleviates early-life antibiotic-induced gut microbiota dysbiosis and mucosa injuries in a neonatal piglet model
3391. Gastrointestinal microbiota dysbiosis associated with SARS-CoV-2 infection in colorectal cancer: the implication of probiotics
3392. Dysbiosis in preeclampsia and treatment with short chain fatty acids
3393. Association of vaginal dysbiosis and gestational diabetes mellitus with adverse perinatal outcomes
3394. The association of microbiome dysbiosis with colorectal cancer
3395. A reappraisal of microbiome dysbiosis during experimental periodontitis
3396. General anesthesia bullies the gut: a toxic relationship with dysbiosis and cognitive dysfunction
3397. Long-term high-fructose high-fat diet feeding elicits insulin resistance, exacerbates dyslipidemia and induces gut microbiota dysbiosis in WHHL rabbits
3398. Dysbiosis and intestinal inflammation caused by Salmonella Typhimurium in mice can be alleviated by preadministration of a lytic phage
3399. Dysbiosis and predicted functions of the dental biofilm of dairy goats with periodontitis
3400. Sodium butyrate ameliorates thiram-induced tibial dyschondroplasia and gut microbial dysbiosis in broiler chickens
3401. … -omics analysis reveals oil mist particulate matter-induced lung injury in rats: Pathological damage, proteomics, metabolic disturbances, and lung dysbiosis
3402. Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis
3403. Healthy cattle microbiome and dysbiosis in diseased phenotypes
3404. Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach
3405. Oral administration of 5-hydroxytryptophan restores gut microbiota dysbiosis in a mouse model of depression
3406. B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients
3407. Gut Microbiota Dysbiosis in the Development and Progression of Gastric Cancer
3408. Oral Intake of the Commercial Probiotic Blend Synbio® for the Management of Vaginal Dysbiosis
3409. Gut-Thyroid axis: How gut microbial dysbiosis associated with euthyroid thyroid cancer
3410. Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation
3411. Novel role of ghrelin receptor in gut dysbiosis and experimental colitis in aging
3412. Periodontitis induced by orthodontic wire ligature drives oral microflora dysbiosis and aggravates alveolar bone loss in an improved murine model
3413. A complete guide to human microbiomes: Body niches, transmission, development, dysbiosis, and restoration
3414. Is there a role for gut microbiome dysbiosis in IgA nephropathy?
3415. Chronic lead exposure exacerbates hepatic glucolipid metabolism disorder and gut microbiota dysbiosis in high-fat-diet mice
3416. Xanthan gum oligosaccharides ameliorate glucose metabolism and related gut microbiota dysbiosis in type 2 diabetic mice
3417. Evidence suggesting the role of gut dysbiosis in diabetic retinopathy
3418. Gut–Brain Axis in Alzheimer’s Disease: Interplay Between Cholecystokinin, Dysbiosis, and Brain-Derived Neurotrophic Factor
3419. Positive effects of Epigallocatechin-3-gallate (EGCG) intervention on insulin resistance and gut microbial dysbiosis induced by bisphenol A
3420. Acute endotoxemia-induced respiratory and intestinal dysbiosis
3421. Dysbiosis of cervical and vaginal microbiota associated with cervical intraepithelial neoplasia
3422. Meta-analysis of microbiome association networks reveal patterns of dysbiosis in diseased microbiomes
3423. Association between gut dysbiosis and sepsis-induced myocardial dysfunction in patients with sepsis or septic shock
3424. Interaction between gut microbiota dysbiosis and lung infection as gut-lung axis caused by Streptococcus suis in mouse model
3425. Microbiome analysis and pharmacovigilance after inhaled glucocorticoid: oral dysbiosis with the isolation of three rothia species and subsequent sjögren’s …
3426. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis
3427. The regulatory effect of fermented black barley on the gut microbiota and metabolic dysbiosis in mice exposed to cigarette smoke
3428. Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett’s esophagus and esophageal adenocarcinoma
3429. A multi-strain probiotic blend reshaped obesity-related gut dysbiosis and improved lipid metabolism in obese children
3430. Acrylamide induced glucose metabolism disorder in rats involves gut microbiota dysbiosis and changed bile acids metabolism
3431. Evidence of immunometabolic dysregulation and airway dysbiosis in athletes susceptible to respiratory illness
3432. Stewed Rhubarb Decoction Ameliorates Adenine-Induced Chronic Renal Failure in Mice by Regulating Gut Microbiota Dysbiosis
3433. Therapy used to promote disease remission targeting gut dysbiosis, in UC patients with active disease
3434. Gut microbiota dysbiosis as an inflammaging condition that regulates obesity-related retinopathy and nephropathy
3435. Heat-Killed Lacticaseibacillus paracasei GMNL-653 Exerts Antiosteoporotic Effects by Restoring the Gut Microbiota Dysbiosis in Ovariectomized Mice
3436. Monascus vinegar protects against liver inflammation in high-fat-diet rat by alleviating intestinal microbiota dysbiosis and enteritis
3437. Gut virome dysbiosis following focal cerebral ischemia in mice
3438. Gut dysbiosis in ocular mucous membrane pemphigoid
3439. The gut microbiota dysbiosis in preeclampsia contributed to trophoblast cell proliferation, invasion, and migration via lncRNA BC030099/NF-κB pathway
3440. Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG/JAK3 deficiency
3441. Lactic Acid Bacterial Supplementation Ameliorated the Lipopolysaccharide-Induced Gut Inflammation and Dysbiosis in Mice
3442. Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a …
3443. Dysbiosis of human tumor microbiome and aberrant residence of Actinomyces in tumor-associated fibroblasts in young-onset colorectal cancer
3444. Exposure to amitriptyline induces persistent gut damages and dysbiosis of the gut microbiota in zebrafish (Danio rerio)
3445. Gardnerella vaginalis in Recurrent Urinary Tract Infection Is Associated with Dysbiosis of the Bladder Microbiome
3446. Compositional alterations of the nasal microbiome and Staphylococcus aureus—Characterized dysbiosis in the nasal mucosa of patients with allergic rhinitis
3447. Oral biofilm dysbiosis during experimental periodontitis
3448. Probiotics and prebiotics alleviate behavioral deficits, inflammatory response, and gut dysbiosis in prenatal VPA-induced rodent model of autism
3449. Mineral-Enriched Postbiotics: A New Perspective for Microbial Therapy to Prevent and Treat Gut Dysbiosis
3450. Dysbiosis in Patients with Chronic Kidney Disease: Let Us Talk About Vitamin K
3451. Dysbiosis in the Rhizosphere Microbiome of Standing Dead Korean Fir (Abies koreana)
3452. Protein Tyrosine and Serine/Threonine phosphorylation in oral bacterial dysbiosis and bacteria-host interaction
3453. Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis
3454. Eurotium cristatum reduces obesity by alleviating gut microbiota dysbiosis and modulating lipid and energy metabolism
3455. Modulatory effects of Huoxiang Zhengqi Oral Liquid on gut microbiome homeostasis based on healthy adults and antibiotic-induced gut microbial dysbiosis …
3456. Melatonin prevents the dysbiosis of intestinal microbiota in sleep-restricted mice by improving oxidative stress and inhibiting inflammation
3457. Aloe Vera-Fermented Beverage Ameliorates Obesity and Gut Dysbiosis in High-Fat-Diet Mice
3458. Gut microbiota dysbiosis of type 2 diabetic mice impairs the intestinal daily rhythms of GLP-1 sensitivity
3459. Induction of distinct neuroinflammatory markers and gut dysbiosis by differential pyridostigmine bromide dosing in a chronic mouse model of GWI showing …
3460. Different effects of Bacillus coagulans vegetative cells and spore isolates on constipation-induced gut microbiota dysbiosis in mice
3461. Dysbiosis of human microbiome and infectious diseases
3462. Instant messaging client gives the opportunity to recognize gut microbiota and dysbiosis-related disease: An investigation study on WeChat APP
3463. … of endotoxin and indoxyl sulfate, gut-derived bacterial metabolites, to vascular endothelial cells in coronary arterial disease accompanied by gut dysbiosis
3464. Characterization of gut microbiota dysbiosis of diarrheic adult yaks through 16S rRNA gene sequences
3465. … circadian rest-activity cycles in inflammatory bowel disease are associated with aggressive disease phenotype, subclinical inflammation, and dysbiosis
3466. Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis
3467. Impact of intestinal dysbiosis on breast cancer metastasis and progression
3468. Dysbiosis in Gut Microbiota in Children Born Preterm Who Developed Autism Spectrum Disorder: A Pilot Study
3469. Treg-associated monogenic autoimmune disorders and gut microbial dysbiosis
3470. The role of gut dysbiosis-associated inflammation in heart failure
3471. Neonatal Streptococcus pneumoniae infection induces long-lasting dysbiosis of the gut microbiota in a mouse model
3472. Heat stress-induced dysbiosis of porcine colon microbiota plays a role in intestinal damage: a fecal microbiota profile
3473. Dispersed Crude Oil Induces Dysbiosis in the Red Snapper Lutjanus campechanus External Microbiota
3474. Intestinal IgA-coated bacteria in healthy-and altered-microbiomes (dysbiosis) and predictive value in successful fecal microbiota transplantation
3475. The potential role of genetics, environmental factors, and gut dysbiosis in the aberrant non-coding RNA expression to mediate inflammation and …
3476. Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis
3477. Lactobacillus Ameliorates SD-Induced Stress Responses and Gut Dysbiosis by Increasing the Absorption of Gut-Derived GABA in Rhesus Monkeys
3478. Major yolk protein from sea cucumber (Stichopus japonicus) attenuates acute colitis via regulation of microbial dysbiosis and inflammatory responses
3479. Non-autophagy role of Atg5 and NBR1 in unconventional secretion of IL-12 prevents gut dysbiosis and inflammation
3480. Could the COVID-19-driven increased use of ivermectin lead to incidents of imbalanced gut microbiota and dysbiosis?
3481. Dysbiosis of gastric mucosal fungal microbiota in the gastric cancer microenvironment
3482. Sodium chloride-induced changes in oxidative stress, inflammation, and dysbiosis in experimental multiple sclerosis
3483. Upregulation of antimicrobial peptide expression in slc26a3-/-mice with colonic dysbiosis and barrier defect
3484. Gut dysbiosis and inflammatory blood markers precede HIV with limited changes after early seroconversion
3485. Gut dysbiosis and body composition in cirrhosis
3486. Paneth cells protect against acute pancreatitis Via modulating gut microbiota dysbiosis
3487. The pivotal role of oral microbiota dysbiosis and microbiota-host interactions in diseases
3488. Prophylactic treatment of undernourished mice with cotrimoxazole induces a different profile of dysbiosis with functional metabolic alterations
3489. Inulin supplementation mitigates gut dysbiosis and brain impairment induced by mild traumatic brain injury during chronic phase
3490. Associations between inflammation-related LL-37 with subgingival microbial dysbiosis in rheumatoid arthritis patients
3491. Dietary Catalase Supplementation Alleviates Deoxynivalenol-Induced Oxidative Stress and Gut Microbiota Dysbiosis in Broiler Chickens
3492. Semen dysbiosis—just a male problem?
3493. Intestine-specific NHE3 deletion in adulthood causes microbial dysbiosis
3494. Targeting keystone species helps restore the dysbiosis of butyrate‐producing bacteria in nonalcoholic fatty liver disease
3495. Hydrogen-rich water partially alleviate inflammation, oxidative stress and intestinal flora dysbiosis in DSS-induced chronic ulcerative colitis mice
3496. Human milk oligosaccharides alleviate stress-induced visceral hypersensitivity and associated microbiota dysbiosis
3497. Intestinal dysbiosis featuring abundance of Streptococcus associates with Henoch-Schönlein purpura nephritis (IgA vasculitis with nephritis) in adult
3498. Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions
3499. Dysbiosis of the gut microbiome is associated with histopathology of lung cancer
3500. Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension
3501. Ligature induced periodontitis in rats causes gut dysbiosis leading to hepatic injury through SCD1/AMPK signalling pathway
3502. Acute sulfide exposure induces hemocyte toxicity and microbiota dysbiosis in blood clam Tegillarca granosa
3503. Fungal dysbiosis in children with celiac disease
3504. Vaginal dysbiosis in pregnancy associates with risk of emergency caesarean section: a prospective cohort study
3505. Sepsis-induced myopathy and gut microbiome dysbiosis: mechanistic links and therapeutic targets
3506. Fermented milk of cheese-derived Lactobacillus delbrueckii subsp. bulgaricus displays potentials in alleviating alcohol-induced hepatic injury and gut dysbiosis in …
3507. … Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis
3508. Polyacetylenes from Codonopsis lanceolata Root Induced Apoptosis of Human Lung Adenocarcinoma Cells and Improved Lung Dysbiosis
3509. A strategic model of a host–microbe–microbe system reveals the importance of a joint host–microbe immune response to combat stress-induced gut dysbiosis
3510. Randomized placebo-controlled trial of oral tannin supplementation on COVID-19 symptoms, gut dysbiosis and cytokine response
3511. Physiopathological mechanisms involved in the development of hypertension associated with gut dysbiosis and the effect of nutritional/pharmacological interventions
3512. Simultaneous Daily Fecal Microbiota Transplantation Fails to Prevent Metronidazole-Induced Dysbiosis of Equine Gut Microbiota
3513. Metabolic reprogramming, gut dysbiosis, and nutrition intervention in canine heart disease
3514. The dysbiosis gut microbiota induces the alternation of metabolism and imbalance of Th17/Treg in OSA patients
3515. DYSBIOSIS OF THE VAGINAL MICROBIOTA IN GYNECOLOGICAL DISEASES
3516. Association between gut microbiota dysbiosis and the CHA2DS2-VASc score in atrial fibrillation patients
3517. Dysbiosis: A Potential Precursor to the Development of a Depressive Disorder
3518. Age-Associated gut dysbiosis, marked by loss of butyrogenic potential, correlates with altered plasma tryptophan metabolites in older people living with HIV
3519. Gut dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus
3520. Microbiota analysis for risk assessment: evaluation of hazardous dietary substances and its potential role on the gut microbiome variability and dysbiosis
3521. Age-Stratified Analysis of Vaginal Microbiota Dysbiosis and the Relationship with HPV Viral Load in HPV-Positive Women
3522. Gut dysbiosis and intestinal barrier dysfunction promotes IgA nephropathy by increasing the production of Gd-IgA1
3523. Pyuria Is Associated with Dysbiosis of the Urinary Microbiota in Type 2 Diabetes Patients Receiving Sodium–Glucose Cotransporter 2 Inhibitors
3524. “Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease”: A letter to the editor
3525. Microbial dysbiosis and metabolic disorders promote rheumatoid arthritis across successive stages: a multi-omics cohort study
3526. Obesity status and obesity-associated gut dysbiosis effects on hypothalamic structural covariance
3527. Gut microbial dysbiosis correlates with stroke severity markers in aged rats
3528. Gut microbiome dysbiosis in inflammatory bowel disease
3529. Mucosal bacterial dysbiosis in patients with nodular lymphoid hyperplasia in the terminal ileum
3530. Destabilization of the bacterial interactome identifies nutrient restriction-induced dysbiosis in insect guts
3531. Oral dysbiosis and systemic diseases
3532. Maternal vaccination against group B Streptococcus glyceraldehyde-3-phosphate dehydrogenase leads to gut dysbiosis in the offspring
3533. Dysbiosis and restoration dynamics of the gut microbiome following therapeutic exposure to florfenicol in snubnose pompano (Trachinotus blochii) to aid in …
3534. Microbiome dysbiosis inhibits carcinogen-induced murine oral tumorigenesis
3535. Gut microbiota dysbiosis induced by polychlorinated biphenyl 126 contributes to increased brain proinflammatory cytokines: Landscapes from the gut-brain …
3536. Pathobiology and dysbiosis of the respiratory and intestinal microbiota in 14 months old Golden Syrian hamsters infected with SARS-CoV-2
3537. Gut microbial dysbiosis and cognitive impairment in bipolar disorder: Current evidence
3538. High-fat diet-induced intestinal dysbiosis is associated with the exacerbation of Sjogren’s syndrome
3539. Ceftriaxone causes dysbiosis and changes intestinal structure in adjuvant obesity treatment
3540. Microbiota dysbiosis in odontogenic rhinosinusitis and its association with anaerobic bacteria
3541. Ulcerative colitis seems to imply oral microbiome dysbiosis
3542. Gut microbiota dysbiosis and COVID-19: possible links
3543. Re-aliment regains feed deprivation-induced microflora dysbiosis and immune stress in the gut of red swamp crayfish (Procambarus clarkii)
3544. Gut microbiome dysbiosis in patients with hepatitis B virus-related hepatocellular carcinoma after extended hepatectomy liver failure
3545. 1312 Gut dysbiosis suppresses anti-tumor ILC2s in pancreatic cancer
3546. Microbial dysbiosis in a mouse model of atopic dermatitis mimics shifts in human microbiome and correlates with the key pro‐inflammatory cytokines IL‐4, IL‐33 and …
3547. Human microbial dysbiosis as driver of gynecological malignancies
3548. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice
3549. Probiotics-containing mucoadhesive gel for targeting the dysbiosis associated with periodontal diseases
3550. Age and injury size influence the magnitude of fecal dysbiosis in adult burn patients
3551. Agr2-associated ER stress promotes adherent-invasive E. coli dysbiosis and triggers CD103+ dendritic cell IL-23-dependent ileocolitis
3552. Butyrate administration strengthens the intestinal epithelium and improves intestinal dysbiosis in a cholestasis fibrosis model
3553. Lead exposure induces structural damage, digestive stress, immune response and microbiota dysbiosis in the intestine of silver carp (Hypophthalmichthys molitrix)
3554. Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice
3555. Biomarkers for monitoring the equine large intestinal inflammatory response to stress-induced dysbiosis and probiotic supplementation
3556. Nimbolide attenuates gut dysbiosis and prevents bacterial translocation by improving intestinal barrier integrity and ameliorating inflammation in hepatocellular …
3557. Pyruvate: Ferredoxin oxidoreductase is involved in IgA-related microbiota dysbiosis and intestinal inflammation
3558. Gut mycobiome dysbiosis in rats showing retinal changes indicative of diabetic retinopathy
3559. Dysbiosis of fish gut microbiota is associated with helminths parasitism rather than exposure to PAHs at environmentally relevant concentrations
3560. Selenomethionine Ameliorates Cognitive Impairment, Decreases Hippocampal Oxidative Stress and Attenuates Dysbiosis in D-Galactose-Treated Mice
3561. Gut dysbiosis during early life: causes, health outcomes, and amelioration via dietary intervention
3562. Association of Gut Microbial Dysbiosis and Hypertension: A Systematic Review
3563. Lactobacillus rhamnosus HN001 ameliorates BEZ235-induced intestinal dysbiosis and prolongs cardiac transplant survival
3564. Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson’s Disease
3565. Moxibustion exhibits therapeutic effects on spinal cord injury via modulating microbiota dysbiosis and macrophage polarization.
3566. Rhubarb alleviates acute lung injury by modulating gut microbiota dysbiosis in mice
3567. Study to explore plant-derived trimethylamine lyase enzyme inhibitors to address gut dysbiosis
3568. Oral microbiome in dogs and cats: dysbiosis and the utility of antimicrobial therapy in the treatment of periodontal disease
3569. Axillary fossaa microbial dysbiosis and its relationship with axillary osmidrosis patients
3570. Airway inflammation and dysbiosis in antibody deficiency despite the presence of IgG
3571. Tartary Buckwheat (Fagopyrum tataricum) Ameliorates Lipid Metabolism Disorders and Gut Microbiota Dysbiosis in High-Fat Diet-Fed Mice
3572. Kidney microbiota dysbiosis contributes to the development of hypertension
3573. Dysbiosis of ocular surface microbiota in patients with refractive allergic conjunctival diseases
3574. Characterization of microbial intolerances and ruminal dysbiosis towards different dietary carbohydrate sources using an in vitro model
3575. Gut Microbiota Dysbiosis after Traumatic Brain Injury Contributes to Persistent Microglial Activation Associated with Upregulated Lyz2 and Shifted Tryptophan …
3576. Salivary microbial dysbiosis is associated with peri-implantitis: A case-control study in a Brazilian population
3577. Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis
3578. Cultivation of gastrointestinal microbiota in a new growth system revealed dysbiosis and metabolic disruptions in carcinoma-bearing rats
3579. Experimental inheritance of antibiotic acquired dysbiosis affects host phenotypes across generations
3580. Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
3581. Partial restoration of gut‐mucosal dysbiosis in late‐treated HIV‐infected subjects with CD4 T‐cell recovery
3582. Microbiota dysbiosis a cause of colorectal cancer or not? A systematic review
3583. Modulating gut dysbiosis and mitochondrial dysfunction in oxazolone-induced ulcerative colitis: the restorative effects of β-glucan and/or celastrol
3584. Retinoic Acid Signaling Is Compromised in DSS-Induced Dysbiosis
3585. A Chinese herbs complex ameliorates gut microbiota dysbiosis induced by intermittent cold exposure in female rats
3586. Chronic alcohol-induced dysbiosis of the gut microbiota and gut metabolites impairs sperm quality in mice
3587. Preterm delivery: Microbial dysbiosis, gut inflammation and hyperpermeability
3588. Distinct effects of TU-100 (daikenchuto) on long-lasting dysbiosis in the small intestine in patients with colorectal cancer and inflammatory bowel disease
3589. Intestinal changes associated with nitrite exposure in Bufo gargarizans larvae: histological damage, immune response, and microbiota dysbiosis
3590. Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients
3591. Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains
3592. Dietary Eggshell Membrane Powder Improves Survival Rate and Ameliorates Gut Dysbiosis in Interleukin-10 Knockout Mice
3593. Gut microbiota dysbiosis exaggerates ammonia-induced tracheal injury Via TLR4 signaling pathway
3594. … sodium-induced colitis by autoinducer-2-deficient Lactiplantibacillus plantarum is mediated by anti-inflammatory effects and alleviation of dysbiosis of the gut …
3595. Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice
3596. Intratracheal transplantation of mesenchymal stem cells attenuates Hyperoxia-Induced microbial dysbiosis in the lungs, brain, and gut in newborn rats
3597. Modification of intestinal microbiota dysbiosis by low-dose interleukin-2 in dermatomyositis: a post hoc analysis from a clinical trial study
3598. Maternal obesity and resistance to breast cancer treatments among offspring: Link to gut dysbiosis
3599. Optimization of conditions for in vitro modeling of subgingival normobiosis and dysbiosis
3600. Influences of gastrointestinal microbiota dysbiosis on serum proinflammatory markers in epithelial ovarian cancer development and progression
3601. Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration
3602. Dysbiosis of nail microbiome in patients with psoriasis
3603. Vaginal dysbiosis and biofilms
3604. Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?
3605. The synergistic interaction of systemic inflammation, dysbiosis and antimicrobial resistance promotes growth restriction in children with acute severe …
3606. Cold-Brewed Jasmine Tea Attenuates High-Fat Diet-Induced Obesity and Gut Microbial Dysbiosis
3607. Intestinal dysbiosis in the infant and the future of lacto-engineering to shape the developing intestinal microbiome
3608. Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin …
3609. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients
3610. The Gut Bacteria Dysbiosis Contributes to Chronic Graft-Versus-Host Disease Associated With a Treg/Th1 Ratio Imbalance
3611. Dysbiosis of the fecal and biliary microbiota in biliary tract cancer
3612. Interplay between Serotonin, Immune Response, and Intestinal Dysbiosis in Inflammatory Bowel Disease
3613. Inulin supplementation prior to mild traumatic brain injury mitigates gut dysbiosis, and brain vascular and white matter deficits in mice
3614. Roles of gut dysbiosis, anti-proliferative proteins, and post-transcriptional regulation in carcinogenesis
3615. The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity
3616. Sub-chronic difenoconazole exposure induced gut microbiota dysbiosis in mice
3617. Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer’s disease
3618. P-041 Elevated beta-defensin 119 level is associated with seminal microbiome dysbiosis in male infertility
3619. Supplement Article: The Role of Epidermal Barrier Dysfunction and Cutaneous Microbiome Dysbiosis in the Pathogenesis and Management of Acne Vulgaris and …
3620. Dysbiosis of Fecal Microbiota in Tg2576 Mice for Alzheimer’s Disease during Pathological Constipation
3621. Alzheimer’s Disease-Related Dysbiosis Might Be Triggered by Certain Classes of Antibiotics with Time-Lapse: New Insights into the Pathogenesis?
3622. Healthy Cattle Microbiome and Dysbiosis in Diseased Phenotypes. Ruminants 2022, 2, 134–156
3623. Studying the Link between Rheumatoid Arthritis and Gut Dysbiosis: A Mini Review
3624. Dysbiosis of gut microbiome contributes to glaucoma pathogenesis
3625. Gut dysbiosis and bacterial translocation in the aneurysmal wall and blood in patients with abdominal aortic aneurysm
3626. Gut Dysbiosis in Children with Cystic Fibrosis: Development, Features and the Role of Gut–Lung Axis on Disease Progression
3627. Ameliorative effects of monascin from red mold rice on alcoholic liver injury and intestinal microbiota dysbiosis in mice
3628. Enoxacin ameliorates polycystic ovary syndrome by promoting the browning of white adipose tissue and restoring gut dysbiosis
3629. Gut microbiota dysbiosis strengthens kupffer cell-mediated hepatitis B virus persistence through inducing endotoxemia in mice
3630. Gut microbial dysbiosis in rheumatoid arthritis: A systematic review protocol of case-control studies
3631. Vibrio splendidus infection induces dysbiosis in the blue mussel and favors pathobiontic bacteria
3632. Dose effect of high‐docosahexaenoic acid tuna oil on dysbiosis in high‐fat diet mice
3633. Dysbiosis in Head and Neck Cancer: Determining Optimal Sampling Site for Oral Microbiome Collection
3634. Gut dysbiosis and homocysteine: a couple for boosting neurotoxicity in Huntington disease
3635. … , metaresistome, metareplicome and causal inference to determine the microbes and their antibiotic resistance gene repertoire that contribute to dysbiosis
3636. Dysbiosis of the Human Urinary Microbiome and its Association to Diseases Affecting the Urinary System
3637. Lactose and casein cause changes on biomarkers of oxidative damage and dysbiosis in an experimental model of multiple sclerosis
3638. Probiotic characterization of Lactiplantibacillus plantarum HOM3204 and its restoration effect on antibiotic‐induced dysbiosis in mice
3639. Comparative effects of two humic substances on microbial dysbiosis in the rhizosphere soil where cucumber (Cucumis sativus L.) is grown
3640. A Novel Adult Murine Model of Typical Enteroaggregative Escherichia coli Infection Reveals Microbiota Dysbiosis, Mucus Secretion, and AAF/II-Mediated …
3641. COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity
3642. Long-Term Lactulose Administration Improves Dysbiosis Induced by Antibiotic and C. difficile in the PathoGutTM SHIME Model
3643. Gut microbiome dysbiosis in the setting of solid organ transplantation: What we have gleaned from human and animal studies
3644. Hymenolepis diminuta Reduce Lactic Acid Bacterial Load and Induce Dysbiosis in the Early Infection of the Probiotic Colonization of Swiss Albino Rat
3645. Strongyloides stercoralis infection induces gut dysbiosis in chronic kidney disease patients
3646. Dysbiosis of Gut Microbiota and Lipidomics of Content Induced by Dietary Methionine Restriction in Rice Field Eel (Monopterus albus)
3647. Dysbiosis and migraine headaches in adults with celiac disease
3648. Quantification of Gut Microbiota Dysbiosis-Related Organic Acids in Human Urine Using LC-MS/MS
3649. Gut dysbiosis in cutaneous T‐cell lymphoma is characterized by shifts in relative abundances of specific bacterial taxa and decreased diversity in more advanced …
3650. A high-carbohydrate diet prolongs dysbiosis and clostridioides difficile carriage and increases delayed mortality in a hamster model of infection
3651. Amelioration of enteric dysbiosis by polyoxotungstates in mice gut
3652. The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer’s Disease (AD) and Related Conditions
3653. … of athletes susceptible to respiratory tract illness? Comment on: Evidence of immunometabolic dysregulation and airway dysbiosis in athletes susceptible to …
3654. The Ethanolic Extract of Lindera aggregata Modulates Gut Microbiota Dysbiosis and Alleviates Ethanol-Induced Acute Liver Inflammation and Oxidative Stress …
3655. Dysbiosis of gut microbiota and intestinal damage in mice induced by a single intravenous exposure to CdTe quantum dots at low concentration
3656. Dysbiosis of the rhizosphere microbiome caused by γ-irradiation alters the composition of root exudates and reduces phosphorus uptake by rice in flooded soils
3657. Focus: Antimicrobial Resistance: Gut Microbiota Modulation and Prevention of Dysbiosis as an Alternative Approach to Antimicrobial Resistance: A Narrative …
3658. HIV-linked gut dysbiosis associates with cytokine production capacity in viral-suppressed people living with HIV
3659. Gut dysbiosis may be associated with hyperemesis gravidarum
3660. Dysbiosis in Children With Neurological Impairment and Long-Term Enteral Nutrition
3661. Does modern research validate the ancient wisdom of gut flora and brain connection? A literature review of gut dysbiosis in neurological and neurosurgical disorders …
3662. … the Metabolome of Breast Tissues from Non-Hispanic Black and Non-Hispanic White Women Reveals Correlations between Microbial Dysbiosis and Enhanced Lipid …
3663. Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis
3664. Dysbiosis: an indicator of COVID-19 severity in critically ill patients
3665. Possible Toxic Mechanisms of Deoxynivalenol (DON) Exposure to Intestinal Barrier Damage and Dysbiosis of the Gut Microbiota in Laying Hens
3666. Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment
3667. Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of Mycobacterium and Mycoplasma in COVID-19 patients: a potential source of co …
3668. Sex Differences in Cardiovascular Impact of Early Metabolic Impairment: Interplay between Dysbiosis and Adipose Inflammation
3669. Microbial dysbiosis and fecal metabolomic perturbations in Yorkshire Terriers with chronic enteropathy
3670. Probiotic Monotherapy with Lactobacillus reuteri (Prodentis) as a Coadjutant to Reduce Subgingival Dysbiosis in a Patient with Periodontitis
3671. Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus?
3672. Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study
3673. Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes
3674. Altered innate immunity and damaged epithelial integrity in vaginal microbial dysbiosis
3675. The potential role of hypochlorhydria in the development of duodenal dysbiosis: a preliminary report
3676. Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases
3677. Gut dysbiosis and metabolic diseases.
3678. Effect of milk protein hydrolysate supplementation on protein energy malnutrition-induced gut dysbiosis
3679. Evaluation of gut dysbiosis using serum and fecal bile acid profiles
3680. Structural and functional dysbiosis of gut microbiota in Tibetan subjects with coronary heart disease
3681. Diet-induced non-alcoholic fatty liver disease and associated gut dysbiosis are exacerbated by oral infection
3682. Frailty-associated dysbiosis of human microbiotas in older adults in nursing homes
3683. 1663MO DAV132 prevents antibiotic-induced intestinal microbiota dysbiosis and maintains anti-PD-1 efficacy: A proof-of-concept in tumor-bearing mice transplanted …
3684. Phage-based therapy: promising applicability in the control of oral dysbiosis and respiratory infections
3685. Intestinal Dysbiosis as a component of pathophysiology in succinic semialdehyde dehydrogenase deficiency (SSADHD)
3686. Orofacial clefts alter early life oral microbiome maturation towards dysbiosis
3687. Gut dysbiosis of bacteria and fungi associated with human immunodeficiency virus infection
3688. The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy
3689. Distinct microbiota dysbiosis in patients with laryngopharynx reflux disease compared to healthy controls
3690. Maternal sleep deprivation induces gut microbial dysbiosis and neuroinflammation in offspring rats
3691. Helicobacter Pylori Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis
3692. Supplement Article: Dysbiosis,(Barrier) Dysfunction, and Dermatoses: A Chicken-and-Egg Dilemma.
3693. Intestinal epithelial cell-specific cftr knockout mice exhibit fecal microbial dysbiosis
3694. A Deep Insight into the Correlation Between Gut Dysbiosis and Alzheimer’s Amyloidopathy
3695. Age-Related Intestinal Dysbiosis and Enrichment of Gut-specific Bacteria in the Lung Are Associated With Increased Susceptibility to Streptococcus …
3696. Therapeutic Potential of Metabolites from Lactobacillus rhamnosus and Mare’s Milk in the Treatment of Dysbiosis
3697. A Gut Feeling: Lipopolysaccharide Links Gut Dysbiosis With Inflammatory Atrial Cardiomyopathy, Obesity, and Atrial Fibrillation
3698. Dysbiosis and Depletion of Fecal Organic Acids Correlate With the Severity of Rejection After Rat Liver Transplantation
3699. Multi-Omics Analysis Reveals Effects of High Fat Diet Induced Gut Dysbiosis on RPE/Choroidal Transcriptome and Microbiome-Transcriptome Associations
3700. Nasal dysbiosis in cutaneous T-cell lymphoma is characterized by shifts in relative abundances of non-staphylococcus bacteria
3701. Constitution of mucosa‐associated microbiota in the lower digestive tract does not change in early stage of non‐alcoholic fatty liver disease with fecal dysbiosis
3702. Early indicators of microbial strain dysbiosis in the human gastrointestinal microbial community of certain healthy humans and hospitalized COVID-19 patients
3703. Connecting the dots: dietary fat, microbiota dysbiosis, altered metabolome, and colon cancer
3704. Waterborne sub-lethal exposure to perfluorobutanesulfonate causes intestinal dysbiosis in tadpoles of Lithobates catesbeianus
3705. Dysbiosis of gut microbiota in patients undergoing cardiac surgery
3706. Acute Kidney Injury and Intestinal Dysbiosis
3707. Untangling Lower Airway Dysbiosis in Critically Ill Patients with COVID-19
3708. Liver Bacterial Dysbiosis With Non-Tuberculosis Mycobacteria Occurs in SIV-Infected Macaques and Persists During Antiretroviral Therapy
3709. Novel Levilactobacillus brevis-based formulation for controlling cell proliferation, cell migration and gut dysbiosis
3710. Relationship between oral microbiota dysbiosis and the atherosclerotic cardiovascular disease
3711. The role of skin dysbiosis in atopic dermatitis
3712. Probiotics Ameliorate Gut–Brain Dysbiosis in Autism Spectrum Disorder by Modulating Nrf2-Keap1 Signaling Pathway
3713. Use of Prebiotics for addressing gut dysbiosis and achieving healthy gut–brain axis
3714. OP-10 Gut microbiota dysbiosis as a driver of inflammation in Ocular Mucous Membrane Pemphigoid
3715. Contribution of HLA DRB1, PTPN22, and CTLA4, to RA dysbiosis
3716. Dysbiosis, Tolerance, and Development of Autoimmune Diseases
3717. Effect of Ayurveda in management of dysbiosis with special reference to Bifidobacterium in children with autism spectrum disorders
3718. IDDF2022-ABS-0201 Vibrio: detecting you earlier, avoiding gastroenteritis and GUT microbiome dysbiosis
3719. Intestinal dysbiosis and increased intestinal permeability as a potential risk factor for the development and progression of rheumatoid arthritis
3720. Dysbiosis and immune dysregulation: distilling the evidence
3721. Effect of Probiotic Therapy on Hemodynamic Response Associated with Systemic Inflammatory Reaction and Antibiotic-Induced Dysbiosis in Chronic Experiments in …
3722. Hidradenitis suppurativa: Consequences of microbiome dysbiosis on immune dysregulation and disease severity
3723. Gut Dysbiosis Has the Potential to Reduce the Sexual Attractiveness of Mouse Female
3724. Disruption of the Mucosal Serotonin Reuptake Transporter (SERT) Through Gut Dysbiosis
3725. Colonic bacterial diversity and dysbiosis in active microscopic colitis as compared to chronic diarrhoea and healthy controls: effect of polyethylene glycol after …
3726. Functional Disease, Dysbiosis, and Dyspepsia: How Helpful Is Rifaximin?
3727. Biochemical study of monkeypox zoonotic disease associated human skin dysbiosis and soft tissue injury–Correspondence
3728. The gut‐liver axis in the liver’s disease: the pathophysiological basic of dysbiosis and hepatopathy’s pharmacorrection
3729. Insight into the gut microbiome dysbiosis in patients with liver failure after extended-hepatectomy
3730. Oral administration of Euglena gracilis paramylon ameliorates chemotherapy-induced leukocytopenia and gut dysbiosis in mice
3731. Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in severe COVID-19
3732. Notable intestinal dysbiosis orchestrated by Escherichia/Shigella, decreased levels of SCFTA (short chain fatty acids) and alterations in metabolic pathways …
3733. Gut Microbiota Dysbiosis in Childhood Vasculitis: A Perspective Comparative Pilot Study
3734. Microbiome composition and autochthonous probiotics from contrasting probiosis/dysbiosis states in cobia (Rachycentron canadum) fish epitheliocystis
3735. Perspective on the relationship between reproductive tract microbiota eubiosis and dysbiosis and reproductive function
3736. Oral microbiome dysbiosis triggers gestational periodontal disease and adverse pregnancy outcomes
3737. Salivary microbial dysbiosis may predict lung adenocarcinoma: A pilot study
3738. The new in the enteral dysbiosis correction intensified by heavy metals and mycotoxins
3739. Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in …
3740. New Insights in the Pathophysiology of Hospital-and Ventilator-Acquired Pneumonia: A Complex Interplay between Dysbiosis and Critical-Illness–Related …
3741. Gut Microbiota Dysbiosis in BK Polyomavirus-Infected Renal Transplant Recipients: A Case-Control Study
3742. Gut microbiota dysbiosis in 4‐to 6‐year‐old children with obstructive sleep apnea–hypopnea syndrome
3743. The influence of high fat diet on gut dysbiosis and myocardial function
3744. Microbial Dysbiosis in Achalasia: Insights on How to Prevent Cancer
3745. Helicobacter Pylori Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis
3746. Hyperoxia combined with the B‐cell antagonist rituximab led to intestinal dysbiosis in neonatal mice
3747. Background: Intestinal dysbiosis might play a pathogenetic role in subjects with symptomatic uncomplicated diverticular disease (SUDD), but the effect of rifaximin …
3748. CHEMOTHERAPY-DRIVEN GUT DYSBIOSIS IN PATIENTS WITH MULTIPLE MYELOMA.
3749. Oral Bacteria Dysbiosis in Patients with Linezolid-Induced Black Hairy Tongue: A Case Series
3750. Gba1 deletion causes immune hyperactivation and microbial dysbiosis through autophagic defects
3751. Dental implants and oral microbiome dysbiosis: An interdisciplinary perspective
3752. Smoking, dysbiosis and weight gain
3753. Gut microbiome dysbiosis in neonatal sepsis
3754. Potential therapeutic options targeting the gut dysbiosis in chronic kidney disease
3755. Perspective on the relationship between microbiota dysbiosis and neuroinflammation: probiotics as a treatment option
3756. Addictions may be driven by competition-induced microbiome dysbiosis
3757. Is dysbiosis a preponderant factor for the occurrence of oral lesions in SARS-CoV-2 positive patients? A critical analysis
3758. Antibiotic-induced dysbiosis does not potentiate the effect of lipopolysaccharide insult in male Wistar rats
3759. Vaginal microbiome dysbiosis in preterm birth
3760. Dysbiosis of the Female Murine Gut Microbiome Exacerbates Neutrophil-mediated Vascular Allograft Injury by Affecting Immunoregulation by Acetate
3761. Measuring the skin microbiome after a 3% aqueous hydrogen peroxide (H2O2) dysbiosis using ATP biofluorescence
3762. Celiac dysbiosis does not transcend geographic boundaries
3763. P709 Distinct Pattern of Gut Microbial Dysbiosis in Crohn’s Disease and Intestinal Tuberculosis-A Machine Learning-based classification model
3764. Virus Infection Causes Dysbiosis to Promote Type 1 Diabetes Onset
3765. Deficiencies of Runx3 and tissue-resident CD4+ intestinal epithelial lymphocytes link intestinal dysbiosis and inflammation in mouse and human spondyloarthropathy
3766. Gut microbiome dysbiosis in malnutrition
3767. … via improving intestinal barrier and modulating gut microbiota dysbiosis: Taraxasterol ameliorates colitis via intestinal barrier and gut microbiota dysbiosis
3768. Work stress, dysbiosis, and immune dysregulation: The interconnected triad in COVID-19 infection in the medical team staff–A mini-review
3769. The Role of Gut Dysbiosis in the Pathophysiology of Tinnitus: A Literature Review
3770. Gut microbiota dysbiosis in patients with intracranial sino-venous thrombosis and acute ischemic stroke in the young
3771. Oligosaccharide and Flavanoid Mediated Prebiotic Interventions to Treat Gut Dysbiosis Associated Cognitive Decline
3772. Nasopharyngeal Dysbiosis Precedes the Development of Lower Respiratory Tract Infections in Young Infants, a Longitudinal Infant Cohort Study
3773. Extraintestinal roles of intestinal vitamin D receptor in protecting against dysbiosis and tumorigenesis in breast cancer
3774. IDDF2022-ABS-0109 Clinical validation of a microbial stool test: towards a quantitative determination of intestinal dysbiosis
3775. Porphyromonas Gingivalis in the Development of Periodontitis: Impact on Dysbiosis and Inflammation
3776. Weil’s Disease-from Gut Dysbiosis to Immunopathogenesis and Multiple Organ Failure
3777. Oyster Protein Hydrolysate Alleviates Cadmium Toxicity by Restoring Cadmium-Induced Intestinal Damage and Gut Microbiota Dysbiosis in Mice via Its …
3778. Diet, Gut Dysbiosis and Liver Cirrhosis and their Influence upon Hepatic Encephalopathy
3779. Dysbiosis and probiotic applications in autoimmune diseases
3780. A novel non-invasive biomarker based on oral microbiome dysbiosis for detection of Community-Acquired Pneumonia
3781. OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic …
3782. IDDF2022-ABS-0100 Taraxasterol ameliorates DSS-induced colitis through improving intestinal barrier and modulating GUT microbiota dysbiosis
3783. The cathelicidin LL-37 and microbial dysbiosis in COPD patients receiving inhaled corticosteroids
3784. ASSOCIATION OF GUT DYSBIOSIS AND DEVELOPMENT OF BRONCHIAL ASTHMA AMONG PEDIATRIC PATIENTS: A SYSTEMATIC REVIEW
3785. Evidence of immunometabolic dysregulation and airway dysbiosis in athletes susceptible to respiratory illness
3786. Microbial Dysbiosis in Oral Cancer
3787. P18 Respiratory viruses lead to airway dysbiosis in exacerbations of chronic obstructive pulmonary disease
3788. Diarrhea, Dysbiosis, Dysfunction, and the Disastrous Global Health Consequences: Piecing the Puzzle Together
3789. Integrated gut metabolome and microbiome fingerprinting reveals that dysbiosis precedes allergic inflammation in IgE-mediated pediatric cow’s milk allergy
3790. Synbiotic intervention ameliorates oxidative stress and gut permeability in an in vitro and in vivo model of ethanol-induced intestinal Dysbiosis
3791. Metataxonomic Analysis of Feces from Older Adults with and without HIV Title 2: Aging, HIV, and Gut Dysbiosis
3792. Nitric Oxide-Related Oral Microbiota Dysbiosis in Type 2 Diabetes
3793. Cognitive Impairment Is Associated With Gut Dysbiosis, Neuroinflammation, and Glymphatic Dysfunction
3794. SARS-CoV-2 Interacts with Mucosal Dysbiosis to Cause the Wide Range of Disease Seen in Covid-19
3795. Gut Dysbiosis and Accelerated Brain Aging: Findings From the Texas Resilience Against Depression (T-RAD) Study
3796. Engineering microbes to combat antibiotic-induced dysbiosis: implications for gastroenterology
3797. Sex differences in stroke dysbiosis in rodent models of focal cortical ischemia
3798. Impact of Ayurvedic drug Tinospora cordifolia in hyperlipidemia induced dysbiosis
3799. 1502P Heavy pre-treatment is associated with microbiome dysbiosis, reduced immune infiltration, and potential resistance to immune checkpoint inhibitors in …
3800. Correction to “Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study”
3801. Gut microbial dysbiosis requires vagus nerve integrity to promote depression
3802. Indole produced during dysbiosis mediates host–microorganism chemical
3803. Smoking-induced subgingival dysbiosis precedes clinical signs of periodontal disease
3804. INTESTINAL FUNGAL DYSBIOSIS IS ASSOCIATED WITH HIGHER ASTHMA-RELATED HOSPITAL USE
3805. Lactobacillus acidophilus CICC 6075 alleviates obesity in mice through modulation of gut microbiota dysbiosis
3806. Dysbiosis of the Human Oral Microbiome During the Menstrual Cycle and Vulnerability to the External Exposures of Smoking and Dietary Sugar
3807. Respiratory microbiome dysbiosis and temporal dynamics in individuals with asthma.
3808. Characteristics of intestinal microflora and dysbiosis in relation to the disease duration in patients with Meniere’s disease
3809. Irritable Bowel Syndrome and Gastrointestinal Dysbiosis Diagnosis and Treatment: An Integrative Review.
3810. HIV‐associated dysbiosis and immune recovery during antiretroviral therapy
3811. Lactobacillus Ameliorates Sd-Induced Stress Responses and Gut Dysbiosis Through Increasing the Absorption of Gut-Derived Gaba in Rhesus Monkeys
3812. IDDF2022-ABS-0128 A novel pathogen enterococcus hirae induced dysbiosis in the stomach and the genomic instability to promote gastric cancer
3813. AB0114 IMPROVEMENT OF GUT MICROBIOTA DYSBIOSIS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AFTER ONE YEAR OF BIOLOGICAL …
3814. Statins and oral biofilm: simvastatin as a promising drug to control periodontal dysbiosis.
3815. Aeromonas hydrophila induces skin disturbance through mucosal microbiota dysbiosis in Pangasianodon hypophthalmus
3816. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis
3817. An Overview on Fecal Microbiota Transplantation and it’s Therapeutic Applications on Dysbiosis: As Golden Juice
3818. A Bioinformatic and Systems Biology Approach to Modelling the Dysbiosis in the Gut Microbiome in Metabolic Disease and Bariatric Surgery
3819. P533. The Relationship of Gut Microbiome Dysbiosis With Clinical Features of Schizophrenia
3820. Correlation between Dysbiosis and Incidence of Gastrointestinal Cancers
3821. The Effect of a Multi-Species Probiotic Formulation to Prevent Chemotherapy-induced Diarrhoea by Rescuing Gastrointestinal Dysbiosis and Mucositis. A Feasibility …
3822. Gut dysbiosis: A pathway to glucose dysregulation?
3823. Polyphenol Enriched Diet Administration During Pregnancy and Lactation Prevents Dysbiosis in Ulcerative Colitis Predisposed Littermates
3824. Chronic blue light-emitting diode exposure harvests gut dysbiosis related to cholesterol dysregulation
3825. Early life dysbiosis drives skin changes associated with increased susceptibility to Atopic Dermatitis
3826. Diet-related gut bacterial dysbiosis correlates with impaired development, increased mortality and Nosema disease in the honeybee (Apis mellifera). Molecular …
3827. Relationship with maternal gut bacteria dysbiosis and gestational weight variation: A Case study of muhoza health center, Rwanda
3828. Dysbiosis: The first hit for digestive system cancer
3829. CORRELATION BETWEEN IBD, INTESTINAL DYSBIOSIS, DIET AND MOOD TONE DISEASE: ANALYSIS OF LITERATURE
3830. Gut Dysbiosis in Insomnia and Diurnal Cycle
3831. The microbiota-gut-brain axis: from dysbiosis to neurodegenerative disease
3832. The Role of Gut Dysbiosis in Malnutrition Mechanism in CKD-5 HD Patients
3833. 900 MHz Electromagnetic Fields Induce Microbiota Dysbiosis and Adaptive Immune System Disorders in Juvenile Rats
3834. Characterizing Bacterial Communities across Diverse Tobacco Products and Dysbiosis in the Oral Microbiome Resulting from Tobacco Use
3835. Evaluating the knowledge on microbiome and dysbiosis in allergic diseases among medical sciences students in Saudi Arabia
3836. AB0202 GUT MICROBIOTA DYSBIOSIS WERE CLOSELY CORRELATED WITH LYMPHOCYTE SUBSETS AND CYTOKINES IN PATIENTS WITH INFLAMMATORY …
3837. Effects of Polysaccharide from Hericium Erinaceus on Diarrhea Rats Induced by Lincomycin Hydrochloride: A Potential Treatment for Gut Microbiota Dysbiosis
3838. Study of eu-and dysbiosis in the intestinal microbiome of very preterm infants in the PRIMAL study cohort
3839. Dysbiosis, Inflammation, and the Blood–Brain Barrier
3840. POS0745 GUT DYSBIOSIS ASSOCIATED WITH PERIPHERAL LYMPHOCYTES AND CYTOKINES IN PATIENTS WITH SJÖGREN’S SYNDROME
3841. Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus …
3842. Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer’s Disease
3843. Exposure to BPA and DEHP Following Myocardial Infarction Affects Gut Dysbiosis, Systemic Inflammation and Body Weight in a Sex-Specific and Dose …
3844. Features of the clinical manifestation of subcompensated intestinal dysbiosis in cats in assessing the effectiveness of its correction
3845. 215: MITOCHONDRIAL PERTURBATION OF THE EPITHELIUM CAUSES MICROBIAL DYSBIOSIS AND UNRESOLVED TISSUE INJURY IN INTESTINAL …
3846. 814 SLEEP DISORDERS AND DYSBIOSIS: CULPRITS IN CARDIOVASCULAR DISEASES
3847. Burning mouth syndrome as a manifestation of an unbalanced psycho-neuro-immuno-endocrine axis in mentally ill women with intestinal dysbiosis: A literature review
3848. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation (preprint)
3849. Resolution of the Council of Experts “Dysbiosis. Immediate and long-term consequences of microbiome disorders and options for their correction with probiotics”
3850. Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice
3851. DYSBIOSIS OF GUT MICROBIOTA, POTENTIAL MEDIATOR OF BILE ACID COMPOSITIONS, AND PREVALENCE OF HAND SYNOVIAL ABNORMALITY: DATA …
3852. Oral Digestive Lavage for the Treatment of Dysbiosis; a Case Report of Psyllium Husk Viscous-Gel Delivery and Oregano Oil in a Green Tea base.
3853. The role of gut microbiota dysbiosis in the occurrence and development of inflammatory bowel disease and its prevention and control strategies
3854. Chronic Mesenteric Ischemia Intestinal Dysbiosis Resolves After Revascularization
3855. Dysbiosis in Alzheimer’s disease might be triggered by certain classes of antibiotics with time-lapse: New insights in the pathogenesis?
3856. Western diets, gut dysbiosis, and obesity: are they linked?
3857. STUDY OF APPLICATION OF MAGNETOTHERAPY IN COMPLEX WITH SYNBIOTIC IN RESTORING TREATMENT OF PATIENTS WITH INTESTINAL DYSBIOSIS
3858. The role of intestinal and vaginal dysbiosis in endometrial cancer: an integrative review
3859. 779. PIDS Featured Oral Abstract: High Beta Lactam Exposure in Neonates with Bloodstream Infection Associated with Intestinal Dysbiosis and Enterococcus spp. …
3860. The role of gut microflora dysbiosis in clinical manifestation of patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
3861. Characterization of biliary microbiota dysbiosis in acute cholecystitis: A reduction in the biodiversity of the bile microbiome
3862. Jian Gan powder exerts anti-inflammatory and pro-proliferative effects and restores the dysbiosis of the gut microbiota and metabolism of the immunological liver injury …
3863. Induction of periodontitis and oral microbiome dysbiosis in a mouse model with heart failure with preserved ejection fraction results in worsening hypertension and …
3864. Obstructive Sleep Apnea Induced Gut Dysbiosis Stimulates A Proinflammatory Response In Gut And Brain That Contribute To Hypertension
3865. Gut dysbiosis: the effects of a high-fat diet on brain-derived neurotrophic factor (BDNF) and pro-BDNF expression in the brain-gut axis
3866. tp53 mutation-induced dysbiosis causes inflammation by impairing sialic acid metabolism
3867. The influence of nasal and oropharyngeal mucosal dysbiosis on the condition of the middle ear in children with congenital cleft palate
3868. Dysbiosis Associated With Esophageal Adenocarcinoma—A Novel Method to Detect Tissue-Associated Microbiome
3869. The Role of Gut Dysbiosis in Inducing gd-IgA1 Production in Patients with Immunoglobulin-A Nephropathy (GUT-IgAN Pilot Study)
3870. The etiology of gut dysbiosis and its role in chronic disease
3871. Biological Effectiveness of Food Additives “Sanjam” During Dysbiosis
3872. S-Equol: A Novel Therapeutic for HIV-1 Induced Gut Dysbiosis
3873. C. DIFFICILE INFECTION AS A MAKER FOR DYSBIOSIS IS LONGITUDINALLY ASSOCIATED WITH COGNITIVE DECLINE AND DEMENTIA
3874. Statins and oral biofilm: Simvastatin as a promising drug to control periodontal dysbiosis
3875. An Apple a Day Keeps the Doctor Away: The Effect of a Low-Fat, High-Fiber Diet on Quality of Life, Inflammation, and Dysbiosis in Patients With Ulcerative Colitis
3876. SALIVARY DYSBIOSIS IN ORAL SQUAMOUS CELL CARCINOMA
3877. Effect of an antidisbiotic agent on the biosynthesis of fatty acids of liver lipids of rats which received palm oil on the background of dysbiosis
3878. … transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis
3879. Abstract C076: Bacterial dysbiosis and its association with pancreatic cancer progression and poor survival
3880. Probiotics as an add-on treatment for Parkinson’s disease patients suffering from motor fluctuations and dysbiosis
3881. Humoral immunity indicators as prediction factors for dysbiosis development risk
3882. A COMBINATION TREATMENT FOR CHRONIC PERIODONTITIS ASSOCIATED WITH DYSBIOSIS OF ORAL MICROBIOTA AND ASSESSMENT OF ITS …
3883. Opioid-induced microbial dysbiosis disrupts CPT-11 metabolism and increases gastrointestinal toxicity in a murine model.
3884. Investigating microbial therapies to combat gut microbiome dysbiosis during pelvic irradiation
3885. Airway inflammation, dysbiosis and respiratory parameters are dependent of the route of sensitization in mouse model of asthma
3886. Neutrophil–Lymphocyte Ratio and Dysbiosis: New Paradigm of Immunonutrition
3887. Unlearning Porphyromonas gingivalis pigments: toward an understanding of periodontal polymicrobial dysbiosis
3888. Antibiotic Induced Dysbiosis Promotes Lung Metastasis
3889. T-cell trafficking and extravasation is suppressed in distal tumors during gastrointestinal tract dysbiosis
3890. Dyslipidemia in combination with dysbiosis of the gastroduodenal zone in patients with reactive arthritis.
3891. CORRECTION OF VAGINAL DYSBIOSIS CAUSED BY THE BIOFILM FORMING STRAIN OF STAPHYLOCOCCUS AUREUS, USING PROBIOTIC BASED ON SPORE …
3892. 1.34-Gut Microbiota Dysbiosis in Non-alcoholic Fatty Liver Disease
3893. CHAPTER FIVE: INTESTINAL DYSBIOSIS AS A COMPONENT OF PATHOPHYSIOLOGY IN SUCCINC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY …
3894. Types of dyslipidemia in patients with reactive arthritis with gastroduodenal dysbiosis.
3895. The impacts and influences of gut-microbiota dysbiosis and gut integrity on age-related neurological disorders
3896. The absence of microbiota dysbiosis is essential to maintain a healthy immune system in cancer patients
3897. GUT DYSBIOSIS: STATE-OF-THE-ART
3898. Chronic Lower Airway Dysbiosis with Human Oral Commensals Leads to Both Increased IL-17A and Immune Exhaustion Tone in the Lower Airways
3899. Gut microbiome dysbiosis in at-risk versus low-risk stroke adults
3900. Dectin-2 Recognizes Gut Dysbiosis of the Commensal Fungi Wallemia Mellicola and Is Essential for the Gut-Lung Axis Interactions Aggravating Asthma in Murine …
3901. Toll-Like-Receptor 5 Protects Against Pulmonary Fibrosis by Reducing Lung Dysbiosis
3902. Pre-existing commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer …
3903. … metabolome analyses reveals an inconsistent dose effect of a tuna oil with more higher docosahexaenoic acid content on intestinal dysbiosis and metabolic disorders …
3904. A combination of genetic factors and dietary tryptophan shapes gut microbial dysbiosis in a lupus-prone mouse model
3905. Obstructive Sleep Apnea Induced Gut Dysbiosis Stimulates a Proinflammatory Response that Promotes Neuroinflammation and Hypertension Sriram Ayyaswamy …
3906. Association Between Intestinal Changes and Systemic Cytokines in Mouse Dysbiosis Models
3907. Dysbiosis as a Factor Influencing Systemic and Oral Pathology: The Significance of the Microbiome
3908. Microbial Dysbiosis and Epithelial Dysfunction in Vitamin A-Deficient Lungs
3909. A Fight Against Gut Dysbiosis: Dendritic‐cell Derived Hepcidin and its Healing Role and Prevention of Neurologic Disease Authors: Barbara Kania, Alexis Sotelo …
3910. Gut Dysbiosis: A Major Concern to Combat Diseases such as COVID-19
3911. Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders
3912. Gut Dysbiosis in Ocular Mucous Membrane Pemphigoid
3913. Dysbiosis prevents age-dependent phenotypes in drosphila Pink1B9 a fly model for parkinson’s disease
3914. Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders.
3915. High-fat diet-induced gut dysbiosis promotes prostate cancer growth through mast cells and histamine 1 receptor
3916. The Gut Microbiota Dysbiosis as a Trigger of Inflammation-Driving Pathogensis of Alzheimer’s Disease
3917. Dysbiosis Prevents Age-Dependent Phenotypes in Drosphila Pink1B9 a Fly Model for Parkinson’s Disease
3918. Dysbiosis of Gut Microbiota Contributes to Uremic Cardiomyopathy via the Induction of Th1 Cells Expansion
3919. Lung Dysbiosis Is a Feature of Frequent Exacerbating COPD Patients and a Lung Gene Expression Profile of Activated Host Immune Function
3920. MICROBIAL DIMENSION OF SYMBIOSIS AND DYSBIOSIS IN FUNGUS–GARDENING ANTS
3921. Effect of Human-Derived Gut Microbiota Dysbiosis on the Intestinal Permeability and Inflammation of Mice with Mild Traumatic Brain Injury
3922. The Gut-Brain Axis: The effect of dysbiosis on mood disorders like anxiety and depression
3923. THE ROLE OF PROBIOTICS IN THE TREATMENT OF INTESTINAL DYSBIOSIS IN PATIENTS WITH LAMBLIOSIS AND ASCARIDOSIS
3924. Xinyang Tablet Attenuates Right Ventricular Remodeling Via Inhibiting Inflammation, Apoptosis, and Gut Microbial Dysbiosis in Chronic Hypoxia-Induced Rats
3925. Withdrawn as duplicate: Dysbiosis and early mortality in zebrafish larvae exposed to subclinical concentrations of streptomycin
3926. The role of intestinal dysbiosis in liver cirrhosis
3927. The relationship between intestinal dysbiosis and multiple sclerosis
3928. Transient Colonising Microbes Promote Gut Dysbiosis and Disease Pathology
3929. MP37-07 DOES VASECTOMY INDUCE SEMEN MICROBIOME DYSBIOSIS?
3930. Gut Microbiota Dysbiosis-Induced Activation of the Tlr-4/Nlrp3 Inflammasome Pathways in Ankylosing Spondylitis
3931. Chronic Stress Induced Gut Microbial Dysbiosis Disturbs Vitamin B6 Metabolism and Results in Abnormal Behaviors in Rats
3932. Gut Dysbiosis: A Review of the Effects of a High‐Fat Diet on Iron Regulation and Brain‐Derived Neurotrophic Factor (BDNF) Expression in the Brain‐Gut Axis
3933. Dental Implants and Oral Microbiome Dysbiosis
3934. Stroke-induced Gut Microbiota Dysbiosis Regulates Microfold Cells In Peyer’s Patches
3935. Correction: The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic
3936. Acute Exposure to Microplastics Induces Metabolic Disturbances and Gut Dysbiosis Through Impaired Gut-Liver-Brain Axis in Adult Zebrafish (Danio Rerio)
3937. Co-occurrence ofLactobacillusandCandida sp.in periodontal disease severity suggests cancer-related dysbiosis
3938. Black corn (Zea mays L.) flour consumption improved the gut dysbiosis promoted by a high-fat diet on mice.
3939. Diesel Exhaust Induces Gut Dysbiosis Along With Reduced Fecal Acetate Levels And Altered Lipid Metabolism
3940. Dysbiosis in the Mouse Esophagus Caused by CaSR Deletion
3941. Vaginal and Endometrial Microbiome Dysbiosis Associated With Adverse Pregnancy Outcomes
3942. PD31-04 LOWER URINARY TRACT MICROBIOTA DYSBIOSIS IS ASSOCIATED WITH URETHRAL FIBROSIS
3943. The Relationship Between Airway Interleukin-1 Beta, Microbial Dysbiosis and Mucus Hyperconcentration in Bronchiectasis: The EMBARC-BRIDGE Study
3944. Ingestion of subtoxic doses of cadmium induces persistent dysbiosis and enhances susceptibility to DSS-induced colitis long after exposure
3945. Anti-Mycobacterials and Micro-Aspiration Drive Lower Airway Dysbiosis in NTM Bronchiectasis
3946. –Dysbiosis of the nasal microbiome in domestic dogs (Canis familiaris) is associated with Mycoplasma cynos infection and clinical signs of respiratory disease
3947. Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota—brain Axis and cognition: Restoration by intake of probiotics and synbiotics
3948. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
3949. Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): Focusing on the gut–liver axis
3950. Successful dietary therapy in Paediatric Crohn’s disease is associated with shifts in bacterial dysbiosis and inflammatory metabotype towards healthy controls
3951. Dysbiosis of a microbiota–immune metasystem in critical illness is associated with nosocomial infections
3952. gutMDisorder v2. 0: a comprehensive database for dysbiosis of gut microbiota in phenotypes and interventions
3953. Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis
3954. Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia
3955. Fish disease prevention via microbial dysbiosis‐associated biomarkers in aquaculture
3956. Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance
3957. Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
3958. Limnospira indica PCC 8005 Supplementation Prevents Pelvic Irradiation-Induced Dysbiosis but Not Acute Inflammation in Mice
3959. Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways
3960. Antimicrobial peptides do not directly contribute to aging in Drosophila, but improve lifespan by preventing dysbiosis
3961. Gut microbiota dysbiosis in AKI to CKD transition
3962. Axl alleviates DSS-induced colitis by preventing dysbiosis of gut microbiota
3963. Microbial dysbiosis tunes the immune response towards allergic disease outcomes
3964. Both disease activity and HLA–B27 status are associated with gut microbiome dysbiosis in spondyloarthritis patients
3965. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease
3966. Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice
3967. A reciprocal link between oral, gut microbiota during periodontitis: the potential role of probiotics in reducing dysbiosis-induced inflammation
3968. Cross talk between Paneth and tuft cells drives dysbiosis and inflammation in the gut mucosa
3969. Comparative in-silico analysis of microbial dysbiosis discern potential metabolic link in neurodegenerative diseases
3970. Acute sleep deprivation exacerbates systemic inflammation and psychiatry disorders through gut microbiota dysbiosis and disruption of circadian rhythms
3971. Systems to model the personalized aspects of microbiome health and gut dysbiosis
3972. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis
3973. Morphine use induces gastric microbial dysbiosis driving gastric inflammation through TLR2 signalling which is attenuated by proton pump inhibition
3974. Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines
3975. Experimental bacterial dysbiosis with consequent immune alterations increase intrarectal SIV acquisition susceptibility
3976. Implication of paraprobiotics in age-associated gut dysbiosis and neurodegenerative diseases
3977. Association between short-term exposure to PM2. 5 and nasal microbiota dysbiosis, inflammation and oxidative stress: A panel study of healthy young adults
3978. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats
3979. Microbiome and Asthma: Microbial Dysbiosis and the Origins, Phenotypes, Persistence, and Severity of Asthma
3980. Moromi mash dysbiosis trigged by salt reduction is relevant to quality and aroma changes of soy sauce
3981. The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphoma
3982. Urolithin A alleviates colitis in mice by improving gut microbiota dysbiosis, modulating microbial tryptophan metabolism, and triggering ahr activation
3983. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review
3984. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis
3985. Dysbiosis of the Subgingival Microbiome and Relation to Periodontal Disease in Association with Obesity and Overweight
3986. Pubertal consumption of R. badensis subspecies acadiensis modulates LPS-induced immune responses and gut microbiome dysbiosis in a sex-specific manner
3987. Effects of periodontal pathogen-induced intestinal dysbiosis on transplant immunity in an allogenic skin graft model
3988. Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
3989. Gut microbiota dysbiosis is associated with sepsis‐induced cardiomyopathy in patients: A case‒control study
3990. Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism
3991. Gut content microbiota dysbiosis and dysregulated lipid metabolism in diarrhea caused by high-fat diet in a fatigued state
3992. Associations between dysbiosis gut microbiota and changes of neurotransmitters and short-chain fatty acids in valproic acid model rats
3993. A comparative analysis of gut microbial dysbiosis by select antibiotics and DSS to understand the effects of perturbation on the host immunity and metabolism
3994. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications
3995. The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME)
3996. Fish waste to sustainable additives: Fish protein hydrolysates alleviate intestinal dysbiosis and muscle atrophy induced by poultry by-product meal in Lates …
3997. IL-17-driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileum
3998. A multi-omic analysis reveals the esophageal dysbiosis as the predominant trait of eosinophilic esophagitis
3999. Gut microbiota dysbiosis correlates with long COVID-19 at one-year after discharge
4000. Role of microbial dysbiosis in the pathogenesis of Alzheimer’s disease
4001. Dietary 5-demethylnobiletin prevents antibiotic-associated dysbiosis of gut microbiota and damage to the colonic barrier
4002. Repeated early-life exposure to anaesthesia and surgery causes subsequent anxiety-like behaviour and gut microbiota dysbiosis in juvenile rats
4003. Adverse effects of polystyrene nanoplastics on sea cucumber Apostichopus japonicus and their association with gut microbiota dysbiosis
4004. Nicotinamide Mononucleotide Ameliorates Sleep Deprivation‐Induced Gut Microbiota Dysbiosis and Restores Colonization Resistance against Intestinal Infections
4005. Stabilization of acne vulgaris-associated microbial dysbiosis with 2% supramolecular salicylic acid
4006. Distinct phyllosphere microbiome of wild tomato species in central Peru upon dysbiosis
4007. Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis
4008. Polymeric immunoglobulin receptor deficiency exacerbates autoimmune hepatitis by inducing intestinal dysbiosis and barrier dysfunction
4009. Oral microbiota dysbiosis accelerates the development and onset of mucositis and oral ulcers
4010. Early infancy dysbiosis in food protein‐induced enterocolitis syndrome: A prospective cohort study
4011. Oral and intestinal dysbiosis in Parkinson’s disease
4012. Gut Dysbiosis: A Target for Protective Interventions against Parkinson’s Disease
4013. Nerve injury-induced gut dysbiosis contributes to spinal cord TNF-α expression and nociceptive sensitization
4014. Airborne polystyrene microplastics and nanoplastics induce nasal and lung microbial dysbiosis in mice
4015. Bamboo shoot dietary fiber alleviates gut microbiota dysbiosis and modulates liver fatty acid metabolism in mice with high-fat diet-induced obesity
4016. Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives
4017. A Novel E3 Probiotics Formula Restored Gut Dysbiosis and Remodelled Gut Microbial Network and Microbiome Dysbiosis Index (MDI) in Southern Chinese Adult …
4018. Piglet cardiopulmonary bypass induces intestinal dysbiosis and barrier dysfunction associated with systemic inflammation
4019. Sialic acid exacerbates gut dysbiosis-associated mastitis through the microbiota-gut-mammary axis by fueling gut microbiota disruption
4020. Advances in Lactobacillus Restoration for β-Lactam Antibiotic-Induced Dysbiosis: A System Review in Intestinal Microbiota and Immune Homeostasis
4021. Tissue vs. Fecal-Derived Bacterial Dysbiosis in Precancerous Colorectal Lesions: A Systematic Review
4022. Sea buckthorn polysaccharide ameliorates high-fat diet induced mice neuroinflammation and synaptic dysfunction via regulating gut dysbiosis
4023. Poria cocos oligosaccharides ameliorate dextran sodium sulfate-induced colitis mice by regulating gut microbiota dysbiosis
4024. Lactulose regulates gut microbiota dysbiosis and promotes short-chain fatty acids production in acute pancreatitis patients with intestinal dysfunction
4025. Lower gut dysbiosis and mortality in acute critical illness: a systematic review and meta-analysis
4026. Cryptosporidium infection induced the dropping of SCFAS and dysbiosis in intestinal microbiome of Tibetan pigs
4027. Bacillus licheniformis reverses the environmental ceftriaxone sodium-induced gut microbial dysbiosis and intestinal inflammation in mice
4028. On the oral microbiome of oral potentially malignant and malignant disorders: dysbiosis, loss of diversity, and pathogens enrichment
4029. Constipation-predominant irritable bowel syndrome (IBS-C): Effects of different nutritional patterns on intestinal dysbiosis and symptoms
4030. Editorial of Special Issues “Gut Microbiota–Host Interactions: From Symbiosis to Dysbiosis 2.0”
4031. … plasma levels of triglyceride-enriched lipoproteins associate with systemic inflammation, lipopolysaccharides, and gut dysbiosis in common variable …
4032. The toxicity of nano polyethylene terephthalate to mice: Intestinal obstruction, growth retardant, gut microbiota dysbiosis and lipid metabolism disorders
4033. Fructose Stimulated Colonic Arginine and Proline Metabolism Dysbiosis, Altered Microbiota and Aggravated Intestinal Barrier Dysfunction in DSS-Induced …
4034. Maternal vitamin D deficiency aggravates the dysbiosis of gut microbiota by affecting intestinal barrier function and inflammation in obese male offspring mice
4035. Virus induced dysbiosis promotes type 1 diabetes onset
4036. Sulfide causes histological damage, oxidative stress, metabolic disorders and gut microbiota dysbiosis in juvenile sea cucumber Apostichopus japonicus Selenka
4037. Clostridium butyricum Prevents Dysbiosis and the Rise in Blood Pressure in Spontaneously Hypertensive Rats
4038. Moxibustion attenuates liver metastasis of colorectal cancer by regulating gut microbial dysbiosis
4039. Microbial Metabolite Dysbiosis and Colorectal Cancer
4040. Analysis of gut microbiota in patients with Williams–Beuren Syndrome reveals dysbiosis linked to clinical manifestations
4041. Lacticaseibacillus rhamnosus dfa1 Attenuate Cecal Ligation-Induced Systemic Inflammation through the Interference in Gut Dysbiosis, Leaky Gut, and Enterocytic …
4042. Gut Dysbiosis in Experimental Kidney Disease: A Meta-Analysis of Rodent Repository Data
4043. Dysbiosis and reduced small intestinal function are required to induce intestinal insufficiency in mice
4044. Dietary approaches for normalizing dysbiosis induced by high-fat, obesogenic diets
4045. Gut microbiota dysbiosis and Huntington’s disease: Exploring the gut-brain axis and novel microbiota-based interventions
4046. MicroRNA‐29a Compromises Hepatic Adiposis and Gut Dysbiosis in High Fat Diet‐Fed Mice via Downregulating Inflammation
4047. Opioid‐induced microbial dysbiosis disrupts irinotecan (CPT‐11) metabolism and increases gastrointestinal toxicity in a murine model
4048. Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection
4049. Ingestion of microplastics by silver carp (Hypophthalmichthys molitrix) larvae: Quantification of ingestion and assessment of microbiota dysbiosis
4050. Microbiome Dysbiosis: A Pathological Mechanism at the Intersection of Obesity and Glaucoma
4051. Fungal dysbiosis facilitates inflammatory bowel disease by enhancing CD4+ T cell glutaminolysis
4052. The key players of dysbiosis in Noma disease; A systematic review of etiological studies
4053. Postoperative probiotics administration attenuates gastrointestinal complications and gut microbiota dysbiosis caused by chemotherapy in colorectal cancer …
4054. Intestinal permeability of stem cell transplant patients correlates with systemic acute phase responses and dysbiosis
4055. Dysbiosis versus diabesity: pathological signaling and promising therapeutic strategies
4056. From Dysbiosis to Neurodegenerative Diseases through Different Communication Pathways: An Overview
4057. Effects of Tiaopi Xiezhuo decoction on constipation and gut dysbiosis in patients with peritoneal dialysis
4058. Adhesive Ergothioneine Hyaluronate Gel Protects against Radiation Gastroenteritis by Alleviating Apoptosis, Inflammation, and Gut Microbiota Dysbiosis
4059. Transepithelial barrier dysfunction drives microbiota dysbiosis to initiate epithelial clock-driven inflammation
4060. Bisphenol P exposure in C57BL/6 mice caused gut microbiota dysbiosis and induced intestinal barrier disruption via LPS/TLR4/NF-κB signaling pathway
4061. Foodborne Carbon Dot Exposure Induces Insulin Resistance through Gut Microbiota Dysbiosis and Damaged Intestinal Mucus Layer
4062. Current understanding of antibiotic-associated dysbiosis and approaches for its management
4063. The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy
4064. Gut dysbiosis promotes the breakdown of oral tolerance mediated through dysfunction of mucosal dendritic cells
4065. Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
4066. Dysbiosis of the stool DNA and RNA virome in Crohn’s disease
4067. Apolipoprotein H induces sex-specific steatohepatitis and gut dysbiosis during chronic hepatitis B infection
4068. Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease?
4069. … -induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis
4070. Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation
4071. Chemotherapy, hypothyroidism and oral dysbiosis as a novel risk factor of cardiovascular pathology development
4072. Does Oxidative Stress Along with Dysbiosis Participate in the Pathogenesis of Asthma in the Obese?
4073. Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism
4074. The NLRP3 inflammasome and gut dysbiosis as a putative link between HIV-1 infection and ischemic stroke
4075. Dysbiosis of gut microbiota and decreased propionic acid associated with metabolic abnormality in Cushing’s syndrome
4076. The gut microbiome dysbiosis is recovered by restoring a normal diet in hypercholesterolemic pigs
4077. Carbon dots induce pathological damage to the intestine via causing intestinal flora dysbiosis and intestinal inflammation
4078. Fungal gut microbiota dysbiosis in systemic lupus erythematosus
4079. Dysbiosis of oral microbiota and metabolite profiles associated with type 2 diabetes mellitus
4080. Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
4081. Gut dysbiosis contributes to chlamydial induction of hydrosalpinx in the upper genital tract
4082. Antibiotic-induced gut microbiota dysbiosis has a functional impact on purine metabolism
4083. Smoking-induced subgingival dysbiosis precedes clinical signs of periodontal disease
4084. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention‐deficit/hyperactivity disorder
4085. Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: challenges and opportunities
4086. CsPbBr3 Perovskite Nanoparticles causes Colitis‐Like Symptom via Promoting Intestinal Barrier Damage and Gut Microbiota Dysbiosis
4087. Dysbiosis of gut microbiota, a potential mediator of bile acid compositions, and prevalence of hand synovitis: a community-based study
4088. A multicentre study reveals dysbiosis in the microbial co-infection and antimicrobial resistance gene profile in the nasopharynx of COVID-19 patients
4089. Gut microbiome dysbiosis in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
4090. Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway
4091. The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability
4092. Future ocean conditions induce necrosis, microbial dysbiosis and nutrient cycling imbalance in the reef sponge Stylissa flabelliformis
4093. Hyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment
4094. Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution and live birth after recurrent pregnancy loss: a proof of concept case …
4095. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
4096. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma
4097. Novel bacterial proteolytic and metabolic activity associated with dental erosion-induced oral dysbiosis
4098. Cannabinoids modulate the microbiota–gut–brain axis in HIV/SIV infection by reducing neuroinflammation and dysbiosis while concurrently elevating …
4099. Estimation of silent phenotypes of calf antibiotic dysbiosis
4100. Effects of Unconventional Work and Shift Work on the Human Gut Microbiota and the Potential of Probiotics to Restore Dysbiosis
4101. Lactobacillus Probiotics Improve Vaginal Dysbiosis in Asymptomatic Women
4102. The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice
4103. Impaired reproduction, energy reserves and dysbiosis: The overlooked consequences of heatwaves in a bivalve mollusc
4104. Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model
4105. Microbiota dysbiosis associated with type 2 diabetes-like effects caused by chronic exposure to a mixture of chlorinated persistent organic pollutants in zebrafish
4106. Dysbiosis—An Etiological Factor for Cardiovascular Diseases and the Therapeutic Benefits of Gut Microflora
4107. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
4108. Intestinal dysbiosis mediates cognitive impairment via the intestine and brain NLRP3 inflammasome activation in chronic sleep deprivation
4109. Limosilactobacillus reuteri ameliorates preeclampsia in mice via improving gut dysbiosis and endothelial dysfunction
4110. Dealcoholized muscadine wine was partially effective in preventing and treating dextran sulfate sodium-induced colitis and restoring gut dysbiosis in mice
4111. Letter to Editor: the mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. is the dysbiosis index really predictive for the …
4112. Subclinical doses of dietary fumonisins and deoxynivalenol cause cecal microbiota dysbiosis in broiler chickens challenged with Clostridium perfringens
4113. Identification of gut dysbiosis in axial spondyloarthritis patients and improvement of experimental ankylosing spondyloarthritis by microbiome-derived butyrate …
4114. Spermidine ameliorates colitis via induction of anti-inflammatory macrophages and prevention of intestinal dysbiosis
4115. … -7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis
4116. Short-term exposure to enrofloxacin causes hepatic metabolism disorder associated with intestinal flora dysbiosis in adult marine medaka (Oryzias melastigma)
4117. Gut microbiome dysbiosis is associated with host genetics in the Norwegian Lundehund
4118. Apoptotic biliary epithelial cells and gut dysbiosis in the induction of murine primary biliary cholangitis
4119. The role of mucin O-glycans in microbiota dysbiosis, intestinal homeostasis, and host-pathogen interactions
4120. Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current …
4121. Gut microbiota associated with cryptococcal meningitis and dysbiosis caused by anti-fungal treatment
4122. Combined exposure to microplastics and amitriptyline caused intestinal damage, oxidative stress and gut microbiota dysbiosis in zebrafish (Danio rerio)
4123. Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signaling pathway
4124. Gut microbiota dysbiosis ameliorates in LNK-deficient mouse models with obesity-induced insulin resistance improvement
4125. Gastric microbiota dysbiosis and Helicobacter pylori infection
4126. Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10−/− mouse model of inflammatory bowel disease
4127. Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis
4128. Short-term trivalent arsenic and hexavalent chromium exposures induce gut dysbiosis and transcriptional alteration in adipose tissue of mice
4129. Depletion of Mcpip1 in murine myeloid cells results in intestinal dysbiosis followed by allergic inflammation
4130. Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses
4131. … Transplantation (VMT) for treatment of vaginal dysbiosis without the use of antibiotics–A Randomized Controlled Trial in healthy women with vaginal dysbiosis
4132. Microbiota dysbiosis caused by dietetic patterns as a promoter of Alzheimer’s disease through metabolic syndrome mechanisms
4133. … red clover extract/β-cyclodextrin dispersion: Enhanced water solubility and activities in alleviating high-fat diet-induced lipid accumulation and gut microbiota dysbiosis …
4134. Lacticaseibacilli attenuated fecal dysbiosis and metabolome changes in Candida-administered bilateral nephrectomy mice
4135. Erythropoietin-mediated IL-17 F attenuates sepsis-induced gut microbiota dysbiosis and barrier dysfunction
4136. Low glycemic index potato biscuits alleviate physio-histological damage and gut dysbiosis in rats with type-2 diabetes mellitus induced by high-sugar and high-fat diet …
4137. Age‐mediated gut microbiota dysbiosis promotes the loss of dendritic cells tolerance
4138. Alterations of the intestinal mucus layer correlate with dysbiosis and immune dysregulation in human Type 1 Diabetes
4139. The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection
4140. Protective effect of rosmarinic acid-rich extract from Trichodesma khasianum Clarke against microbiota dysbiosis in high-fat diet-fed obese mice
4141. Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review
4142. Fecal microbiota transplantation from sodium alginate-dosed mice and normal mice mitigates intestinal barrier injury and gut dysbiosis induced by antibiotics and …
4143. Chronic exposure to UVB induces nephritis and gut microbiota dysbiosis in mice based on the integration of renal transcriptome profiles and 16S rRNA sequencing …
4144. Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis
4145. Cholestyramine resin administration alleviated cerebral ischemic injury in obese mice by improving gut dysbiosis and modulating the bile acid profile
4146. Elevated estuary water temperature drives fish gut dysbiosis and increased loads of pathogenic vibrionaceae
4147. … of cinaciguat in the treatment of mixed hyperlipidemia through targeting PTL/NPC1L1 and alleviating intestinal microbiota dysbiosis and metabolic disorders
4148. Microbial dysbiosis and the host airway epithelial response: insights into HIV-associated COPD using multi’omics profiling
4149. Cherry juice alleviates high-fat diet-induced obesity in C57BL/6J mice by resolving gut microbiota dysbiosis and regulating microRNA
4150. Evaluation of the contribution of gut microbiome dysbiosis to cardiac surgery-associated acute kidney injury by comparative metagenome analysis
4151. Dengyinnaotong attenuates atherosclerotic lesions, gut dysbiosis and intestinal epithelial barrier impairment in the high fat diet-fed ApoE−/− mice
4152. Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration
4153. Tris (1, 3-dichloro-2-propyl) phosphate causes female-biased growth inhibition in zebrafish: Linked with gut microbiota dysbiosis
4154. Systematic review on oral microbial dysbiosis and its clinical associations with head and neck squamous cell carcinoma
4155. Goji berry leaf exerts a comparable effect against colitis and microbiota dysbiosis to its fruit in dextran-sulfate-sodium-treated mice
4156. Diarrhea accompanies intestinal inflammation and intestinal mucosal microbiota dysbiosis during fatigue combined with a high-fat diet
4157. Gut dysbiosis-derived low-grade endotoxemia: A common soil for liver and cardiovascular disease
4158. Pecans and Its Polyphenols Prevent Obesity, Hepatic Steatosis and Diabetes by Reducing Dysbiosis, Inflammation, and Increasing Energy Expenditure in Mice Fed a …
4159. Apple peel polyphenol alleviates antibiotic-induced intestinal dysbiosis by modulating tight junction proteins, the TLR4/NF-κB pathway and intestinal flora
4160. Blood Stream Microbiota Dysbiosis Establishing New Research Standards in Cardio-Metabolic Diseases, A Meta-Analysis Study
4161. The Potential Role of Gut Bacteriome Dysbiosis as a Leading Cause of Periprosthetic Infection: A Comprehensive Literature Review
4162. Gut microbial dysbiosis in patients with Cushing’s disease in long-term remission. Relationship with cardiometabolic risk
4163. Therapeutically targeting the consequences of HIV-1-associated gastrointestinal dysbiosis: Implications for neurocognitive and affective alterations
4164. Long-term prednisone treatment causes fungal microbiota dysbiosis and alters the ecological interaction between gut mycobiome and bacteriome in rats
4165. Multi-Omics Data Integration Reveals Key Variables Contributing to Subgingival Microbiome Dysbiosis-Induced Inflammatory Response in a Hyperglycemic …
4166. Effect of fermented red ginseng on gut microbiota dysbiosis-or immobilization stress-induced anxiety, depression, and colitis in mice
4167. Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future …
4168. Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of …
4169. Lactobacillus plantarum HF02 alleviates lipid accumulation and intestinal microbiota dysbiosis in high‐fat diet‐induced obese mice
4170. Korean Red Ginseng extract treatment prevents post-antibiotic dysbiosis-induced bone loss in mice
4171. Salt-contaminated water exposure induces gut microbial dysbiosis in chickens
4172. Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging
4173. Probiotic‐fermented Qushi decoction alleviates reserpine induced spleen deficiency syndrome by regulating spleen function and gut microbiota dysbiosis
4174. Dysfunction of Foxp3+ Regulatory T Cells Induces Dysbiosis of Gut Microbiota via Aberrant Binding of Immunoglobulins to Microbes in the Intestinal Lumen
4175. Dysbiosis of gut microbiota by actual long-term exposure to textile wastewater treatment plant effluents in adult zebrafish (Danio rerio) using aquatic microcosm …
4176. Effects of Royal Jelly on Gut Dysbiosis and NAFLD in db/db Mice
4177. Resilience and probiotic interventions to prevent and recover from shrimp gut dysbiosis
4178. Antimony Compounds Associate with Atopic Dermatitis and Influence Models of Itch and Dysbiosis
4179. … in the transcriptome between the gut, peripheral and axial joints in the Spondyloarthritis DBA/1 mice: Improvement of intestinal dysbiosis and the overall …
4180. Short-Term Dietary Intervention with Whole Oats Protects from Antibiotic-Induced Dysbiosis
4181. Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System
4182. Herbicide propisochlor exposure induces intestinal barrier impairment, microbiota dysbiosis and gut pyroptosis
4183. The critical role of gut microbiota dysbiosis in skeletal muscle wasting: a systematic review
4184. When dysbiosis meets dystrophy: an unwanted gut‐muscle connection
4185. Endometriosis and dysbiosis: State of art
4186. Microbial Indicators of Dental Health, Dysbiosis, and Early Childhood Caries
4187. … LR-32 on the gut microbiota, barrier integrity, and 5-HT metabolism in reducing feather-pecking behavior in laying hens with antibiotic-induced dysbiosis
4188. Biotin Deficiency Induces Intestinal Dysbiosis Associated with an Inflammatory Bowel Disease-like Phenotype
4189. Zooming into Gut Dysbiosis in Parkinson’s Disease: New Insights from Functional Mapping
4190. Gut-Microbiota Dysbiosis in Stroke-Prone Spontaneously Hypertensive Rats with Diet-Induced Steatohepatitis
4191. Eucommiae cortex polysaccharides attenuate gut microbiota dysbiosis and neuroinflammation in mice exposed to chronic unpredictable mild stress: Beneficial in …
4192. Risk Factors and Immunoinflammatory Mechanisms Leading to Atherosclerosis: Focus on the Role of Oral Microbiota Dysbiosis
4193. Exploring the role of gut microbiota dysbiosis in gout pathogenesis: a systematic review
4194. Resident Esophageal Microbiota Dysbiosis Correlates with Cancer Risk in Barrett’s Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR …
4195. Guar gum as galactomannan source induces dysbiosis and reduces performance in broiler chickens and dietary β-mannanase restores the gut homeostasis
4196. Colitis-Mediated Dysbiosis of the Intestinal Flora and Impaired Vitamin A Absorption Reduce Ovarian Function in Mice
4197. Gut dysbiosis in autoimmune diseases: Association with mortality
4198. Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
4199. Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice …
4200. Dysbiosis in gastrointestinal pathophysiology: Role of the gut microbiome in Gulf War Illness
4201. The probiotic Lactobacillus casei Zhang-mediated correction of gut dysbiosis ameliorates peritoneal fibrosis by suppressing macrophage-related inflammation via the …
4202. The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
4203. Effects of Taurine on Gut Microbiota Homeostasis: An Evaluation Based on Two Models of Gut Dysbiosis
4204. Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity
4205. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
4206. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications
4207. Beyond cellulose: pharmaceutical potential for bioactive plant polysaccharides in treating disease and gut dysbiosis
4208. Evidence of the Dysbiotic Effect of Psychotropics on Gut Microbiota and Capacity of Probiotics to Alleviate Related Dysbiosis in a Model of the Human Colon
4209. Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children
4210. Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder
4211. … with colorectal cancer (CRC) or intestinal pre-cancerous lesions versus healthy individuals and evaluation of environmental factors involved in intestinal dysbiosis
4212. Microbiome Dysbiosis Shows Strong Association of Gut-Derived Altered Metabolomic Profile in Gulf War Chronic Multisymptom Illness Symptom Persistence …
4213. Microbial dysbiosis precedes signs of sea star wasting disease in wild populations of Pycnopodia helianthoides
4214. Implications of gut microbiota dysbiosis and fecal metabolite changes in psychologically stressed mice
4215. Polystyrene micro-and nanoparticles exposure induced anxiety-like behaviors, gut microbiota dysbiosis and metabolism disorder in adult mice
4216. Dysbiosis in Takayasu arteritis complicated with infectious endocarditis following tocilizumab administration
4217. Oral Microbiome in Health and Disease: Maintaining a Healthy, Balanced Ecosystem and Reversing Dysbiosis
4218. … diet induced anxiety-like behavior and social withdrawal of male mice by improving antioxidant capacity, intestinal barrier function and modulating intestinal dysbiosis
4219. Sleep Deprivation and Gut Microbiota Dysbiosis: Current Understandings and Implications
4220. Mucosal bleeding correlates with submucosal microbial dysbiosis in peri‐implant mucositis of patients with periodontitis
4221. … -based pesticide in mice during adulthood elevated anxiety and depression-like behaviors: Involvement of serotoninergic depletion and gut microbiota dysbiosis
4222. Programming Factors of Neonatal Intestinal Dysbiosis as a Cause of Disease
4223. Prolonged dysbiosis and altered immunity under nutritional intervention in a physiological mouse model of severe acute malnutrition
4224. MiGut: A scalable in vitro platform for simulating the human gut microbiome—Development, validation and simulation of antibiotic‐induced dysbiosis
4225. Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
4226. Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID‐19 patients
4227. Microbiome and Its Dysbiosis in Inborn Errors of Immunity
4228. Association between Pregestational Vaginal Dysbiosis and Incident Hypertensive Disorders of Pregnancy Risk: a Nested Case-Control Study
4229. Correcting dysbiosis in the lungs of COPD, one pathogen at a time
4230. Oroxin B improves metabolic-associated fatty liver disease by alleviating gut microbiota dysbiosis in a high-fat diet-induced rat model
4231. Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort
4232. Eucommia Polysaccharides Ameliorate Aging-Associated Gut Dysbiosis: A Potential Mechanism for Life Extension in Drosophila
4233. Oral dysbiosis in the onset and carcinogenesis of oral epithelial dysplasia: A systematic review
4234. Risk of dietary hazardous substances and impact on human microbiota: possible role in several dysbiosis phenotypes, volume II
4235. Alteration of gut microbiome and metabolome by Clostridium butyricum can repair the intestinal dysbiosis caused by antibiotics in mice
4236. … − Gan Powder Alleviates Environmental Stress− Induced Decline in Immune and Antioxidant Function and Gut Microbiota Dysbiosis in Litopenaeus vannami
4237. Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis
4238. Antibiotic use during pregnancy is linked to offspring gut microbial dysbiosis, barrier disruption, and altered immunity along the gut–lung axis
4239. Dysbiosis and Alzheimer’s disease: role of probiotics, prebiotics and synbiotics
4240. Association between oral microbiota dysbiosis and the development of systemic conditions
4241. Dysbiosis of gut microbiota due to diet, alcohol intake, body mass index, and gastrointestinal diseases in India
4242. Antibiotic-induced gut microbiota dysbiosis altered host metabolism
4243. Microbial dysbiosis in oral squamous cell carcinoma: A systematic review and meta-analysis
4244. Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO
4245. Unraveling the Dysbiosis of Vaginal Microbiome to Understand Cervical Cancer Disease Etiology—An Explainable AI Approach
4246. The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis
4247. Irradiation-Induced Dysbiosis: The Compounding Effect of High-Fat Diet on Metabolic and Immune Functions in Mice
4248. The Association between Dysbiosis and Neurological Conditions Often Manifesting with Chronic Pain
4249. The Gut Microbiome of an Indigenous Agropastoralist Population in a Remote Area of Colombia with High Rates of Gastrointestinal Infections and Dysbiosis
4250. Intratumoral Bacteria Dysbiosis Is Associated with Human Papillary Thyroid Cancer and Correlated with Oncogenic Signaling Pathways
4251. Improvements in Gut Microbiota Dysbiosis in Aged Mice Transplanted with Adipose-Derived Stem Cells
4252. Long-term high fructose intake promotes lacrimal gland dysfunction by inducing gut dysbiosis in mice
4253. Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy
4254. Metagenomics reveals structural and functional gut mycobiota dysbiosis in Tibetan subjects with coronary heart disease
4255. Dynamics and consequences of nutrition-related microbial dysbiosis in early life: study protocol of the VITERBI GUT project
4256. A parasitic nematode induces dysbiosis in susceptible but not resistant gastropod hosts
4257. Plasma non-transferrin-bound iron uptake by the small intestine leads to intestinal injury and intestinal flora dysbiosis in an iron overload mouse model and Caco-2 …
4258. Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets
4259. Dysbiosis of intestinal homeostasis contribute to Whitmania pigra edema disease
4260. Dysbiosis and primary B-cell immunodeficiencies: current knowledge and future perspective
4261. A dysregulated bile acids pool is associated with metabolic syndrome and gut microbial dysbiosis in early adolescence
4262. Effects of Intestinal Microorganisms on Influenza-Infected Mice with Antibiotic-Induced Intestinal Dysbiosis, through the TLR7 Signaling Pathway
4263. Characterization of dysbiosis of the conjunctival microbiome and nasal microbiome associated with allergic rhinoconjunctivitis and allergic rhinitis
4264. The effect of gut microbiota dysbiosis on patients with preeclampsia
4265. Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis
4266. Gochujang Ameliorates Hepatic Inflammation by Improving Dysbiosis of Gut Microbiota in High-Fat Diet-Induced Obese Mice
4267. Gut Microbiota Dysbiosis in Suspected Food Protein Induced Proctocolitis—A Prospective Comparative Cohort Trial
4268. Germinated brown rice relieves hyperlipidemia by alleviating gut microbiota dysbiosis
4269. Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice
4270. Influence of biosynthesized nanoparticles exposure on mortality, residual deposition, and intestinal bacterial dysbiosis in Cyprinus carpio
4271. Oral microbial dysbiosis in patients with periodontitis and chronic obstructive pulmonary disease
4272. Promising Markers of Inflammatory and Gut Dysbiosis in Patients with Post-COVID-19 Syndrome
4273. Microbiome-Based Therapeutics and Their Physiological Effects: Dysbiosis and reduced small intestinal function are required to induce intestinal insufficiency …
4274. Effect and correlation of Cordyceps guangdongensis ethanolic extract on obesity, dyslipidemia and gut microbiota dysbiosis in high-fat diet mice
4275. The role of nutrition, food allergies, and gut dysbiosis in immune-mediated inflammatory skin disease: a narrative review
4276. Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
4277. Down-Syndrome-Related Maternal Dysbiosis Might Be Triggered by Certain Classes of Antibiotics: A New Insight into the Possible Pathomechanisms
4278. Lupus Nephritis and Dysbiosis
4279. Neuroprotective effect of Vitamin K2 against gut dysbiosis associated cognitive decline
4280. The improvement of intestinal dysbiosis and hepatic metabolic dysfunction in dextran sulfate sodium‐induced colitis mice: effects of curcumin
4281. Disordered expression of tight junction proteins is involved in the Mo-induced intestinal microenvironment dysbiosis in sheep
4282. Limosilactobacillus mucosae FZJTZ26M3 prevents NAFLD in mice through modulation of lipid metabolism and gut microbiota dysbiosis
4283. A Randomized Controlled Trial of Probiotics Targeting Gut Dysbiosis in Huntington’s Disease
4284. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets
4285. The relationship between nutrition, gut dysbiosis, and pediatric sickle cell pain outcomes: A pilot study
4286. Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data concerning Vaginal Infection and Dysbiosis
4287. Dysbiosis of Gut Microbiota Contributes to Uremic Cardiomyopathy via Induction of IFNγ-Producing CD4+ T Cells Expansion
4288. Paneth Cell, Gut Microbiota Dysbiosis and Diabetes Mellitus
4289. Enteropathy and gut dysbiosis as obstacles to achieve immune recovery in undetectable people with HIV: a clinical view of evidence, successes, and projections
4290. Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
4291. Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain
4292. P-340 Endometrial microbiome-is every dysbiosis an inflammation?
4293. Elevated serum anti‐Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson …
4294. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics
4295. The effect of occlusal disharmony on a chronic stress‐induced animal model of gut microbiota dysbiosis
4296. Asperosaponin VI Protects Against Bone Loss Due to Hindlimb Unloading in Skeletally Growing Mice Through Regulating Microbial Dysbiosis Altering the 5-HT …
4297. Intestinal Dysbiosis in Rats: Interaction between Amoxicillin and Probiotics, a Histological and Immunohistochemical Evaluation
4298. Bacterial vaginosis: A state of microbial dysbiosis
4299. Dysbiosis of the gut microbiota in children with severe motor and intellectual disabilities receiving enteral nutrition: A pilot study
4300. Bacterial dysbiosis and epithelial status of the California sea lion (Zalophus californianus) in the Gulf of California
4301. Intestinal dysbiosis and probiotic use: its place in hepatic encephalopathy in cirrhosis
4302. Gut microbiota dysbiosis associated with different types of demyelinating optic neuritis in patients
4303. Plasmodium infection and dysbiosis: A new paradigm in the host–parasite interaction
4304. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis
4305. Chronic Morphine and Fentanyl Induce Intestinal Dysbiosis by Decreasing the Antimicrobial Activity of the Ileum
4306. Antibiotics-induced dysbiosis in gut microbiota affects bumblebee health via regulating host amino acid metabolism
4307. Oral and Gut Microbiota Dysbiosis is Associated with Mucositis Severity in Autologous Hematopoietic Stem Cell Transplant: Evidence from an Asian Population
4308. O-261 The relationship of abnormal vaginal microbiome (dysbiosis of vaginal microbiome) and proinflammatory cytokines in recurrent implantation failure patients
4309. Dual mode of Triphala in the reversal of cognition through gut restoration in antibiotic mediated prolonged dysbiosis condition in 5XFAD mice
4310. A seed and soil model of gut dysbiosis in Alzheimer’s disease
4311. Association of gut microbiome dysbiosis with the progression of atrial fibrillation: A systematic review
4312. Common dysbiosis features between patients of different social environments in Takayasu arteritis: comment on the article by Fan et al
4313. Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance
4314. Early-life dysbiosis and Th17 asthma: Never is better than late
4315. The Association of Oral Microbiome Dysbiosis with Gastrointestinal Cancers and Its Diagnostic Efficacy
4316. Probiotic profiling of bifidobacteria indigenous to the human intestinal mucosa shows alleviation of dysbiosis-associated pathogen biofilms
4317. The effect of FMT and vitamin C on immunity-related genes in antibiotic-induced dysbiosis in mice
4318. Fecal microbiota transplant from common variable immunodeficiency patients to germ-free mice recapitulates gut dysbiosis
4319. Common variable immunodeficiency patient fecal microbiota transplant recapitulates gut dysbiosis
4320. Gut Microbiota Dysbiosis and Increased NLRP3 Levels in Patients with Pregnancy-Induced Hypertension
4321. Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status
4322. P-549 Endometrial eubiosis vs dysbiosis: what role does the abundance of Lactobacillus play in endometrial receptivity?
4323. Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved
4324. Postnatal 14D is the Key Window for Mice Intestinal Development‐An Insight from Age‐Dependent Antibiotic‐Mediated Gut Microbial Dysbiosis Study
4325. Ginkgo biloba extract (GbE) restores gut microbiota dysbiosis in a rat model of lard-rich diet-induced obesity
4326. Dysbiosis and leaky gut in hyper-inflated COPD patients: Have smoking and exercise training any role?
4327. Oral flora and functional dysbiosis of cleft lip and palate patients: A scoping review
4328. Microbial gut dysbiosis induced by xenobiotics in model organisms and the relevance of experimental criteria: a minireview
4329. Effects of concentrated fecal microbiota transplant on the equine fecal microbiota after antibiotic-induced dysbiosis
4330. Anxiety Disorders and Gut Dysbiosis in Primary Sjögren’s Syndrome-Mediated Dry Eye Patients
4331. Gut Microbiome Dysbiosis in Patients with Endometrial Cancer vs. Healthy Controls Based on 16S rRNA Gene Sequencing
4332. That sinking gut feeling: is transplant-induced dysbiosis contributing to allograft outcomes?
4333. Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of …
4334. Gut microbiota dysbiosis observed in tuberculosis patients resolves partially with anti-tuberculosis therapy.
4335. Impact of intestinal dysbiosis on clinical course in severe acute pancreatitis: a multicenter prospective observational study
4336. In silico study of hyposalivation and sugar exposure on biofilm dysbiosis
4337. Dysbiosis of the respiratory tract mucosa—how microbial imbalances lead to asthma
4338. Exploring microbial dysbiosis in orchards affected by little cherry disease
4339. Ivermectin-induced bacterial gut dysbiosis does not increase susceptibility to Pseudomonas aeruginosa lung infection but exacerbates liver damage
4340. Net cleaning impacts Atlantic salmon gill health through microbiome dysbiosis
4341. … attached to tooth surfaces triggers and maintains periodontitis. Previously, late-onset periodontitis has been considered a consequence of dysbiosis and a resultant …
4342. Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis
4343. Effect of fecal microbial transplantation on Clostridioides difficile infection: dysbiosis, metabolites and health related quality of life
4344. Sjögren’s syndrome patients shares stereotypic B cell receptor clonotypes with distinct dysbiosis of the gut microbiome
4345. Chronic mesenteric ischemia-induced intestinal dysbiosis resolved after revascularization
4346. Re-defining the Gut Heart Axis: A Systematic Review of the Literature on the Role of Gut Microbial Dysbiosis in Patients With Heart Failure
4347. IDDF2023-ABS-0249 Implications of oro-pharyngeal dysbiosis in head and neck cancer: oral microbiome and chemoradiation-related complications
4348. Gut microbiota dysbiosis in rats with LPS-induced liver diseases affected by Aronia melanocarpa polyphenols
4349. Excessive consumption of the sugar rich longan fruit promoted the development of nonalcoholic fatty liver disease via mediating gut dysbiosis
4350. Immune response to intestinal microbial dysbiosis
4351. Ischemic Stroke and Dysbiosis of Gut Microbiota: Changes to LPS Levels and Effects on Functional Outcomes.
4352. Dysbiosis of a leaf microbiome is caused by enzyme secretion of opportunistic Xanthomonas strains
4353. Gut microbiota dysbiosis and cardiovascular disease–The chicken and the egg
4354. Chlorella modulation of gut microbiota dysbiosis in patients with type-2 diabetes
4355. The Microbiota of a Mite Prey-Predator System on Different Host Plants Are Characterized by Dysbiosis and Potential Functional Redundancy
4356. Microbiome Structure and Mucosal Morphology of Jejunum Appendix and Colon of Rats in Health and Dysbiosis
4357. … Effect of the Microbiota Metabolite—Butyric Acid on Motor Coordination, Muscle Strength and the Level of Oxidative Stress in Skeletal Muscles in Mice with Dysbiosis
4358. Dysbiosis of Gut Microbiota in Patients with Chronic Kidney Disease
4359. Expression of Concern: Progression of Parkinson’s disease is associated with gut dysbiosis: Two-year follow-up study
4360. Fusobacterium nucleatum Pyogenic Liver Abscess and the Role of Bacterial Virulence and Gut Microbiota Dysbiosis
4361. What is microbial dysbiosis and how does it impact human health?
4362. Anti-diarrheal drug loperamide induces dysbiosis in zebrafish microbiota via bacterial inhibition
4363. Dysbiosis and the Chemopreventive Role of Prebiotics in Colorectal Cancer
4364. Impact of multiple different high-fat diets on metabolism, inflammatory markers, dysbiosis, and liver histology: study on NASH rat model induced diet
4365. Dysbiosis of Gut microbiota in patients with Large-Artery Atherosclerotic Stroke: a pilot study
4366. Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma
4367. The possible role of gut microbiota dysbiosis in the pathophysiology of delirium in older persons
4368. DOP66 Ileal resections from fibrotic-CD patients present microbiota dysbiosis, altered metabolomic profiles and metabolite-sensing GPCRs expression
4369. Dysbiosis of the larval gut microbiota of Spodoptera frugiperda strains feeding on different host plants
4370. Pelvic irradiation induces behavioral and neuronal damage through gut dysbiosis in a rat model
4371. Multiple adult-onset xanthogranulomas associated with skin dysbiosis: A presenting sign of common variable immune deficiency, supported by next …
4372. Shifting the Inflammatory Balance in Ulcerative Colitis Through Diet: A Mediterranean Diet Pattern is Associated with Improvements in Dysbiosis and Disease Activity
4373. Esophageal dysbiosis and esophageal squamous cell carcinoma
4374. Decongestants, proton pump inhibitors, and systemic antibiotics are associated with an increased occurrence of dysbiosis.
4375. The level of dysbiosis of the oral cavity depends on the type of dental prosthesis of the patient.
4376. Ischemic Stroke and Dysbiosis of Gut Microbiota: Changes to LPS Levels and Effects on Functional Outcomes
4377. Ruminant Gut Microbiota: Importance, Development, and Alternative Therapeutics for Dysbiosis.
4378. Research progress on the relationship between gut microbiota dysbiosis and osteoarthritis
4379. POS0090 DYSBIOSIS OF GUT MICROBIOME, BILE ACID COMPOSITIONS, AND PREVALENCE OF HYPERURICEMIA: DATA FROM THE XIANGYA …
4380. Esophageal dysbiosis and esophageal motility disorders
4381. Intestinal microbiota dysbiosis and liver metabolomic changes during brain death
4382. Laryngopharyngeal reflux and dysbiosis
4383. Transmission of Alzheimer’s Disease-Associated Microbiota Dysbiosis and its Impact on Cognitive Function: Evidence from Mouse Models and Human Patients
4384. … IMPAIRMENT OF MESENTERIC ENDOTHELIAL FUNCTION CONTRIBUTES INTO GUT-LIVER AXIS VIA INTESTINAL DYSBIOSIS AND HEPATIC STEATOSIS, AND …
4385. Liposomal Epigallocatechin-3-Gallate for the Treatment of In-testinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review
4386. Fusobacterium nucleatum Induces Gut Dysbiosis and Inflammasome and Promotes Colonic Inflammation
4387. Ethanol-Producing Enterocloster bolteae is enriched in Hepatitis B Virus-Associated Gut Dysbiosis: A Case-Control Culturomics Study
4388. Developing the Principles of Studying and Treatment of Vaginal Dysbiosis During Pregnancy.
4389. The Role of Morphine-Induced Impairment of Intestinal Epithelial Antibacterial Activity in Dysbiosis and its Impact on the Microbiota-Gut-Brain Axis
4390. Intra-genus dysbiosis of Streptococcus in tonsillar microbiota is associated with host immune features in rheumatoid arthritis
4391. Esophageal dysbiosis—Correcting the paradox: Prebiotics, probiotics, or antibiotics?
4392. Esophageal dysbiosis and eosinophilic esophagitis—Bacteria to blame?
4393. Adverse effects of early life dysbiosis on pulmonary and allergic asthma development
4394. Assessment of Saudi medical students’ knowledge about microbiota, dysbiosis and gut-brain interplay in neuropsychiatric disorders
4395. Gut Dysbiosis: A Target for Protective Interventions against Parkinson’s Disease. Microorganisms 2023, 11, 880
4396. Long-term exposure to polystyrene microplastics promotes HFD-induced obesity in mice through exacerbating microbiota dysbiosis
4397. Down-Syndrome Development might be Associated with Dysbiosis, Triggered by Certain Classes of Antibiotics: Altered Maternal Microbiome as a New Insight into the …
4398. Gut dysbiosis induced by a high-salt diet aggravates atherosclerosis by increasing the absorption of saturated fatty acids in ApoE-deficient mice
4399. P-191 Helicobacter pylori ancestors associated to gastric microbiota dysbiosis in Colombian patients with gastric cancer precursor lesions
4400. Bacterial Gut Dysbiosis, Colorectal Cancer, and the Role of Probiotics
4401. Effects of the Phytocompound Combination against Dysbiosis Induced by AGE-Rich High-fat Diet in Mice
4402. DEFB119 stratifies dysbiosis with distorted networks in the seminal microbiome associated with male infertility
4403. Copper contraceptive induces dysbiosis
4404. Melatonin Alleviates Chronic Intermittent Hypoxia-induced Microbiota Dysbiosis and Attenuates Intestinal Barrier Dysfunction via STAT3/Th17 signalling pathway
4405. The 5-HT4 receptor agonist, Velusetrag, rescues GI dysfunction, gut inflammation and dysbiosis in the A53T αS mouse model of Parkinson’s Disease.
4406. 204P Dysbiosis of the gut microbiome impairs EGFR-tyrosine kinase inhibitors responses in H1975 xenografts mice models
4407. Facial dysbiosis induced by photoprotectors. Is there evidence for such an assumption?
4408. AB0141 GUT MICROBIOTA DYSBIOSIS IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
4409. Correction: Polymeric immunoglobulin receptor deficiency exacerbates autoimmune hepatitis by inducing intestinal dysbiosis and barrier dysfunction
4410. Prevention of antibiotic-induced dysbiosis in human volunteers by DAV132 and preservation of responsiveness to anti-PD-1 demonstrated by transplantation of …
4411. Gut Microbiota Dysbiosis and Its Impact On Immune Re-sponse In Covid-19 Patients: A Review
4412. Gut Fungal Dysbiosis And Altered Fungi-Bacteria Correlation Network Were Associated With Knee Synovitis In A Middle-Aged And Older General Population In China
4413. Retraction Note: Gut Microbiome Dysbiosis and Depression: A Comprehensive Review
4414. Gut Microbiota Dysbiosis Characterized by Abnormal Elevation of Lactobacillus in Patients with Immune-mediated Necrotizing Myopathy
4415. Peripheral Indicators of Dysbiosis in Heart Transplant Recipients (PoD-HTR)
4416. Clinical study on the relationship between gut microbiota dysbiosis and iron metabolism and septic cardiomyopathy
4417. CLO23-038: The Impact of Dysbiosis Agents on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Melanoma Patients: A Systematic Review With Meta …
4418. Oral microbiota dysbiosis and increased inflammatory cytokines with different stroke subtypes
4419. … Frequency and Patterns of Age-and Gender-Specific Neurogastroenterological Consequences in Saudi Millennial Women Imply Potential Post-COIVD-19 Dysbiosis
4420. 1344-P: Multiomic Signatures of Gut Dysbiosis and Diabetes in HIV Infection
4421. Fecal Dysbiosis and Inflammation in Intestinal-Specific Cftr Knockout Mice
4422. Activated glycyrrhizic acid in the combination treatment of patients with vaginitis and dysbiosis: results of a multicenter study
4423. Abstract P6-05-16: Social isolation induces gut dysbiosis, mitochondrial metabolic dysfunction, and infiltration of tumor immunosuppressive cells: do they explain …
4424. IDDF2023-ABS-0240 High-fat diet promotes radiation resistance in rectal cancer through inducing gut dysbiosis and increasing bile acid metabolites
4425. Gut microbiome dysbiosis promotes immune suppression and lung cancer development
4426. Esophageal dysbiosis and pathogenesis of gastroesophageal reflux disease
4427. The Influence of Vaginal Dysbiosis on Intracytoplasmic Sperm Injection Outcome
4428. WCN23-0905 SYSTEMATIC MICROBIOME DYSBIOSIS ARE ASSOCIATED WITH IGA NEPHROPATHY
4429. Corrigendum: The effect of gut microbiota dysbiosis on patients with preeclampsia
4430. Anti-diarrheal drug loperamide induces dysbiosis in zebrafish microbiota via bacterial inhibition
4431. Change in intestinal alkaline phosphatase activity is a hallmark of antibiotic-induced intestinal dysbiosis.
4432. Esophageal dysbiosis and neoplasia: Moving from Barrett’s esophagus to adenocarcinoma
4433. Ethanol-Producing Enterocloster bolteae is enriched in Hepatitis B Virus-Associated Gut Dysbiosis: A Case-Control Culturomics Study
4434. An overview of normal human gut microbiota and dysbiosis
4435. DYNAMICS OF UREASE AND LYSOZYME ACTIVITY IN THE ORAL FLUID AND THE DEGREE OF ORAL DYSBIOSIS IN PERSONS WITH PERIODONTAL TISSUE …
4436. Metabolic endotoxemia caused by dysbiosis-induced elevated lipopolysaccharide (LPS) levels increases susceptibility to cholesterol gallstone formation in mice
4437. Bitter taste receptors link between microbiome dysbiosis and programmed cell death in oral squamous cell carcinoma
4438. Relation of Three-Dimensional Circumferential Strain Rate to Mediators of Intestinal Dysbiosis in Children with Chronic Systolic Dysfunction
4439. CORRECTION OF DYSBIOSIS AND ELIMINATION OF INFLAMMATION OF THE ORAL CAVITY IN PATIENTS WITH MALIGNANT TUMORS.
4440. Elevated Derived Neutrophil-to-Lymphocyte Ratio Is Associated With Lower Airway Dysbiosis in Non-Small Cell Lung Cancer
4441. Investigating the Role of Hyperandrogenism and Estrogen Insufficiency in Metabolic Dysregulation and Gut Dysbiosis
4442. Social isolation induces gut dysbiosis, mitochondrial metabolic dysfunction, and infiltration of tumor immunosuppressive cells: Do they explain enhanced mammary …
4443. The results of dysbiosis in the structure of periodontopathogens of the II order in patients with non-alcoholic fatty liver disease
4444. 1620-P: Royal Jelly Improved Dysbiosis and Glucose Intolerance in db/db Mice
4445. Integrated gut metabolome and microbiome fingerprinting reveals that dysbiosis precedes allergic inflammation in IgE-mediated pediatric cow’s milk allergy
4446. Maternal Exposure to Polycyclic Aromatic Hydrocarbons (PAH) s Causes Lung Microbiome Dysbiosis in Mice Lacking the CYP1A2 Gene-A Potential Protective Role
4447. Evaluating the Impact of Routine Enteral Iron Fortification on Gastrointestinal Dysbiosis in Premature Infants
4448. 1312: SEX-SPECIFIC INTESTINAL DYSBIOSIS PERSISTS AFTER MULTICOMPARTMENTAL TRAUMATIC INJURY
4449. Dysbiosis of the Intestine in the Genesis of the Immune Failure in Children with Recurrent Bronchitis
4450. Impact of Saccharomyces cerevisiae on the intestinal microbiota of dogs during antibiotic-induced dysbiosis
4451. Research progress on gut microbiota dysbiosis in patients with pulmonary tuberculosis
4452. … YOUR GREAT, GREAT GRANDPARENTS PARENTS ATE: PRE-NATAL GLYPHOSATE EXPOSURE INDUCES DYSBIOSIS, METABOLIC DYSFUNCTION AND …
4453. The uraemic microbiome: Oral and gut dysbiosis in experimental uraemia
4454. Abstract TP238: Acute Ischemic Stroke Induces Gut Virome And Bacteriome Dysbiosis
4455. Interaction Between the Intestinal Microbial Structure and Function Dysbiosis and Hippocampal Transcriptome Profile for Anxiety-like Induced by Doxorubicin in Mice.
4456. Brown rice improves obesity parameters and dysbiosis of gut microbiota
4457. Gut Dysbiosis Exacerbates Neuroinflammation By Activation Of B Cells In A Mouse Model Of Cerebral Amyloid Angiopathy
4458. On the features of the correction of intestinal dysbiosis in chronic pancreatitis (literature review)
4459. Bacterial Vaginosis-Vaginal Polymicrobial Biofilms and Dysbiosis.
4460. Design and development of a recombinant probiotic for the prevention of antibiotic-mediated dysbiosis
4461. Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection
4462. Effect of probiotics on aging-dependent gut dysbiosis in autoimmune dry eye mouse model
4463. Mastitis is associated with gut dysbiosis and barrier disruption caused by elevated sialic acid
4464. Antibiotic-Induced Gut Dysbiosis During Adolescence Dysregulates Metabolism and Skeletal Maturation
4465. Neonatal mortality in koalas linked to dysbiosis in pouch microbiota
4466. Abstract A44: The influence of dietary one-carbon metabolites on gut dysbiosis during pre-malignant hematopoiesis
4467. … OF A STRUCTURAL MATERIAL FOR THE BASIS OF A REMOVABLE PROSTHESIS IN PATIENTS WITH ORAL DYSBIOSIS BASED ON TOXICOLOGICAL …
4468. Microbiota dysbiosis in secondary chronic rhinosinusitis
4469. The Role of Gastric Microecological Dysbiosis in Gastric Carcinogenesis
4470. Probiotics treatment ameliorated Mycophenolic Acid-induced colitis by enhancing intestinal barrier function and improving intestinal microbiota dysbiosis in mice
4471. Dysbiosis of the Gut Microbiota and the Use of Fecal Microbiota Transplantation For Gastrointestinal and Extra-Gastrointestinal Diseases: An Umbrella Review
4472. Gut dysbiosis associates with cytokine production capacity in viralsuppressed people living with HIV Authors
4473. Oral Microbiota Dysbiosis: Significance in Coexistence of Rheumatoid Arthritis and Oral Lichen Planus
4474. Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency
4475. INTESTINAL DYSBIOSIS IN INFLAMMATORY DISEASES
4476. Dysbiosis of Gut Microbiota in Patients with Chronic Kidney Disease
4477. Bacterial dysbiosis and epithelial transformation of the California sea lion (Zalophus californianus)
4478. Cryptosporidium parvum dysbiosis of the faecal microbiome of bovine livestock: A computational metagenomic approach
4479. Gut Dysbiosis and Metabolism Alteration in Variant Transthyretin Amyloidosis